Scientific Programme
Scientific
Programme
P O S T G R A D U A T E C O U R S E S
Postgraduate Courses
Room
Saturday, October 4
09:30–17:30
Room London 3
Postgraduate Course
PG1 – EU GRACE Network Full-day Postgraduate Course: Antibiotics or not: from acute bronchitis to acute exacerbation of
chronic bronchitis
Room
Saturday, October 4
09:30–13:00
Room Berlin
Core Curriculum Postgraduate Course
PG2 – Asthma: natural history, risk factors and overall management
Room 5.2c
Core Curriculum Postgraduate Course
PG3 – Respiratory physiology: respiratory and peripheral muscle function in health and disease
Room New York 1 Core Curriculum Postgraduate Course
PG4 – Paediatric respiratory medicine: wheezing children: asthma and beyond
Room Paris 2
Core Curriculum Postgraduate Course
PG5 – Interstitial lung diseases: selected orphan diseases
Room New York 3 Core Curriculum Postgraduate Course
PG6 – Thoracic oncology: new treatments for thoracic malignancies (other than nonsmall cell lung cancer)
Room 5.2a
Postgraduate Course
PG7 – ABC of domiciliary ventilation
Room 1.2c
Postgraduate Course
PG8 – Cellular and molecular technologies of today – treatments of tomorrow
Room Europa 2
Postgraduate Course
PG9 – Nonapnoeic respiratory disorders during sleep
Room 1.2g
Postgraduate Course
PG10 – Getting it right – planning, realising, analysing and publishing research projects
Room 1.2e
Postgraduate Course
PG11 – Tobacco addiction in women
Room Paris 1
Postgraduate Course
PG12 – Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Room
Saturday, October 4
14:00–17:30
Room New York 1 Core Curriculum Postgraduate Course
PG13 – Respiratory failure: skills needed to treat an episode of acute respiratory failure
Room Europa 2
Core Curriculum Postgraduate Course
PG14 – COPD: management of advanced disease
Room 5.2c
Postgraduate Course
PG15 – High-resolution computed tomography of the lung: pattern recognition and role in diagnosis
Room New York 3 Postgraduate Course
PG16 – Basic principles of cardiopulmonary exercise testing and interpretation
Room Berlin
Postgraduate Course
s
PG17 – An expert view of the differences between asthma and COPD
es
Room 1.2c
Postgraduate Course
PG18 – Respiratory infections in immunosuppressed children
Room 5.2a
Postgraduate Course
PG19 – Ventilatory management and cough enhancement in patients with neuromuscular disease
Room 1.2e
Postgraduate Course
PG20 – Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course
Room Paris 2
Postgraduate Course
PG21 – Practical problems with aerosol therapy
Room Paris 1
Postgraduate Course
PG22 – Interventional bronchoscopy: theory and practice
Room 1.2g
Educational Workshop
WS1 – Gene–environment interactions: challenges and pitfalls in study design, ethical issues and statistical analyses
ERS Berlin 2008 Annual Congr
126
M E E T T H E P R O F E S S O R S E M I N A R S
HERMES Examination
Room
Saturday, October 4
14:00–17:00
Room Budapest
European examination in Adult Respiratory Medicine
Meet the Professor Seminars
Room
Sunday, October 5
13:00–14:00
Room 1.2b
126 MP1
Physiotherapy in the critical care areas
Room 1.2g
127 MP2
Rehabilitation and exercise in patients other than COPD
Room 1.2d
128 MP3
Oxidative stress in lung diseases
Room 1.2e
129 MP4
The right decision, in an interactive session: making your next career move
Room 1.2f
130 MP5
Sensory nerves and airway irritability
Room 1.2c
131 MP6
Role of allied respiratory professionals in clinical research
Room
Monday, October 6
13:00–14:00
Room 1.2b
274 MP7
Diagnostic approach to pleural effusions
Room 1.2g
275 MP8
Mechanisms of exercise intolerance in COPD, and their amelioration
Room 1.2d
276 MP9
Home mechanical ventilation: initiation
Room 1.2e
277 MP10
Allergen immunotherapy in paediatric respiratory disease
Room 1.2f
278 MP11
MRI for the lung: what can we see and what can’t we see?
Room 1.2c
279 MP12
How to organise and run a smoking cessation clinic: recipe for success
s
es
Room
Tuesday, October 7
13:00–14:00
Room 1.2c
399 MP13
Poor performance status patient in advanced lung cancer: to treat or not to treat?
Room 1.2b
400 MP14
The approach to antibiotic treatment in community-acquired pneumonia
Room 1.2g
401 MP15
Pharmacology of cough
Room 1.2f
402 MP16
Failures and successes in lung transplantation: cases and controversies
Room 1.2d
398 MP17
ACCP: Is telemedicine in your future?
Room 1.2e
403 MP18
ERS Berlin 2008 Annual Congr
ACCP: Patient simulation: a valuable adjunct to training chest physicians
127
S U N D A Y O C T O B E R 5
Room
08:30–10:30
10:45–12:45
Room 1.2a
32 Maurizio Vignola Award on Innovation in Pneumology 51 Grand Round
33 Year in review
Occupational Grand Round – an interactive session
CLINICAL
Scientific year in review: airway remodelling
Room 2.2a
34 Symposium
52 Symposium
PAEDIATRIC
COPD – the holistic perspective
Asthma: from clinical pattern to genetic background
ONCOLOGY
Room Dublin
35 Symposium
53 Symposium
The use of field exercise tests in clinical services
Models of pulmonary rehabilitation in non-COPD patients
INFECTION
Room 5.2b
36 Symposium
54 Symposium
Night time is not the right time – nocturnal aspects of
New imaging modalities in the staging of lung cancer
INTENSIVE
asthma
Room Helsinki
37 Symposium
55 Symposium
BASIC
Management of cystic fibrosis in 2008
Acute lung injury. Do we know what it is? A look at
different models
SLEEP
Room Budapest
38 Hot Topic
56 Year in review
New age lung carcinogenesis: clinical impact
Infection year in review
ENVIRONMENT
Room Berlin
39 Oral Presentation
57 Oral Presentation
New methods to diagnose tuberculosis infection and
New challenges and maintained quality: lung function for
disease
the future
Room 5.2c
40 Oral Presentation
58 Hot Topic
Pathophysiology of acute lung injury
Deadly networks: disease-causing protein and DNA
modifications
Room Europa 2
41 Oral Presentation
59 Oral Presentation
The role of flexible bronchoscopy and bronchoalveolar
Cell biology of asthma and COPD
lavage in lower airway disease
Room Paris 1
42 Oral Presentation
60 Oral Presentation
Environmental risk factors for respiratory symptoms and
Progress and a new era for noninvasive mechanical
COPD
ventilation
Room Paris 2
43 Oral Presentation
61 Oral Presentation
New insights into the pathogenesis of idiopathic
Social determinants and psychological issues in primary
pulmonary fibrosis and sarcoidosis
care respiratory diseases
Room 5.2a
44 Oral Presentation
62 Oral Presentation
Respiratory muscle pathophysiology
Innovative treatments in sleep disordered breathing
Room New York 1 45 Oral Presentation
63 Oral Presentation
New imaging techniques in chest imaging
COPD
s
RoomNew York 2 46 E-Communication
64 E-Communication
es
Wider aspects of managing respiratory disease in primary Novel trends in functional genomics and molecular
care
pathology of neoplastic and non-neoplastic lung diseases
Room New York 3 47 E-Communication
65 E-Communication
Miscellaneous aspects of interstitial lung disease
Exercise intolerance: mechanism, intervention and
assessment
Room London 1
48 E-Communication
66 E-Communication
Microbiology and treatment of bronchiectasis and
Towards smoking cessation
exacerbations of COPD
Room London 2
49 E-Communication
67 E-Communication
Pathophysiology of pulmonary hypertension
COPD: from bench to bedside
ERS Berlin 2008 Annual Congr
Room London 3
50 E-Communication
68 E-Communication
Actual challenges in thoracic surgery
Respiratory disorders in paediatric intensive care unit
128
S U N D A Y O C T O B E R 5
Thematic Poster Sessions
Hall 6.2
08:30–12:45
Poster display
12:50–13:40
Poster manned by author
13:40–14:40
Poster session with coordinator
14:40–16:30 Poster
display
79
Markers and triggers of asthma
Hall 6.2-1
80
Comorbid cardiovascular condition and therapy of asthma
Hall 6.2-2
81
Pathophysiology of COPD
Hall 6.2-3
82
Prognosis in COPD
Hall 6.2-4
83
COPD in the elderly – quality of life and scores in COPD
Hall 6.2-5
84
Rare clinical cases
Hall 6.2-6
85
Sarcoidosis and other interstitial lung diseases
Hall 6.2-7
86
Infectious lung diseases including tuberculosis
Hall 6.2-8
87
Lung cancer and other malignant diseases involving the lungs
Hall 6.2-9
88
Lung function, airways and cough
Hall 6.2-10
89
Imaging of different lung diseases: clinical and experimental observations
Hall 6.2-11
90
Diagnostic and therapeutic approaches in pleural diseases
Hall 6.2-12
91
Regulatory mechanisms of cell activation, renewal and recruitment
Hall 6.2-13
92
Structural remodelling in COPD
Hall 6.2-14
93
Animal models of pulmonary fibrosis: mechanisms and therapies
Hall 6.2-15
94
Pulmonary mechanics and gas exchange
Hall 6.2-16
95
Exercise: system responses
Hall 6.2-17
96
Clinical aspects of continuous positive airway pressure therapy
Hall 6.2-18
97
Weight control and comorbidity in obstructive sleep apnoea
Hall 6.2-19
98
Assessment of sleep apnoea
Hall 6.2-20
99
Cardiovascular complications in obstructive sleep apnoea
Hall 6.2-21
100
Metabolic and sex-related aspects of obstructive sleep apnoea
Hall 6.2-22
101
Socioepidemiological studies in obstructive sleep apnoea
Hall 6.2-23
102
Control of breathing and respiratory disorders during sleep
Hall 6.2-24
103
Respiratory muscles in disease
Hall 6.2-25
104
Lung function in respiratory disease
Hall 6.2-26
105
Assessment of the respiratory system
Hall 6.2-27
106
Respiratory structure and function
Hall 6.2-28
107
Pulmonary vascular biology
Hall 6.2-29
108
Pulmonary hypertension I
Hall 6.2-30
109
Pulmonary hypertension II
Hall 6.2-31
110
Pulmonary venous thromboembolic disease
Hall 6.2-32
111
Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Hall 6.2-33
112
Cough and airway hyperresponsiveness
Hall 6.2-34
113
Inflammatory biomarkers
Hall 6.2-35
114
Clinical utility of exhaled nitric oxide measurement
Hall 6.2-36
115
Asthma: growing understanding of influential factors
Hall 6.2-37
116
COPD – clinical and epidemiological aspects
Hall 6.2-38
117
Epidemiology of asthma and allergy
Hall 6.2-39
118
The air we breathe indoors and outdoors
Hall 6.2-40
s
119
The biology of smoking and COPD
Hall 6.2-41
es
120
Cystic fibrosis: factors affecting lung health
Hall 6.2-42
121
Cystic fibrosis: a disease with many aspects
Hall 6.2-43
122
The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Hall 6.2-44
Room
Lunchtime Programme Sessions
Room 1.2a
123 Clinical Trial – Understanding the potential long-term impacts on function with Tiotropium: the 13:00–14:00
UPLIFT trial
Room 2.2a
124 Paediatric respiratory research award
13:00–14:30
ERS Berlin 2008 Annual Congr
Room Helsinki
125 ERS fellows' lunch
13:00–14:30
129
S U N D A Y O C T O B E R 5
Room
14:45–16:45
17:15–19:15
Room 1.2a
138 Special session starting at 14:15 – Sadoul Lecture
166 Evening Symposium
and Presentation by the 2008 ELF Awardee (see page
COPD: Current views on the clinical course of COPD
CLINICAL
202)
139 Hot Topic Should we change our attention to
PAEDIATRIC
respiratory diseases because of climate change?
Room 2.2a
140 Symposium
ONCOLOGY
Non-CPAP therapies in sleep apnoea: crossing the
borders?
INFECTION
Room Dublin
141 Symposium
167 Evening Symposium
Lung imaging in critically ill patients
Maintaining asthma control: the main challenge for both
patients and physicians?
INTENSIVE
Room 5.2b
142 Symposium
The use of inhaled mannitol for assessing airway disease
BASIC
Room Helsinki
143 Symposium
168 Evening Symposium
Is microbiological diagnosis of community-acquired
Taking a multi-faceted view on COPD
SLEEP
pneumonia possible and useful?
Room Budapest
144 Symposium
169 Evening Symposium
ENVIRONMENT
Guideline development workshop summary: ATS/ERS
Phenotypes: the forefront of asthma diagnosis and
integrating and coordinating efforts in COPD
treatment
Room Berlin
145 Oral Presentation
170 Evening Symposium
Vascular and interstitial remodelling in chronic lung
EXACTLE: EXAcerbations and CT scans as Lung Endpoints
disease: therapeutic interventions on the horizon
in Alpha-1-Antitrypsin Deficiency
Room 5.2c
146 Oral Presentation
171 Evening Symposium
Assessing profiles of rehabilitation candidates
Mastering pulmonary arterial hypertension: defined by
evidence – enhanced by experience
Room Europa 2
147 Oral Presentation
172 Evening Symposium
Biology in thoracic tumours
From revolution to evolution in anti-IgE therapy
Room Paris 1
148 Oral Presentation
173 Evening Symposium
Nursing interventions in the management of COPD and
Inspiring approaches to clinical challenges in pulmonary
dyspnoea
hypertension
Room Paris 2
149 Oral Presentation
Multidrug-resistant and the emerging threat of extensively
drug-resistant tuberculosis
Room 5.2a
150 Oral Presentation
Strategies of patient management in different settings
Room New York 1 151 Oral Presentation
Severe asthma: a heterogeneous clinical entity
s
es
Room New York 2 152 E-Communication
Air pollution effects on lung and heart
Room New York 3 153 E-Communication
Management, quality aspects and prognosis in thoracic
oncology
Room London 1
154 E-Communication
Pulmonary arterial hypertension and other pulmonary
vascular diseases
Room London 2
155 E-Communication
Paediatric airway diseases – pathophysiology and
monitoring
ERS Berlin 2008 Annual Congr
Room London 3
156 E-Communication
Trends in interventional pulmonology
130
M O N D A Y O C T O B E R 6
Room
08:30–10:30
10:45–12:45
Room 1.2a
181 Year in review
199 Grand Round
Paediatric year in review
Thoracic Oncology Grand Round – an interactive session
CLINICAL
Room 2.2a
182 Symposium
200 Symposium
PAEDIATRIC
Multigenic expression analyses: a guide for diagnosis and Update on lung transplantation 2008
therapy
ONCOLOGY
Room Dublin
183 Symposium
201 Symposium
Defining COPD using the "fixed ratio" (FEV /FVC <0.70) – Impact of nursing interventions on the quality of care for
1
pro and con
COPD patients
INFECTION
Room 5.2b
184 Symposium
202 Symposium
Multidisciplinary approach in interstitial lung disease
“Omics” and systems biology: the promise of future
INTENSIVE
disease understanding
Room Helsinki
185 Symposium
203 Symposium Priorities for tuberculosis research in
BASIC
Chest physiotherapy in the intensive care unit
Europe: discussing the results of the Tuberculosis Network
European Trials Group (TBNET)
SLEEP
Room Budapest
186 Symposium
204 Hot Topic Noninvasive positive pressure in heart
Treating cough
failure – where are we now with two large multicentre
studies showing no apparent benefit?
ENVIRONMENT
Room Berlin
187 Oral Presentation
205 Oral Presentation
Therapy in thoracic oncology
Preschool wheezing: advances in diagnosis, phenotyping
and therapy
Room 5.2c
188 Oral Presentation
206 Oral Presentation
Factors related to outcome of community-acquired
Lung, traffic and volcanoes
pneumonia
Room Europa 2
189 Oral Presentation
207 Oral Presentation
New frontiers in noninvasive assessment of the lungs
Novel mechanisms in the pathogenesis of pulmonary
inflammation
Room Paris 1
190 Oral Presentation
208 Oral Presentation
Environmental tobacco smoke and smoking ban
Alternatives for continuous positive airway pressure
therapy in obstructive sleep apnoea
Room Paris 2
191 Oral Presentation
209 Oral Presentation
Pulmonary vascular medicine
Effects of rehabilitation in very disabled COPD patients
Room 5.2a
192 Oral Presentation
210 Oral Presentation
New trends in interventional pulmonology
Best of lung epithelial cells 2008
Room New York 1 193 Oral Presentation
211 Oral Presentation
Clinical epidemiology of tuberculosis
Management of COPD
s
RoomNew York 2 194 E-Communication
212 E-Communication Mucociliary clearance, novel
es
Diagnostic aspects of sleep apnoea
techniques and assessments, in adult, paediatric and
mechanically ventilated patients
Room New York 3 195 E-Communication
213 E-Communication
Lung and bone marrow transplantation: miscellaneous
Diagnostic paediatric lung function: technical and clinical
aspects
Room London 1
196 E-Communication
214 E-Communication
Risk factors for allergic asthma and allergic rhinitis
Inflammatory trigger mechanisms in asthma and COPD
Room London 2
197 E-Communication
215 E-Communication
Pleural diseases and interventions
COPD epidemiology
Room London 3
198 E-Communication
216 E-Communication
ERS Berlin 2008 Annual Congr
Border patrol: the alveolar barrier in lung injury
Treatment and outcome in hospitalised patients with
community-acquired pneumonia
131
M O N D A Y O C T O B E R 6
Thematic Poster Sessions
Hall 6.2
08:30–12:45 Poster
display
12:50–13:40 Poster manned by author
13:40–14:40 Poster session with coordinator
14:40–16:30 Poster
display
218
Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Hall 6.2-1
219
Interstitial lung disease in systemic and vascular disorders
Hall 6.2-2
220
Acute lung injury and weaning
Hall 6.2-3
221
Mechanical ventilation and airway management
Hall 6.2-4
222
Noninvasive mechanical ventilation in the acute setting
Hall 6.2-5
223
Noninvasive ventilation in the chronic setting
Hall 6.2-6
224
Basic science in asthma and COPD II
Hall 6.2-7
225
Airway infection and host defence
Hall 6.2-8
226
Improving asthma and anti-allergic therapy
Hall 6.2-9
227
Understanding allergic airway inflammation with the help of animal models
Hall 6.2-10
228
Epidemiology of respiratory symptoms and COPD
Hall 6.2-11
229
Smoking cessation and new tobacco uses
Hall 6.2-12
230
Risk factors for childhood asthma and allergy
Hall 6.2-13
231
Pleuropulmonary infections; thoracic trauma
Hall 6.2-14
232
Diagnostic and therapeutic problems in thoracic surgery
Hall 6.2-15
233
Mediastinal lesions; rare pathology
Hall 6.2-16
234
Surgical treatment of lung tuberculosis
Hall 6.2-17
235
Donor organs and complications after lung transplantation
Hall 6.2-18
236
Beyond spirometry: the skills behind lung function testing
Hall 6.2-19
237
Diagnostic tests in lower respiratory tract infections
Hall 6.2-20
238
Lower respiratory tract infection: from outbreak to prognostic tests
Hall 6.2-21
239
Community-acquired pneumonia: prognosis, complications and prevention
Hall 6.2-22
240
Aetiology of respiratory infections: mycobacteria and fungi
Hall 6.2-23
241
Mechanisms of respiratory infections: interaction between the pathogen and the host
Hall 6.2-24
242
Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection
with other pathogens
Hall 6.2-25
243
Clinical epidemiology of tuberculosis
Hall 6.2-26
244
Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Hall 6.2-27
245
Problems in managing pulmonary and extrapulmonary tuberculosis
Hall 6.2-28
246
Diagnosis of tuberculosis: problems and perspectives
Hall 6.2-29
247
Outcomes of tuberculosis treatment
Hall 6.2-30
248
Specific tuberculosis management problems in children and adolescents
Hall 6.2-31
249
Clinical epidemiology of tuberculosis I
Hall 6.2-32
250
Clinical epidemiology of tuberculosis II
Hall 6.2-33
251
Clinical epidemiology of tuberculosis III
Hall 6.2-34
252
The challenge of multidrug-resistant tuberculosis
Hall 6.2-35
253
Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Hall 6.2-36
254
Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Hall 6.2-37
255
Difficult tuberculosis cases
Hall 6.2-38
256
Various thoracic tumours and interesting cases
Hall 6.2-39
257
Biology and prognosis in thoracic oncology
Hall 6.2-40
258
Diagnostic aspects in thoracic oncology
Hall 6.2-41
s
259
Treatment of thoracic tumours
Hall 6.2-42
es
260
Various aspects of thoracic oncology
Hall 6.2-43
261
Impact of patient education on cost-effectiveness of treatment
Hall 6.2-44
Room
Lunchtime Programme Sessions
Room Helsinki
266 Clinical trial – The effects of an anti-IL-13 human monoclonal antibody, IMA-638, on allergen- 13:00–14:00
induced airway responses in subjects with mild atopic asthma
Room 2.2a
263 A step-change in asthma. The Lancet/ERS symposium
13:00–14:30
Room Budapest
267 The EU Innovative Medicines Initiative (IMI) – a new "pre-competitive" strategy for enhanced
13:00–14:30
drug development in Europe
Room Europa 2
270 Berlin – views and insights guided by the history of medicine
13:00–14:30
Room Paris 2
271 Practical workshop: Practical aspects of applying noninvasive ventilation from acute to chronic 13:00–14:30
ERS Berlin 2008 Annual Congr
132
Room New York 1 273 Educational seminar – Harmonising standards for education and training in respiratory
13:00–14:30
medicine: prospects and challenges
M O N D A Y O C T O B E R 6
Room
14:45–16:45 17:15–19:15
Room 1.2a
280 COPD Award
281 Grand Round
CLINICAL
Clinical Grand Round – an interactive session
Room 2.2a
282 Symposium
299 Evening Symposium Improving long-term manage-
PAEDIATRIC
Patient–ventilator interactions during ventilation
ment of COPD through a better understanding of the dis-
ease: introducing the ECLIPSE study
ONCOLOGY
Room Dublin
283 Symposium
300 Evening Symposium
Malignant pleural mesothelioma: new aspects in
Current realities and practical applications in asthma
treatment and aetiology
management
INFECTION
Room 5.2b
284 Symposium
301 Evening Symposium
New insights into COPD pathophysiology
Aclidinium bromide: a new long-acting muscarinic
INTENSIVE
antagonist for COPD
Room Helsinki
285 Symposium
302 Evening Symposium
BASIC
Computer-aided imaging of lung parenchyma and airways Update on long-term oxygen therapy in COPD
SLEEP
Room Budapest
286 Symposium
303 Evening Symposium
The battle between environmental “invaders” and airway
COPD treatment: pitfalls and promises
epithelial defences
ENVIRONMENT
Room Berlin
287 Oral Presentation
304 Evening Symposium
Novel treatments for respiratory disease
Treatment of small airway diseases – today and tomorrow
Room 5.2c
288 Oral Presentation
305 Evening Symposium
Rehabilitation and influencing factors
Current and future pulmonary arterial hypertension
combination therapy
Room Europa 2
289 Oral Presentation
306 Evening Symposium
Biomarkers and antibiotic treatment of exacerbations of
Evolution of bronchodilators for COPD: developing new
COPD
therapeutic options to meet patients' needs
Room Paris 1
290 Oral Presentation
307 Evening Symposium
Genetic risk factors for asthma and COPD
Evidence-based prescribing in hospitalised community-
acquired pneumonia
Room Paris 2
291 Oral Presentation
Pulmonary infections in children – rare but important
aspects
Room 5.2a
292 Oral Presentation
Pathogenesis of obstructive sleep apnoea
Room New York 1 293 Oral Presentation
308 Evening Symposium
Discovery of novel targets in lung disease by means of
20 years of endothelin-1 – transformations in pulmonary
functional genomics
arterial hypertension (PAH) treatment
s
Room New York 2 294 E-Communication
es
Asthma control or asthma severity
Room New York 3 295 E-Communication
Integrated care and long-term strategies
Room London 1
296 E-Communication
309 Evening Symposium
Congenital lung lesions and emphysema; lung cancer
Why vaccinate patients with chronic respiratory condi-
surgery
tions? Today and tomorrow's perspectives
Room London 2
297 E-Communication
New tests and methods to diagnose tuberculosis
infection and disease and to monitor treatment
Room London 3
298 E-Communication
ERS Berlin 2008 Annual Congr
Cystic fibrosis: new mechanisms, monitoring and
treatment tools
133
T U E S D A Y O C T O B E R 7
Room
08:30–10:30
10:45–12:45
Room 1.2a
310 Year in review
329 Grand Round
Air pollution year in review
Radiology Grand Round – an interactive session
CLINICAL
Room 2.2a
311 Pulmonary Arterial Hypertension Research Award
330 Symposium
PAEDIATRIC
312 Symposium
High-risk patients for major lung cancer surgery
Pulmonary hypertension in connective tissue diseases
ONCOLOGY
Room Dublin
313 Symposium
331 Symposium
Management of solitary pulmonary nodules
Tracheostomy in critically ill patients
INFECTION
Room 5.2b
314 Symposium
332 Symposium
Exacerbations of chronic respiratory disease – state of
Tissue plasticity: balancing between emphysema and
INTENSIVE
the art
fibrosis
Room Helsinki
315 Symposium
333 Symposium
BASIC
Integrated multidisciplinary care of COPD
New insights into tuberculosis control
SLEEP
Room Budapest
316 Hot Topic
334 Hot Topic
The obese: a pulmonary patient
Mitochondria in muscle-related respiratory disorders
ENVIRONMENT
Room Berlin
317 Oral Presentation
335 Oral Presentation
Understanding the mechanisms and the impact of severe Tobacco control and teenagers
asthma
Room 5.2c
318 Oral Presentation
336 Oral Presentation
Ways into the mediastinum
Cystic fibrosis: novel aspects of airway function and
inflammation
Room Europa 2
319 Oral Presentation
337 Oral Presentation
New diagnostic methods in viral and atypical infections
Sarcoidosis: pathophysiology and severity
Room Paris 1
320 Oral Presentation
338 Oral Presentation
Novel targets in the molecular pathology of lung cancer
Medical treatment of pulmonary hypertension
and COPD
Room Paris 2
321 Oral Presentation
339 Oral Presentation
Respiratory physiology in health and disease
New mechanisms in the pathogenesis of asthma and its
response to treatment
Room 5.2a
322 Oral Presentation
340 Oral Presentation
New treatments for asthma
Asthma and inhalation injuries at work
Room New York 1 323 Oral Presentation
341 Oral Presentation
Respiratory muscle limitations to exercise tolerance
COPD and comorbidities
s
RoomNew York 2 324 E-Communication
342 E-Communication
es
Epidemiological and clinical aspects of tuberculosis
Quality spirometry: the only spirometry!
control
Room New York 3 325 E-Communication
343 E-Communication
Drug therapy and assessment of control in childhood
Metabolic syndrome and systemic inflammation in
asthma
obstructive sleep apnoea
Room London 1
326 E-Communication
344 E-Communication
Asthma and miscellaneous disorders
News from diagnostic bronchoscopy
Room London 2
327 E-Communication
345 E-Communication
Pathophysiology of respiratory diseases
Early life risk factors for childhood asthma: evidence from
birth cohort studies II
ERS Berlin 2008 Annual Congr
Room London 3
328 E-Communication
346 E-Communication
Biomarkers and disease assessment in COPD
Physiological response to exercise performance
134
T U E S D A Y O C T O B E R 7
Thematic Poster Sessions
Hall 6.2
08:30–12:45 Poster
display
12:50–13:40 Poster manned by author
13:40–14:40 Poster session with coordinator
14:40–16:30
Poster display
347
Organisation of care and management of COPD
Hall 6.2-1
348
Technologies and techniques in rehabilitation
Hall 6.2-2
349
Impact of rehabilitation programmes in COPD and non-COPD patients
Hall 6.2-3
350
Functionality and metabolism in rehabilitation candidates
Hall 6.2-4
351
Quality of life and mood disturbances in rehabilitation
Hall 6.2-5
352
Endoscopic needle techniques
Hall 6.2-6
353
Hot and cold techniques
Hall 6.2-7
354
Clinical aspects in the management of sarcoidosis
Hall 6.2-8
355
Clinical aspects of interstitial lung disease
Hall 6.2-9
356
Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Hall 6.2-10
357
Diagnosing, monitoring and treating respiratory diseases in primary care
Hall 6.2-11
358
Issues in the management of COPD in the community
Hall 6.2-12
359
Novel mechanisms and targets of molecular pulmonary pathology
Hall 6.2-13
360
Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Hall 6.2-14
361
Basic science in asthma and COPD
Hall 6.2-15
362
Airway cell biology and immunology
Hall 6.2-16
363
Pathogenesis and treatment of asthma and COPD
Hall 6.2-17
364
Recent advances in the treatment and pathogenesis of asthma
Hall 6.2-18
365
Novel experimental approaches to understanding asthma and COPD
Hall 6.2-19
366
Novel experimental approaches to understanding asthma and COPD II
Hall 6.2-20
367
Advances in the treatment and pathogenesis of pulmonary diseases
Hall 6.2-21
368
Risk factors for asthma versus asthma control
Hall 6.2-22
369
Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Hall 6.2-23
370
Allergy and immunology of asthma and beyond
Hall 6.2-24
371
Asthma: mechanisms and treatment
Hall 6.2-25
372
Asthma epidemiology
Hall 6.2-26
373
COPD and miscellaneous
Hall 6.2-27
374
Occupational asthma – agents and management
Hall 6.2-28
375
COPD and other environment-related lung diseases
Hall 6.2-29
376
Occupational lung diseases
Hall 6.2-30
377
Health effects of passive smoking and of a smoking ban
Hall 6.2-31
378
Tobacco smoking by population subgroups
Hall 6.2-32
379
Clinical applications of ventilatory function tests in paediatric pulmonology
Hall 6.2-33
380
Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Hall 6.2-34
381
Clinical aspects of asthma in school-aged children
Hall 6.2-35
382
Wheezing in preschool children
Hall 6.2-36
383
Exercise-induced asthma, acute severe asthma and allergic rhinitis in children
Hall 6.2-37
384
Miscellaneous respiratory infections
Hall 6.2-38
385
Neonatal intensive care: ventilation and beyond
Hall 6.2-39
386
Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing,
exercise-induced symptoms and rare diseases
Hall 6.2-40
387
Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology
Hall 6.2-41
388
Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Hall 6.2-42
s
389
Respiratory mechanics, muscles and breathing; functional status measures and coping styles
Hall 6.2-43
es
390
Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing
Hall 6.2-44
Room
Lunchtime Programme Sessions
Room 1.2a
391 EASE trial: protocol design, initial screening and pre-procedure status from the international
13:00–14:30
exhale airway stents for emphysema (EASE) trial of airway bypass
Room 2.2a
392 How to write a scientific paper
13:00–14:30
Room Dublin
393 ERS Task Force report: primary ciliary dyskinesia (PCD) in children
13:00–14:30
Room 5.2b
394 A young scientist's roadmap to the ERS meeting
13:00–14:30
Room Berlin
395 Meet the occupation and epidemiology assembly awardees
13:00–14:30
ERS Berlin 2008 Annual Congr
Room Paris 2
397 Practical workshop: Compliance to nasal continuous positive airway pressure: what makes the 13:00–14:30
difference?
135
T U E S D A Y O C T O B E R 7
Room
14:45–16:45
17:15–19:15
Room 1.2a
404 Grand Round
Paediatric Grand Round – an interactive session
CLINICAL
Room 2.2a
405 Symposium
PAEDIATRIC
Biomarkers in COPD – application in clinical and
epidemiological studies
ONCOLOGY
Room Dublin
406 Symposium
422 Evening Symposium
Physical activity and pulmonary rehabilitation – not two of Nocturnal environmental control with laminar airflow – a
INFECTION
a kind
novel approach for treating perennial asthma
Room 5.2b
407 Symposium
Interventional pneumology – what went wrong and what
INTENSIVE
was never published
Room Helsinki
408 Symposium
423 Evening Symposium
BASIC
Community-acquired pneumonia and COPD: what do we
Improving outcomes in COPD: developing a patient
know?
assessment test
SLEEP
Room Budapest
409 Year in review
424 Evening Symposium
Physiological year in review
Moving forward in pulmonary arterial hypertension
ENVIRONMENT
management
Room Berlin
410 Oral Presentation
425 Evening Symposium
Outcome and trends in obstructive lung disease (OLD)
Addressing and targeting airway inflammation and
and cardiovascular relation to OLD
hyperresponsiveness to achieve optimal asthma control
Room 5.2c
411 Oral Presentation
426 Evening Symposium
New tools in tuberculosis diagnosis
Improving pulmonary distribution of combination therapy:
implications for asthma treatment
Room Europa 2
412 Oral Presentation
427 Evening Symposium
Recent advances in the pathogenesis and treatment of
Improved diagnosis and clinical decision-making by
asthma and COPD
integrating information from new biomarkers
Room Paris 1
413 Oral Presentation
428 Evening Symposium
The adaptive and innate immune system at work
Optimising Therapeutic Outcomes for Patients with
Advanced Non-Small Cell Lung Cancer
Room Paris 2
414 Oral Presentation
Risk assessment and treatment of complications in
thoracic surgery patients
Room 5.2a
415 Oral Presentation
Outcome of adaptive servo ventilation in sleep apnoea
Room New York 1 416 Oral Presentation
New therapeutic strategies in idiopathic pulmonary
fibrosis
s
Room New York 2 417 E-Communication
es
Invasive and noninvasive measurements of lung
inflammation
Room New York 3 418 E-Communication
Acute lung injury and weaning
Room London 1
419 E-Communication
Recent advances in the treatment and pathogenesis of
pulmonary diseases
Room London 2
420 E-Communication
Imaging and measurement techniques in the evaluation
of pulmonary embolism, COPD and pleural diseases
ERS Berlin 2008 Annual Congr
Room London 3
421 E-Communication
Therapy of thoracic tumours
136
W E D N E S D A Y O C T O B E R 8
Room
08:30–10:30
10:45–12:45
Room 1.2a
429 Grand Round
447 Romain Pauwels Award
Interventional Pulmonology Grand Round – an interactive 448 Year in review
CLINICAL
session
Clinical year in review
Room 2.2a
430 Symposium
449 Symposium
PAEDIATRIC
Smoking-related lung disease: from emphysema to
When teenagers start jobs: what does the clinician need
pulmonary fibrosis
to know?
ONCOLOGY
Room Dublin
431 Symposium
450 Symposium
Diagnosis and management of chronic pulmonary
Legionella infection: from outbreak to prevention
aspiration in children
INFECTION
Room 5.2b
432 Symposium
451 Symposium
Epigenetic modifications in lung disease
Future management of pulmonary arterial hypertension
INTENSIVE
Room Helsinki
433 Symposium
452 Symposium
BASIC
The thoracic surgeon facing infection
Smokers with asthma versus COPD: differences and
similarities
SLEEP
Room Budapest
434 Hot Topic
453 Symposium
Portable monitoring for sleep apnoea: the way forward?
The new staging system for lung cancer
ENVIRONMENT
Room Berlin
435 Oral Presentation
454 Oral Presentation
Diagnosis and outcome in critically ill patients
Pleural effusion
Room 5.2c
436 Oral Presentation
455 Oral Presentation
Diagnosis and prognosis in thoracic oncology
Sleep apnoea in childhood
Room Europa 2
437 Hot Topic
456 Oral Presentation
Should asthma no longer be considered an allergic
Interferon-gamma methods for the diagnosis of
disease?
tuberculosis infection and disease
Room Paris 1
438 Oral Presentation
457 Oral Presentation
Phenotyping of asthma and COPD
New insights and treatment options for bronchiolitis
obliterans syndrome after lung transplantation
Room Paris 2
439 Oral Presentation
458 Oral Presentation
Early life risk factors for childhood asthma: evidence from Treatment and outcome of childhood asthma: new
birth cohort studies I
perspectives
Room 5.2a
440 Oral Presentation
459 Oral Presentation
Rationale of self-education in asthma therapy
Acute and chronic pulmonary thromboembolic disease
Room New York 1 441 Oral Presentation
460 Oral Presentation
Respiratory pathophysiology from cell and animal
Pulmonary assessment and outcomes in newborn infants
research
s
Room New York 2 442 E-Communication
461 E-Communication
es
Understanding airway inflammation
Influence of teaching models on skills and knowledge of
medical doctors
Room New York 3 443 E-Communication
462 E-Communication
Inorganic dust exposure and the lung
Recent advances in the treatment and pathogenesis of
pulmonary diseases II
Room London 1
444 E-Communication
463 E-Communication
Airway cell biology
COPD
Room London 2
445 E-Communication
464 E-Communication
Comorbidities in COPD
Use of noninvasive ventilation in various conditions
446 E-Communication
465 E-Communication
ERS Berlin 2008 Annual Congr
Room London 3
Genetics, immunology and microbiology of tuberculosis
Biology and diagnosis of thoracic tumours
137
A S S E M B L Y A N D G R O U P M E M B E R S ’ M E E T I N G S
Assembly and Group Members’ Meetings
Room
Sunday, October 5
12:50–13:35
New York 1
1.1 Clinical Problems Group Members’ Meeting
Room Paris 2
1.5 Diffuse Parenchymal Lung Disease Group Members’ Meeting
Room Europa 2
3.1 Molecular Pathology and Functional Genomics Group Members’ Meeting
Room 5.2c
5.1 Airway Pharmacology and Treatment Group Members’ Meeting
Room Dublin
6.1 Epidemiology Group Members’ Meeting
Room Berlin
9.1 Respiratory Function Technologists/Scientists Group Members’ Meeting
12:50–14:40
Room Paris 1
2 Respiratory Intensive Care Assembly Members’ Meeting
2.1 Acute Critical Care Group, 2.2 Noninvasive Ventilatory Support Group Members’ Meetings
Room 5.2a
8 Thoracic Surgery Assembly Members’ Meeting
8.1 Thoracic Surgery Group, 8.2 Transplantation Group Members’ Meetings
Room Budapest
10 Respiratory Infections Assembly Members’ Meeting
10.1 Respiratory Infections, 10.2 Tuberculosis Group Members’ Meetings
Room 5.2b
11 Thoracic Oncology Section Members’ Meeting
13:45–14:30
Room New York 1 1.4 Interventional Pulmonology Group Members’ Meeting
Room Paris 2
1.6 General Practice and Primary Care Group Members’ Meeting
Room Europa 2
3.2 Airway Cell Biology and Immunopathology Group Members’ Meeting
Room 5.2c
5.3 Allergy and Immunology Group Members’ Meeting
Room Dublin
6.3 Tobacco, Smoking Control and Health Education Group Members’ Meeting
Room Berlin
9.2 Physiotherapists Group Members’ Meeting
17:00–18:00
Room 2.2a
1.2 Rehabilitation and Chronic Care Group Members’ Meeting
Room London 1
1.3 Imaging Group Members’ Meeting
Room 5.2b
3.3 Mechanisms of Lung Injury and Repair Group Members’ Meeting
Room 5.2a
5.2 Airway Regulation, Provocation and Monitoring Group Members’ Meeting
Room New York 1 6.2 Occupational and Environmental Health Group Members’ Meeting
Room New York 2 7.1 Paediatric Respiratory Physiology, 7.2 Paediatric Asthma and Allergy Group Members’ Meetings
Room New York 3 7.3 Cystic Fibrosis, 7.7 Paediatric Bronchology Group Members’ Meetings
Room London 3
7.4 Paediatric Respiratory Infection and Immunology, 7.5 Neonatology and Paediatric Intensive Care, 7.6 Paediatric
Respiratory Epidemiology Group Members’ Meetings
Room London 2
9.3 Nurses Group Members’ Meeting
Room
Monday, October 6
12:50–14:40
Room Paris 1
4 Clinical Physiology and Integrative Biology Assembly Members’ Meeting
4.1 Gas Exchange and Exercise, 4.2 Sleep and Control of Breathing, 4.3 Respiratory Structure and Function,
4.4 Pulmonary Circulation and Pulmonary Vascular Disease Group Members’ Meetings
s
13:00–14:15
es
Room 5.2a
3 Cell and Molecular Biology Assembly Members’ Meeting
Room 5.2b
5 Inflammatory Airway Diseases and Clinical Allergy Assembly Members’ Meeting
Room 5.2c
6 Occupation and Epidemiology Assembly Members’ Meeting
Room Berlin
7 Paediatrics Assembly Members’ Meeting
Room Dublin
9 Allied Respiratory Professionals Assembly Members’ Meeting
13:00–14:40
Room 1.2a
1 Clinical Assembly Members’ Meeting and Discussion on FP/Proposal PAN-NET
Room
Tuesday, October 7
13:00–14:30
Room Paris 1
ERS Extraordinary/Ordinary General Assembly
ERS Berlin 2008 Annual Congr
138
S A T U R D A Y O C T O B E R 4
Room London 3
Postgraduate Course 1
09:30–17:30
PG1 EU GRACE Network Full-day Postgraduate Course: Antibiotics or not: from
acute bronchitis to acute exacerbation of chronic bronchitis
Aims: To update the participants on the role of infections in COPD and to discuss the dilemma of appropriate antibiotic use. All
sessions will be interactive, and will include clinical case presentations. The involvement of microorganisms in the pathogenesis of
COPD in terms of possible promotion or modulation of the disease will be addressed. The role of emerging as well as established
drivers of infection in the pathophysiology and its implications for diagnosis and management in the context of adult lower respiratory
tract infection (LRTI) and COPD will be discussed.
Target audience: Pneumologists, infectious diseases specialists, clinical microbiologists, clinical pharmacologists, research fellows,
training specialists interested in updating their knowledge on bronchitis and COPD management.
Chairs: R. Cosentini (Milan, Italy), C. Butler (Cardiff, United Kingdom)
09:30 Debate: Bacteria are a cause of acute bronchitis – PRO
R. Cosentini (Milan, Italy)
60
10:10 Debate: Bacteria are a cause of acute bronchitis – CON
R. Wilson (London, United Kingdom)
61
10:50 The EU GRACE project: first data on LRTIs from the European GPs Network
C. Butler (Cardiff, United Kingdom)
62
11:30 Break
63
12:00 Debate: Antibiotic treatment is contraindicated in acute bronchitis – PRO
T. Verheij (Utrecht, The Netherlands)
64
12:40 Debate: Antibiotic treatment is contraindicated in acute bronchitis – CON
M. Woodhead (Manchester, United Kingdom)
65
13:20 Lunch
66
14:20 The pathogenesis of acute infection in COPD
A. Anzueto (San Antonio, United States of America)
67
15:00 Laboratory investigations of infection in COPD: current best practice and future possibilities
A. Papi (Ferrara, Italy)
68
15:40 Break
69
16:10 Clinical management of COPD: recommended practice including the place of antibiotics
F. Blasi (Milan, Italy)
70
16:50 COPD guidelines in relation to infections: a critical analysis
A. Torres (Barcelona, Spain)
71
Room Berlin
Postgraduate Course 2
09:30–13:00
PG2 Core Curriculum Postgraduate Course: Asthma: natural history, risk factors
and overall management
Aims: This is the third course in a three-year postgraduate core curriculum covering the main issues on asthma from pathogenetics
to current treatment strategies. Participants can attend a single module and earlier modules can be accessed on the ERS e-learning
site. The main aims of this third module in the series are:
- to describe the key risk factors and events involved in the development of asthma in children, and to understand the principles
behind the development and natural progression of asthma in adulthood;
- to review how risk factors interact with the human immune system, and discuss the causal relationship between inhaled allergen
exposure and asthma and the biological mechanisms underlying the interaction between infective agents and airway inflammation;
s
- to define the goals and importance of asthma education, and to identify the resources and strategies that enhance optimal
es
outcomes;
- to understand whether allergen-specific immunotherapy may, by altering the natural course of allergic disease, have a preventive
effect on asthma.
Target audience: Pulmonary and critical care physicians, allergists, pulmonary and allergy postdoctoral fellows, nurses, clinical
researchers.
Chairs: M. Cazzola (Rome, Italy), R. Dahl (Aarhus, Denmark)
09:30 Natural history of asthma
M. Kraft (Durham, United States of America)
1
10:15 Risk factors for asthma and their prevention
J. C. Virchow (Rostock, Germany)
2
11:00 Break
3
11:30 Control of asthma
ERS Berlin 2008 Annual Congr
M. Gaga (Athens, Greece)
4
12:15 Specific immunotherapy in the management of allergic asthma
139
J. Bousquet (Montpellier, France)
5
S A T U R D A Y O C T O B E R 4
Room 5.2c
Postgraduate Course 3
09:30–13:00
PG3 Core Curriculum Postgraduate Course: Respiratory physiology: respiratory
and peripheral muscle function in health and disease
Aims: This is the third course in a three-year postgraduate core curriculum covering different aspects of respiratory physiology in
clinical practice. Participants can attend a single module and earlier modules can be accessed on the ERS e-learning site. The main
aims of this third module in the series are:
- to improve the participants’ understanding of how respiratory disease affects skeletal muscle function;
- to provide the latest information about the measurement of respiratory and peripheral muscle function;
- to understand how peripheral muscle dysfunction contributes to respiratory morbidity;
- to develop insights into the effective treatment of respiratory and peripheral muscle dysfunction.
Target audience: Clinicians, physiologists and allied professionals working with patients with chronic lung disease.
Chairs: M. Polkey (London, United Kingdom), A. Schols (Maastricht, The Netherlands)
09:30 Skeletal muscle function and the respiratory system
M. A. Spruit (Horn, The Netherlands)
6
10:15 Testing respiratory and peripheral muscle performance
J. Moxham (London, United Kingdom)
7
11:00 Break
8
11:30 The clinical impact of skeletal muscle dysfunction
M. Polkey (London, United Kingdom)
9
12:15 Evaluating treatment in skeletal muscle dysfunction
A. Schols (Maastricht, The Netherlands)
10
Room New York 1
Postgraduate Course 4
09:30–13:00
PG4 Core Curriculum Postgraduate Course: Paediatric respiratory medicine:
wheezing children: asthma and beyond
Aims: Asthma is the most common chronic disease in childhood. This core curriculum course on the current state of the art in
childhood asthma will be useful to all ERS members working with children in their practice. Participants will acquire knowledge of
numerous recent developments, both for pre-school asthma and asthma in school-aged children and adolescents.
The main learning objectives of this course are:
- to review risk factors for different clinical phenotypes of asthma in children;
- to review diagnosis and management of childhood asthma, both chronic care and management of acute severe asthma;
- to present highlights of the ERS Task Force’s Report on pre-school wheeze.
Target audience: Paediatricians, paediatric chest physicians, paediatric intensivists involved in the care of children with severe
asthma.
Chairs: A. Bush (London, United Kingdom), H. Bisgaard (Copenhagen, Denmark)
09:30 Early origins: gene–environment interactions
M. Kabesch (Munich, Germany)
33
10:05 Evidence-based guidelines for the management of pre-school wheeze: highlights from the ERS Task Force’s
report
P. J. F. M. Merkus (Nijmegen, The Netherlands)
34
10:40 Severe asthma: approach to diagnosis and treatment
L. Fleming (London, United Kingdom)
35
11:15 Break
36
s
11:50 Maintenance treatment in school children with persistent asthma
es
H. Bisgaard (Copenhagen, Denmark)
37
12:25 Acute severe asthma: evidence-based management of asthma exacerbations
M. Smith (Craigavon, United Kingdom)
38
Room Paris 2
Postgraduate Course 5
09:30–13:00
PG5 Core Curriculum Postgraduate Course: Interstitial lung diseases: selected
orphan diseases
Aims: This is the third course in a three-year postgraduate core curriculum covering some of the rare, as well as the more common,
interstitial lung diseases (ILD). Participants can attend a single module, and can view previous courses in the series via the ERS e-
learning resources. This third module in the series will provide a detailed update on selected orphan diseases among the interstitial
pneumonias.
The specific aims of this third module in the series are:
- to provide information on rare and/or neglected ILD;
- to give a comprehensive review and updated information on alveolar lipoproteinosis including the recent pathogenetic advances
ERS Berlin 2008 Annual Congr
and therapeutic orientations;
- to review the clinical and imaging features, and management of lymphangioleiomyomatosis, either sporadic or associated with
140
S A T U R D A Y O C T O B E R 4
tuberous sclerosis complex;
- to provide an overview of the idiopathic eosinophilic pneumonias (chronic, acute), as well as of those occurring in Churg-Strauss
syndrome and the hypereosinophilic syndrome;
- to review the pulmonary features of Langerhans cell histiocytosis and discuss this disorder within the spectrum of smoking-related
ILD.
Target audience: Pulmonary physicians, pathologists, radiologists, cell biologists.
Chairs: J-F. Cordier (Lyon, France), P. Camus (Dijon, France)
09:30 Orphan ILD: a spectrum of rare and/or neglected diseases
P. Camus (Dijon, France)
22
10:05 Idiopathic alveolar lipoproteinosis
U. Costabel (Essen, Germany)
23
10:40 Lymphangioleiomyomatosis
S. Johnson (Nottingham, United Kingdom)
24
11:15 Break
25
11:50 Idiopathic eosinophilic pneumonias
J-F. Cordier (Lyon, France)
26
12:25 Pulmonary Langerhans cell histiocytosis
R. Vassallo (Rochester, United States of America)
27
Room New York 3
Postgraduate Course 6
09:30–13:00
PG6 Core Curriculum Postgraduate Course: Thoracic oncology: new treatments
for thoracic malignancies (other than nonsmall cell lung cancer)
Aims: This is the third course in a three-year postgraduate core curriculum devoted to thoracic oncology. Participants can attend a
single module and earlier modules in the series can be viewed on the ERS e-learning resources. This last course focuses on innovative
treatments for thoracic malignancies other than nonsmall cell lung cancer.
The specific aims of this last module in the series are:
- to review the current knowledge on the optimal integration of systemic and local treatments for small cell lung cancer;
- to review the approach to mediastinal tumours;
- to summarise the current treatment of mesothelioma;
- to address issues in supportive care, including anti-emetics, growth factors and symptomatic treatments.
Target audience: All chest physicians, thoracic oncologists and thoracic surgeons involved in the treatment of thoracic tumours.
Chairs: A-P. Meert (Brussels, Belgium), R. M. Huber (Munich, Germany)
09:30 Systemic treatment of small cell lung cancer
E. Quoix (Strasbourg, France)
39
10:05 Optimal integration of chemo- and radiotherapy in small cell lung cancer
D. De Ruysscher (Maastricht, The Netherlands)
40
10:40 Mediastinal tumors
H. Ris (Lausanne, Switzerland)
41
11:15 Break
42
11:50 Mesothelioma
A. Scherpereel (Lille, France)
43
12:25 Supportive care and local palliation for thoracic malignancies
R. M. Huber (Munich, Germany)
44
Room 5.2a
Postgraduate Course 7
09:30–13:00
s
PG7 ABC of domiciliary ventilation
es
Aims: Domiciliary ventilation is a highly prevalent treatment throughout Europe.
At the end of the course, participants will be able to:
- better understand the modalities of domiciliary ventilation, mostly performed today via noninvasive ventilation;
- decide what is the better strategy to indicate, monitor and organise domiciliary ventilation.
Target audience: Chest physicians, respiratory therapists, intensivists, nurses.
Chairs: J-F. Muir (Rouen, France), B. Schoenhofer (Hanover, Germany)
09:30 How physiopathology helps me to set domiciliary ventilation
A. Simonds (London, United Kingdom)
28
10:15 In which situations do I have to consider domiciliary ventilation?
W. Windisch (Freiburg, Germany)
29
11:00 Break
30
11:30 How can I monitor a patient with domiciliary ventilation?
ERS Berlin 2008 Annual Congr
A. Cuvelier (Rouen, France)
31
12:15 How do I facilitate the return home of a patient with domiciliary ventilation?
141
M. Vitacca (Lumezzane, Italy)
32
S A T U R D A Y O C T O B E R 4
Room 1.2c
Postgraduate Course 8
09:30–13:00
PG8 Cellular and molecular technologies of today – treatments of tomorrow
Aims: This course will introduce and outline in detail novel developments of cutting-edge techniques that are appropriate for the
analysis of patient-obtained material, e.g. biopsies or blood samples, irrespective of the underlying lung disease. Findings of
particular interest to the respiratory community will be presented, alongside outlining the capabilities of novel technologies applicable
to respiratory research.
At the end of the course, the audience will have obtained:
- detailed information about novel technological achievements applicable to their own research;
- novel ideas on how to integrate novel technologies into respiratory research;
- resources and practical advice for new users;
- the knowledge to identify the appropriate experimental technique, as well as its limitations, that needs to be implemented for a
given research question.
Target audience: Basic scientists, physician scientists, pneumologists, clinical investigators and trainees.
Chairs: O. Eickelberg (Giessen, Germany), R. Chambers (London, United Kingdom)
09:30 Obtaining the right cell: primary cell cultures from tissue biopsies
R. Morty (Giessen, Germany)
45
10:15 Gene expression profiling: identifying novel gene targets for therapeutic intervention
C. Scotton (London, United Kingdom)
46
11:00 Break
47
11:30 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates
S. Fowler (Preston, United Kingdom)
48
12:15 Proteomic research tools for respiratory medicine
E. Mortz (Odense, Denmark)
49
Room Europa 2
Postgraduate Course 9
09:30–13:00
PG9 Nonapnoeic respiratory disorders during sleep
Aims: In addition to providing an overview of all possible treatment options, the main aims of this course are to improve knowledge
on:
- the basic mechanisms of interaction between sleep and breathing;
- the overall impact of sleep on several chronic respiratory conditions, either revealing or aggravating the disease or the related
respiratory failure.
Target audience: Chest physicians with special interest in sleep-disordered breathing, but also cardiologists, neurologists and
general physicians.
Chairs: J. Verbraecken (Antwerp, Belgium), P. M. A. Calverley (Liverpool, United Kingdom)
09:30 Sleep in COPD, asthma and restrictive lung disease
P. M. A. Calverley (Liverpool, United Kingdom)
11
10:15 Monitoring and capnography during sleep
C. Van Der Grinten (Maastricht, The Netherlands)
12
11:00 Break
13
11:30 Arousals in nonapnoeic respiratory disorders
J. Verbraecken (Antwerp, Belgium)
14
12:15 Treatment options for chronic respiratory failure
M. W. Elliott (Leeds, United Kingdom)
15
s
Room 1.2g
Postgraduate Course 10
09:30–13:00
es
PG10 Getting it right – planning, realising, analysing and publishing research
projects
Aims: Many original and scientifically interesting research projects suffer from common methodological, statistical and design
problems, which are well known and could be easily avoided. This postgraduate course will outline a number of the most important
pitfalls in all stages of respiratory research (planning, realisation, analysis and publication) and for various research fields (clinical,
epidemiological and physiological).
The main aim is to highlight common pitfalls in respiratory research and learn how to avoid them. The four speakers will use very
interactive approaches to discuss problems related to:
- planning and conducting epidemiological and clinical research;
- planning and conducting physiological and experimental research;
- statistical analysis and interpretation of results;
- writing up and publishing results.
Target audience: Everybody involved in respiratory research (epidemiological, clinical and physiological). In particular, the course will
suit young paediatric and adult pneumologists, physiologists and epidemiologists with some previous research experience who are
ERS Berlin 2008 Annual Congr
about to set up and conduct their own research projects.
142
S A T U R D A Y O C T O B E R 4
Chairs: C. Kuehni (Bern, Switzerland), S. Turner (Aberdeen, United Kingdom)
09:30 Common pitfalls in planning and conducting epidemiological and clinical research
T. Frischer (Vienna, Austria)
50
10:15 Common pitfalls in planning, conducting and interpreting physiological research
J. Stocks (London, United Kingdom)
51
11:00 Break
52
11:30 Modern approaches to statistical analysis and interpretation of results
J. Sterne (Bristol, United Kingdom)
53
12:15 Pitfalls in writing up and publishing results
P. J. Sterk (Amsterdam, The Netherlands)
54
Room 1.2e
Postgraduate Course 11
09:30–13:00
PG11 Tobacco addiction in women
Aims: This course addresses a major emerging issue in respiratory health, the increasing problem of tobacco addiction in women
and the health consequences.
The main aim is to provide participants with a state-of-the-art update on:
- the sharp worldwide rise of female tobacco smoking;
- the efforts the tobacco industry is making to recruit new smokers among women;
- knowledge that there are several sex-specific health effects of women smoking;
- evidence that treatment of tobacco addiction is, to some extent, specific in women.
Target audience: Chest physicians, general practitioners, nurses, trainees and all others with an interest in smoking and respiratory
health.
Chairs: E. Dagli (Istanbul, Turkey), C. Gratziou (Athens, Greece)
09:30 Women smoking in Europe and the world
E. Tamang (Venice, Italy)
55
10:15 Weight, tobacco and women
K. Gallopel-Morvan (Rennes, France)
56
11:00 Break
57
11:30 The health consequences of female tobacco use and effects on pregnancy
E. Dagli (Istanbul, Turkey)
58
12:15 The treatment of tobacco addiction
C. Gratziou (Athens, Greece)
59
Room Paris 1
Postgraduate Course 12
09:30–13:00
PG12 Challenges in pulmonary embolism: hot issues and interactive cases (jointly
organised with ACCP)
Aims: The purpose of this course, organised jointly by the American College of Chest Physicians (ACCP) and the ERS, is to provide a
state-of-the-art update on current practice, challenges and hot issues in the diagnosis and management of patients with acute
pulmonary embolism. Recent advances in knowledge of risk factors, pathogenesis and prognostic indicators will also be reviewed,
as will advances in noninvasive diagnostic procedures and patient-specific treatment strategies. Experts will employ a combination
of didactic and case-based interactive approaches, to update participants on:
- advances in knowledge of epidemiology, pathogenesis and risk factors;
- challenges in diagnosis, and the contribution of newer noninvasive techniques;
- advances in knowledge of risk assessment models and prognostic markers;
- therapeutic strategies, including patient-specific strategies, anticoagulants, thrombolysis, and indications for, and complications of,
s
inferior vena cava filters;
es
- thromboembolism in pregnancy.
Target audience: Chest physicians, cardiologists, critical care specialists, cardiothoracic surgeons and others who want an update
on management of acute pulmonary embolism.
Chairs: A. Thomas (Washington, United States of America), G. Simonneau (Clamart, France)
09:30 Introduction: Acute pulmonary embolism: still a challenge
A. Thomas (Washington, United States of America)
16
10:05 Advances in knowledge of global epidemiology, pathogenesis and risk factors
G. Simonneau (Clamart, France)
17
10:40 Diagnosis, prognosis and risk assessment models: hot issues
A. Torbicki (Warsaw, Poland)
18
11:15 Break
19
11:50 Therapeutic strategies: what treatment for what patient
ERS Berlin 2008 Annual Congr
L. Moores (Bethesda, United States of America)
20
12:25 How to manage thromboembolism in pregnancy
143
J. Mathers (Richmond, United States of America)
21
S A T U R D A Y O C T O B E R 4
Room Budapest
Examination
14:00–17:00
European examination in Adult Respiratory Medicine
14:00 Instructions
72
14:10 Examination
73
16:55 Collection of answer sheets
74
Room New York 1
Postgraduate Course 13
14:00–17:30
PG13 Core Curriculum Postgraduate Course: Respiratory failure: skills needed to
treat an episode of acute respiratory failure
Aims: This is the third course in a three-year postgraduate core curriculum providing a basic overview on the diagnosis and
management of patients with respiratory failure. Participants can attend a single module and earlier modules can be accessed on
the ERS e-learning site. The main aims of this third module in the series are to describe the skills needed to treat an episode of acute
respiratory failure.
At the end of the course, participants will:
- understand the diagnostic and therapeutical procedures necessary to manage a respiratory emergency;
- understand the rationale of preventing infections;
- know how to approach difficulty in weaning.
Target audience: Pulmonary physicians, intensivists, emergency medicine doctors, nurses, respiratory therapists.
Chairs: P. Pelosi (Milan, Italy), B. Schoenhofer (Hanover, Germany)
14:00 How to ventilate patients affected by different pathologies: keys for success
J-F. Muir (Rouen, France)
108
14:30 How do I perform invasive diagnostic procedures in critically ill patients?
P. Navalesi (Novara, Italy)
109
15:00 Break
110
16:30 How can I prevent infectious complications in critically ill patients?
S. Ewig (Bochum, Germany)
111
17:00 How can I improve the weaning process?
B. Schoenhofer (Hanover, Germany)
112
Room Europa 2
Postgraduate Course 14
14:00–17:30
PG14 Core Curriculum Postgraduate Course: COPD: management of advanced
disease
Aims: This is the third course in a three-year postgraduate core curriculum on COPD. Participants can attend a single module and
earlier modules in the series can be viewed on the ERS e-learning resources. This last course focuses on severe COPD and will cover
important issues related to the management of advanced disease and the care of end-stage patients.
The specific aims of the third module in the series are:
- to discuss indications for oxygen treatment;
- to describe the clinical picture of an acute exacerbation and review its treatment, including mechanical ventilation;
- to review the important issues related to patients with severe, end-stage COPD, including ethical considerations at the end-of-life
stage;
- to discuss the role for surgery in and for COPD, including lung transplantation.
Target audience: Trainees, chest physicians, intensivists, thoracic surgeons and primary care practitioners.
s
es
Chairs: B. Balbi (Veruno, Italy), C. Löfdahl (Lund, Sweden)
14:00 Indications for oxygen treatment in COPD
M. Morgan (Leicester, United Kingdom)
85
14:45 Managing severe acute exacerbations in COPD, including mechanical ventilation
N. Ambrosino (Pisa, Italy)
86
15:30 Break
87
16:00 Severe COPD: home care, palliative treatment and end-of-life issues
S. Nava (Pavia, Italy)
88
16:45 Indications and results of surgical intervention in COPD, including lung transplantation
D. Van Raemdonck (Leuven, Belgium)
89
ERS Berlin 2008 Annual Congr
144
S A T U R D A Y O C T O B E R 4
Room 5.2c
Postgraduate Course 15
14:00–17:30
PG15 High-resolution computed tomography of the lung: pattern recognition and
role in diagnosis
Aims: A good understanding of the interpretation of high-resolution computed tomography (HRCT) is now an essential requirement
for modern practice in respiratory medicine. It is often the basis of a good differential diagnosis. This course is designed for pulmonary
specialists, trainees and any others who require a basic update on the interpretation and diagnostic applications of HRCT appearance
patterns.
At the end of this course participants will be able to:
- recognise the different basic HRCT appearance patterns of lung disease;
- suggest a good differential diagnosis based on the recognition of these appearance patterns and on the study of the distribution
pattern.
Target audience: Specialists and trainees in respiratory medicine, clinicians in general.
Chairs: R. Kubale (Pirmasens, Germany), C. Schaefer-Prokop (Amsterdam, The Netherlands)
14:00 Nodular pattern
M. Maffessanti (Trieste, Italy)
113
14:45 Reticular pattern
M. Storto (Chieti, Italy)
114
15:30 Break
115
16:00 Increased lung attenuation
K. Malagari (Papagou, Greece)
116
16:45 Decreased lung attenuation
C. Schaefer-Prokop (Amsterdam, The Netherlands)
117
Room New York 3
Postgraduate Course 16
14:00–17:30
PG16 Basic principles of cardiopulmonary exercise testing and interpretation
Aims: There is an ongoing need in Europe and beyond for workshops on cardiopulmonary exercise testing (CPET) for a range of
clinically based populations and therapeutic paradigms. The main focus of this course is on practical aspects of clinical CPET.
Indications, protocols, measurements and data interpretation will be discussed. The sensitivity and specificity of different response
patterns will be reviewed. At the end of the course, participants will be able to:
- understand the physiological significance of cardiorespiratory response profiles;
- describe the typical response profiles observed in patients with different cardiac and respiratory diseases;
- recognise the prognostic value of particular CPET indices.
Target audience: Clinicians and scientists with interest in cardiorespiratory medicine and/or clinical rehabilitation, exercise
physiologists, and respiratory therapists. Participants will be expected to have some knowledge of exercise physiology.
Chairs: L. Puente Maestu (Madrid, Spain), S. Ward (Crickhowell, United Kingdom)
14:00 Physiological principles of exercise physiology
S. Ward (Crickhowell, United Kingdom)
80
14:45 Optimising measurement and design
R. Casaburi (Rancho Palos Verdes, United States of America)
81
15:30 Break
82
16:00 Exercise testing in the evaluation of interventions
L. Puente Maestu (Madrid, Spain)
83
16:45 Prognostic value of exercise testing
P. Palange (Rome, Italy)
84
s
Room Berlin
Postgraduate Course 17
14:00–17:30
es
PG17 An expert view of the differences between asthma and COPD
Aims: The purpose of this course is to provide an expert view on some major unresolved issues in asthma and COPD. We need to
evaluate new diagnostic tools for asthma and COPD; to target older people in epidemiological studies to identify and describe the
extent of asthma; to define the clinical and physiological features of asthma and COPD in older people that indicate when and which
treatments will achieve maximum benefit with least harm; to develop strategies for better, patient-focused care of people with severe
airway disease, concentrating on device use, action plans, side effects, end-of-life decisions, exercise and independence in activities
of daily living; and to maintain research into new drugs and targets for preventing progressive loss of lung function in asthma and
COPD.
The main learning objectives of the course are:
- to consider the essential differences in the inflammatory process that lead to different pathological outcomes in asthma and COPD;
- to discuss what factors cause some patients with asthma to have clinical features indistinguishable from COPD, and whether these
patients should be treated differently from those with early-onset, atopic asthma;
- to inform whether the response to bronchodilators in asthma and COPD predicts prognosis and response to other interventions;
ERS Berlin 2008 Annual Congr
- to know whether people with asthma (airway obstruction, hyperresponsiveness and atopy) and COPD (fixed airflow limitation) have
different natural histories, responses to treatment and prognoses.
145
S A T U R D A Y O C T O B E R 4
Target audience: Pulmonary and critical care physicians, allergists, pulmonary and allergy postdoctoral fellows, nurses, clinical
researchers.
Chairs: A. Rossi (Bergamo, Italy), J. C. Virchow (Rostock, Germany)
14:00 Mechanisms in chronic obstructive pulmonary disease: comparisons with asthma
P. J. Barnes (London, United Kingdom)
75
14:45 Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary
disease
D. S. Postma (Groningen, The Netherlands)
76
15:30 Break
77
16:00 Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations
K. F. Rabe (Leiden, The Netherlands)
78
16:45 Therapeutic responses in asthma and chronic obstructive pulmonary disease
M. Cazzola (Rome, Italy)
79
Room 1.2c
Postgraduate Course 18
14:00–17:30
PG18 Respiratory infections in immunosuppressed children
Aims: The main aim of this course is to update the audience on the prevalence, diagnosis and management of paediatric respiratory
infections in various immunological conditions or disorders. The improved survival of children with immunological disorders, the
increased survival of paediatric oncology patients, and the altered virulence or prevalence of pathogens continue to affect the way
opportunistic infections present themselves and need to be managed.
Target audience: Clinical pneumologists, paediatricians, respiratory infection specialists, thoracic oncologists, transplant surgeons.
Chairs: P. J. F. M. Merkus (Nijmegen, The Netherlands), L. Dracea (Brasov, Romania)
14:00 Respiratory infections in congenital immunological disorders
A. Cant (Newcastle-upon-Tyne, United Kingdom)
124
14:45 Respiratory infections in transplant patients
H. Hirsch (Basel, Switzerland)
125
15:30 Break
126
16:00 Respiratory infections in HIV patients
V. Novelli (London, United Kingdom)
127
16:45 Respiratory infections in oncology patients
N. Hartwig (Rotterdam, The Netherlands)
128
Room 5.2a
Postgraduate Course 19
14:00–17:30
PG19 Ventilatory management and cough enhancement in patients with
neuromuscular disease
Aims: Respiratory management of neuromuscular disease is commonly overlooked, and simple measures and techniques that are
not universally taught or used can make large differences to the patients’ morbidity and quality of life, as well as to mortality. This
course aims to provide participants with the tools and knowledge to better manage these patients by providing the following:
- knowledge of the main issues in mechanisms, diagnosis and management of respiratory failure and inadequate cough;
- an update in respiratory assessment and patient evaluation;
- an update in intervention and clinical management of chronic, and prevention of acute, ventilatory failure;
- updates of current evidence and practical descriptions for inspiratory and expiratory aids and techniques for secretion
management.
Target audience: Pulmonary and paediatric physicians, intensivists and allied health professionals with an interest in neuromuscular
s
disorders.
es
Chair: J. Bott (Chertsey, United Kingdom)
14:00 Ventilatory impairment in neuromuscular dysfunction: What to measure? When to treat?
A. Simonds (London, United Kingdom)
102
14:35 Cough dysfunction: What to measure? When to treat?
J. Winck (Porto, Portugal)
103
15:10 Managing respiratory failure and symptom control in acute and chronic settings
M. Toussaint (Brussels, Belgium)
104
15:45 Break
105
16:20 Manual techniques for lung expansion and cough augumentation
M. Goncalves (Porto, Portugal), J. Bott (Chertsey, United Kingdom)
106
16:55 Mechanical aids for secretion clearance
M. Chatwin (London, United Kingdom), M. Toussaint (Brussels, Belgium)
107
ERS Berlin 2008 Annual Congr
146
S A T U R D A Y O C T O B E R 4
Room 1.2e
Postgraduate Course 20
14:00–17:30
PG20 Advances in the diagnosis of Mycobacterium tuberculosis infection: an
interactive, case-based course
Aims: Recently, advances in the diagnosis of Mycobacterium tuberculosis (MTB) infection have been made, modifying the traditional
approach to diagnosis of MTB infection. This course is composed of a mixture of presentations and interactive case discussions. All
speakers have recently published important papers on the specific topics discussed.
The main aim of this course is to update participants on the current advances in knowledge regarding the diagnosis of active and
latent infection with MTB. At the end of the course participants will be able to:
- understand the correct methodological approach to the diagnosis of tuberculosis;
- define the different new diagnostic tools for the detection of MTB infection;
- understand the advantages of the new techniques in the diagnosis of tuberculosis in special populations;
- understand the open questions for research in this field.
Target audience: Clinicians, microbiologists and public health specialists involved in tuberculosis care, surveillance, control and
research. Fellows and training specialists interested in updating their knowledge regarding the diagnosis of tuberculosis.
Chairs: A. W. J. Bossink (Utrecht, The Netherlands), C. Lange (Borstel, Germany)
14:00 Interactive case presentation 1: clinical management of active tuberculosis, including reading of chest
radiographs
J-P. Zellweger (Fribourg, Switzerland)
129
14:45 Update: T-cell interferon- release assays for the diagnosis of MTB infection
L. Richeldi (Modena, Italy)
130
15:30 Break
131
16:00 Interactive case presentation 2: differentiation between active and latent TB infection
S. Arend (Leiden, The Netherlands)
132
16:45 Outlook: Future developments for the diagnosis of MTB infection
D. Goletti (Rome, Italy)
133
Room Paris 2
Postgraduate Course 21
14:00–17:30
PG21 Practical problems with aerosol therapy
Aims: Inhalation is the preferred route of delivery for anti-asthma drugs. However, the proliferation of inhaler devices has resulted in
a confusing number of choices for clinicians who are selecting a delivery device for aerosol therapy. There are advantages and
disadvantages associated with each device category. In reality, inhalers are often prescribed on an empirical basis rather than on
evidence-based awareness. Evidence-based recommendations for the selection of the appropriate aerosol delivery device in specific
clinical settings are needed.
The main aims of this course are:
- to compare the efficacy and adverse effects of treatment using different device categories;
- to illustrate the differences in the selection criteria according to who you are asking (i.e. the inhalation technologist, the physician
or the patient);
- to provide recommendations to clinicians to aid them in selecting a particular aerosol delivery device for their patients.
Target audience: Pulmonary and critical care physicians, fellows, nurses, and respiratory therapists.
Chairs: G. Joos (Ghent, Belgium), D. Olivieri (Parma, Italy)
14:00 A comparison of the effectiveness of different inhaler devices
S. Newman (Nottingham, United Kingdom)
97
14:45 Device selection in the outpatient setting
N. Hanania (Houston, United States of America)
98
15:30 Break
s
99
es
16:00 Device selection in the hospital acute care setting
B. J. O’Connor (London, United Kingdom)
100
16:45 Use of inhaler devices in children
S. Pedersen (Kolding, Denmark)
101
ERS Berlin 2008 Annual Congr
147
S A T U R D A Y O C T O B E R 4
Room Paris 1
Postgraduate Course 22
14:00–17:30
PG22 Interventional bronchoscopy: theory and practice
Aims: The main aim of this course is to expose pulmonary fellows and practising pulmonary physicians to advanced, yet simple,
practical pulmonary interventions. Didactic lectures will be followed by practical demonstrations and possibilities for hands-on
experiences. At the conclusion of this course, participants will:
- be able to recognise indications and contra-indications of various interventions;
- be able to identify benefits and limitations of these interventions;
- have experienced a first hands-on training tutored by world experts in the field.
Target audience: Pulmonary fellows, pulmonary physicians, thoracic surgeons.
Chairs: F. Herth (Heidelberg, Germany), J. Janssen (Nijmegen, The Netherlands)
14:00 “Old” diagnostic techniques revisited: transbronchial needle aspiration (TBNA)
S. Gasparini (Ancona, Italy)
90
14:30 New diagnostic techniques: real-time endobronchial ultrasound (rtEBUS), trans-oesophageal ultrasound-guided
fine needle aspiration and navigation
F. Herth (Heidelberg, Germany)
91
15:00 Indications and anaesthesia for interventional bronchoscopy
M. Noppen (Brussels, Belgium)
92
15:30 Break
93
16:00 Rapid desobstruction techniques: laser and electrocautery
J. Janssen (Nijmegen, The Netherlands)
94
16:30 Delayed desobstruction techniques (cryo-, brachy- and phototherapy)
J. Vergnon (St-Etienne, France)
95
17:00 Silicone stents and metal stents
L. Freitag (Hemer, Germany)
96
Room 1.2g
Educational Workshop
14:00–17:30
WS1 Gene–environment interactions: challenges and pitfalls in study design,
ethical issues and statistical analyses
Aims: National and international studies on gene–environment interactions are conducted all over the world. However, many of them
are faced with problems of small sample sizes and inadequate methods of statistical analyses.
This workshop will include problem-based learning discussions and should enable participants to find an adequate, powerful study
design. Furthermore, they should be able to deal with ethical issues and have an idea about different methods to analyse data of
gene–environment interactions. They will also be able to read scientific papers on gene–environment interactions more critically.
Target audience: Researchers (general, occupational, environmental, paediatrics and adults), epidemiologists, physicians reading
the scientific literature.
Chairs: T. Sigsgaard (Aarhus, Denmark), K. Radon (Munich, Germany)
14:00 How to design powerful international studies on gene–environment interaction
M. Kabesch (Munich, Germany)
118
14:40 Ethical challenges in international studies on gene–environment interaction
F. Kauffmann (Villejuif, France)
119
15:20 Break
120
15:50 Statistical analysis of gene–environment interactions – all just chance?
M. Kogevinas (Barcelona, Spain)
121
s
16:30 Genetic programming optimised neural network (GPNN) as a method for improved identification of
es
gene–environment interactions
A. Motsinger (Raleigh, United States of America)
122
17:10 Concluding consensus discussion
123
ERS Berlin 2008 Annual Congr
148
S U N D A Y O C T O B E R 5
Room 1.2a
Session 32
08:30–10:30
Maurizio Vignola Award on Innovation in Pneumology (supported by the Chiesi
Foundation)
Chair: E. Bel (Amsterdam, The Netherlands)
08:30 Introduction
E. Bel (Amsterdam, The Netherlands)
138
08:35 Maurizio Vignola Award on Innovation in Pneumology
D. Hartl (Munich, Germany)
139
Room 1.2a
Session 33
Scientific year in review: airway remodelling
Aims: This symposium presents some of the recent concepts in understanding the pathobiology and molecules related to the
development of lung disease. This will accelerate the dissemination of scientific advances in the improvement of clinical care to the
medical and scientific respiratory community.
Target audience: Scientists, clinical researchers, pulmonary physicians.
Chairs: E. Bel (Amsterdam, The Netherlands), T. Geiser (Bern, Switzerland)
08:50 Chitinases and airways remodelling
J. C. Virchow (Rostock, Germany)
134
09:15 Is COPD an autoimmune disease?
N. Voelkel (Richmond, United States of America)
135
09:40 Dendritic cells and the regulation of the immune response
M. Idzko (Freiburg, Germany)
136
10:05 Hypoxia signalling and sensing
P. Ratcliffe (Oxford, United Kingdom)
137
Room 2.2a
Session 34
08:30–10:30
Symposium: COPD – the holistic perspective
Aims: This symposium will:
- emphasise the notion that COPD is often associated with other medical conditions (e.g. anaemia, heart failure and systemic
inflammation) that may contribute to morbidity and mortality;
- provide an update on the possible mechanisms that may explain the strong association between COPD and cardiovascular disease;
- point out that smoking cessation is an important component of COPD management because of its direct influence on the driving
aetiological factor and for its indirect beneficial effect on the smoking-related medical conditions frequently associated with COPD.
Target audience: Pulmonologists, allergists, cardiologists, internists, primary care physicians, fellows-in-training, medical students,
clinical research coordinators.
Chairs: E. F. M. Wouters (Maastricht, The Netherlands), M. Cazzola (Rome, Italy)
08:30 Recognising the importance of anaemia in COPD
T. Similowski (Paris, France)
140
09:00 Heart failure and COPD: an ignored combination?
A. Hoes (Utrecht, The Netherlands)
141
09:30 COPD and systemic inflammation
A. Agusti (Palma de Mallorca, Spain)
142
10:00 Successful smoking cessation: the internist view
R. Polosa (San Gregorio, Italy)
143
s
Room Dublin
Session 35
08:30–10:30
es
Symposium: The use of field exercise tests in clinical services
Aims: This symposium will:
- introduce the key field exercise tests, i.e. incremental shuttle walk test (ISWT), 6-minute walking distance (6MWD) and endurance
shuttle walk test (EWT);
- outline the role of these field exercise tests in modern respiratory assessment;
- outline the advantages and limitations of ISWT, EWT and 6MWD tests.
Target audience: Doctors, nurses, physiotherapists, scientists, technologists in primary and secondary care.
Chairs: B. G. Cooper (Birmingham, United Kingdom), S. Ward (Crickhowell, United Kingdom)
08:30 Introduction to field exercise testing
S. Singh (Leicester, United Kingdom)
144
09:00 The role of field exercise testing
S. Jenkins (Perth, Australia)
145
ERS Berlin 2008 Annual Congr
09:30 Results and interpretation of field exercise tests
T. Troosters (Leuven, Belgium)
146
10:00 Exercise training and exercise capacity
149
H. Magnussen (Grosshansdorf, Germany)
147
S U N D A Y O C T O B E R 5
Room 5.2b
Session 36
08:30–10:30
Symposium: Night time is not the right time – nocturnal aspects of asthma
Aims: This symposium will give an update on the impact of night symptoms and daytime sleepiness caused by asthma.
Target audience: Clinicians, general practitioners, paediatricians, nurses.
Chairs: C. Janson (Uppsala, Sweden), P. Burney (London, United Kingdom)
08:30 Insomnia and sleepiness in asthmatics
C. Janson (Uppsala, Sweden)
148
08:54 Nocturnal asthma – a review
M. Kraft (Durham, United States of America)
149
09:18 Gender aspects of nocturnal asthma
C. Svanes (Bergen, Norway)
150
09:42 Asthma and gastro-oesophageal reflux
T. Kiljander (Pikkio, Finland)
151
10:06 Asthma, snoring and sleep apnoea
T. Gislason (Reykjavik, Iceland)
152
Room Helsinki
Session 37
08:30–10:30
Symposium: Management of cystic fibrosis in 2008
Aims: The aims of this symposium are to give an update on the moving fields in cystic fibrosis, from background information on
recent developments in research to practical guidelines on new treatment strategies in paediatric as well as adult patients with cystic
fibrosis.
Target audience: Pulmonologists, paediatricians, nurses, physiotherapists and researchers with an interest in cystic fibrosis.
Chairs: L. Mared (Lund, Sweden), C. Knoop (Brussels, Belgium)
08:30 Standard of care in childhood
J. Davies (London, United Kingdom)
153
09:00 Which changes in the adult patient
A. Boehler (Zurich, Switzerland)
154
09:30 Surgical management for evolutive complications
P. Thomas (Marseille, France)
155
10:00 When to transplant for which results?
P. Corris (Newcastle-upon-Tyne, United Kingdom)
156
Room Budapest
Session 38
08:30–10:30
Hot Topic: New age lung carcinogenesis: clinical impact
Aims: To provide the most recent information on biomarker strategies to select patients by individual risk and predict the success of
specific treatments.
Target audience: Clinicians, oncologists, surgeons, biologists.
Chairs: C. Brambilla (Grenoble, France), R. M. Huber (Munich, Germany)
08:30 Introduction: new age of lung carcinogenesis
C. Brambilla (Grenoble, France)
157
08:54 The natural history of lung cancer: lessons from early detection
C. Henschke (New York, United States of America)
158
09:18 How to select patients for chemotherapy
E. Brambilla (Grenoble, France)
159
s
09:42 Predictive biomarkers for targeted therapy
es
F. Hirsch (Aurora, United States of America)
160
10:06 Harvesting biomarkers for early risk assessment
P. Yang (Taipei, Taiwan, Republic of China)
161
Room Berlin
Session 39
08:30–10:30
Oral Presentation: New methods to diagnose tuberculosis infection and disease
Chairs: C. Lange (Borstel, Germany), L. Richeldi (Modena, Italy)
08:30 Comparison of BAL ELISPOT and NAT for the diagnosis of smear-negative tuberculosis – a TBNET study
C. Jafari, S. Thijsen, A. Bossink, D. Goletti, M. Losi, L. Richeldi, L. Codecasa, A. Strassburg, U. Greinert, B. Kalsdorf,
D. Kirsten, S. Winteroll, R. Eberhardt, M. Ernst, C. Lange (Borstel, Großhansdorf, Heidelberg, Germany; Utrecht,
The Netherlands; Rome, Modena, Milan, Italy)
162
08:45 Response to RD1 selected epitopes is associated to active TB. Results of a European multicentre
ERS Berlin 2008 Annual Congr
hospital-based study of the European tuberculosis network (TBNET)
D. Goletti, S. Carrara, C. Lange, F. Mengoni, C. Mastroianni, D. Cirillo, R. Markova, R. Drenska, J. Dominguez,
150
I. Latorre, M. Amicosante, C. Saltini, E. Girardi (Rome, Milan, Italy; Borstel, Germany; Sophia, Bulgaria;
Barcelona, Spain)
163
S U N D A Y O C T O B E R 5
09:00 Rapid diagnosis of tuberculous meningitis by enumeration of cerebrospinal fluid antigen-specific T cells
T. Hinks, M. Thomas, S. Raghuraman, N. Ramalingam, M. Ernst, R. Nau, K. Koesters, C. Gnanamuthan, G. John,
B. Marshall, A. Lalvani (Southampton, London, United Kingdom; Vellore, India; Borstel, Krefeld, Germany)
164
09:15 Performance of blood tests for the diagnosis of latent tuberculosis infection in children
B. M. Bergamini, M. Losi, F. Vaienti, M. Meacci, B. Meccugni, D. De Giovanni, C. Molinari, L. Richeldi
(Modena, Italy)
165
09:30 Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10
M. Ruhwald, N. Hiroshi, L. Cuevas, J. Petersen, K. Kofoed, L. Lawson, S. B. Squire, J. Eugen-Olsen, P. Ravn
(Copenhagen, Denmark; Liverpool, United Kingdom; Abuja, Nigeria)
166
09:45 Memory response to RD1 antigens in TST+ subjects: a better tool to detect LTBI?
S. Carrara, O. Butera, V. Vanini, T. Chiacchio, R. Casetti, F. Lauria, P. Laurenti, E. Girardi, D. Goletti (Rome, Italy)
167
10:00 IFN- response on T-cell based assays in HIV patients for detection of tuberculosis infection
I. Latorre, A. Lacoma, M. De Souza-Galvao, C. Prat, L. Haba, J. Maldonado, C. Tural, G. Sirera, N. Altet, J. Ruiz-
Manzano, J. Domínguez (Badalona, Madrid, Barcelona, Spain)
168
10:15 Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of infection with Mycobacterium
tuberculosis
M. Ruhwald, T. Bodmer, C. Maier, M. Jepsen, M. Bonde Andersen, P. Ravn (Copenhagen, Denmark;
Bern, Switzerland)
169
Room 5.2c
Session 40
08:30–10:30
Oral Presentation: Pathophysiology of acute lung injury
Chairs: P. Rocco (Rio de Janeiro, Brazil), S. Orfanos (Haidari, Greece)
08:30 The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury
I. Araujo, S. Abreu, F. Cruz, L. Fujisaki, L. F. Prota, D. Ornellas, C. Baez-Garcia, H. Castro-Faria-Neto, E. Parra,
W. Teodoro, V. Capelozzi, C. Peres da Costa, P. Pelosi, M. Morales, P. Rocco (Rio de Janeiro, Sao Paulo, Recife,
Brazil; Varese, Italy)
170
08:45 Effect of activated protein C on cell contraction of human alveolar epithelial cells subjected to thrombin
F. Puig, M. Adda, O. Marti-Sistac, D. Navajas, R. Farre, A. Artigas (Sabadell, Barcelona, Bunyola, Spain)
171
09:00 Mechanical ventilation in healthy lungs and micromechanics: increase in tissue elastance and resistance
in the non dependant lung within 30 min
C. C. Calciolari, V. S. Piccin, T. Lanças, K. Yoshizaki, S. Gomes, D. Frediani-Barbeiro, M. Dolhnikoff, E. M. Negri
(Sao Paulo, Brazil)
172
09:15 Crackle sound analysis in a porcine ARDS model to create a non-invasive recruitment monitoring
S. J. Schließmann, K. Möller, Y. Lu, G. Wagner, J. Guttmann (Freiburg, Villingen-Schwenningen, Germany)
173
09:30 Open lung positive end-expiratory pressure (PEEP) titration by respiratory system input reactance (Xrs)
R. Dellaca, M. Andersson-Olerud, E. Zannin, P. Kostic, P. Pompilio, M. Romano, S. Bernardinello, A. Pedotti,
P. Frykholm, G. Hedenstierna (Milan, Italy; Uppsala, Sweden)
174
09:45 Serum inflammatory response during weaning from mechanical ventilation
J. Sellares, M. Ferrer, H. Loureiro, X. Filella, C. Esquinas, R. Piner, R. Farre, A. Torres (Barcelona, Mallorca, Spain) 175
10:00 Exhaled nitric oxide in brain-injured, mechanically ventilated patients with no acute lung injury or sepsis
I. Korovesi, E. Papadomichelakis, A. Kotanidou, C. Sotiropoulou, A. Koutsoukou, I. Dimopoulou, A. Armaganidis,
C. Roussos, N. Marczin, S. Orfanos (Athens, Haidari, Greece; London, United Kingdom)
176
10:15 Physiologic comparison of pressure support ventilation and neurally adjusted ventilatory assist at
different levels of assistance
G. Cammarota, D. Colombo, V. Bergamaschi, M. De Lucia, F. Della Corte, P. Navalesi (Novara, Italy)
177
s
Room Europa 2
Session 41
08:30–10:30
es
Oral Presentation: The role of flexible bronchoscopy and bronchoalveolar lavage
in lower airway disease
Chairs: S. Cunningham (Edinburgh, United Kingdom), I. Azevedo (Porto, Portugal)
08:30 A new ABCA3 gene mutation in a now 2-yr-old boy
E. Eber, G. Thalhammer, G. Zobel, M. Griese, C. Aslanidis, G. Schmitz, H. Popper, M. Zach (Graz, Austria;
Munich, Regensburg, Germany)
178
08:45 Safety of double endoscopy in children with gastroesophageal reflux and difficult-to-treat respiratory
symptoms
N. Ullmann, M. Silvestri, O. Sacco, A. Pistorio, S. Panigada, A. Barabino, G. A. Rossi (Genoa, Italy)
179
09:00 Inflammatory mediators in the BAL of children in relation to asthma and atopy
D. Snijders, P. Dalla Via, E. Michelin, T. Tagliaferro, S. Baraldo, G. Turato, K. Lokar-Oliani, M. Saetta, A. Barbato
(Padova, Italy)
180
ERS Berlin 2008 Annual Congr
09:15 Bronchological examinations in the neonatal intensive care unit
L. Kovacs (Budapest, Hungary)
181
151
S U N D A Y O C T O B E R 5
09:30 Multiple bronchoalveolar lavage as an important tool for treating lipoid pneumonia associated with ascariasis
S. Sias, P. Daltro, E. Marchiori, R. Caetano, T. Quirico-Santos (Niterói, Rio de Janeiro, Brazil)
182
09:45 The role of bronchoscopy in children with atelectasis
S. Galbova, B. Dimceva, B. Manceva, L. Petrusevska, K. Obocki (Skopje, FYROM)
183
10:00 Role of temporary bronchial endoscopic occlusion (TBEO) in surgical pulmonology
P. Gvetadze, N. Adamia (Tbilisi, Georgia)
184
10:15 Primary bronchomalacia successfully treated with bronchopexy
S. Banac, V. Ahel, V. Rozmanic, K. Manestar, A. Ivancic, V. Curuvija (Rijeka, Croatia)
185
Room Paris 1
Session 42
08:30–10:30
Oral Presentation: Environmental risk factors for respiratory symptoms and COPD
Chairs: B. Lundbäck (Gothenburg, Sweden), I. Annesi-Maesano (Paris, France)
08:30 Vehicle exhausts outside home and incident asthma among adults. A prospective cohort study in three
Swedish cities
L. Modig, K. Torén, B. Forsberg (Umea, Gothenburg, Sweden)
186
08:45 Air travel and respiratory related symptoms in patients with COPD and controls
A. Edvardsen, A. Akerø, T. M. Eagan, M. Ryg, J. Hardie, P. Bakke, O. H. Skjønsberg (Hakadal, Oslo, Bergen,
Norway)
187
09:00 Are spirometric criteria good predictors of longitudinal outcomes in COPD patients without taking chronic
respiratory symptoms into account? Results from ECRHS
R. de Marco, S. Accordini, C. Janson, D. Jarvis, M. Wjst, P. Burney (Verona, Italy; Uppsala, Sweden; London,
United Kingdom; Neuherberg, Germany)
188
09:15 Yearly seasonal changes in COPD exacerbations, cold symptoms, temperature and hours of sunlight
J. Goldring, G. Donaldson, R. Baghai Ravary, J. Hurst, J. Wedzicha (London, United Kingdom)
189
09:30 Relationships between school indoor viable moulds and dry cough at night in children of five European
countries (HESE study)
M. Simoni, I. Annesi-Maesano, T. Sigsgaard, D. Nordback, G. Wieslander, W. Nystad, M. Canciani, G. Viegi,
P. Sestini (Pisa, Siena, Italy; Paris, France)
190
09:45 Social class, climate, and building age as confounders influencing associations between respiratory
ymptoms, moulds and dampness in dwellings within the ERCHS-II
D. Norback, E. Plana, J. P. Zock, J. Heinrich, C. Svanes, J. Sunyer, N. Kunzli, S. Villani, M. Olivieri, A. Soon,
D. Jarvis (Uppsala, Sweden; Barcelona, Spain; Neuherberg, Germany; Bergen, Norway; Pavia, Verona,
Italy; Tartu, Estonia; London, United Kingdom)
191
10:00 Gender differences in the relation between respiratory symptoms and emphysema estimated by HRCT
T. Grydeland, H. Coxson, A. Dirksen, S. Sharma, S. Pillai, W. Anderson, A. Gulsvik, P. Bakke (Bergen, Norway;
Vancouver, Canada; Copenhagen, Denmark; NC, United States of America)
192
10:15 The lifetime risk of developing COPD. The Rotterdam study
Y. van Durme, K. Verhamme, G. Van Pottelberge, T. Stijnen, G. Joos, A. Hofman, B. Stricker, G. Brusselle (Ghent,
Belgium; Rotterdam, Leiden, The Netherlands)
193
Room Paris 2
Session 43
08:30–10:30
Oral Presentation: New insights into the pathogenesis of idiopathic pulmonary
fibrosis and sarcoidosis
Chairs: M. Petrek (Olomouc, Czech Republic), L. Nicod (Bern, Switzerland)
08:30 Defective p53-mediated pro-apoptotic pathway in idiopathic pulmonary fibrosis
s
A. Ricci, S. Mariotta, E. Cherubini, L. Tabi, L. Pisani, P. Bruno, S. Sciacchitano (Rome, Italy)
194
es
08:45 Nanoparticle-assisted gene delivery in a bleomycin-injured lung fibrosis model
C. von Garnier, A. Gazdhar, A. Fink, H. Hofmann, L. Nicod, T. Geiser (Bern, Lausanne, Switzerland)
195
09:00 Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4
(SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study
A. Proklou, K. Antoniou, G. Soufla, F. Economidou, K. Samara, M. Manousakis, I. Drositis, D. Spandidos,
N. Siafakas (Heraklion, Greece)
196
09:15 Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs)
in patients with idiopathic pulmonary fibrosis (IPF)
K. Antoniou, H. Papadaki, G. Soufla, A. Darivianaki, H. Koutala, M. C. Kastrinaki, D. Spandidos, N. Siafakas
(Heraklion, Greece)
197
09:30 NIR spectroscopy of penetrating light and its diagnostic value in idiopatic pulmonary
J. Votruba, T. Bruha, T. Baláz (Prague, Brno, Czech Republic)
198
09:45 A possible role for toll-like receptor (TLR) 5 in fibrotic pulmonary sarcoidosis
ERS Berlin 2008 Annual Congr
M. Veltkamp, J. Grutters, C. van Moorsel, G. Rijkers, H. Ruven, J. van den Bosch (Nieuwegein, The Netherlands)
199
152
S U N D A Y O C T O B E R 5
10:00 Chemokine mRNA expression profiling in pulmonary sarcoidosis
E. Kriegova, R. Fillerova, A. Arakelyan, F. Mrazek, B. Hutyrova, V. Kolek, R. du Bois, M. Petrek (Olomouc, Czech
Republic; Denver, United States of America)
200
10:15 Frequency of beryllium and mycobacterial specific blood CD4+ T-cells in patients with sarcoidosis
L. Cervis, G. Zissel, N. Lutzen, J. Muller-Quernheim, A. Prasse (Bucharest, Romania; Freiburg, Germany)
201
Room 5.2a
Session 44
08:30–10:30
Oral Presentation: Respiratory muscle pathophysiology
Chairs: A. Schols (Maastricht, The Netherlands), J. Gea (Barcelona, Spain)
08:30 Evidence for early onset of skeletal muscle abnormalities in smoking mice
H. Gosker, R. Langen, K. Bracke, G. Joos, E. Wouters, A. Schols, B. Guy (Maastricht, The Netherlands; Ghent,
Belgium)
202
08:45 Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with
muscle wasting
A. Remels, H. Gosker, J. Gea, P. Sliwinski, M. Polkey, J. Galdiz, A. Schols (Maastricht, The Netherlands; Barcelona,
Vizcaya, Spain; Warsaw, Poland; London, United Kingdom)
203
09:00 Neural respiratory drive in patients with COPD
H. D. Wu, C. Jolley, Y. R. Lu, J. Steier, J. Moxham, M. I. Polkey, Y. M. Luo, N. S. Zhong (Guangzhou, China; London,
United Kingdom)
204
09:15 Signaling of angiopoietin-1 in human skeletal cells: role of NADPH oxidase
M. Mofarrahi, F. Vilhardt, S. Hussain (Montreal, Canada; Copenhagen, Denmark)
205
09:30 Contribution of respiratory muscle blood flow to exercise-induced diaphragmatic fatigue in trained cyclists
I. Vogiatzis, D. Athanasopoulos, R. Boushel, J. Guenette, M. Koskolou, H. Wagner, C. Roussos, P. Wagner,
S. Zakynthinos (Athens, Greece; Vancouver, Montreal, Canada; San Diego, United States of America)
206
09:45 Damage and expression of TNF receptors in respiratory muscles of COPD patients: temporal sequence
C. Casadevall, C. Coronell, A. Ramirez-Sarmiento, M. Orozco-Levi, E. Barreiro, J. Gea (Barcelona, Spain)
207
10:00 Aminophylline increases respiratory muscle activity during hypercapnia in humans
M. Yokoba, M. Katagiri, Y. Nishii, T. Yanaihara, Y. Okada, N. Masuda, P. Easton, T. Abe (Sagamihara, Izu, Japan;
Calgary, Canada)
208
10:15 Effects of swallowing and inspiratory efforts on pharyngeal cortical control and pharyngeal muscle strength
E. Verin, Y. Ouahchi, J. P. Marie (Rouen, France)
209
Room New York 1
Session 45
08:30–10:30
Oral Presentation: New imaging techniques in chest imaging
Chairs: R. Kubale (Pirmasens, Germany), C. Dooms (Leuven, Belgium)
08:30 EBUS TBNA and EUS FNA in preventing unnecessary surgical procedures
M. Krasnik, R. Eberhart, B. Skov, F. Herth (Copenhagen, Denmark; Heidelberg, Germany)
210
08:45 Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer
S. Krueger, A. Buck, G. Glatting, S. Pauls, G. Halter, S. Reske (Aachen, Munich, Ulm, Germany)
211
09:00 18F-FDG-PET/CT appearances in pulmonary fibrosis; initial experience
T. Win, A. Groves, N. Screaton, M. Berovic, H. Booth, R. Endogo, P. Ell (Stevenage, London, Papworth Everard,
United Kingdom)
212
09:15 Quantitative perfusion lung SPECT (QPLS): correlation with alveolar volume in smoking patients
P. R. Masiero, S. S. Menna Barreto, M. A. F. Moreira, C. M. Mayer, R. A. Tonon, D. B. Pessoa, B. L. Spiro
(Porto Alegre, Brazil)
213
s
09:30 Quantitative analysis of volumetric computed tomography scans and pulmonary function tests in severe
es
emphysema
A. Grgic, H. Wilkens, J. M. Kuhnigk, R. Kubale, K. Franzen, A. Buecker, G. W. Sybrecht (Homburg, Pirmasens,
Bremen, Germany)
214
09:45 Narrow band imaging (NBI) – a new method in the diagnostics of pulmonary diseases
G. Ondrejka, R. Tyl (Novy Jicin, Czech Republic)
215
10:00 A novel image based method for the evaluation of regional changes in lung mechanics
W. Vos, J. De Backer, S. Verhulst, L. De Backer, K. Desager, R. Salgado, F. Wuyts, W. De Backer (Antwerp,
Belgium)
216
Room New York 2
Session 46
08:30–10:30
E-Communication Session: Wider aspects of managing respiratory disease in
primary care
Chairs: M. Levy (Wembley, United Kingdom), B. Stallberg (Uppsala, Sweden)
ERS Berlin 2008 Annual Congr
E217 The level of sexual hormones in postmenopausal women with COPD (stage I-II)
G. L. Ignatova, L. A. Stepanisheva, E. Blinova, I. Grebneva (Chelyabinsk, Russian Federation)
153
S U N D A Y O C T O B E R 5
E218 Health care professionals’ (HCPs) experiences and attitudes toward asthma management in rural communities
S. Bosnic-Anticevich, B. Kraljevski-Cvetkovski, C. Armour (NSW, Australia)
E219 The effects of vocal effort on respiratory health status in teachers
M. Micaela, M. Iustin, C. Marcela (Iasi, Romania)
E220 Effectiveness of guideline implementation within the German competence network CAPNETZ
M. Schnoor, T. Schaefer, H. Raspe, T. Welte (Lübeck, Hanover, Germany)
E221 High prevalence of poorly controlled asthma amongst patients visiting clinics in Pune City, India
B. Brashier, D. Kekan, A. Bamnikar, D. Kolte, M. Dhakar, A. Kessari, S. Valsa, S. Mandrekar, S. Limaye, S. Salvi
(Pune, Maharashtra, India)
E222 Diagnostic accuracy of lipopolysaccharide-binding protein (LBP), fibrinogen and C-reactive protein (CRP) in
differentiating pneumonia from acute bronchitis in primary care
R. Hopstaken, J. Cals, G. J. Dinant (Maastricht, The Netherlands)
E223 Novel intradermal influenza vaccine: phase 3 data in targeted adult populations
R. Arnou, G. Icardi, M. De Decker, A. Ambrozaitis, P. Eavis, J. R. De Juanes Pardo, M. P. Kazek, A. Hoffenbach (Angers,
Lyon, France; Genoa, Italy; Antwerp, Belgium; Vilnius, Lithuania; Bath, United Kingdom; Madrid, Spain)
E224 Comparability of Asthma Control Test (ACT) scores between different administration forms
J. Carranza Rosenzweig, A. E. Williams, A. Kite, M. Yang, M. Kosinski (RTP, Lincoln, United States of America)
E225 Mind the gap. A qualitative study of planned respiratory service development
H. Pinnock, G. Huby, A. Tierney, S. Hamilton, T. Kielmann, A. Powell, A. Sheikh (Edinburgh, United Kingdom)
E226 Asthma care in Wakefield prisons, UK
G. Day, L. Chandler, J. Weldon, S. Meghjee, S. Williams (Wakefield, United Kingdom)
E227 Predictive factors of asthma control in clinical practice in France
A. Didier, P. Godard, D. Vervloet, C. Pribil, G. El Azzi, P. Serrier, J. P. Dumur, S. Salmeron (Toulouse, Montpellier,
Marseille, Marly-le-Roi, Paris, Aix-en-Provence, France)
E228 Clinical implications of diagnosing underlying chronic bronchitis (CB) in at-risk patients (pts) with acute
bronchitis (AB) visiting general practitioners (GPs)
N. Roche, J. Gaillat, M. Garré, H. Bendjenana (Paris, Annecy, Brest, Rungis, France)
E229 Retrospective analysis of ambulance calls caused by severe asthma exacerbation
M. Ovcharuk, Y. Mostovoy (Vinnitsa, Ukraine)
E230 A new model of training to make spirometry in primary health care services
G. García, M. Beamud, G. Mora, J. J. Muñoz, F. Muñoz (Madrid, Spain)
E231 Prevalence of asthma symptoms in athletes in the region of Tricity (Poland)
K. Kuziemski, K. Specjalski, L. Gorska, W. Slominski, R. Kalicka, E. Jassem, M. Slominski (Gdansk, Poland)
E232 The COPD dietician: food for thought
A. Evans, G. South (Rotherham, United Kingdom)
E233 Should guidelines be revised for add-on therapy in asthma? A 2 year randomized pragmatic equivalence trial of
leukotriene antagonists (LTRAs) and long-acting beta agonists (LABAs) with inhaled corticosteroids (ICS) in
primary care
E. Sims, D. Freeman, L. Kemp, S. Musgrave, L. Juniper, R. Gilbert, J. Ayres, A. Blyth, I. Harvey, E. Wilson, M. Mugford,
S. Wolfe, L. Shepstone, J. Murdoch, D. Price (Norwich, Aberdeen, Hamilton, United Kingdom)
E234 Non-inferiority comparison of budesonide HFA (BUD-HFA) pMDI with budesonide CFC (BUD-CFC) pMDI in
patients with persistent moderate asthma
S. Saboo, D. Christopher, A. Mesquita, V. Singh, S. Salvi, M. Shete, J. Po, S. Chachad, S. Purandare, A. Lulla,
A. Sule (Hyderabad, Vellore, Goa, Jaipur, Pune, Mumbai, India)
Room New York 3
Session 47
08:30–10:30
s
E-Communication Session: Miscellaneous aspects of interstitial lung disease
es
Chairs: E. Fireman (Tel-Aviv, Israel), T. Peros Golubicic (Zagreb, Croatia)
E235 New therapy for pulmonary-renal Goodpasture’s syndrome
A. Demin (Novosibirsk, Russian Federation)
E236 Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary
fibrosis
T. Akagi, T. Matsumoto, R. Aramaki, C. Yoshimura, T. Kuraki, H. Toyoshima, M. Fujita, K. Watanabe (Fukuoka, Japan)
E237 Hypersensitivity pneumonitis: diagnostic mistakes
D. Stupachenko, O. Semendyayeva, A. Visotskiy, N. Monogarova (Donetsk, Ukraine)
E238 Non-infectious pulmonary involvement in myelodysplastic syndrome
K. Umeki, H. Ishii, A. Iwata, R. Shirai, K. Kishi, I. Tokimatsu, M. Ogata, J. I. Kadota (Yufu, Japan)
E239 Depiction of malignancy in patients with diffuse interstitial lung disease (DILD) presenting with nodular opacities
R. Triggidou, F. P. Kokkinis, I. Tsangaridou, P. Tsagouli, K. Pottaris, K. Malagari, L. Thanos, M. A. Dimadi (Athens, Lamia,
Greece)
ERS Berlin 2008 Annual Congr
E240 Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation
154
M. Sterclova, M. Vasakova, M. Metlicka, J. Pavlicek, I. Striz (Prague, Czech Republic)
S U N D A Y O C T O B E R 5
E241 Difference in accuracy of interstitial lung disease HRCT interpretation between radiologists with and without a
specialist interest in thoracic radiology
R. Heinink, B. Holloway, S. Trotter, M. Djearaman, J. Reynolds, S. Burge (Birmingham, United Kingdom)
E242 De novo interstitial fibrosis after pulmonary resection
K. Kant, M. Grootenboers (Breda, The Netherlands)
E243 Different treatment approaches according to immunological factors in pulmonary sarcoidosis
O. Tolokh, O. Ladny, N. Rudnycka (Lviv, Ukraine)
E244 Analysis of BAL and clinical-radiologic features of a population of PLCH
E. Bargagli, M. Abbritti, R. M. Refini, M. A. Mazzei, P. Rottoli (Siena, Italy)
E245 BAL cytology in pulmonary alveolar proteinosis: a review of 7 cases
I. Papanikolaou, K. Tsakanika, V. Skouras, N. Karagianidis, V. Polychronopoulos, M. Kokosi, D. Mermigkis,
E. Papageorgiou (Athens, Attiki, Greece)
E246 Pulmonary alveolar microlithiasis: report of two patients with this rare disorder.
A. Mohan, S. Gokhale, R. Guleria, P. Das, S. P. Bhatt, C. Sarkar, C. Mohan (New Delhi, India)
E247 A case with pulmonary histiocytosis X and lung cancer
B. Uskul, F. Turan, O. Bayraktar, O. Celenk, F. Aksoy, H. Turker (Istanbul, Turkey)
E248 Pulmonary Langerhans’ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular
involvement via exercise tests
A. Yilmaz, S. Akpinar, G. E. Ayten, Y. Erdogan, U. Yilmaz Turay, L. Yilmaz Aydin, B. Ciftci, C. Biber, P. Ergun, S. Sahin
(Ankara, Turkey)
E249 Are lung biopsy and steroid treatment mandatory for cryptogenic organizing pneumonia with typical radiographic
presentation such as “reversed halo sign” on CT-scan?
B. Godbert, C. Clément-Duchêne, A. D. Paoli, S. Corhut, D. Braun, D. Régent, Y. Martinet (Vandoeuvre-lès-Nancy,
Briey, France)
E250 Lung cancer in patients with cryptogenic fibrosing alveolitis
J. Homolka, M. Pesek, L. Svobodova, R. Bittenglova (Prague, Pilsen, Czech Republic)
E251 Estimation of antibiotic effect on the development of bleomycin-induced pulmonary fibrosis
L. Novikova, E. Lebedeva, L. Danilov, I. Dvorakovskaya (St Petersburg, Russian Federation)
E252 Differences in the immunolocalization of surfactant protein (SP)-A, SP-D and KL-6 in pulmonary alveolar
proteinosis
M. Kobayashi, S. Hirose, A. Murata, N. Morishita, T. Kitagawa, Y. Ohtsuki (Kochi, Matsuyama, Japan)
E253 Baseline characteristics of the Italian cohort of patients affected by pulmonary alveolar proteinosis (PAP)
Z. Kadija, I. Campo, G. Rodi, F. Mariani, A. Corsico, P. Ernesto, M. Luisetti (Pavia, Italy)
E254 Clinical presentation and outcome of fibrosing mediastinitis
T. Peikert, T. Colby, D. Midthun, E. Edell, U. Specks (Rochester, Scottsdale, United States of America)
Room London 1
Session 48
08:30–10:30
E-Communication Session: Microbiology and treatment of bronchiectasis and
exacerbations of COPD
Chair: E. Kosmas (Voula, Greece)
E255 Characterization and effects of bronchial colonization and inflammation in stable COPD patients. PAC-COPD study
A. Marin-Tapia, J. García-Aymerich, E. Monsó, J. Sauleda, M. Garcia, F. Gómez, J. M. Antó, On Behalf of the PAC-
COPD Study Group (Badalona, Barcelona, Palma Mallorca, Spain)
E256 Resolution of isolated compared to recurrent COPD exacerbations
R. Baghai-Ravary, J. Quint, J. Goldring, J. Hurst, G. Donaldson, J. Wedzicha (London, United Kingdom)
E257 Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term
s
survival
es
A. Tsimogianni, S. Papiris, S. Kanavaki, E. Manali, P. Michalopoulou, C. Sotiropoulou, C. Roussos, A. Kotanidou
(Athens, Haidari, Athens, Greece)
E258 Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during
exacerbation and after treatment
I. Tseimakh, T. Martynenko, P. Shpigotskaya (Barnaul, Russian Federation)
E259 The role of procalcitonin in the differential diagnosis and in the response to treatment of lower respiratory tract
infections
M. Kalamanoglu, B. Ceyhan, S. Aydogan, T. Kuyucu, H. Altinoz (Istanbul, Turkey)
E260 Cytokine profile of blood and sputum at infectional COPD exacerbation
S. Nesterovich (Tomsk, Russian Federation)
E261 Sputum purulence guided antibiotic therapy in patients with exacerbations of COPD requiring hospitalization
N. Soler, M. Esperatti, C. Esquinas, E. Ballester, A. Torres (Barcelona, Spain)
E262 Composition of bronchial brush-biopsies in dependence on infectional agent species at COPD exacerbation
ERS Berlin 2008 Annual Congr
S. Nesterovich, E. Bukreeva (Tomsk, Russian Federation)
E263 Antibiotic prescribing practises of hospital doctors for COPD exacerbations
I. White, V. Dudzevicius, N. Krishnaraj, S. Murphy (Middlesbrough, Doncaster, United Kingdom)
155
S U N D A Y O C T O B E R 5
E264 Are we over-prescribing antibiotics in acute hospital admissions for exacerbations of COPD?
S. Saha, W. Ahmed, C. Brook, T. Fernandez, S. Fong, P. Raines, A. Choudhury (London, Romford, United Kingdom)
E265 Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
C. Mayaud, S. Lignot, S. Lamarque, R. Lassalle, M. A. Bernard, J. L. Demeaux, D. Guillemot, B. Housset,
D. Peyramond, D. Pouchain, P. Blin, N. Moore, M. Molimard (Paris, Bordeaux, Creteil, Lyon, Vincennes, France)
E266 Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD)
A. Kosma, V. Dramba, G. Koundi, E. Markopoulou, E. Fouka, E. Kalaitzidou, N. Galanis (Thessaloniki, Greece)
E267 Pulsed moxifloxacin therapy and health status in patients with acute exacerbations of chronic obstructive
pulmonary disease (the PULSE study)
P. Jones, T. Evers, D. Haverstock, S. Sethi (London, United Kingdom; Wuppertal, Germany; Connecticut, Buffalo,
United States of America)
E268 Role of colonization on inflammation in COPD patients with bronchiectasis
M. Pappalettera, G. Migliara, A. Stefano, V. Popescu Janu, S. Dallari, B. Galbiati, L. Allegra (Milan, Italy)
E269 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
L. Ruvolo, M. Pappalettera, S. M. Donghi, G. Migliara, S. Aliberti, K. Dimakou, F. Blasi, L. Allegra (Milan, Italy; Athens,
Greece)
E270 Sputum analysis and management of non-CF bronchiectasis in Singleton hospital
A. Dushianthan, S. Packham (Swansea, United Kingdom)
E271 Non-CF bronchiectasis: nebulised colistimethate sodium improves symptoms and bacterial load in sputum of
patients with Pseudomonas aeruginosa
K. Dimakou, K. Tsikritsaki, G. Hillas, M. Toumbis (Athens, Greece)
E272 Bacterial pathogens in sputum and pharyngeal specimens in elderly chronic lung disease patients
P. Torkko, A. Palmu, L. Erkkilä, A. Saukkoriipi, T. Kilpi, T. Pascal (Tampere, Oulu, Helsinki, Finland; Rixensart, Belgium)
E273 Non-cystic fibrosis bronchiectasis: series of 89 patients
T. M. Alfaro, C. Robalo Cordeiro, M. Loureiro, M. Fontes Baganha (Coimbra, Portugal)
E274 Stable non-cystic fibrosis bronchiectasis is associated with deficiency of the pattern recognition molecule
L-Ficolin
J. Chalmers, S. MacDonald, A. Mohammed, M. Murray, S. Hart, D. Kilpatrick, A. Hill (Edinburgh, United Kingdom)
Room London 2
Session 49
08:30–10:30
E-Communication Session: Pathophysiology of pulmonary hypertension
Chairs: J. Barbera (Barcelona, Spain), R. Naeije (Brussels, Belgium)
E275 A single pathogenetic mechanism for vascular remodeling and inflammation in PAH
S. Hamidi, A. Szema, S. Said (Stony Brook, Northport, United States of America)
E276 Identification of target antigens of anti-fibroblast antibodies in pulmonary arterial hypertension
M. Tamby, B. Terrier, L. Camoin, P. Guilpain, C. Broussard, G. Bussone, A. Yaici, F. Hotellier, G. Simonneau, L. Guillevin,
M. Humbert, L. Mouthon (Paris, Clamart, France)
E277 Hypoxia-dependent Fhl-1 regulation leads to proproliferative effects in PASMC
G. Kwapiszewska, M. Wygrecka, L. Marsh, S. Schmitt, R. Troesser, A. Zakrzewicz, W. Seeger, O. Eickelberg, L. Fink,
N. Weissmann (Giessen, Germany)
E278 Dysregulated bone morphogenetic protein signaling in pulmonary arterial hypertension
L. Dewachter, E. Marcos, E. Fadel, L. I. Tu, P. Zadigue, S. Adnot, M. Humbert, R. Naeije, S. Eddahibi (Paris, Clamart,
Le Plessis Robinson, France; Brussels, Belgium)
E279 Endothelin-1 inhibits TASK-1 in human pulmonary artery smooth muscle cells via phospholipase C-diacylglycerol-
protein kinase C-pathway
B. Tang, Y. Li, N. Chandran, K. Katharina, S. Gabor, H. Popper, H. Olschewski, A. Olschewski (Graz, Austria)
s
E280 Effects of BMPR-II signal transduction in the pulmonary vascular remodeling of monocrotaline induced pulmonary
es
hypertension in rats
T. Kuang, C. Wang, B. Pang, J. Wang (Beijing, China)
E281 Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension
K. T. B. Mouchaers, Y. Y. Wong, I. Schalij, G. P. van Nieuw Amerongen, A. Vonk-Noordegraaf, W. J. van der Laarse
(Amsterdam, The Netherlands)
E282 Superoxide generation in pulmonary and systemic arterial smooth muscle cells and fibroblasts under hypoxic
conditions
B. Fuchs, B. Ahmet, E. Bakytbek, R. Markus, S. Natascha, R. T. Schermuly, G. Hossein A., S. Werner, G. Friedrich,
W. Norbert (Giessen, Germany)
E283 Alveolar hypoxia induces generation of IL-18 in mice. IL-18 reduces phosphorylation of the calcium handling
protein phospholamban in cardiomyocytes
K. O. Larsen, B. Lygren, I. Sjaastad, K. A. Krobert, G. Florholmen, K. Arnkvaern, F. O. Levy, O. H. Skjonsberg, K. Tasken,
G. Christensen (Oslo, Norway)
ERS Berlin 2008 Annual Congr
E284 Involvement of pulmonary artery smooth muscle cell apoptosis in simvastatin-induced regression of hypoxic
156
pulmonary hypertension
A. Boueiz, S. Mozammel, P. Kesari, M. Crow, R. Johns, P. Hassoun, R. Girgis (Baltimore, United States of America)
S U N D A Y O C T O B E R 5
E285 Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human
pulmonary arterial smooth muscle cells
Y. Wang, C. Wang, C. Wang, J. Wang (Beijing, China)
E286 Stable prostacyclin analogues treprostinil and iloprost activates K
and two-pore domain TASK-1 channels in
Ca
human pulmonary artery smooth muscle cells
Y. Li, B. Tang, N. Chandran, K. Leithner, F. M. Smolle-Juettner, E. Stacher, H. Olschewski, A. Olschewski (Graz, Austria)
E287 Vascular progenitor cells are subjected to epithelial to mesenchymal transition (EMT)-like during smooth muscle
cell differentiation
M. M. Musri, M. Diez, J. A. Barberà, V. I. Peinado (Barcelona, Spain)
E288 Cigarette smoke upregulates endothelin B receptors in human pulmonary arteries
G. Juan, M. Ramon, I. Lluch, M. Losada, J. Milara, J. L. Ortiz, J. Cortijo, E. Morcillo (Valencia, Madrid, Spain)
E289 Phosphodiesterase 4 and 5 inhibitors decrease HO-1 and IL-8 gene expression induced by cigarette smoke
G. Juan, M. Ramon, I. Arroyo, J. Milara, J. L. Ortiz, E. Donet, J. Cortijo, E. Morcillo (Valencia, Madrid, Spain)
E290 Long term exposure to cigarette smoke associated with hypoxia promotes further development of pulmonary
hypertension in the guinea pig
E. Ferrer, V. I. Peinado, J. Prieto-Lloret, M. Díez, M. V. Vega-Agapito, M. C. González-Martín, M. T. Agapito, A. Obeso,
C. González, J. A. Barberà (Barcelona, Valladolid, Spain)
E291 Growth-differentiation factor-15 as a prognostic indicator in idiopathic pulmonary arterial hypertension
N. Nickel, T. Kempf, H. Golpon, K. Wollert, M. Wilkins, S. Gibbs, M. Hoeper (Hanover, Germany; London, United
Kingdom)
E292 High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary
arterial hypertension
A. Filusch, E. Giannitsis, H. Katus, J. Meyer (Heidelberg, Germany)
E293 Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive
protein
M. Wynants, R. Quarck, E. Alfaro-Moreno, B. Meyns, M. Delcroix (Leuven, Belgium; Mexico City, Mexico)
Room London 3
Session 50
08:30–10:30
E-Communication Session: Actual challenges in thoracic surgery
Chair: K. Athanassiadi (Cholargos, Greece)
E294 Small cell lung cancer (SCLC) in Norway. A population-based study
H. Rostad, A. Naalsund, T. E. Strand, S. Hummerfelt, T. Amundsen, S. L. Steinshamn (Oslo, Trondheim, Norway)
E295 Parasternal videomediastinoscopic resection of ectopic mediastinal parathyroid adenoma
S. T. Liman, S. Topcu, E. Dervisoglu, G. Daglioz Gorur, A. Elicora, K. Burc (Kocaeli, Turkey)
E296 Safety and experience with awake video-assisted thoracoscopic surgery (VATS) in compromized patients
T. Mohsen, A. Abou Zeid, T. Osama (Cairo, Egypt)
E297 Surgical treatment of right middle lobe syndrome in children
S. Eren, F. Gurkan, A. Avci, C. Eren (Diyarbakir, Turkey)
E298 Recurrence of neuroendocrine tumours after surgery
M. Krasnik, B. Skov (Copenhagen, Denmark)
E299 Inflammatory pseudotumors involving lung and mediastinum: a rare clinical entity
K. Athanassiadi, F. Laenger, N. Dickgreber, A. Haverich (Athens, Greece; Hanover, Germany)
E300 The effect of proanthocyanidin on re-expansion pulmonary edema in rat
O. Yucel, E. Tozkoparan, A. Gunal, E. Macit, H. Caylak, S. Gurkok, K. Kavakli, H. Gul, O. Genc (Ankara, Turkey)
E301 Investigating the efficacy of cyanoacrylate in bronchus closure methods in sheep trachea: an experimental study
A. Yildizhan, T. Isitmangil, R. Gorur, S. Selcuk, N. Yiyit (Istanbul, Turkey)
s
E302 Primary benign tracheal tumors: 10 years experience at Instituto Nacional De Enfermedades Respiratorias (INER),
es
Mexico
E. S. Pena Mirabal, E. Robles Perez, J. A. Pinedo Onofre, J. A. Hernandez Carrillo, J. A. Avalos Bracho (Mexico City,
Mexico)
E303 Quality of life evolution after pulmonary metastasectomy: a prospective study
B. Balduyck, J. Hendriks, J. Van Thielen, A. Wittock, P. Lauwers, P. Van Schil (Edegem, Antwerp, Belgium)
E304 Surgical treatment of tracheal stenosis
I. Cordos, C. Bolca, C. Paleru, R. Posea (Bucharest, Romania)
E305 Postpneumonectomy fistula – transsternal approach – one unit experience
I. Cordos, C. Bolca, C. Paleru (Bucharest, Romania)
E306 Bronchial stump fistula after pneumonectomy: methods of prophylaxis
A. Pavlunin, A. Artifexova, D. Korotin (Nizhny Novgorod, Russian Federation)
E307 Plastic and reconstructive procedures in tracheobronchial surgery
Y. Kolkin, O. Stupachenko, D. Stupachenko, I. Sukhomlin (Donetsk, Ukraine)
ERS Berlin 2008 Annual Congr
E308 Efficacy of long-acting bronchodilator inhalation on postoperative pulmonary function and quality of life in lung
cancer patients with chronic obstructive pulmonary disease
H. Suzuki, Y. Sekine, T. Nakajima, K. Yasufuku, S. Yoshida, M. Suzuki, K. Shibuya, S. Mizuno, K. Tatsumi, Y. Nakano,
157
I. Yoshino (Inohana, Chuo-ku, Chiba, Japan)
S U N D A Y O C T O B E R 5
E309 Partial lung resection during videothoracoscopy by the use of ultrasonic surgical equipment
A. Pismennyy, E. Korimasov (Samara, Russian Federation)
E310 Tracheobronchopulmonary carcinoid tumors surgical management and long term outcome
R. Bagheri, Z. Haghi (Mashhad, Islamic Republic of Iran)
E311 Side effects, complications and outcome of thoracoscopic sympathicolysis for palmar and axillary hyperhidrosis in
406 patients
J. Freixinet, P. Rodriguez, M. Hussein (Las Palmas, Spain)
E312 Surgical treatment of the subglottic cicatrical stenoses
I. Mosin, V. Gerasin, A. Derevyanko, N. Mosina (St Petersburg, Russian Federation)
E313 Talc pleurodesis: talc slurry versus thoracoscopic talc poudrage
C. Bolca, O. Danaila, I. Bordinca, C. Paleru, I. Cordos (Bucharest, Romania)
Room 1.2a
Session 51
10:45–12:45
Occupational Grand Round – an interactive session
Aims: Four clinical cases will be presented, illustrating the range of lower respiratory diseases resulting from inhalation injuries. The
range of nonrespiratory adverse health effects of inhalation injuries (including upper airway disease, psychological diseases and
others) will be reviewed. Available diagnostic approaches and treatment options for inhalation injuries will be discussed.
Target audience: Physicians and health care professionals with interest in respiratory toxicology, and pulmonary, occupational and
critical care medicine.
Chairs: P. S. Burge (Birmingham, United Kingdom), R. De La Hoz (New York, United States of America)
10:45 Pistachio Fumigator’s Lung
P. Blanc (San Francisco, United States of America)
314
11:15 Dyspnea in an emergency medical technician
R. De La Hoz (New York, United States of America)
315
11:45 Dyspnea in a young coach builder: diagnosis and treatment
P. De Vuyst (Brussels, Belgium)
316
12:15 A breathless boat builder popping popcorn?
P. S. Burge (Birmingham, United Kingdom)
317
Room 2.2a
Session 52
10:45–12:45
Symposium: Asthma: from clinical pattern to genetic background
Aims: This symposium will discuss the impact of genetic association studies on asthma phenotypes and atopy in children and the
role of environmental and epidemiological factors.
Target audience: Paediatricians, fellows in paediatrics, epidemiologists, chest physicians, geneticists.
Chairs: A. Bush (London, United Kingdom), J. Gerritsen (Groningen, The Netherlands)
10:45 Preschool wheeze syndrome: a need for better treatment
S. Saglani (Sidcup, United Kingdom)
318
11:15 Childhood asthma: which predictors from infancy?
K. Lodrup Carlsen (Oslo, Norway)
319
11:45 Effects of pollution: antenatal and post-natal, indoor and outdoor
P. Sly (Perth, Australia)
320
12:15 Gene–environment interactions: a primary preventive strategy for asthma?
E. von Mutius (Munich, Germany)
321
Room Dublin
Session 53
10:45–12:45
Symposium: Models of pulmonary rehabilitation in non-COPD patients
s
Aims: This symposium will give an overview of current results following application of rehabilitation programmes in non-COPD
es
patients, in order to widen the current evidence-based referral.
Target audience: Clinicians, pulmonologists and allied health professionals interested in pulmonary rehabilitation.
Chairs: N. Ambrosino (Pisa, Italy), T. Troosters (Leuven, Belgium)
10:45 Effectiveness of rehabilitation in patients with asthma
M. Emtner (Uppsala, Sweden)
322
11:15 Is the pulmonary rehabilitation model applicable to chronic heart failure patients?
S. Singh (Leicester, United Kingdom)
323
11:45 Who is the best candidate for rehabilitation among patients with restrictive disease?
M. A. Spruit (Horn, The Netherlands)
324
12:15 Early rehabilitation after lung resection
G. Biscione (Velletri, Italy)
325
ERS Berlin 2008 Annual Congr
158
S U N D A Y O C T O B E R 5
Room 5.2b
Session 54
10:45–12:45
Symposium: New imaging modalities in the staging of lung cancer
Aims: In view of the large number of patients involved, spread of knowledge of new imaging modalities is important.
Target audience: Pulmonary physicians, radiologists, thoracic surgeons, medical oncologists, nuclear medicine physicians, trainees
in these specialities.
Chairs: P. Van Schil (Edegem, Belgium), J. Vansteenkiste (Leuven, Belgium)
10:45 Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer
S. Stroobants (Leuven, Belgium)
326
11:15 Endobronchial ultrasound (EBUS) – a novel dimension for bronchoscopy
F. Herth (Heidelberg, Germany)
327
11:45 Trans-oesophageal ultrasound (EUS) – why it is needed for accurate lung cancer staging
J. Annema (Leiden, The Netherlands)
328
12:15 Surgical staging – how it will survive in a changing staging environment
P. De Leyn (Leuven, Belgium)
329
Room Helsinki
Session 55
10:45–12:45
Symposium: Acute lung injury. Do we know what it is? A look at different models
Aims: This symposium aims to compare established experimental models of acute lung injury (ALI). To that end, each speaker will
apply a similar set of criteria to compare one particular model with the most frequently used model, the endotoxin model. This
symposium will identify benefits and, in particular, underline shortcomings of currently used ALI models for the study of human
disease. As particular attention is given to endotoxin models, one speaker speaks from the perspective of the animal model, while
one clinician-scientist with an interest in acute respiratory distress syndrome (ARDS) speaks from the human ALI/ARDS perspective.
The session should provide valuable mechanistic insights into the disease processes of the models and of ALI/ARDS.
Target audience: Respiratory/critical care physicians and scientists who are interested in basic mechanisms of acute lung injury.
Chairs: S. Uhlig (Aachen, Germany), M. Takata (London, United Kingdom)
10:45 The endotoxin model in the year 2008
M. Takata (London, United Kingdom)
330
11:09 Mechanically induced lung injury
J. Pugin (Geneva, Switzerland)
331
11:33 The acid aspiration model of acute lung injury
Y. Imai (Akita, Japan)
332
11:57 The zymosan model of acute lung injury and multiple organ failure
S. Cuzzocrea (Messina, Italy)
333
12:21 Human acute lung injury versus the endotoxin model
G. Downey (Denver, United States of America)
334
Room Budapest
Session 56
10:45–12:45
Infection year in review
Aims: This symposium will provide state-of-the art updates on four important infection topics that have seen advances over the last
year. The latest developments will be discussed, based on recent key literature, by experts in the respective areas.
Target audience: Clinicians, microbiologists, specialist nurses and public health workers involved in respiratory infections care and
control.
Chairs: A. Torres (Barcelona, Spain), R. Cosentini (Milan, Italy)
10:45 Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: epidemiology, diagnosis and
treatment
s
G. B. Migliori (Tradate, Italy)
335
es
11:15 Lower respiratory tract infections: bacteria and virus, antibiotics and steroids
S. Ewig (Bochum, Germany)
336
11:45 Healthcare-associated pneumonia (HCAP): a new entity?
T. Bauer (Berlin, Germany)
337
12:15 Influenza: still a threat?
A. Osterhaus (Rotterdam, The Netherlands)
338
Room Berlin
Session 57
10:45–12:45
Oral Presentation: New challenges and maintained quality: lung function for the
future
Chairs: B. G. Cooper (Birmingham, United Kingdom), I. Steenbruggen (Zwolle, The Netherlands)
10:45 Vibration response imaging [VRI]: a new dynamic system for the regional assessment of lung function
ERS Berlin 2008 Annual Congr
R. Bossi, C. Baldessari, C. Carnevale, V. Betti, A. Palleschi (Milan, Italy)
339
11:00 Ventilatory pattern monitoring with electrical impedance tomography (EIT): validation for COPD patients
M. Balleza, C. Nuria, T. Feixas, M. Gonzalez, D. Anton, P. J. Riu, C. Pere (Barcelona, Spain)
340
159
S U N D A Y O C T O B E R 5
11:15 Air travel hypoxemia versus the hypoxic challenge test in patients with restrictive lung disease
P. Kelly, M. Swanney, L. Seccombe, M. Peters, L. Beckert (Christchurch, New Zealand; Sydney, Australia)
341
11:30 Design of accurate COPD classification model based on volatile organic compounds from exhaled air
J. van Berkel, J. Dallinga, G. Möller, R. Godschalk, E. Wouters, F. J. van Schooten (Maastricht, The Netherlands)
342
11:45 Comparing cardiopulmonary exercise test results between centres assists quality control
A. Coates, J. Savage, S. Holiday, S. D’Auria (South Brisbane, Auchenflower, Nathan, Australia)
343
12:00 Enhanced quality of forced spirometry in primary care
F. Burgos, C. Disdier, N. Roger, M. Rivera, R. Hervas, E. Lopez de Santamaria, E. Duran, J. Garcia-Aymerich,
J. Roca (Barcelona, Caceres, Vic, Badalona, Bilbao, Spain)
344
12:15 Evaluation of data requirements to establish biologic quality control ranges in a multi-center clinical trial for
inhaled insulin
S. Blonshine, R. Harris, S. Cangiamilla, R. Warshaw (Mason, Paramus, United States of America)
345
12:30 Quality control for static lung volumes in a multi-centred clinical trial
B. Cooper, J. Wanger, S. Hill, S. Soleman (Birmingham, United Kingdom; Lenexa, United States of
America; Basel, Switzerland)
346
Room 5.2c
Session 58
10:45–12:45
Hot Topic: Deadly networks: disease-causing protein and DNA modifications
Aims: At the conclusion of this session, the participant will be able to:
- describe the cutting-edge current concepts about how changes in histone and DNA structure regulate cell proliferation and gene
expression at the ‘epigenetic’ level, and how these can apply to human pulmonary diseases;
- understand the importance of oxidative and nitrative stress in regulating signalling pathways and controlling cell function;
- appreciate the wealth of data implicating abnormal signalling in the control of epithelial cell function;
- understand the potential for the targeting of these processes in the development of novel drug treatments for diseases such as
lung cancer, fibrosis, severe asthma and COPD.
Target audience: Researchers and clinical scientists and clinicians with an interest in signal transduction and gene expression in
lung disease.
Chairs: I. M. Adcock (London, United Kingdom), M. Cazzola (Rome, Italy)
10:45 Epigenetics and lung cancer
M. Sanchez-Cespedes (Barcelona, Spain)
347
11:15 ROS, carbonyl stress and cell function
P. Kirkham (London, United Kingdom)
348
11:45 Nitration and phosphorylation in the control of epithelial function
B. Schmeck (Berlin, Germany)
349
12:15 Clinical implications and opportunities for new drug therapies
P. J. Barnes (London, United Kingdom)
350
Room Europa 2
Session 59
10:45–12:45
Oral Presentation: Cell biology of asthma and COPD
Chairs: P. Hiemstra (Leiden, The Netherlands), C. Greene (Dublin, Ireland)
10:45 Attenuation of lung inflammation and emphysema induced by cigarette smoke exposure in CXCR3 knockout
mice
R. Xiang, L. Nie, J. Gao (Beijing, Chengdu, China)
351
11:00 Epigenetic changes are associated with altered hBD-1 gene expression in patients with COPD
E. Andresen, J. Bullwinkel, H. Heine, C. Lange (Borstel, Germany)
352
11:15 Muscarinic receptor stimulation potentiates cigarette smoke extract induced IL-8 production by airway
s
smooth muscle
es
R. Gosens, D. Rieks, T. Pera, S. Zuyderduyn, P. Hiemstra, A. Halayko, J. Zaagsma, H. Meurs (Groningen, Leiden,
The Netherlands; Winnipeg, Canada)
353
11:30 Activation of IL-32 pathway in COPD
F. Calabrese, S. Baraldo, E. Bazzan, F. Lunardi, G. Turato, K. Lokar-Oliani, P. Sfriso, F. Rea, P. Maestrelli, A. Papi,
R. Zuin, C. Dinarello, M. Saetta (Padova, Ferrara, Italy; Denver, United States of America)
354
11:45 Alteration of ROS metabolism and cell type-specific differentiation markers in the lungs of Pex11b (-/-)
mice, a mouse model deficient in peroxisome proliferation
S. Karnati, E. Baumgart-Vogt (Giessen, Germany)
355
12:00 Steroid responsiveness of natural killer T cell mediated airway inflammation
Z. I. Komlosi, E. Palinger, V. Muller, G. Losonczy (Budapest, Hungary)
356
12:15 The asthma-like phenotype in VIP-/- mice may be related to activation of transcription factor NFAT
A. Szema, S. Hamidi, S. Said (Stony Brook, Northport, United States of America)
357
12:30 CD4+Foxp3+ regulatory T cells from lungs of healthy subjects
ERS Berlin 2008 Annual Congr
M. Heron, J. C. Grutters, G. T. Rijkers, D. Hijdra, A. M. E. Claessen, J. M. M. van den Bosch (Nieuwegein, Utrecht,
160
The Netherlands)
358
S U N D A Y O C T O B E R 5
Room Paris 1
Session 60
10:45–12:45
Oral Presentation: Progress and a new era for noninvasive mechanical ventilation
Chairs: J-F. Muir (Rouen, France), M. Chatwin (London, United Kingdom)
10:45 Non-invasive ventilation (NIV) after extubation in hypercapnic patients with chronic respiratory disorders: a
randomized trial
M. Ferrer, M. Valencia, J. Sellares, A. Carrillo, G. Gonzalez, J. R. Badia, R. Piñer, C. Esquinas, J. M. Nicolas,
A. Torres (Barcelona, Murcia, Spain)
359
11:00 Nocturnal non-invasive positive pressure ventilation (NIPPV) in stable hypercapnic COPD patients –
a randomized controlled trial
G. C. Funk, M. Breyer, O. C. Burghuber, K. Kirchheiner, I. Schmidt, S. Hartl (Vienna, Austria)
360
11:15 Performance of ventilators for noninvasive positive pressure ventilation in children
B. Fauroux, K. Leroux, G. Desmarais, D. Isabey, A. Clement, F. Lofaso, B. Louis (Paris, Puteaux, Creteil, Garches,
France)
361
11:30 Magnetic ventilation – first evaluation of artificial ventilation with magnetic stimulation in humans
B. Sander, F. Homringhausen, T. Dieck, C. Tschan, J. Steffens, J. Ahrens, H. Hecker, S. Piepenbrock, K. Raymondos
(Hanover, Germany)
362
11:45 Extubation and noninvasive ventilatory management of unweanable patients with neuromuscular weakness
M. Goncalves, J. R. Bach, I. Hamdani, J. C. Winck (Porto, Portugal; Newark, United States of America)
363
12:00 Does patient-ventilator asynchrony actually affect sleep during nocturnal noninvasive ventilation?
H. Rabarimanantsoa, U. S. Freitas, C. Letellier, L. Achour, L. C. Molano, F. Portier, E. Delagree, J. F. Muir,
A. Cuvelier (Rouen, France)
364
12:15 A randomised trial of home non-invasive ventilation vs. sham ventilation in survivors of acute hypercapnic
respiratory failure in COPD
C. M. Chu, A. Cheung, V. Chan, J. Liong, W. S. Leung, A. Lin (Kowloon, Hong Kong)
365
12:30 Average volume assured pressure support mask ventilation in patients with hypercapnic COPD: a pilot
study on night-time efficacy
E. M. Clini, E. Crisafulli, O. Coletti, D. Dell’Orso, G. Rossi, L. M. Fabbri (Pavullo, Modena, Italy)
366
Room Paris 2
Session 61
10:45–12:45
Oral Presentation: Social determinants and psychological issues in primary care
respiratory diseases
Chairs: S. Walker (Warwick, United Kingdom), N. Chavannes (Rotterdam, The Netherlands)
10:45 Personality influences the reporting of side effects of inhaled corticosteroids
J. M. Foster, R. Sanderman, T. Van der Molen, T. Müller, E. van Sonderen (Groningen, The Netherlands; Konstanz,
Germany)
367
11:00 Is poor educational attainment in white and Bangladeshi children related to asthma? A study linking health,
education and social care datasets
C. Griffiths, P. Sturdy, L. Mayhew, A. Sheikh, J. Eversley, G. Feder, S. Hunter, S. Eldridge (London, Edinburgh,
United Kingdom)
368
11:15 BMI in COPD – not just a lightweight issue
G. South, J. Miles (Rotherham, Manchester, United Kingdom)
369
11:30 Development of the chronic obstructive pulmonary disease assessment questionnaire
F. Martinez, F. Sciurba, K. Rosa, E. Piault, P. Berry, W. Bailey (Ann Arbor, Pittsburgh, Boston, Birmingham,
United States of America; Stockley Park, United Kingdom)
370
s
11:45 Long-term maintenance of pharmacists inhaler technique with a novel educational tool
es
I. Basheti, H. Reddel, C. Armour, S. Bosnic-Anticevich (Camperdown, Australia)
371
12:00 Educational level of the patients – does it matter for the outcomes of COPD?
K. Lisspers, B. Stallberg, C. Janson (Uppsala, Sweden)
372
12:15 Patients’ beliefs about inhaled corticosteroids (ICS): relationship with adherence
J. Clatworthy, D. Price, R. Parham, D. Ryan, J. Haughney, R. Horne (London, Aberdeen, United Kingdom)
373
12:30 Time to exacerbation in the “real-life” management of asthma (GPRD-REALITY)
L. Kemp, N. Barnes, J. Haughney, R. Featherstone, E. Sims, J. von Ziegenweidt, D. Price (Norfolk, Scotland,
London, Essex, United Kingdom)
374
Room 5.2a
Session 62
10:45–12:45
Oral Presentation: Innovative treatments in sleep disordered breathing
Chairs: J. A. Hedner (Gothenburg, Sweden), P. M. A. Calverley (Liverpool, United Kingdom)
10:45 The ImPAP-mode – a new therapy for Cheyne Stokes respiration
ERS Berlin 2008 Annual Congr
S. Boecker, H. Wenz, E. Gruenig, F. J. F. Herth (Heidelberg, Germany)
375
161
S U N D A Y O C T O B E R 5
11:00 Efficacy of an open nasal cannula system (TNI) to treat obstructive sleep apnea – results from a clinical
multi-center trial
G. Nilius, T. Wessendorf, W. Wolfgang, J. T. Maurer, L. Knaak, H. Schneider (Hagen, Essen, Mannheim, Dortmund,
Germany; Baltimore, United States of America)
376
11:15 Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular
alterations in rats
E. Belaidi, P. Levy, C. Ribuot, D. Godin-Ribuot (Grenoble, France)
377
11:30 Transcutaneous electrical stimulation of the genioglossus muscle in obstructive sleep apnoea
J. Steier, C. Jolley, G. Rafferty, J. Seymour, K. Ward, C. Reilly, Y. Luo, M. I. Polkey, J. Moxham (London,
United Kingdom; Guangzhou, China)
378
11:45 Pressure reduction during exhalation in sleep apnea patients treated by continuous positive airway pressure
(CPAP)
J. L. Pepin, J. F. Muir, T. Gentina, Y. Dauvilliers, R. Tamisier, M. Sapene, P. Escourrou, B. Fleury, F. Philip-Joet,
P. Philip, M. P. D’Ortho (Grenoble, Lille, Montpellier, Bordeaux, Creteil, Clamart, Paris, Marseille, Rouen, France) 379
12:00 Expiratory pressure-relief reduces the need for heated humidification in association with continuous positive
airway pressure therapy for obstructive sleep apnea
A. Valipour, G. Kapfhammer, R. Pokorny, W. Pohl, N. Vetter, O. C. Burghuber (Vienna, Grimmenstein, Austria)
380
12:15 The role of bi-level therapy in obstructive sleep apnoea
T. Gentina, F. Fortin, B. Douay, J. M. Dernis, F. Herengt, J. C. Bout, C. Lamblin (Lille, France)
381
12:30 Pneumatic compression devices are effective for restless legs syndrome: a prospective, randomized, double-
blinded, sham-controlled trial
C. Lettieri, A. Eliasson, D. Greenburg (Washington, Bethesda, United States of America)
382
Room New York 1
Session 63
10:45–12:45
Oral Presentation: COPD
Chairs: A. Agusti (Palma de Mallorca, Spain), O. C. Burghuber (Vienna, Austria)
10:45 Adherence to medication, mortality and severe exacerbations in the TORCH study
J. Vestbo, J. Anderson, P. Calverley, B. Celli, G. Ferguson, C. Jenkins, J. Yates, P. Jones (Hvidovre, Denmark; Stockley
Park, London, Liverpool, United Kingdom; Research Triangle Park, Boston, Livonia, United States of America; Sydney,
Australia)
383
11:00 The multidimensional BOD: association with mortality in the TORCH trial
B. Celli, P. Jones, J. Vestbo, J. Anderson, G. Ferguson, J. Yates, C. Jenkins, P. Calverley (Boston, Livonia, Research
Triangle Park, United States of America; London, Stockley Park, Liverpool, United Kingdom; Hvidovre, Denmark;
Sydney, Australia)
384
11:15 Determinants of the relationship between changes in FEV and SGRQ: analysis of the TORCH data
1
P. Jones, J. Vestbo, J. Anderson, P. Calverley, B. Celli, G. Ferguson, J. Yates, C. Jenkins (London, Manchester,
Stockley Park, Liverpool, United Kingdom; Boston, Livonia, Research Triangle Park, United States of America;
Sydney, Australia)
385
11:30 Role of the osteoprotegerin in the formation of osteopenic syndrome in chronic obstructive lung disease
E. Kochetkova, Y. Maistrovskay, V. Nevzorova, G. Massard, R. Kessler (Vladivostok, Russian Federation;
Strasbourg, France)
386
11:45 Anemia predicts survival in patients with chronic obstructive pulmonary disease
M. Lainscak, S. von Haehling, I. Sarc, K. Ziherl, W. Doehner, S. Suskovic, M. Kosnik, S. D. Anker (Golnik,
Slovenia; Berlin, Germany)
387
12:00 Insulin resistance in non-diabetic patients with chronic obstructive pulmonary disease
M. Lainscak, W. Doehner, I. Sarc, T. Jeric, S. Suskovic, S. von Haehling, M. Kosnik, M. Flezar, S. D. Anker
s
(Golnik, Slovenia; Berlin, Germany)
388
es
12:15 Altered control of cerebral circulation in chronic obstructive pulmonary disease: an early sign of
cardiovascular autonomic dysfunction
L. Bernardi, G. Casucci, T. Haider, E. Brandstätter, E. Pocecco, I. Ehrenbourg, M. Burtscher (Pavia, Italy;
Innsbruck, Austria; Moscow, Russian Federation)
389
12:30 Heart rate variability during six-minute-walking test in chronic obstructive pulmonary disease
R. Inchingolo, G. M. Corbo, G. A. Sgueglia, G. Lanza, S. Valente (Rome, Italy)
390
Room New York 2
Session 64
10:45–12:45
E-Communication Session: Novel trends in functional genomics and molecular
pathology of neoplastic and non-neoplastic lung diseases
Chairs: D. S. Postma (Groningen, The Netherlands), B. Housset (Creteil, France)
E391 Host-derived osteopontin is important for malignant pleural effusion formation
ERS Berlin 2008 Annual Congr
I. Psallidas, G. T. Stathopoulos, C. Moschos, A. Kollintza, S. Karabela, P. Theodoropoulou, S. A. Papiris,
162
C. Roussos, I. Kalomenidis (Athens, Greece)
S U N D A Y O C T O B E R 5
E392 Association of inflammatory mediator gene polymorphisms (IL1B, TNFA, LTA, IL8, IL6, IL1RN, IL10, TGFb, TLR4,
DBP) with chronic lung disease in children
G. Korytina, O. Celousova, L. Akhmadishina, T. Victorova (Ufa, Russian Federation)
E393 Forced chemokine ligand 2 overexpression renders melanoma cells capable of inducing experimental malignant
pleural effusion
G. T. Stathopoulos, I. Psallidas, A. Moustaki, C. Moschos, A. Kollintza, S. Karabela, I. Porfyridis, S. Vassiliou,
M. Karatza, Z. Zhou, M. Joo, T. S. Blackwell, C. Roussos, D. Graf, I. Kalomenidis (Athens, Vari, Greece; Nashville,
United States of America)
E394 Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell
sensitivity to cisplatin via MAPK / mitochondrial pathway
W. L. Zhuo, Y. Wang, X. L. Zhuo, Z. T. Chen (Chongqing, China)
E395 Effect of smoking on microRNA expression profile in the lung
I. Yang, S. Savarimuthu Francis, M. Davidson, J. Larsen, P. Zimmerman, R. Bowman, N. Hayward, K. Fong
(Brisbane, Australia)
E396 Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small
cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases
(MMPs), and tissue inhibitors of MMPs (TIMPs)
E. Herpel, C. Schopf, A. Warth, F. J. F. Herth, P. A. Schnabel, P. Schirmacher, H. Hoffmann, M. Thomas,
D. Kieslich de Hol (Heidelberg, Germany)
E397 Roles
for
SERPINE2 in pulmonary homeostasis in mice
S. Srisuma, T. Mariani (Bangkok, Thailand; Rochester, United States of America)
E398 Cytotoxic T cell lymphocyte-associated 4 (CTLA4) polymorphisms in UK sarcoidosis patients
A. Lagan, A. Abdallah, P. Spagnolo, R. du Bois, K. Welsh, A. Wells, H. Sato (London, United Kingdom)
E399 Free plasmatic circulating DNA as prognostic and diagnostic lung cancer biomarker
M. Paci, S. Maramotti, E. Bellesia, D. Formisano, T. Ricchetti, V. Annessi, G. Ferrari, C. Carbonelli, L. Zucchi,
G. Sgarbi (Reggio Emilia, Italy)
E400 Association of the 3A/4A (134delA) and Lys198Asn polymorphisms of the endothelin-1 gene with chronic
obstructive pulmonary disease
F. Sampsonas, A. Antonacopoulou, C. Flordellis, H. Kalofonos, K. Spiropoulos (Patras, Greece)
E401 Adrenergic regulation of the lung inflammatory response
P. A. Ward, M. A. Flierl, D. Rittirsch, J. V. Sarma, F. S. Zetoune (Ann Arbor, United States of America)
E402 The role of GSTT1 and GSTM1 in the risk of bronchial asthma (BA) formation in early kids, born by BA females
O. Lavrova, M. Petrova, T. Ivaschenko, M. Vaxarlovskaja (St Petersburg, Russian Federation)
E403 Quantitative RT-PCR 3-gene expression signature predicts survival in early-stage non-small cell lung cancer
(NSCLC) patients
M. Skrzypski, E. Jassem, M. Taron, G. Gulida, W. Rzyman, S. Benlloch, J. J. Sanchez, R. Rosell, J. Jassem
(Gdansk, Poland; Barcelona, Madrid, Spain)
E404 Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls
E. Csanky, R. Ruhl, A. Vako, L. Takacs, W. Hempel (Debrecen, Hungary; Evry, France)
E405 Dynamic global gene expression shows mitigation of the effects of cigarette smoke extract by antioxidants in
airway cells
M. Moffatt, K. Xu, L. Hao, L. Donnelly, W. Cookson (London, United Kingdom)
E406 Exposure time and pressure-related correlation of hyperbaric oxygen induced oxidative stress in rat lung
S. Oter, A. Korkmaz, S. Sadir, S. Gumus, O. Deniz, H. Ay, T. Topal, H. Bilgic (Ankara, Turkey)
E407 Apoptosis regulatory protein (p53, Bcl-2, survivin) expression in lung cancer-preliminary study
I. Porebska, E. Sobanska, E. Wyrodek, M. Kosacka, R. Jankowska (Wroclaw, Poland)
E408 Gene expression profiling in peripheral blood in COPD
s
P. Ausin, E. Luesink, J. Kehren, P. Lloyd, P. Barnes, S. Kharitonov (London, United Kingdom; Basel, Switzerland;
es
Barcelona, Spain)
E409 A haplotype of HLA-class II and BTNL2 associates with the diagnosis of extrinsic allergic alveolitis (EAA)
C. H. M. van Moorsel, J. C. Grutters, V. L. J. Karthaus, H. J. T. Ruven, J. M. M. van den Bosch (Nieuwegein, The
Netherlands)
E410 The role of MMP1, MMP3 and MMP12 in the respiratory phenotype of alpha-1-antitrypsin deficiency
C. McAloon, A. Wood, S. Gough, R. Stockley (Birmingham, United Kingdom)
Room New York 3
Session 65
10:45–12:45
E-Communication Session: Exercise intolerance: mechanism, intervention and
assessment
Chairs: J. Neder (Sao Paulo, Brazil), P. Palange (Rome, Italy)
E411 Effects of exercise in skeletal muscle mitochondrial DNA content in COPD
ERS Berlin 2008 Annual Congr
L. Puente-Maestu, F. Villar, A. Ferreira, J. de Miguel, S. Caramllo, A. Tejedor (Madrid, Spain)
163
S U N D A Y O C T O B E R 5
E412 Permeability transition pore kinetics, cytochrome C release in mitochondria isolated from skeletal muscle of
patients with COPD
L. Puente-Maestu, F. Villar, N. Moreno, F. Gonzalez-Aragoneses, S. Caramllo, A. Tejedor, J. Garcia de Pedro, A. Agusti
(Madrid, Palma de Mallorca, Spain)
E413 Dynamics of estimated microvascular O extraction during ramp-incremental exercise in patients with advanced
2
COPD
M. Reis, A. Borghi-Silva, G. Chiappa, A. C. Gimenes, J. Maia, E. Meda, D. Bravo, A. C. Barroso Siqueira,
L. E. Nery, J. A. Neder (Sao Paulo, Sao Carlos, Brazil)
E414 Kinetics of oxygen delivery and utilization at the onset of heavy intensity exercise in patients with moderate-to-
severe COPD
J. A. Neder, G. Chiappa, A. Borghi-Silva, L. Ferreira, C. Carrascosa, C. Oliveira, E. Ferreira, D. Berton,
F. Queiroga, C. Machado, L. Nery (Sao Paulo, Brazil; Lexington, United States of America)
E415 Dynamics of skeletal muscle reoxygenation after high-intensity exercise in mitochondrial myopathy
A. C. Oliveira Gimenes, D. Manzoli Bravo, E. D. S. Meda, G. Rogério Chiappa, A. C. Barroso Siqueira, D. Cortozi
Berton, F. Queiroga Junior, E. Vieira Machado Ferreira, A. Bulle, J. A. Neder, L. Eduardo Nery (Sao Paulo, Brazil)
E416 The effects of ageing on the on-transient kinetics of peripheral muscle deoxygenation at heavy-intensity exercise
in non-trained men
J. Maia, E. Meda, D. Bravo, A. C. Oliveira Gimenes, A. C. Barroso Siqueira, A. Borghi-Silva, C. Regina Carrascossa,
C. Oliveira Carneiro, G. Rogério Chiappa, D. Cortozi Berton, E. Vieira Machado Ferreira, C. Machado, L. Eduardo
Nery, J. A. Neder (Sao Paulo, Brazil)
E417 Mechanism of the greater oxyhemoglobin desaturation in treadmill as compared to cycle ergometer exercise in
COPD
R. Casaburi, J. Porszasz, D. Hsia (Torrance, United States of America)
E418 Independence of exercise-induced diaphragmatic fatigue from ventilatory demands
H. J. Kabitz, D. Walker, S. Walterspacher, F. Sonntag, A. Schwoerer, K. Roecker, W. Windisch (Freiburg, Germany)
E419 Right and left chest wall asymmetries and asynchronies in unilateral diaphragmatic paralysis
B. Weingard, U. Mack, A. Aliverti, A. Lo Mauro, G. W. Sybrecht (Homburg, Germany; Milan, Italy)
E420 Mild bronchial epithelial damage after endurance exercise in humans
L. Chimenti, A. Paternò, R. Santagata, S. Reitano, G. Morici, V. Bellia, M. R. Bonsignore (Palermo, Italy)
E421 Locus of symptom limitation during treadmill exercise testing in COPD
C. Cooper, M. Abrazado, D. Legg, S. Kesten (Los Angeles, Ridgefield, United States of America)
E422 Contrasting dynamic cardiopulmonary responses to incremental cycle ergometer exercise testing in patients with
COPD and pulmonary hypertension
D. Cortozi Berton, E. Vieira Machado Ferreira, A. Albuquerque, M. Silva Reis, A. C. Barroso Siqueira, E. Meda,
D. Bravo, J. Arakaki, L. E. Nery, J. A. Neder (Sao Paulo, Brazil)
E423 Interval hypoxic training improves autonomic cardiovascular and respiratory control in mild chronic obstructive
pulmonary disease
T. Haider, G. Casucci, T. Linser, M. Faulhaber, H. Gatterer, I. Ehrenbourg, E. Tkatchouk, M. Burtscher, L. Bernardi
(Pavia, Italy; Innsbruck, Austria; Moscow, Russian Federation)
E425 The index distance-saturation product like predicting of mortality in patients with COPD
S. Pecho (Lima, Peru)
E426 The 30-sec heart rate recovery index for estimation of maximal exercise impairment in pre-capillary pulmonary
hypertension
E. V. M. Ferreira, J. SO Arakaki, D. M. Bravo, L. D. Batista, L. E. Nery, J. A. Neder (Sao Paulo, Brazil)
E427 Methods for assessment of ventilatory efficiency during exercise in healthy pediatric population
B. Marinov, S. Mandadzhieva, K. Terziyski, S. Kostianev (Plovdiv, Bulgaria)
s
Room London 1
Session 66
10:45–12:45
es
E-Communication Session: Towards smoking cessation
Chairs: B. Dautzenberg (Paris, France), E. Dagli (Istanbul, Turkey)
E429 Some experiences from a large public spirometry event – ERS 2007 in Stockholm
A. Renström, I. Kull, A. S. Karlsson, G. Hedlin, S. E. Dahlén (Stockholm, Sweden)
E430 Screening spirometry in students with reduces smoking
A. Kamenov, S. Cekic (Nis, Republic of Serbia)
E431 Smoking habits are unaffected by CT screening at 1 year follow up in the Danish lung cancer screening trial
(DLCST)
H. Ashraf, P. Tønnesen, J. H. Pedersen, A. Dirksen, M. Døssing (Copenhagen, Denmark)
E432 Antismoking counselling for inpatients undergoing to a diagnostic bronchoscopy
T. Semotyuk, I. Boguckyy, I. Hipp (Lviv, Ukraine)
E433 Does reimbursement increase smoking cessation rate? – Outcomes of “stop smoking” national program in a
ERS Berlin 2008 Annual Congr
smoking cessation center.
164
A. Trofor, V. Esanu, M. Sandu, R. Miron, T. Mihaescu, I. Bordeianu (Iasi, Romania)
S U N D A Y O C T O B E R 5
E434 Differences between the way of giving two tests on an anti-smoking consult
M. Pavon, V. Almadana, H. D. Garcia, A. S. Valido, E. Luque, T. Montemayor (Seville, Spain)
E435 Is motivational Mondor test useful to predict smoking cessation?
V. Dipietro, E. Taormina, M. R. Furia, G. Tamajo, M. Gallo, R. Natoli, A. Serauto, G. Genovese, C. Sorino, G. Nicolini
(Palermo, Parma, Italy)
E436 Effect of smoking cessation on sputum HNP levels in COPD patients and asymptomatic smokers
G. Paone, M. Serpilli, V. Conti, G. Puglisi, S. D’Antonio, G. Lucantoni, M. G. Zotti, I. Cammarella, E. Li Bianchi,
G. Schmid (Rome, Italy)
E437 Six month and 1 year smoking cessation decrease sputum inducible nitric oxide synthase and nitrotyrosine
expression at the never-smokers’ levels
I. Bouloukaki, M. Tsoumakidou, I. Mitrouska, N. Siafakas, N. Tzanakis (Heraklion, Greece)
E438 Is a percentage a percentage? Systematic review of the effectiveness of Scandinavian smoking cessation courses
and quitlines
P. B. Poulsen, J. Dollerup, A. Møller (Ballerup, Herlev, Denmark)
E439 Smoking cessation and the characters of human intelligence
A. Di Marzo, A. M. Santini, E. P. Navarese, G. Scittarelli (Rome, Italy)
E440 Differences in management of smoking cessation program between an urban and rural health center
A. Perez, J. R. Lopez, A. Avellaneda, M. Izquierdo, F. Martin, T. Dierssen (Cantabria, Madrid, Spain)
E441 Smoking cessation treatment in smokers with psychiatric problems
S. Vakali, D. Michailidis, A. Florou, N. Soureti, K. Triviza, C. Roussos, C. Gratziou (Athens, Greece)
E442 Smoking cessation and follow-up of depression in a group of Mexican smokers
G. Ponciano, A. Morales (Mexico City, Mexico)
E443 A psychiatric patients’ evaluation in an anti-smoking medical practice
V. Almadana, A. S. Valido, H. D. Garcia, M. Pavon, E. Luque, T. Montemayor (Seville, Spain)
E444 The effects of confrontational counselling on smoking cessation in smokers with COPD
D. Kotz, M. J. H. Huibers, R. J. West, G. Wesseling, O. C. P. van Schayck (Maastricht, The Netherlands; London, United
Kingdom)
E445 The content and structure of self management education at nurse-led COPD clinics in primary health care
E. Österlund Efraimsson, B. Klang, A. Ehrenberg, L. Kjell, B. Fossum (Stockholm, Falun, Sweden)
E446 Formation of health professionals in basic intervention in smoking cessation
M. Garcia, T. Puebla, G. Luque, M. A. Perez, J. L. De la Cruz, M. Entrambasaguas (Malaga, Spain)
E447 Four years follow-up in patients seeking medical support for smoking cessation
F. Caeiro, M. Aguiar, F. Todo Bom, O. Monteiro, R. Sotto-Mayor, A. Bugalho de Almeida (Lisbon, Portugal)
Room London 2
Session 67
10:45–12:45
E-Communication Session: COPD: from bench to bedside
Chairs: H. Magnussen (Grosshansdorf, Germany), M. Saetta (Padova, Italy)
E448 Can retinoic acid protect the development of pulmonary emphysema induced by cigarette smoke in rats?
L. An, H. Zhang, B. Pang, S. Niu, X. Weng (Beijing, China)
E449 Merits of spirometry plus bronchodilator reversibility in the diagnosis of air flow obstruction
I. Muhammad, A. S. Huque, Z. Waheed, N. A. Rao, A. B. S. Zubairi, J. Husain, N. Salahuddin, J. Khan (Karachi,
Pakistan)
E450 Impact of treatment on a number of BALF inflammatory cells and cytokines concentrations in patients with
moderate COPD
A. Chcialowski, W. Lubinski, I. Toczyska, S. Dudko, E. Pirozynska, W. Kozlowski, W. Stankiewicz (Warsaw, Poland)
E451 Cough in exacerbations of COPD
s
V. Mann, H. Fathi, R. Aul, A. Morice (Cottingham, United Kingdom)
es
E452 International investigation into the impact of dyspnea on activities of daily living
A. Jargot, S. Muller, D. A. Mahler (Lyon, France; Lebanon, United States of America)
E453 Changes of ventilatory function in patients affected by COPD after five years
R. Giura, G. Lanati, A. Martinelli, M. Erba (Como, Italy)
E455 Airway wall thickness by HRCT in patients with COPD
N. Scichilone, M. Bellia, A. La Sala, F. Cannizzaro, S. Russo, A. Togias, R. Brown, M. Midiri, R. Lagalla,
V. Bellia (Palermo, Italy; Bethesda, Baltimore, United States of America)
E456 Prevalence of COPD with reversible obstruction in first spirometries, among patients with obstructive airways
disease in western Maharashtra, India
N. Abhyankar, S. Salvi (Pune, India)
E457 Pooled clinical trial analysis of the rate of decline in FEV according to perceived dyspnea and health status
1
M. Decramer, D. Tashkin, B. Celli, I. Leimer, S. Kesten (Los Angeles, Boston, United States of America; Leuven,
Belgium; Ingelheim, Germany)
ERS Berlin 2008 Annual Congr
E458 Airway inflammation and fat free mass measurements using dual energy X-ray absorptiometry in a population of
chronic obstructive pulmonary disease patients
M. Bafadhel, S. Saha, S. McKenna, M. Steiner, P. Newbold, C. E. Brightling (Leicester, Loughborough,
165
United Kingdom)
S U N D A Y O C T O B E R 5
E459 Association between serum leptin, nutritional status and severity of chronic obstructive pulmonary disease
(COPD)
R. Guleria, S. Arora, G. Kumar, T. C. Chawla, A. Mohan (New Delhi, India)
E460 The failure rate of sputum induction following inhaled lipopolysaccharide (LPS) challenge in healthy subjects
S. Greenaway, G. Adcock, W. Y. James, L. Siew, B. O’Connor (London, United Kingdom)
E461 Breathing pattern monitor using standard ECG electrodes
R. Zulkarneev, S. Zagidulin, L. Bakusov, N. Hafizov, G. Abdrahmanova (Ufa, Russian Federation)
E462 Influence of tracheal tube caliber, positive pressure applied, and methacholine inhalation on the flow-volume
curve in rats
T. Kondo, T. Tanigaki, C. Tsuji (Hachioji, Isehara, Japan)
E463 Measurement of pulmonary function in asthmatic rats
T. Kondo, T. Tanigaki, C. Tsuji (Hachioji, Isehara, Japan)
Room London 3
Session 68
10:45–12:45
E-Communication Session: Respiratory disorders in paediatric intensive care unit
Chairs: S. Kotecha (Cardiff, United Kingdom), R. Ross-Russell (Cambridge, United Kingdom)
E464 Acute lung injury and acute respiratory distress syndrome at the intensive care unit of a Vinnitsa Region children
hospital in Ukraine. An epidemiological study using the American-European consensus criteria
D. Dmytriiev, K. Bercun (Vinnitsa, Ukraine)
E465 Assessing the pre-operative child with scoliosis
R. Ross Russell, A. Jordan, D. Conlan (Cambridge, United Kingdom)
E466 Lung de-recruitment and re-recruitment after suction of the endotracheal tube in ventilated children
J. Jauncey-Cooke, K. Foster, A. Schibler (South Brisbane, Australia)
E467 Positioning for unilateral pneumonia in the PICU – up or down?
R. Ross Russell, K. Chawla, D. Sapsford, R. Tasker (Cambridge, United Kingdom)
E468 Nasal continuous positive airway pressure decreases respiratory muscles overload in young infants with severe
acute viral bronchiolitis
G. Cambonie, C. Milesi, S. Jaber, F. Amsallem, J. C. Picaud, S. Matecki (Montpellier, France)
E469 Effect of extubation on lung volume
S. Humphreys, K. Foster, A. Schibler (South Brisbane, Australia)
E470 Influence of nebulizer type, position and bias flow on aerosol drug delivery to a pediatric model of mechanical
ventilation
A. Ari, J. Fink (Atlanta, San Carlos, United States of America)
E471 The evaluation of pulmonary mechanics after administration of furosemide/natrium chloride aerosols in
ventilated children with normal lung function
S. Iurian, B. Neamtu, C. Berghea-Neamtu, H. Jidveianu, M. L. Neamtu, P. Nicolcescu (Sibiu, Romania)
E472 Inhaled nitric oxide (iNO) in a pediatric critical care unit. A retrospective review 1994–2006
D. Hutter, S. Sambamoorthi, T. Humpl (Toronto, Canada)
E473 Alpha1-antitrypsin
( 1-AT) and secretory leukocyte protease inhibitor (SLPI) in acute lung injury/acute
respiratory distress syndrome (ALI/ARDS) in critically ill infants
S. El-Sahrigy, M. Abdel-Aziz, A. Hamed (Cairo, Egypt)
ERS Members’ Meetings
Open to ERS Members and interested participants
Sessions 69–78
s
es
Scientific Group Members’ Meetings
12:50–13:35
1.1 Clinical Problems
Room New York 1
1.5 Diffuse Parenchymal Lung Disease
Room Paris 2
3.1 Molecular Pathology and Functional Genomics
Room Europa 2
5.1 Airway Pharmacology and Treatment
Room 5.2c
6.1 Epidemiology
Room Dublin
9.1 Respiratory Function Technologists/Scientists
Room Berlin
Scientific Assembly and Group Members’ Meetings
12:50–14:40
ERS Berlin 2008 Annual Congr
2 Respiratory Intensive Care
Room Paris 1
166
8 Thoracic Surgery
Room 5.2a
S U N D A Y O C T O B E R 5
10 Respiratory Infections
Room Budapest
11 Thoracic Oncology Section
Room 5.2b
Hall 6.2-1
Session 79
12:50–14:40
Thematic Poster Session: Markers and triggers of asthma
Chairs: J. Sont (Leiden, The Netherlands), R. Stelmach (Sao Paulo, Brazil)
P474 Airway wall thickness in patients with uncontrolled asthma
A. Mohamed-Hussein, S. Ahmed (Assiut, Egypt)
P475 Neutrophilic inflammation in airways in patients with nonallergic late-onset asthma with upper respiratory tract
disorders
E. Leshenkova, S. Sobchenko, V. Kravtsov (St Petersburg, Russian Federation)
P476 Do anxiety and depression affect patients’ perceived level of asthma control?
F. Di Marco, M. Verga, P. Santus, F. Giovannelli, F. Andò, P. Ruggeri, M. Neri, G. Girbino, S. Centanni (Milan, Tradate,
Messina, Italy)
P477 The effect of obesity and central obesity on pulmonary function of asthmatics
S. Tavasoli, H. Heidarnazhad, S. Eghtesadi, M. R. Gohari (Tehran, Islamic Republic of Iran)
P478 Psychosomatic correlation between asthma course, patient’s adherence and hypochondriac disorders
S. I. Ovcharenko, A. B. Smulevich, M. Y. U. Drobizhev, M. N. Akulova, E. N. Ishchenko (Moscow, Russian Federation)
P479 Evolution of childhood-onset bronchial asthma
A. Ivanov, B. Chernyak (Irkutsk, Russian Federation)
P480 A population-based clinical study of allergic and non-allergic asthma
T. Knudsen, S. F. Thomsen, H. Nolte, V. Backer (Copenhagen, Denmark)
P481 Frecuency of gastroesophageal reflux in patients with intrinsic or extrinsic difficult asthma
A. Pacheco, V. Faro, M. Cuevas, A. Royuela, J. Vallejo (Madrid, Spain)
P482 Nasal polyps and asthma; the need of multidisciplinary cooperation
M. J. Zamfirescu, S. Samuila (Bucharest, Romania)
P483 Emotional distress in patients with bronchial asthma
A. Rasheva, K. Kostov (Sofia, Bulgaria)
P484 A case of laryngo-tracheal amyloidosis, evaluated as refractory asthma
L. Pur Ozyigit, A. Yakar, G. Okumus, E. Kiyan (Istanbul, Turkey)
P485 Pneumothorax and pneumomediastinum in asthma – experience of 10 years
G. Silva, G. Loureiro, A. Szantho, C. Chieira, M. Loureiro, M. Baganha (Coimbra, Portugal)
P486 Problematic issues of the diagnostics and differential diagnostics of broncial asthma
N. Monogarova, V. Noreyko, O. Semendyayeva, T. Moroz (Donetsk, Ukraine)
P487 Persistent local side effects of inhaled corticosteroids in asthmatics; the possible role of GERD
V. Meissner (Plzen, Czech Republic)
P488 Effect of body mass index on exercise as an asthma trigger
A. Wright, K. Lavoie, A. Rizk, G. Lacoste, S. Bacon (Montreal, Canada)
P489 Effectiveness of prolonged cholinolytic in complex basic therapy on the tolerability of physical load in severe
bronchial asthma patients
L. Iashyna, Y. Feshchenko, M. Polianska, I. Dzhavad, S. Moskalenko (Kiev, Ukraine)
Hall 6.2-2
Session 80
12:50–14:40
Thematic Poster Session: Comorbid cardiovascular condition and therapy of
asthma
s
Chairs: P. Kuna (Lodz, Poland), J. Vestbo (Hvidovre, Denmark)
es
P490 Functional tests during estimation of arterial stiffness in asthma patients
T. Brodskaya, V. Nevzorova, B. Geltser (Vladivostok, Russian Federation)
P491 Estimation of the central arterial pressure in asthma patients
T. Brodskaya, B. Geltser, V. Nevzorova (Vladivostok, Russian Federation)
P492 Effects of salmeterol on heart rate variability in patients with bronchial asthma and coronary artery disease
E. Petukhova, J. Krasnova, A. Dzizinskii (Irkutsk, Russian Federation)
P493 The study of the damage degree of myocardial coronary blood flow in patients with chronic obstructive pulmonary
disease and severe bronchial asthma
Y. Sorokina, M. Kharitonov, S. Shustov, V. Sukhov (St Petersburg, Russian Federation)
P494 Glucocorticoid therapy in male hypophysial gonadal system with bronchial asthma
M. Kuandykova, V. Baranov, M. Kharitonov (St Petersburg, Russian Federation)
P495 Compliance index among patients with mild asthma
ERS Berlin 2008 Annual Congr
V. Kupaev, O. Vakhno, M. Anipchenko, I. Davydkin (Samara, Russian Federation)
P496 Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and
mild bronchial asthma
167
M. Imaoka, T. Shimoda, R. Kishikawa, S. Shoji, S. Nishima, Y. Obase (Fukuoka, Kurashiki, Japan)
S U N D A Y O C T O B E R 5
P497 Reduced bone density in inhaled corticosteroids-treated asthmatic patients showing decreased cortisol response
to low-dose ACTH test
K. Fujita, S. Kasayama, M. Otsuki, M. Tanemura, A. Miyatake (Hikone, Shiga, Osaka, Japan)
P498 It does matter which inhalative corticosteroids asthmatic patient use! Looking at ICS side effects from users
perspective
P. Kuna, M. Kokot (Lodz, Warsaw, Poland)
P499 Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients
Y. Feschenko, L. Iashyna, I. Iliinskaya, J. Matvienko, S. Moskalenko (Kiev, Ukraine)
P500 Influence of N-acetylcystein in complex basic therapy on the dynamics of pulmonary function test indices in
severe bronchial asthma patients
Y. Feschenko, L. Iashyna, S. Moskalenko, N. Kramarska, S. Ischuk (Kiev, Ukraine)
P501 Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model
of allergic asthma
C. Dick, R. Clayton, M. Laudon, E. Pinner (Glasgow, United Kingdom; Tel Aviv, Israel)
P502 Salt chamber treatment had no effect on fractional exhaled nitric oxide (FeNO) in patients with symptoms
suggesting asthma
J. Sandell, J. Hedman, K. Saarinen, T. Haahtela (Joutseno, Lappeenranta, Helsinki, Finland)
P503 Cost-effectiveness of fluticasone/salmeterol inhaler in treatment of moderate and severe bronchial asthma
P. Vorobyev, M. Aksentyeva, M. Smirnova (Moscow, Russian Federation)
P504 Pharma-epidemiology of bronchial asthma (BA) in Russia. The results of the program “BASIS”.
N. Shartanova, N. Ilina (Moscow, Russian Federation)
P505 Magnetocardiographic assessment of therapeutic efficacy of b –agonists and corticosteroids in patients with
2
COPD and bronchial asthma
A. Vasnev, V. Dubynina, Y. Maslennikov (Troitsk, Russian Federation)
Hall 6.2-3
Session 81
12:50–14:40
Thematic Poster Session: Pathophysiology of COPD
Chairs: M. Tamm (Basel, Switzerland), M. Luisetti (Pavia, Italy)
P506 Circulating auto antibodies in patients with chronic obstructive pulmonary disease (COPD)
B. Núñez, J. Sauleda, M. R. Julià, J. García-Aymerich, J. M. Antó, J. Gea, E. Monsó, F. Gómez, J. Roca, E. Farrero,
A. Agustí, PAC-COPD Study Group (Palma de Mallorca, Bunyola, Barcelona, Badalona, Hospitalet de Llobregat,
Spain)
P507 Arterial stiffness in COPD is not related to endothelial function
J. Maclay, D. McAllister, N. Mills, F. Paterson, W. MacNee (Edinburgh, United Kingdom)
P508 Magnetocardiographic study of blood flow redistribution in patients with COPD
A. Vasnev, V. Dubynina, Y. Maslennikov (Troitsk, Moscow, Russian Federation)
P509 Nocturnal hypercapnia and oxygen therapy in COPD patients
J. Tarrega, A. Anton, R. Guell, M. Mayos, J. Sanchis (Barcelona, Spain)
P510 On importance of interventricular interaction under the hypoxic pulmonary hypertension due to COPD
I. Sabirov, A. Maripov, A. Akunov, T. Khan, S. Yusupov, A. Sarybaev (Bishkek, Kyrgyzstan)
P511 Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD)
C. Minet, J. C. Borel, B. Wuyam, P. Faure, J. F. Timsit, C. Pison, P. Levy, J. L. Pepin (Grenoble, France)
P512 Function tests during research of arterial stiffness in COPD patients
T. Brodskaya, B. Geltser, V. Nevzorova (Vladivostok, Russian Federation)
P513 Are there gender differences of systemic inflammatory state in COPD patients?
L. Konopkina, T. Pertseva (Dnipropetrovsk, Ukraine)
s
P515 Peripheral muscle weakness and exercise capacity in patients with COPD
es
I. Cekerevac, Z. Lazic, L. Novkovic, M. Petrovic, V. Cupurdija, G. Kitanovic (Kragujevac, Republic of Serbia)
P516 Alpha1-antitrypsin levels and phenotypes in COPD patients in Kyrgyz population
S. Sydykova, M. Alymbayeva, C. Vogelmeier, R. Heine, N. Brimkulov (Bishkek, Kyrgyzstan; Marburg, Halle, Germany)
P517 Findings of the central arterial pressure investigation in COPD patients
T. Brodskaya, B. Geltser, V. Nevzorova (Vladivostok, Russian Federation)
P518 Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD)
B. Núñez, J. Sauleda, E. Monsó, A. Noguera, J. Gea, J. García-Aymerich, C. Villena, F. Gómez, J. Roca, E. Farrero,
A. Agustí, J. M. Antó, PAC-COPD Study Group (Palma de Mallorca, Bunyola, Badalona, Barcelona, Hospitalet de
Llobregat, Spain)
P519 Evaluation of different exercise tests and follow-up parameters in COPD patients – preliminary reports
N. Yaman, P. Celik, A. Ozgen, A. Sakar Coskun, A. Yorgancioglu, B. Cengiz Ozyurt (Manisa, Turkey)
P520 Exercise tolerance in clinically stable COPD patients after first admission
D. A. Rodriguez, J. Garcia-Aymerich, J. Roca, J. L. Valera, J. Sauleda, J. B. Galdiz, J. Gea, M. Orozco, A. Ferrer,
ERS Berlin 2008 Annual Congr
J. A. Barberà, F. P. Gomez, I. Serra, J. M. Anto (Barcelona, Mallorca, Bilbao, Spain)
168
P521 The comparison of carotid artery intima media thickness and inflamatory markers in patients with COPD
E. Aynaci, G. Ortakoylu, E. Caglar, A. Bahadir, F. Alkan, G. Ozgul, F. Cetinkaya (Istanbul, Turkey)
S U N D A Y O C T O B E R 5
P522 COPACETIC: unraveling the genetics of COPD
P. Zanen, J. W. Lammers, D. Postma, C. Wijmenga, H. Groen, M. Boezen, J. Vestbo, B. Nordestgaard, E. Nizankowska-
Mogilnicka, M. Eichinger, H. U. Kauczor, K. Forsman-Semb, M. Rutgers, M. Verduyn (Utrecht, Groningen, Leusden, The
Netherlands; Copenhagen, Denmark; Krakow, Poland; Heidelberg, Germany; Lund, Sweden)
Hall 6.2-4
Session 82
12:50–14:40
Thematic Poster Session: Prognosis in COPD
Chairs: M. Saetta (Padova, Italy), N. Roche (Paris, France)
P523 Radiological COPD phenotypes influence BODE
M. Han, J. Curtis, B. Bartholmai, M. Frederick, R. Karwoski, D. Li, A. Limper, F. Sciurba, M. Schwarz, B. Thompson,
F. Martinez (Ann Arbor, Rochester, Baltimore, Pittsburgh, Denver, United States of America)
P524 The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes
F. Pozo-Rodriguez, C. Esteban Gonzalez, R. Agüero Balbin, A. Capelastegui Sanz, R. Garcia Garcia, C. J. Alvarez
(Madrid, Galdakao, Santander, Spain)
P525 Is Hoover’s sign helpful to detect expiratory flow limitation in chronic obstructive pulmonary disease (COPD)?
V. Jacob, M. Bruyneel, C. Sanida, L. Ameye, R. Sergysels, V. Ninane (Brussels, Belgium)
P526 Death causes in COPD inpatients
A. Ferreira, J. de Miguel-Diez, S. Lucero, F. Villar-Alvarez, F. Marta, M. J. Chillon-Martin, L. Puente-Maestu
(Madrid, Spain)
P527 Health status and gender predict time to next exacerbation in patients with COPD
J. W. H. Kocks, S. M. Uil, H. Kerstjens, T. Van der Molen, J. W. K. Van den Berg (Groningen, Zwolle, The Netherlands)
P528 The correlation of annual rate of FEV decline with the temperature of expired air in COPD patients
1
A. V. Prozorova, A. G. Prikhodko, J. M. Perelman (Blagoveschensk, Russian Federation)
P529 Influence of tobacco-smoking on systemic inflammation (SI) in male and female with COPD
L. Konopkina (Dnipropetrovsk, Ukraine)
P530 The new prognostic multidimensional index HODEH in patient with COPD
N. Karoli, A. Rebrov (Saratov, Russian Federation)
P531 Validation of bode index as a predictor of mortality in COPD patients
P. Sobradillo, M. Iriberri, B. Gomez, J. I. Pijoan, A. Gomez, N. Marina, S. Pedrero (Bilbao, Spain)
P532 Can we predict who is mostly likely to re-exacerbate after a COPD exacerbation?
P. Albert, V. Osman-Hicks, A. Hicks, P. Calverley (Liverpool, United Kingdom)
P533 Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
X. Bu, M. Thompson, A. Hutchinson, D. Smallwood, L. Irving (Beijing, China; Melbourne, Australia)
P534 The survival of patients afflicted with COPD and influencing factors
E. Shehu, J. Bushati, E. Petrela (Tirana, Albania)
P535 Evaluation of physical signs and symptoms in patients with acute exacerbation of COPD
G. Nuralieva, S. Avdeev, A. Chuchalin (Moscow, Russian Federation)
P536 The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients
M. R. De Carlo, M. Moretti, L. M. Fabbri (Modena, Italy)
P537 Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD)
C. Minet, J. C. Borel, B. Wuyam, P. Faure, J. F. Timsit, C. Pison, P. Levy, J. L. Pepin (Grenoble, France)
P538 Exacerbations of COPD: effect of airflow obstruction and gas transfer on exacerbations reporting and frequency
K. Vijayasaratha, R. Stockley (Birmingham, United Kingdom)
P539 Comparison of dyspnea scoring methods and BODE index with functional parameters in stable COPD
M. Tepetam, A. Fidan, G. Sarac, B. Salepci, N. Kiral, B. Caglayan (Istanbul, Turkey)
s
Hall 6.2-5
Session 83
12:50–14:40
es
Thematic Poster Session: COPD in the elderly – quality of life and scores in COPD
Chairs: D. Gorecka (Warsaw, Poland), D. Stolz (Basel, Switzerland)
P540 The mini nutritional assessment (MNA) and the perception of dyspnea in elderly subjects with COPD. The
MINUTRA project
V. Bellia, G. Paglino, S. Battaglia, N. Scichilone, G. Augugliaro, G. B. Figlioli, C. Sorino, S. Reitano, R. Pistelli,
V. Grassi, R. Antonelli Incalzi (Palermo, Rome, Brescia, Italy)
P541 Prevalence and determinants of anaemia in hospitalized elderly COPD patients
P. Ranieri, A. Bianchetti, C. Cornali, E. M. Clini, M. Trabucchi (Brescia, Modena, Italy)
P542 Impact of age in the clinical expression of COPD
A. Corlateanu, C. Cote (Chishinau, Republic of Moldova; Bay Pines, United States of America)
P543 The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects
F. Pozo-Rodriguez, J. Fernández Francés, J. Hueto Perez de Heredia, J. L. Izquierdo Alonso, C. Melero-Moreno,
ERS Berlin 2008 Annual Congr
C. J. Alvarez (Madrid, Guadalajara, Pamplona, Spain)
P544 Autonomic function in elderly COPD patients with and without hypoxemia
R. Zulli, D. Turini, V. Pinelli, M. De Vecchi, F. Nicosia, E. Boni, G. Romanelli, C. Tantucci (Brescia, Italy)
169
S U N D A Y O C T O B E R 5
P545 Activities of daily living and health status impairment in elderly COPD outpatients
B. Gvozdenovic, S. Cucak, A. Gvozdenovic (Belgrade, Kraljevo, Republic of Serbia)
P546 Living with COPD in Canada: patient self-assessment and objective measures of disease impact
R. Hodder, P. Hernandez, M. Balter, J. Bourbeau (Ottawa, Halifax, Toronto, Montreal, Canada)
P547 The miners’ disability score is a useful measure of respiratory disability and reflects activities of daily living
scores in COPD
S. D. W. Miller, C. Armstrong, M. W. Elliott (Leeds, United Kingdom)
P548 Determinants of health-related quality of life (HRQL) in patients with COPD
T. Perez, R. Escamilla, C. Pinet, D. Caillaud, P. Carré, N. Roche (Paris, France)
P549 Influence of smoking on quality of life (QoL) and dyspnoea in patients with COPD
T. Pertseva, K. Gashynova (Dnipropetrovsk, Ukraine)
P550 Assessing reluctance to adapt to COPD: preliminary results of the acceptance of disease and impairments
questionnaire (ADIQ)
L. M. Boer, L. Daudey, J. B. Peters, Y. F. Heijdra, J. Molema, P. N. R. Dekhuijzen, J. H. Vercoulen (Nijmegen,
The Netherlands)
P551 Symptom scoring in COPD patients
G. Cakmak, Z. A. Saglam, T. Saler, M. Yenigun, E. Atsoglu, L. U. Temiz, T. Demir (Istanbul, Turkey)
P552 The relationship between Bode index and quality of life, CRP, TNF- , Il-8 in COPD patients
N. Sarioglu, A. Ozgen, A. Sakar Coskun, P. Celik, B. Cengiz Ozyurt, F. Taneli, A. Yorgancioglu (Manisa, Turkey)
P553 Influence smoking on the health-related quality of life in COPD patients III-IV stages
I. Trofimenko, B. Chernyak (Irkutsk, Russian Federation)
P554 Self-reported COPD: spirometric validation in a resource limited setting
A. S. Haque, M. Irfan, Z. Waheed, J. A. Khan (Karachi, Pakistan)
P555 Quality of life in Russian patients with COPD complicated by pulmonary artery hypertension
V. Pyankov, Y. Chuyasova (Kirov, Russian Federation)
Hall 6.2-6
Session 84
12:50–14:40
Thematic Poster Session: Rare clinical cases
Chairs: M. Kneussl (Vienna, Austria), S. Johnson (Nottingham, United Kingdom)
P556 Williams-Campbell syndrome: is an infantile rare disease with poor prognosis?
H. Tsukamoto, S. Sasaki, T. Kawamura, Y. Nakahara, Y. Mochiduki (Himeji, Japan)
P557 Unusual cause of haemoptysis – case report
M. Marc, I. Ungurean, G. Miclaus, C. Oancea, V. Tudorache (Timisoara, Romania)
P558 PAS-negative pulmonary alveolar proteinosis
H. Alahdab, E. Duman, O. Yapicier, R. Bag (Gebze Kocaeli, Turkey)
P559 The respiratory manifestations of Behcet disease: a study about 26 cases colligated in 12 years (1995-2007)
S. Nafti, A. Hamizi (Algiers, Batna, Algeria)
P560 Lymphangioleiomyomatosis: characteristics of 96 patients in China
Q. Ye, H. Dai, X. Li, M. Zhu, L. Zhang, C. Wang (Beijing, China)
P561 Successive treatment of Churg-Strauss syndrome with cyclesonide after oral steroids discontinuation due to side
effects
E. Swietlik, A. Doboszynska (Warsaw, Poland)
P562 A 28-year-old man with dyspnea and generalized edema
C. U. Chung, H. S. Park, S. S. Jung, J. O. Kim, S. Y. Kim, J. E. Lee, J. Y. Sin, J. W. Park, S. Y. Jung (Daejeon,
Republic of Korea)
P563 Invasive aspergillus tracheobronchitis (AT) in non-neutropenic, immunocompromised patients
s
R. Krenke, E. M. Grabczak, A. Kolkowska-Lesniak, M. Przybylski, M. Prochorec-Sobieszek, L. Konopka, R. Chazan
es
(Warsaw, Poland)
P564 Tracheobronchial straight metallic pin aspiration (SMP) in young Jordanian females
A. Sharara, H. El-Khushman, M. Saada, A. AlSuleihat, M. Hijazi (Amman, Jordan)
P565 A rare case of lithoptysis in a patient with Kartagener’s syndrome
V. S. Sreeguru Lakshman, P. Stockton (Merseyside, United Kingdom)
P566 Primary cardiac angiosarcoma and diffuse pulmonary hemorrhage: case report
M. Buyuksirin, G. Polat, A. Usalan, G. Tibet (Izmir, Turkey)
P567 A case of toxocariasis diagnosed as bronchiolitis obliterans with organizing pneumonia
R. Qualizza, C. Incorvaia (Milan, Italy)
P568 Pulmonary hypertension due to ligation of pulmonary arteriovenous malformations
Z. P. Onen, G. Koycu, G. Karabiyikoglu (Ankara, Turkey)
P569 A case of bronchial anthracofibrosis
P. Gupta, M. Bhattacharya, V. Desai, R. Mukherjee (Milton Keynes, United Kingdom)
ERS Berlin 2008 Annual Congr
P570 Paraneoplastic syndrome in 70-year old male? A rare presentation of Streptococcus intermedius (SI) infection
170
A. Raufi, M. Ali, A. Waheed, J. Rowley, R. Dwaihy (Detroit, Chicago, United States of America)
P571 Rhabdomyoma as a tumor of the posterior mediastinum
J. Kuschill-Dziurda, L. Mastalerz, P. Grzanka, E. Nizankowska-Mogilnicka (Krakow, Poland)
S U N D A Y O C T O B E R 5
P572 Brown tumor of the rib – a case with parathyroid adenoma
K. Ozmen, I. Etcioglu, B. Yazici, U. Toru, O. Balbay, Z. Soypacaci (Duzce, Turkey)
P573 Mediastinal lymphadenopathies: a rare location of amylodosis
Z. Yakoub, A. Chtourou, R. Mahouachi, O. Ismail, S. Taktak, B. Smati, F. El Mezni, A. Ben Kheder (Ariana, Tunisia)
P574 An unusual case of catamenial pneumothorax (CP)
V. S. Sreeguru Lakshman, A. Mohammed, T. Idama, P. Stockton (Merseyside, United Kingdom)
P575 Rituximab-induced lung disease. Case and review
D. Nguyen, C. Camus, A. Grandvuillemin, C. Rabec, P. Bonniaud, P. Foucher, P. Vabres, P. Camus (Dijon, France)
Hall 6.2-7
Session 85
12:50–14:40
Thematic Poster Session: Sarcoidosis and other interstitial lung diseases
Chairs: W. Pohl (Grimmenstein, Austria), U. Costabel (Essen, Germany)
P576 Airway obstruction in sarcoidosis
A. Baran, S. Gungor, S. Bilgin, M. Yalcinsoy, B. Bagci, G. Can, E. Akkaya (Istanbul, Turkey)
P577 Health related quality of life in sarcoidosis
A. Ilic, V. Vucinic, B. Gvozdenovic, V. Zugic, B. Milenkovic (Belgrade, Republic of Serbia)
P578 ECG abnormalities in patients with cardiac sarcoidosis in Serbia
N. Vasic, V. Vucinic, V. Djukanovic, D. Trifunovic, R. Stevic (Belgrade, Republic of Serbia)
P579 The significance of serum angiotenzin converting enzyme in diagnosing sarcoidosis
S. Kasikovic Lecic, V. Kuruc, M. Ilic, G. Popovic, D. Stanojev (Sremska Kamenica, Republic of Serbia)
P580 Immune reponses against mycobacterial antigens in sarcoidosis
M. Morishita, S. Sato, H. Maeda, H. Katoh, Y. Oki, M. Tokudome, R. I. Kamazawa, K. Kashima, M. Kusunoki,
H. Miyara (Nagoya, Seto, Kohda, Japan)
P581 Pulmonary function and radiological stage in newly diagnosed sarcoidosis
D. Ionita, N. Bisca, R. Nemes, S. Vasile Bugarin, D. Rosca, D. Marta, C. Cilt, C. Tudose, I. Balcu, I. P. Stoicescu
(Bucharest, Romania)
P582 Unusual involvements of sarcoidosis
B. Gorbatâi, K. N’guyen, E. Torabi, C. Lebreton, J. B. Auliac (Mantes la Jolie, Paris, France)
P583 Cardiac sarcoidosis presenting as a Heerfordt syndrome
K. Karadakhy, M. Tangen (Fredrikstad, Oslo, Norway)
P584 The importance of inflammatory markers in sarcoidosis
S. Gungor, F. Ozseker, A. Baran, M. Yalcinsoy, S. Genc, H. Eroglu, G. Can, E. Akkaya (Istanbul, Turkey)
P585 Activities of daily living and health status impairment in sarcoidosis patients
B. Gvozdenovic, V. Mihailovic-Vucinic, V. Zugic, A. Dudvarski-Ilic (Belgrade, Republic of Serbia)
P586 Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated
with chronic sarcoidosis
D. Ionita, C. Cilt, C. Tudose, N. Bisca, A. Serbescu, D. Marta, D. Bumbacea, L. Cervis, R. Nemes, C. Teleaga,
I. Balcu, I. P. Stoicescu (Bucharest, Romania)
P587 Clinical, radiographic and therapeutic features of sarcoidosis in menopausal women
V. Miloskovic, D. Pesut, V. Vucinic, L. Corkovic, S. Ignjatovic, B. Petrovic (Kragujevac, Belgrade, Republic of Serbia)
P588 The pulmonary disorders associated with autoimmune pancreatitis
T. Yokoyama, H. Yamamoto, K. Kubo (Matsumoto, Japan)
P589 Interstitial lung disease in patients with rheumatoid arthritis
M. Sheyanov, V. Sulimov, S. Ternovoy, E. Fominykh, I. Zavrazhina, N. Petuhova, V. Makolkin (Moscow, Russian
Federation)
P590 Pulmonary involvement in rheumatoid arthritis
s
V. Djuric, L. Stojanovic (Belgrade, Republic of Serbia)
es
P591 Good tolerance of aspirin in Churg-Strauss syndrome
W. Szczeklik, L. Mastalerz, B. Sokolowska, E. Nizankowska-Mogilnicka, M. Sanak, A. Szczeklik (Krakow, Poland)
P592 Is simvastatin a lung toxin? Clinical evidence for partially reversible interstitial lung disease after administration
of simvastatin for hypercholesterinemia in ischemic vascular disease
J. Weber, H. P. Eulenbruch (Gerlingen, Germany)
P593 Drug induced eosinophilic pneumonia
R. Parameswari, S. Parakkal, V. Kummannoor Parameswara Pillai (Kerala, India)
P594 Correction of endothelial dysfunction in patients with pulmonary diseases
N. V. Yahorava, I. S. Karpova, H. L. Hurevich, I. M. Lapteva (Minsk, Belarus)
Hall 6.2-8
Session 86
12:50–14:40
Thematic Poster Session: Infectious lung diseases including tuberculosis
Chairs: P. van der Valk (Enschede, The Netherlands), G. Sotgiu (Sassari, Italy)
ERS Berlin 2008 Annual Congr
P595 Effect of bronchial artery embolization (BAE) on the management of hemoptysis associated with pulmonary
tuberculosis; factors influencing recurrent hemoptysis
171
H. G. Hwang, J. S. Choi, K. H. Seo, Y. H. Kim (Kumi-si, Chonan, Republic of Korea)
S U N D A Y O C T O B E R 5
P596 Tuberculin test in BCG vaccinated children
J. K. Karahyla, K. K. Locham, J. Singh, A. K. Gill, A. P. Prasad (Patiala, India)
P597 Laser dopplerflowmetry in diagnosis of tuberculosis
E. Kulchavenya, E. Brizhatyuk (Novosibirsk, Russian Federation)
P598 Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary
disease
S. Tasaka, N. Hasegawa, T. Nishimura, W. Yamasawa, K. Miyamoto, Y. Nakano, H. Kamata, H. Seki, H. Hirose,
A. Ishizaka (Tokyo, Japan)
P599 Study of drug resistance among untreated new cases of tuberculosis in Oran, Algeria
S. Abdelmajid, C. Saada, G. Yasmine, O. Nacer, G. Malika, S. Fatna (Oran, Algeria)
P600 VRI for the diagnosis of community acquired pneumonia: preliminary results
K. Bartziokas, C. Daenas, P. Zygoulis, A. Triantaris, D. Makris, K. I. Gourgoulianis (Larissa, Greece)
P601 Pathophysiological risk factors for chronization of bronchitis in children aged 7-10 years
I. Mankovska, K. Nesvitaylova, V. Nosar (Kiev, Ukraine)
P602 A randomised, placebo-controlled trial of inhaled mannitol in patients with bronchiectasis
D. Bilton, E. Daviskas, A. Jaques, S. Anderson, B. Charlton, Bronchitol Study Team (London, United Kingdom;
Sydney, Australia)
P603 Lymphocytic interstitial pneumonia in a patient with HTLV-1 infection
M. J. Martins Costa, J. Subilhaga, M. J. Andrada-Serpa, L. P. Quintella, A. C. Sanchez Toledo, G. Modesto Leal
(Rio de Janeiro, Brazil)
P604 The clinical characteristics of non-resolving or slow-resolving pneumonia associated with the pathology of an
organizing pneumonia
H. B. Lee, S. J. Park, S. R. Kim, Y. C. Lee, Y. K. Rhee (Jeonj, Republic of Korea)
P605 Establishment of reference values for cellularity in induced sputum of healthy adults in Guangzhou
W. Luo, K. Lai, R. Chen, Q. Chen (Guangzhou, China)
P606 Characteristics of pneumonia, initially misdiagnosed as pulmonary TB
Z. Laushkina, P. Filimonov (Novosibirsk, Russian Federation)
P607 Peculiarities of the immune response in teenagers with pneumonia of different etiology
S. N. Teplova, V. G. Muchamedzynova (Chelyabinsk, Russian Federation)
P608 Lung cancer presented as painful swelling of lower legs
J. Y. Ahn (Cheongju/Chungcheongbukdo, Republic of Korea)
P609 Studies conducted in the field of TB and lung diseases in Iran during 1997-2002
M. Kaykha, F. Chamyani (Tehran, Islamic Republic of Iran)
P610 Comparison of lymphocyte characters between those with and without tuberculosis
M. M. Zahmatkesh, G. Azimi (Tehran, Islamic Republic of Iran)
P611 The risk of community-acquired pneumonia and the use of statins, ACE inhibitors and gastric acid suppressants
P. Myles, T. McKeever, Z. Hoare, C. Smith, R. Hubbard (Nottingham, United Kingdom)
Hall 6.2-9
Session 87
12:50–14:40
Thematic Poster Session: Lung cancer and other malignant diseases involving the
lungs
Chair: G. Zalcman (Caen, France)
P612 Primary pulmonary manifestation of intravascular large B-cell lymphoma as a cause of severe hypoxemia in
patient with normal chest x-ray picture
M. Martusewicz-Boros, E. Wiatr, R. Langfort, E. Radzikowska, K. Roszkowski-Sliz (Warsaw, Poland)
P613 Endoscopic diagnostics of bronchopulmonary changes in patients with malignant hematological diseases
s
es
J. Schreiber, B. Bohnsteen, C. Schreiber, J. Knolle (Magdeburg, Dessau, Germany)
P614 Morphological and histological profile of lung masses
J. K. Samaria, S. Kumar (Varanasi, India)
P615 Ultrasound guided core needle for anterior mediastinal masses
A. Tatabitovska, T. Stefanovski, S. Stojkovski, B. Kaeva, M. Zdraveska, J. Spasevski (Skopje, Veles, FYROM)
P616 Clinical characteristics of lung cancer – comparative study male/female
M. Man, C. Pop, D. Todea, R. Rajnoveanu, D. Alexandrescu (Cluj Napoca, Brasov, Romania)
P617 High-dose-rate brachytherapy (HDR-BT) in the treatment of lung cancer – Greatpoland Cancer Center experience
M. Kubaszewska, J. Skowronek, M. Kanikowski, A. Chichel, M. Fundowicz, G. Zwierzchowski, M. Dymnicka (Poznan,
Poland)
P618 Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for
patients with presumed or established lung cancer
J. Miller, P. Davis, G. Travis (Hamilton, Canada)
P619 HDR endobronchial brachytherapy (HDR-BT) in the management of advanced lung cancer – comparison of
ERS Berlin 2008 Annual Congr
different protocols
172
J. Skowronek, M. Kubaszewska, A. Chichel, M. Kanikowski (Poznan, Poland)
P620 Detection of ProGRP and NSE in exhaled breath condensate (EBC) of patients with SCLC and NSCLc
S. Tahanovich, C. Gessner, H. Kuhn, H. Wirtz (Leipzig, Germany)
S U N D A Y O C T O B E R 5
P621 Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer
F. Xu, J. Xia, Y. Fu, Y. Yang, X. Chen, X. Li, Y. Zhou, J. Li, K. Dalhoff, H. Shen (Hangzhou, China; Rochester, United States
of America; Lübeck, Germany)
P622 Principals for formation of risk group for lung cancer malignancy in clean up workers of Chernobyl NPP accident
L. Shvayko, V. Sushko, A. Prisyajnuk, P. Fedirko (Kiev, Ukraine)
P623 Clinical and endoscopic presentation of bronchopulmonary carcinoid tumors
S. Jens, W. Nadine, S. Christel, K. Juergen (Magdeburg, Dessau, Germany)
Hall 6.2-10
Session 88
12:50–14:40
Thematic Poster Session: Lung function, airways and cough
Chairs: R. Buhl (Mainz, Germany), M. Studnicka (Salzburg, Austria)
P625 Using of impulse oscillometry in bronchodilatation response evaluation in patients with chronic cough
D. Koruga, G. Plavec, B. Ciric, I. Tomic, K. Boskovic (Novi Sad, Belgrade, Republic of Serbia)
P626 Etiological study of chronic cough in Japan
H. Shimizu, M. Okazawa, Y. Mieno, Y. Takeuchi, M. Hahashi, Y. Saito, F. Sasaki, H. Sakakibara, K. Naito (Toyoake City,
Japan)
P628 Causes of chronic cough in patients with interstitial pneumonia
Y. Waseda, M. Yasui, K. Inuzuka, H. Takato, Y. Ichikawa, Y. Nishizawa, M. Fujimura (Kanazawa, Japan)
P629 Bronchial responsiveness and chronic non-productive cough responding to bronchodilator therapy
M. Abo, M. Fujimura, N. Ookura, Y. Waseda (Kanazawa, Japan)
P630 Incidence and clinical features of persistent cough associated with Bordetella pertussis infection
T. Takeda, A. Niimi, H. Matsumoto, I. Ito, M. Yamaguchi, H. Matsuoka, M. Jinnai, K. Otsuka, T. Oguma, H. Nakaji,
M. Mishima (Kyoto, Japan)
P631 Chronic cough, quality of life and the partner
M. Wu, S. Uil, W. Burgersdijk, L. Boom, L. Korper, J. W. K. Van den Berg (Zwolle, The Netherlands)
P632 Step wise approach for therapeutic diagnosis of chronic cough: Bangladesh experience
M. R. Hassan, A. A. Khan, M. A. Hossain, A. M. Mahmud, K. S. Bennoor, M. M. Rahman (Dhaka, Bangladesh)
P633 Lung function and airway hyperresponsiveness in adult patients with sickle cell disease
N. Sen, I. Kozanoglu, M. Karatasli, H. Ermis, C. Boga, F. Oner Eyuboglu (Ankara, Turkey)
P634 Dyspnea and flow-volume curve analysis in spasmodic dysphonia
A. Ruiz, A. Acuña, E. Adams, I. Avellan (Caracas, Venezuela)
P635 Peak expiratory flow (PEF) measurement: a new approach
K. Nimako, N. Stolagiewicz, T. K. Loke (Croydon, United Kingdom)
P636 Lung function in subclinical hypothyroidism
G. Cakmak, Z. A. Saglam, T. Saler, M. Yenigun, E. Ataoglu, L. U. Temiz, T. Demir (Istanbul, Turkey)
P637 Comparison of pulmonary test results in terminal stage patients with renal failure before and after haemodialysis
in a three-year period
M. Obradovic, M. Stojanovic-Stanojevic, L. Corkovic (Mladenovac, Belgrade, Republic of Serbia)
P638 Lung function and nutritional status in Brazilian patients with bronchiolitis obliterans
A. Hoffmann, F. Tybusch, C. D. Ricachinewsky, M. I. S. S. Simon, F. A. A. Silva (Porto Alegre, Brazil)
P639 Can spirometry values alone be used to define pulmonary disease?
S. Jack, M. Heinz, A. Albuquerque, J. Syson (Liverpool, United Kingdom; Bad Kissingen, Germany)
P640 Metabolic syndrome and airway obstruction
P. Rogliani, G. Curradi, D. Lauro, M. Federici, C. Saltini, M. Cazzola (Rome, Italy)
P641 The relationship between lung function and blood glucose control in type 2 diabetic patients
Y. Yan, Y. Zhou, Z. Liao (Guangzhou, China)
s
P642 Persistent airflow obstruction at long-term follow-up in patients with Churg-Strauss syndrome
es
V. Cottin, R. Dubost, C. Khouatra, J. F. Cordier (Lyon, France)
Hall 6.2-11
Session 89
12:50–14:40
Thematic Poster Session: Imaging of different lung diseases: clinical and
experimental observations
Chairs: W. De Wever (Leuven, Belgium), A. Grgic (Homburg, Germany)
P643 Lung tumor growth quantification in transgenic mice using CT and PET
T. Rodt, C. von Falck, R. Halter, M. Galanski, J. Borlak (Hanover, Germany)
P644 HRCT imaging of lung parenchyma in chronic heart failure (CHF) patients: correlation with pulmonary function
tests
L. Velentza, A. Paridou, A. Kalianos, K. Kostopoulos, E. Gialafos, J. Nikas, G. Dionelis, M. Fragou, A. Moulopoulou,
F. Katsaros, C. Kostopoulos (Athens, Greece)
ERS Berlin 2008 Annual Congr
P645 Comparison of two in vivo microscopy techniques to visualize alveolar mechanics
J. Bickenbach, E. Ogawa, M. Czaplik, E. Koch, R. Rossaint, R. Kuhlen (Aachen, Dresden, Berlin, Germany)
P646 A comparison study of fiberoptic vs virtual bronchoscopy
173
K. Pappas, K. Psaras, K. Pigakis, M. Kokkinaki, G. Meletis, M. Ferdoutsis, K. Psillakis, G. Patsourakis, L. Triantafillou,
N. Bachlitzanakis (Heraklion, Greece)
S U N D A Y O C T O B E R 5
P647 Does pulmonary aspiration have a role in patients with chronic cough due to gastroesophageal reflux disease?
N. Songur, Y. Songur, S. Cerci, O. Ozturk, A. Senol, M. Yariktas, U. Sahin (Isparta, Turkey)
P648 A new technique to visualize alveolar dynamics in a rabbit model
J. Bickenbach, M. Czaplik, E. Koch, R. Rossaint, R. Kuhlen (Aachen, Dresden, Berlin, Germany)
P649 Lung deposition of BDP/formoterol HFA pMDI in healthy subjects, asthmatic and COPD patients
F. Mariotti, G. Poli, D. Acerbi, C. Herpich, P. Brand, T. Meyer (Parma, Italy; Gauting, Germany)
P650 Lung hernia – clinical findings and follow-up
R. Kubale, A. Grgic, J. Ernst-Michael, H. Wilkens (Pirmasens, Homburg, Regensburg, Germany)
P651 Accuracy of chest x-ray in differentiation of obstructive and restrictive pulmonary patterns in comparison to
plethysmograghy
H. Abtahi, N. Nikoo, S. Shahriaran (Tehran, Islamic Republic of Iran)
P652 Changes in chest radiographs in HIV/AIDS patients in Enugu, Nigeria
N. Njeze, U. Itanyi, A. Onuh, C. Chukwuka (Enugu, Nigeria)
P653 Endothelial function in patients with pulmonary diseases
N. V. Yahorava, I. S. Karpova, H. L. Hurevich, I. M. Lapteva (Minsk, Belarus)
P654 Radiographic manifestations in TB/HIV patients
M. Bakhshayeshkaram, S. Zahirifard (Tehran, Islamic Republic of Iran)
P655 Long-acting bronchodilatators influence on degree of bronchus inflammation process in COPD patients
V. Elena, R. Viktoria, L. Anton (Dnepropetrovsk, Ukraine)
P656 GDV – bioelectrography in diagnostics of the oncologic and others pathological processes of the thorax
Y. Kolkin, V. Vecherko, O. Dzhereliy, V. Kolkina (Donetsk, Kiev, Ukraine)
P657 Normal lung density in helical computed tomography
K. Irion, E. Marchiori, B. Hochhegger, E. Irion, J. Holemans (Liverpool, United Kingdom; Rio de Janeiro,
Porto Alegre, Brazil)
P658 Influence of tuberculosis in CT staging of lung neoplasm
A. Ivkovic, T. Spasic, S. Ristic (Nis, Vranje, Republic of Serbia)
P659 Clinical features of organizing pneumonia primed by radiation therapy to the breast
T. Jinta, K. Oikado, M. Matsusako, S. Gotoh, S. Yamao, R. Gugiura, H. Horinouchi, H. Ono, H. Yagata, S. Nakamura,
K. Sekiguchi, N. Nishimura, N. Chohnabayashi (Tokyo, Japan)
P660 The radiological spectrum of pulmonary multidrug-resistant tuberculosis in HIV-negative patients
S. Zahirifard, M. Bakhshayeshkaram (Tehran, Islamic Republic of Iran)
P661 Chest ultrasound examination (for pleural effusions) by chest physicians in the United Kingdom: a national web-
based survey of the practice
A. Guhan, P. Walker, G. S. Leen, G. Naisby (Middlesbrough, United Kingdom)
P662 Vibration response imaging (VRI) in COPD patients
M. Mineshita, J. Saji, H. Kida, F. Ishikawa, H. Nishine, M. Nakamura, M. Ohshige, A. Ishida, S. Nobuyama,
Y. Matsuoka, T. Inoue, M. Hoshino, T. Shirakawa, T. Miyazawa (Kawasaki, Japan)
Hall 6.2-12
Session 90
12:50–14:40
Thematic Poster Session: Diagnostic and therapeutic approaches in pleural
diseases
Chairs: P. Chhajed (Basel, Switzerland), N. Schoenfeld (Berlin, Germany)
P663 Feasibility of short term drainage for diagnostic thoracoscopy
D. P. Breen, S. Mallawathantri, A. Fraticelli, L. Greillier, P. Astoul (Marseille, France; Dublin, Ireland; Nottingham,
United Kingdom)
P664 Predictors of survival in patients with recurrent malignant pleural effusion
s
es
R. Terra, L. Antonangelo, M. Suesada, V. Capelozzi, P. Pego-Fernandes, F. Vargas, F. Jatene (Sao Paulo, Brazil)
P665 Incidence and diagnostic utility of pleural fluid eosinophilia
R. Krenke, P. Korczynski, J. Nasilowski, K. Gorska, T. Przybylowski, J. Domagala-Kulawik, R. Chazan (Warsaw, Poland)
P666 Medical thoracoscopy and guided chest tube drainage as effective management of spontaneous pneumothorax
A. Pismennyy, E. Korimasov, I. Fedorin (Samara, Russian Federation)
P667 Lung function and respiratory muscles strength in patients undergoing medical thoracoscopy
A. Pataka, G. Kouliatsis, P. Steiropoulos, D. Makris, S. Anevlavis, D. Bouros, M. Froudarakis (Alexandroupolis, Greece)
P668 Diagnostic value of medical thoracoscopy in pleural disease – a 5-year retrospective study
X. Tsiafaki, N. Maounis, S. Karampi, M. Chorti (Athens, Greece)
P669 ‘Redo’ medical thoracoscopy is feasible in patients with pleural diseases – a series
D. P. Breen, A. Fraticelli, L. Greillier, S. Mallawathantri, P. Astoul (Marseille, France; Dublin, Ireland; Nottingham,
United Kingdom)
P670 Closed pleural brushing in the diagnosis of malignant pleural effusions
G. Anzalone, M. C. Truglia (Prato, Italy)
ERS Berlin 2008 Annual Congr
174
S U N D A Y O C T O B E R 5
P671 Relationship between survival after talc pleurodesis and classic prognostic factors in pleural metastatic breast
carcinoma
A. Romero Falcon, A. Montes Worboys, J. L. Lopez-Campos Bodineau, A. Casas Fernandez de Tejerina, F. Rodriguez
Panadero (Seville, Spain)
P672 Diagnostic and therapeutic thoracoscopy in sole thoracic epidural anaesthesia
C. Steppert, T. Holl, C. Sommer, G. Habich (Ebensfeld, Germany)
P673 Role of medical pleuroscopy for management of pleural effusion: a 3 years period review
J. Bento, A. P. Vaz, A. Amorim, V. Hespanhol, A. Magalhaes (Porto, Portugal)
P674 Nonspecific pleuritis – clinical characteristics and follow-up
S. Figueiredo, P. Caetano Melo, F. Jesus Coelho, A. Magalhaes (Porto, Portugal)
P675 Long term follow up in patients with idiopathic pleuritis
D. Zachilas, A. Asimakos, H. Michaelides, G. Papavasiliou, N. Anastasiou (Athens, Greece)
P676 Sedative drug requirements during thoracoscopy
P. Chhajed, J. Fernando, D. Stolz, M. Tamm (Basel, Switzerland)
P677 Empyema thoracis in children: clinical staging and video assisted thoracoscopic surgery (VATS)
K. Lahiri, M. Engade, R. Agarwal (Mumbai, India)
P678 Management of pneumothorax in a district general hospital comparing with the British Thoracic Society
guidelines
K. Pannu, A. Kavidasan, M. Goolam (Wiltshire, United Kingdom)
P679 Evaluation of long term safety of a novel sealant to prevent pneumothorax in transthoracic needle biopsy
S. Kee, E. Lee, C. Loh, G. Gong, M. Cham, D. Yankelevitz (Los Angeles, Mountain View, New York, United States of
America)
P680 Prevention of pneumothorax following transthoracic needle biopsy (TTNB): feasibility study of safety and
effectiveness of a new sealant system
S. Lindemayr, M. Kreuter, R. Hammerstingl, T. J. Vogl (Frankfurt am Main, Heidelberg, Germany)
P681 Comparison aspiration and core needle biopsy of thoracic tumour
J. Plutinsky, E. Pechacova, K. Bitter, S. Petricek, D. Magula, B. Matula, M. Michalickova (Nitra, Slovakia)
P682 The diagnostic value of closed pleural needle biopsy in tuberculous pleurisy
M. Vejnovic, D. Jelacic, A. Ogrizovic Ponjevic (Sombor, Republic of Serbia)
Hall 6.2-13
Session 91
12:50–14:40
Thematic Poster Session: Regulatory mechanisms of cell activation, renewal and
recruitment
Chairs: A. Millar (Bristol, United Kingdom), R. Lutter (Amsterdam, The Netherlands)
P683 Immunophenotypic and functional characterization of adult lung epithelial and stromal progenitor cell targets
I. Bertoncello, K. Yuen, B. Williams, J. McQualter (Melbourne, Australia)
P684 The effects of bortezomib on endothelial progenitor cells
T. Resch, H. Vogelsinger, J. Loeffler-Ragg, C. M. Kähler (Innsbruck, Austria)
P685 The influence of endobronchial laser irradiation on gas transport and immune cells functions
U. Demkow, M. Wasik, E. Gorska, K. Nowicki (Warsaw, Poland)
P686 Effect of endothelin-1 on migration of endothelial progenitor cells in vitro
D. Ziupa, S. Desole, H. Vogelsinger, C. M. Kähler (Innsbruck, Austria)
P687 The effects of raloxifine and tamoxifine on respiratory system of rats with acute spinal cord injury
O. Ozturk, N. Songur, O. Ismailoglu, A. Turhan, Y. Kara, N. Yilmaz, O. Kilic, H. Vural (Isparta, Istanbul, Turkey)
P688 Bosentan, epoprostenol and iloprost affect migration of human monocytes in vitro
S. Desole, H. Vogelsinger, K. Cima, C. M. Kähler (Innsbruck, Austria)
s
P689 Mitochondria related hormone stanniocalcin-1 (STC-1) derived from human multipotent stromal cells (MSCs)
es
reduce cell death of human lung epithelial cell line (A549) under fetal acidosis and/or hypoxia
S. Okochi, G. Block, T. Nukiwa, D. Prockop (Sendai, Japan; New Orleans, United States of America)
P690 Endothelial progenitor cells in patients with chronic obstructive pulmonary disease
M. Hoogenboom, J. MacLay, A. Robb, N. Mills, D. Newby, W. MacNee (Edinburgh, United Kingdom; Utrecht,
The Netherlands)
P691 Screening tool for lung cancer based on feed-forward neural network
N. Minic, S. Zunic (Belgrade, Republic of Serbia)
P692 Exercise training reduces pulmonary ischaemia–reperfusion-induced inflammatory responses
R. Kalaf Mussi, I. Toro, E. Antunes, E. Camargo, A. Zanesco, E. Landucci (Campinas, Rio Claro, Brazil)
P693 Roles of Rho-Rock and Smad pathways in TGFb1-mediated lung fibroblast differentiation
D. Yang, T. Wu, H. Xie (Shanghai, Dalian, China)
P694 N-acetylcysteine correct the disturbances in functional and metabolic activity of hypoxic and hyperthermic
alveolar macrophages
ERS Berlin 2008 Annual Congr
L. Barabanava (Minsk, Belarus)
175
S U N D A Y O C T O B E R 5
Hall 6.2-14
Session 92
12:50–14:40
Thematic Poster Session: Structural remodelling in COPD
Chairs: N. Weissmann (Giessen, Germany), O. Holz (Grosshansdorf, Germany)
P695 Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic
obstructive pulmonary disease?
B. Oktay, S. Ardic (Ankara, Turkey)
P696 Type I and III collagen protein precursors in the airways of smokers and COPD-patients
T. Harju, H. Merikallio, J. Risteli, V. Kinnula, R. Kaarteenaho-Wiik (Oulu, Helsinki, Finland)
P697 Activation and cytokine profiles of killer cells in COPD
R. Urbanowicz, J. Richens, P. O’Shea, J. Corne, J. Lamb, L. Fairclough (Nottingham, Edinburgh, United Kingdom)
P698 Low expression of cellular retinoic acid binding protein 2 and dysregulation of elastin expression in pulmonary
emphysema fibroblasts
L. Plantier, C. Rochette-Egly, D. Goven, A. Boutten, M. Bonay, G. Lesèche, M. Fournier, B. Crestani, J. Boczkowski
(Paris, Illkirch, France)
P699 Inspiratory threshold loading increases TNF-
in the rat diaphragm
M. Dominguez, J. B. Galdiz, V. Mielgo, S. Mas, F. J. Alvarez, J. Marin, E. Barreiro, J. Gea (Barcelona, Baracaldo, Spain)
P700 Influence of recombinant human vascular endothelium growth factor- (rhVEGF-) 165 on surfactant proteins (SPs)
mRNA levels in emphysematous rat lungs
J. Prakash Muyal, A. Plagens, M. Herrmann, C. Vogelmeier, H. Fehrenbach, C. Seifart (Marburg, Germany)
P701 Age-related impairment of nitric oxide involvement in regulation of airways smooth muscle tone
B. Gurzu, I. L. Dumitriu, B. C. Petrescu, B. M. Gurzu, S. M. Slatineanu, M. Costuleanu, G. Petrescu (Iasi, Romania)
P702 Free radical processes and their correction in patients with lung diseases
U. Farkhutdinov, S. Farkhutdinov, A. Mirchaidarov, V. Petryakov (Ufa, Russian Federation)
P703 The overexpression iNOS and relative lower eNOS contributed to the severe lung injury in Pseudomonas
aeruginous pneumonia of immunocompromised rats
J. Xu, J. Qu, H. Li (Shanghai, China)
P704 Indicators of oxidative stress of COPD patients
J. Lalic, I. Stankovic, T. Pejcic, I. Djordjevic, V. Cosic, V. Veljovic (Nis, Republic of Serbia)
P705 Protein S inhibits the secretion of inflammatory cytokines from alveolar epithelial cells
T. Takagi, E. Gabazza, A. Fujiwara, H. Nakahara, H. Fujimoto, A. Yamaguchi, H. Yasui, T. Kobayashi, H. Kobayashi,
C. D’Alessandro-Gabazza, Y. Takei, O. Taguchi (Tsu, Japan)
P706 Microsatellite DNA instability in epithelial barrier cells in COPD
K. Samara, E. Tzortzaki, E. Neofytou, A. Karatzanis, N. Siafakas (Heraklion, Greece)
P707 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
N. Agarwal, A. Mohan, R. Guleria, C. Mohan, S. Arora (New Delhi, India)
P708 CRP and LTE4 in COPD
M. A. Martinez Cortizas, M. P. Pereiro, C. N. Artana, N. Pistillo, J. J. Scarimbolo, J. M. Figueroa (Avellaneda/Buenos
Aires, Caba, Argentina)
P709 Evaluation of oxidative stress on pathogenesis and severity of chronic obstructive pulmonary disease
C. Cristóvão, L. Cristóvão, R. Rodrigues, S. Marques, N. Murinello, L. Oliveira, F. Nogueira, M. Bicho (Lisbon, Portugal)
P710 Pathogenic aspects of pulmonary complications in acute pancreatitis patients
R. Vatseba, S. Chooklin (Lviv, Ukraine)
P711 Elevation of interleukin-8 in epithelial lining fluid of collapsed lung during 1-lung ventilation
Y. Komatsu, H. Yamamoto, T. Yokoyama, K. Kubo (Matsumoto, Japan)
s
Hall 6.2-15
Session 93
12:50–14:40
es
Thematic Poster Session: Animal models of pulmonary fibrosis: mechanisms and
therapies
Chairs: M. Kolb (Hamilton, Canada), R. Chambers (London, United Kingdom)
P712 VEGF gene transfer enhances fibrosis but improves pulmonary hemodynamics in experimental pulmonary fibrosis
L. Farkas, K. Ask, A. Möller, D. Farkas, P. Margetts, J. Gauldie, M. Inman, M. Kolb (Hamilton, Canada; Regensburg,
Germany)
P713 Aminoguanidine attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of heat shock protein
47 and TGF-b1 expression
L. Chen, F. Q. Wen, T. Wang, X. Wang, D. S. Liu (Chengdu, China)
P714 The PDE4 inhibitor roflumilast reduced bleomycin-induced pulmonary fibrotic and vascular remodeling in mice
in vivo
R. Benito, J. Cortijo, E. Donet, M. Mauricio, D. Ivars, E. Morcillo (Valencia, Spain)
ERS Berlin 2008 Annual Congr
P715 Carbon nanoparticles (CN) are a dramatic trigger in the process of bleomycin-induced pleural and subpleural
176
fibrosis
N. Decologne, G. Wettstein, C. Didelot, C. Garrido, P. Camus, P. Bonniaud (Dijon, France)
S U N D A Y O C T O B E R 5
P716 Inhibition of napsin A induces proSP-B accumulation and ER-stress: a novel mouse model for lung fibrosis
C. Ruppert, P. Mahavadi, T. Mokry, L. Schwertner, M. Korfei, I. Henneke, P. Markart, W. Seeger, A. Günther (Giessen,
Germany)
P717 Anti-fibrotic effect of telmisartan on bleomycin-induced lung fibrosis in mice
K. Miyamoto, S. Tasaka, H. Kamata, H. Seki, Y. Nakano, W. Yamasawa, N. Hasegawa, S. Fujishima, A. Ishizaka
(Tokyo, Japan)
P718 Circulating fibrocytes in interstitial lung disease
A. Fujiwara, H. Kobayashi, M. Masuya, A. Yamaguchi, T. Takagi, H. Nakahara, H. Fujimoto, T. Kobayashi, E. Gabazza,
Y. Takei, O. Taguchi (Tsu, Japan)
P719 Morphometric characteristic of pulmonary artery in COPD and idiopathic pulmonary fibrosis (IPF)
L. M. Mikhaleva, A. L. Cherniayev, A. V. Bykanjva, M. V. Samsonova, T. G. Barkhina, G. V. Nekludova (Moscow, Russian
Federation)
P720 Alveolar extracellular 20S proteasome in patients with acute respiratory distress syndrome
S. Sixt, J. Hakenbeck, M. Adamzik, D. Spyrka, B. Saul, B. Dahlmann, J. Peters (Essen, Berlin, Germany)
P721 Role of TGF-b1 in type I collagen production in bronchial epithelial cells: effects on Smad7 inhibitory role?
F. Magno, E. Jazrawi, P. Chou, G. La Rocca, B. Balbi, A. Di Stefano, I. Adcock (London, United Kingdom; Palermo,
Veruno, Italy)
P722 Time course of lung parenchyma remodelling in different models of extrapulmonary acute lung injury
M. Chao, M. Oliveira, P. Silva, R. Santos, E. Parra, W. Teodoro, V. Capelozzi, P. Rocco (Rio de Janeiro, Sao Paulo,
Brazil)
P723 Idiopathic interstitial pneumonia in relation to the gene polymorphisms of TNF-
and TNFR II
N. Li, H. Dai, P. Xin, X. Li, L. V. Yueping, C. Wang (Beijing, China)
P724 Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory
signaling
A. Birukova, F. Fu, K. Birukov (Chicago, United States of America)
P725 Efficacy
of -tocoferol in the treatment of patients with pneumonia
U. Farkhutdinov (Ufa, Russian Federation)
P726 Characterization of small airways structural alterations in acute respiratory distress syndrome
M. M. Morales, R. C. Pires-Neto, T. Lanças, L. F. F. Silva, N. Inforsato, T. Mauad, M. Dolhnikoff (Sao Paulo, Brazil)
P727 Processes of free radical oxidation in experimentally induced pneumonia
U. Farkhutdinov (Ufa, Russian Federation)
P728 Evidence of type II pneumocyte apoptosis in the murine model of Hermansky-Pudlak-syndrome associated
interstitial pneumonia
P. Mahavadi, M. Korfei, I. Henneke, W. Seeger, A. Guenther, C. Ruppert (Giessen, Germany)
P729 Pathological evaluation of the bleomycin induced lung injury in rats
M. Kontogiorgi, I. Agrogiannis, G. Tsoukalas, A. Papalois, E. Patsouris (Athens, Greece)
P730 Capsaicin-sensitive nerves inactivation reduces lung parenchyma remodeling in guinea pigs with chronic allergic
pulmonary inflammation
C. Prado, G. da Rocha, E. Leick-Maldonado, C. Starling, V. Capelozzi, M. Martins, I. Tibério (Sao Paulo, Brazil)
Hall 6.2-16
Session 94
12:50–14:40
Thematic Poster Session: Pulmonary mechanics and gas exchange
Chairs: A. Aliverti (Milan, Italy), R. Rodríguez-Roisin (Barcelona, Spain)
P731 Time course of changes in bronchial reactivity during early training in healthy subjects
N. Scichilone, S. Reitano, E. Davi, D. Zangla, G. Morici, A. Togias, V. Bellia, M. Bonsignore (Palermo, Italy; Bethesda,
United States of America)
s
P732 Time course of changes in airway cells during early training in healthy subjects
es
L. Chimenti, A. Paternò, R. Santagata, S. Reitano, D. Zangla, F. Velardo, G. Morici, V. Bellia, M. R. Bonsignore
(Palermo, Italy)
P733 Diffusing capacity for nitric oxide and capillary blood volume in patients with idiopathic interstitial pneumonia
L. Stervinou, T. Perez, V. Debroucker, R. Neviere, B. Wallaert (Lille, France)
P734 Diffusing capacity of the lung for carbon monoxide (D
) and pulmonary blood flow during incremental and
LCO
intermittent-work exercise tests
I. Enache, A. Charloux, R. Richard, M. Oswald, B. Geny (Strasbourg, France)
P735 Increased diffusing capacity for carbon monoxide after strenuous exercise
R. Prediletto, E. Fornai, G. Catapano, C. Cristina, G. Erika, B. Remo, A. L’Abbate (Pisa, Italy)
P736 Ventilation-perfusion mismatch during different exercise modalities in idiopathic pulmonary arterial hypertension
(IPAH)
G. Valli, D. Martolini, R. Poscia, R. Badagliacca, G. Alessandrini, D. C. Vizza, P. Palange (Rome, Italy)
P737 Heliox ameliorate the ventilation-perfusion mismatch during exercise in COPD patients
ERS Berlin 2008 Annual Congr
G. Valli, D. Martolini, P. Onorati, P. Paoletti, A. Fedeli, P. Palange (Rome, Italy)
P738 Alveolar fraction of exhaled NO (Calv) in patients with heart failure is higher than in asthmatic and normal
subjects
177
P. Pozzi, A. Fumagalli, F. Luisi, A. Foresi, G. Fragasso, P. Zannini, G. Cremona (Milan, Sesto San Giovanni, Italy)
S U N D A Y O C T O B E R 5
P739 Gas exchange impairment under incremental exercise in sarcoidosis patients with normal resting pulmonary
functions
B. Matula, S. Majernik, D. Magula, J. Plutinsky, S. Petricek (Nitra, Slovakia)
P740 PaO during exercise as a predictor for in-flight hypoxemia in COPD patients
2
A. Akerø, A. Edvardsen, M. Ryg, O. H. Skjønsberg (Oslo, Hakadal, Norway)
P741 Hyperoxic effects on inspiratory muscle fatigue in cycling healthy humans
M. Segizbaeva (St Petersburg, Russian Federation)
P742 The influence of changes in airflow limitation, ventilation and perfusion of lungs on exercise capacity in patients
with COPD
E. V. Kolotowa, N. N. Vavilova, L. G. Nakhamchen (Blagoveschensk, Russian Federation)
P743 Changes in breathing pattern and arterial blood oxygenation following laparoscopic and open cholecystectimy
S. Michaelides, G. Bablekos, K. Charalabopoulos, M. Tsakopoulos (Athens, Ioannina, Greece)
P744 Respiratory muscle training improves thoracoabdominal coordination and work efficiency during incremental
exercise in healthy subjects
L. Pomidori, S. Uliari, G. Mazzoni, F. Manfredini, G. Grazzi, A. Cogo (Ferrara, Italy)
P745 Baseline lung function and ventilatory response to exercise in patients with chronic heart failure
P. Tzani, F. Longo, M. Aiello, W. Serra, D. Olivieri, A. Chetta (Parma, Italy)
P746 Slope of exercise ventilation to carbon dioxide production in patients with pulmonary arterial hypertension, either
primary or associated with connective tissue disease
M. Schwaiblmair, C. Faul, T. Berghaus (Augsburg, Germany)
P747 Latest developments in diagrammatic diagnosis of acid-base disorders
N. Theakos, A. Loukos, B. Panagiotis (Athens, Greece)
Hall 6.2-17
Session 95
12:50–14:40
Thematic Poster Session: Exercise: system responses
Chairs: L. Puente-Maestu (Madrid, Spain), P. Palange (Rome, Italy)
P748 Addition of respiratory muscle endurance training (RMET) to improve the benefits of an exercise and nutrition
program in overweight subjects
I. Frank, R. Briggs, C. M. Spengler (Zurich, Switzerland)
P749 Effect of sub-maximal exercise on breathing energy expenditure
T. Powell, N. Thomas, E. M. Williams (Pontypridd, United Kingdom)
P750 Running time trial performance after respiratory muscle endurance training in overweight and obese subjects
I. Frank, R. Briggs, C. M. Spengler (Zurich, Switzerland)
P751 Effects of helium-hyperoxia on maximal and submaximal exercise responses in hypoxaemic males with COPD
F. J. Queiroga, Jr., E. Meda, D. Fonseca, G. Siqueira, M. Souza, M. C. Machado, J. A. Neder, L. E. Nery (Sao Paulo,
Brazil)
P752 Hypercapnia does not affect inspiratory muscle fatigue in exercising human
M. Segizbaeva (St Petersburg, Russian Federation)
P753 Dyspnea and hypoxemia in COPD and CHF patients is more severe and prolonged after acetate hemodialysis
K. Navari, H. Sohrabpour, N. Ziaee (Bandarabbas, Tehran, Islamic Republic of Iran)
P754 Standardized maximal exercise perception score – a practical approach to cardiopulmonary rehabilitation
outcome assessment
S. Kostianev, K. Terziyski, B. Marinov, M. Tokmakova (Plovdiv, Bulgaria)
P755 Oxygen uptake efficiency slope in chronic heart failure and chronic obstructive pulmonary disease
K. Terziyski, B. Marinov, O. Aliman, S. Kostianev (Plovdiv, Bulgaria)
P756 Comparison of measured maximum oxygen consumption with cardiopulmonary exercise test to six minute walking
s
test results
es
S. Bilgin Kiziltas, A. Ongel, H. Kurtel, N. Bakirci, S. Pamuk, H. C. Calisir (Istanbul, Turkey)
P757 Validity of a seismic accelerometer for estimating energy expenditure under sedentary conditions
V. T. van Hees, R. C. van Lummel, K. R. Westerterp (Maastricht, Amsterdam, The Hague, The Netherlands)
P758 Relationships between severity of COPD and EPCs, thrombosis, proteolysis, and exercise capacity
P. Wollmer, S. Franz, T. Higenbottam, P. Persson, U. Nihlen, T. Bengtsson (Malmo, Lund, Sweden; Loughborough,
United Kingdom)
P759 Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO)
K. Vonbank, B. Marzluf, C. Lambers, B. Burian, L. Stiebellehner, V. Petkov, R. Ziesche, P. Haber, L. H. Block (Vienna,
Austria)
P760 Impaired exercise performance in systemic sclerosis. Clinical correlations
G. Valentini, C. Santoriello, G. Cuomo, V. Musella, F. Polverino, M. Polverino (Naples, Cava de Tirreni, Italy)
P761 Should all chronic obstructive pulmonary disease (COPD) patients with cardiac co-morbidities have ambulatory
oxygen assessment?
ERS Berlin 2008 Annual Congr
T. Eugene, C. Victoria, K. Vaibhav, K. Ravindra (Crewe, United Kingdom)
178
P762 Field testing of ventilatory responses associated with walking and walking with poles (Nordic walking)
L. Pomidori, A. Lionello, A. Cogo (Ferrara, Italy)
S U N D A Y O C T O B E R 5
P763 Gender-related differences in intermittent hypoxia training (IHT) effects on ventilation and exercise performance
T. Serebrovska, V. Shatilo, V. Ishchuk, A. Serebrovsky (Kiev, Ukraine)
P764 A descriptive analysis of exercise capacity before and after solid organ transplant
M. A. Montoliu, T. Ortega, M. Iscar, M. J. Villanueva, B. Rodriguez (Oviedo, Spain)
P765 Combination of risk factors of bronchopulmonary and cardiovascular diseases in people of young age
A. Sidorov, Y. Mostovoy, N. Slepchenko (Vinnitsa, Ukraine)
Hall 6.2-18
Session 96
12:50–14:40
Thematic Poster Session: Clinical aspects of continuous positive airway pressure
therapy
Chairs: W. Randerath (Solingen, Germany), D. Pevernagie (Heeze, The Netherlands)
P766 Insomnia, OSAS and CPAP treatment
X. L. Nguyen, D. Rakotonanahary, B. Fleury (Paris, France)
P767 Effects of air humidification on an air-leak controlled nasal-CPAP experimental rat model
B. Martiez-Vidal, J. M. Montserrat, R. Farre, M. Torres, I. Almendros, I. Vilaseca (Barcelona, Spain)
P768 Index for comfort of patients with obstructive sleep apnea on continuous positive airway pressure therapy
T. Mondeshki, O. Georgiev, D. Petrova, R. Bilyukov, A. Stavrakis (Sofia, Bulgaria)
P769 Occurrence and predisposition for complex apneas during CPAP titration in OSA patients
I. Fietze, D. Ringel, M. Glos, D. Buck, T. Penzel (Berlin, Germany)
P770 Compliance of positive airway pressure therapy in patients with sleep related breathing disorder
Z. Z. Ucar, S. Olcay, A. U. Demir, R. Ozacar (Izmir, Ankara, Turkey)
P771 CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study
K. K. Y. Chan, S. Birring, G. Cossa, L. Laks, A. Ing (New South Wales, Australia; London, United Kingdom)
P773 Algorithm-based
versus titrated CPAP: a randomized study
A. Noseda, S. Andre, V. Potmans, M. Kentos, G. Hoffmann (Brussels, Belgium)
P774 Implementation of continuous positive airway pressure treatment in patients with obstructive sleep apnoea-
hypopnoea syndrome by the self titration method with auto-adjusting CPAP at home. Experience in the real life
P. A. Hauss, N. Amiot, F. Portier, L. C. Molano, D. Benhamou, J. F. Muir (Rouen, France)
P775 Randomized study of an auto-titration protocol v.s. manual CPAP titration
J. Herold, T. Ebert, E. Roessner, S. Zanner, A. Steinmann, J. Ficker (Nuernberg, Germany)
P776 Titration of home CPAP in obstructive sleep apneas syndrome (OSAS) through real time telemetry
R. Dellaca, L. Govoni, M. Mayos, A. Pedotti, J. M. Montserrat, R. Farre (Milan, Italy; Barcelona, Spain)
P777 Nasopharyngeal symptoms do not predict poor adherence to nCPAP treatment
H. R. Kreivi, J. Lehto, P. E. Brander (Helsinki, Hyvinkää, Finland)
P778 CPAP therapy and travelling
T. Aalto, P. Maasilta, A. Bachour (Helsinki, Finland)
P779 Psychological variables as predictors of adherence to continuous positive airway pressure
C. Poulet, J. Tyrrell, D. Veale, N. Arnol, J. L. Pepin (Grenoble, St Julien du Ratz, France)
P780 CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive
sleep apnoea–hypopnoea (OSAH). A controlled study
D. C. Joaquín, A. Felipe, M. N. Cristina, R. Ramón, T. Joaquín, A. MariLuz, A. Jose Ignacio, L. Patricia, M. Mercedes,
B. Eugeni, M. Jose María, C. Santiago, C. Rosario, G. Mónica, M. Juan Fernando, M. De la Peña, B. Ferrán
(Citoria, Burgos, Bilbao, Barcelona, Zaragoza, Cantabria, Cáceres, Mallorca, Lleida, Spain)
P781 Long term effects of CPAP in blood pressure in nonsleepy hypertensive OSA patients
S. Gomez, C. Carmona, J. Duran-Cantolla, J. F. Masa, F. Garcia-Rio, M. Lumbierres, C. Monasterio, J. M. Marin,
F. del Campo, M. de la Pena, E. Chiner, J. Diaz de Atauri, M. Mayos, M. Gonzalez, M. L. Alonso, M. Martinez,
s
J. M. Montserrat, F. Barbe (Lleida, Spain)
es
P782 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive
sleep apnea syndrome
Z. Xilong, L. Yanqun, Y. Kaisheng (Nanjing, China)
P783 Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive
sleep apnea (OSA) and hypertension
P. Pinto, C. Barbara, J. Calaca, P. Calaca, A. S. Oliveira, C. Canhao, A. R. Dias, J. Teixeira, M. J. Marques Gomes
(Lisbon, Portugal)
P784 Comparison of standard humidification and humidification with a heated breathing tube in CPAP therapy of
obstructive sleep apnea
W. Galetke, S. Stieglitz, C. Priegnitz, T. Schaefer, W. Randerath (Solingen, Germany)
P785 Efficacy of OSA treatment with a new auto-CPAP mode
K. Bielicke, A. Blau, B. Diecker, T. Penzel, G. Baumann, I. Fietze (Berlin, Germany)
ERS Berlin 2008 Annual Congr
179
S U N D A Y O C T O B E R 5
Hall 6.2-19
Session 97
12:50–14:40
Thematic Poster Session: Weight control and comorbidity in obstructive sleep
apnoea
Chair: M. Eijsvogel (Enschede, The Netherlands)
P786 Does surgical weight loss improve (or cure) obstructive sleep apnea? A meta-analysis
D. Greenburg, C. Lettieri, A. Eliasson (Washington, United States of America)
P787 The importance of sleep studies in morbidly obese patients prior to bariatric surgery
M. A. Nieto, J. L. álvarez-Sala, J. M. Fernández, M. A. Rubio, C. Fernández (Madrid, Spain)
P788 Impact of weight loss following bariatric surgery on sleep respiratory disorders, in patients with morbid obesity
(MO) and concomitant obstructive sleep apnea syndrome (OSAS)
M. Gasa, N. Salord, M. J. Manuel, S. Perez, N. Vilarrasa, C. Masdevall, C. Monasterio (Hospitalet de Llobregat,
Barcelona, Spain)
P789 Heart rate variability analysis during sleep in obese patients with obstructive sleep apnoea submitted a bariatric
surgery
C. M. Plens, M. L. Shah, P. C. Bosio, L. C. Giannasi, L. V. F. Oliveira (Sao Jose dos Campos, Ribeirao Preto,
Sao Paulo, Brazil)
P790 CPAP use and weight control in obese OSA patient improves by a tele-assistance program.
F. Fanfulla, A. E. Taurino, N. D’Artavilla Lupo, M. Piran, S. Scalvini, C. Fracchia (Pavia, Montescano, Lumezzane, Italy)
P791 Weight changes and CPAP pressure in obesity patients with SAHS
E. Serasli, M. Antoniadou, M. Matzourani, A. Chasiotou, P. Christaki, V. Tsara (Thessaloniki, Greece)
P792 Body composition correlates with the severity of obstructive sleep apnea syndrome
S. Lovin, R. Bercea, C. Cojocaru, G. Rusu, T. Mihaescu (Galati, Iasi, Romania)
P793 The frequency of rhinitis in patients with obstructive sleep apnea syndrome (OSAS)
O. T. Dogan, O. Abadoglu, E. Cakmak (Sivas, Turkey)
P794 Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea
syndrome
M. Czystowska, A. Skoczylas, J. Czerniawska, R. Plywaczewski, D. Gorecka, P. Sliwinski (Warsaw, Poland)
P795 Do nocturnal apnoeas contribute to increased cardiovascular risk in end stage renal disease patients?
M. Sivalingam, S. Mowatt, K. Hall, I. Chakravorty, K. Farrington (Stevenage, United Kingdom)
P796 Dental status in obstructive aleep apnea syndrome patients
P. Korczynski, A. Nowogorska, K. Gorska, P. Bielicki, R. Chazan (Warsaw, Poland)
P797 Relationship between age and cardiovascular diseases (CVD) in obstructive sleep apnoea (OSA)
R. Plywaczewski, A. Skoczylas, M. Czystowska, D. Gorecka, P. Sliwinski (Warsaw, Poland)
P798 Sleep apnea in patients with heart failure effectiveness of continuous positive airway pressure
J. J. Blanco-Pérez, I. Parente-Lamela, R. Almazán-Ortega, M. Tumbeiro-Novoa, C. Zamarrón-Sanz, M. García-García,
P. Marcos-Velazquez, M. Toubes-Navarro, C. Fernandez-Alvarez (Ourense, Santiago de Compostela, Spain)
P799 Outcome of periodic leg movements (PLMs) in sleep apnea patients after continuous positive air pressure (CPAP)
treatment
F. Cheliout-Heraut, P. Deblois, N. Zrek, H. Khemliche, F. Bour (Garches, Gonesse, France)
P800 Microalbuminuria in sleep apnea patients: correlation with sleep and blood pressure parameters
C. Liavvas, E. Daskalopoulou, O. Nikitidou, N. Kartali, Z. Koukoulidou, E. Vlachogiannis, N. Dombros (Thessaloniki,
Greece)
P801 Predictor factors of nocturnal hypoventilation in primary neuromuscular diseases
S. Merai, J. Ben Amar, H. Daghfous, S. BenMrad, F. Tritar (Ariana, Tunisia)
P802 Respiratory function and sleep respiratory disorders in facio-scapulo-humeral dystrophy (FSHD)
s
es
G. Bourdin, F. Philit, T. Petitjean, P. Le Cam, C. Guerin (Lyon, France)
P803 Association between sleep related breathing disorders and trauma
Z. Z. Ucar, S. Olcay, A. U. Demir, R. Ozacar (Izmir, Ankara, Turkey)
P804 Usefulness of sleep studies in patients with neuromuscular diseases
C. Senent Español, E. Gómez-Merino, E. Chiner Vives, J. Signes-Costa Miñana, A. L. Andreu Rodríguez, A. Camarasa
Escrig, J. N. Sancho Chust, J. M. Arriero Marín, J. Marco Such (San Juan de Alicante, Spain)
P805 Diffusion tensor imaging (DTI) in obstructive sleep apnea (OSA)
V. Castronovo, P. Scifo, D. Perani, S. Cappa, A. Falini, M. Aloia, V. Ginex, L. Ferini Strambi (Milan, Italy; Denver,
United States of America)
Hall 6.2-20
Session 98
12:50–14:40
Thematic Poster Session: Assessment of sleep apnoea
Chairs: J. Montserrat (Barcelona, Spain), T. Penzel (Berlin, Germany)
ERS Berlin 2008 Annual Congr
P806 Clinical and polysomnographic features in complex sleep apnea syndrome
180
H. Inonu, T. Ciftci, O. Kokturk (Tokat, Ankara, Turkey)
P807 Disturbed sleep in obstructive sleep apnoea expressed in a single index of sleep disturbance (SDI)
W. Cassel, T. Ploch, B. Griefahn, T. Speicher, T. Penzel, U. Koehler, S. Canisius (Marburg, Dortmund, Berlin, Germany)
S U N D A Y O C T O B E R 5
P808 Eszopiclone improves the quality of polysomnography: prospective, blinded, placebo-controlled trial
C. Lettieri, T. Quast, A. Eliasson, D. Greenburg (Washington, Bethesda, United States of America)
P809 Correlation between the architecture of sleep and depressive symptoms in patients with obstructive sleep apnea
R. Bilyukov, O. Georgiev, T. Mondeshki, D. Petrova, A. Stavrakis (Sofia, Bulgaria)
P810 Differences in the daytime sleepiness between sleep apnoea and hypersomnia patients
E. Feketeová, V. Donic, Z. Tomori (Ko˘
sice, Slovakia)
P811 Correlation between Epworth sleepiness score and polysomnographic indices in sleep disordered breathing
R. Chetambath, S. Babu, P. T. James (Calicut, Kerala, India)
P812 Sleep alteration in patients admitted to a respiratory intensive care unit (RICU)
F. Fanfulla, P. Ceriana, F. Frigerio, R. Trentin, N. D’Artavilla Lupo, S. Nava (Pavia, Montescano, Italy)
P813 Gender difference on EEG arousal in patients with obstructive sleep apnea hypopnea syndrome
L. W. Hang, C. L. Lin, C. W. Yen (Taichung, Kaohsiung, Taiwan, Republic of China)
P814 Clinical, polysomnographic, antrophometric and inflammatory profile of patients with obstructive sleep apnea
syndrome based on gender
C. Martinez Rivera, J. Abad Capa, E. Valverde, S. Ros, P. Serra, A. Baya, E. Fuentes, J. Morera Prat (Badalona,
Barcelona, Spain)
P815 The importance of sleep position in treatment planning of patients with obstructive sleep apnea syndrome
H. Inonu, O. Kokturk, T. Ciftci (Tokat, Ankara, Turkey)
P816 Association between duration of sleep and systemic diseases
Z. Z. Ucar, A. U. Demir, A. K. Cirak, S. Olcay, H. Uysal (Izmir, Ankara, Turkey)
P817 Skeletal changes in the sagittal, vertical, and transverse dimensions after rapid palatal expansion in children with
OSAS
A. Rizzoli, C. Massolo, M. Evangelisti, M. C. Paolino, F. Ianniello, A. Crescenzi, M. Forlani, M. P. Villa (Rome, Italy)
P818 Computed tomographic and cephalometric studies in obstructive sleep apnea (OSA)
N. Abdelaty, M. Awad, S. Ashmawi (Ismailia, Cairo, Egypt)
P819 Working memory in obstructive sleep apnea (OSA) patients: a functional MRI study
V. Castronovo, D. Perani, N. Canessa, S. Cappa, M. Consonni, A. Bruschi, S. Marelli, A. Falini, M. Aloia, L. Ferini
Strambi (Milan, Italy; Denver, United States of America)
P820 Nocturnal energy expenditure, heat flux and galvanic skin response in mild and moderate-to-severe obstructive
sleep apnea (OSA)
J. Verbraecken, S. Van Grasdorff, F. Michiels, E. Hamans, A. Boudewyns, P. Van de Heyning, W. De Backer, R. Cluydts
(Antwerp, Belgium)
P821 Obstructive sleep apnea syndrome and quality of life determinant factors (SF 36-v2)
J. Valenca, M. Garcia, F. Caeiro, M. Aguiar, S. Moreira, R. Sotto-Mayor, A. A. Bugalho de Almeida (Lisbon, Portugal)
P822 Determinants of subjective sleepiness in suspected obstructive sleep apnoea
I. Koutsourelakis, E. Perraki, E. Vagiakis, S. Zakynthinos, C. Roussos (Athens, Greece)
P823 Excessive daytime sleepiness (ESS) and general sleep quality questionnaires (PSQI) accuracy in elderly OSA
subjects
S. Scarlata, G. Abbruzzese, M. E. Conte, I. Caridi, C. Pedone, R. Antonelli Incalzi (Rome, Taranto, Italy)
P824 The application of the Athens insomnia scale, Pittsburgh sleep quality index and Epworth sleepiness scale in
patients with obstructive sleep apnea
A. Jerzemowska, K. Adamczyk-Bak, J. Drozdowski, R. Szymczak, K. Kuziemski, M. Slominski (Gdansk, Poland)
P825 Impact of sleep apnoea syndrome on perception and memory
M. Farnik, W. Pierzchala (Katowice, Poland)
Hall 6.2-21
Session 99
12:50–14:40
Thematic Poster Session: Cardiovascular complications in obstructive sleep
s
apnoea
es
Chairs: S. Andreas (Immenhausen, Germany), N. Dursunoglu (Denizli, Turkey)
P826 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
M. Ruis, I. Mikulic, F. Tichelmann, O. C. Burghuber, A. Valipour (Vienna, Austria)
P827 Sympathetic activity at rest and during exercise in metabolic syndrome subjects with and without obstructive
sleep apnea
R. Tamisier, A. Houssière, P. Faure, J. P. Baguet, P. Lévy, J. L. Pépin (Grenoble, France)
P828 Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome
B. Amra, E. Karbasi, M. Hashemi, M. Golshan (Isfahan, Islamic Republic of Iran)
P829 Sleep-related breathing disorders in patients under cardiac resynchronization therapy with ventricular pacing
V. Di Spirito, I. De Crescenzo, G. Fiorentino, A. Molino, L. Santangelo, R. Calabro, M. Caputi, M. Sofia (Naples, Italy)
P830 High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA
trial
ERS Berlin 2008 Annual Congr
Y. Peker, H. Glantz, E. Thunström, A. Kallryd, J. Ejdebäck, J. Herlitz (Skövde, Lidköping, Gothenburg, Sweden)
P831 The relation between obstructive apneas in OSA patients and autonomic activity
A. Feliciano, L. Silva Carvalho, T. Paiva (Lisbon, Portugal)
181
S U N D A Y O C T O B E R 5
P832 Prediction of circadian changes in time domain (TD) heart rate variability (HRV); use of short term HRV
monitoring
M. Ali, A. Waheed, D. Mohan, S. Ghosh-Dastidar, J. Colombo, D. Jurivich, D. Singer (Chicago, Detroit,
United States of America)
P833 Autonomic responses to apneas in relation with the severity of sleep apnea syndrome
S. Lovin, R. Bercea, C. Cojocaru, G. Rusu, T. Mihaescu (Galati, Iasi, Romania)
P834 Obstructive sleep apnea syndrome – the evaluation of right ventricular function in moderate – severe patients
M. Hobzova, E. Sovova, V. Kolek, T. Skala, M. Hutyra (Olomouc, Czech Republic)
P835 Association of vascular endothelial dysfunction with disease severity in obstructive sleep apnoea
A. Panoutsopoulos, A. Kallianos, I. Nikolopoulos, K. Kostopoulos, G. Dionellis, L. Velentza, C. Kostopoulos,
C. Papamichael, M. Frangou, M. Theodorakis, A. Protogerou (Athens, Greece)
P836 Sleep patterns in patients with acute coronary syndromes
S. Schiza, E. Simantirakis, I. Bouloukaki, D. Arfanakis, S. Chrysostomakis, E. Kallergis, P. Vardas, N. Siafakas
(Heraklion, Greece)
P837 Prevalence of obstructive sleep apnoea and its association with aortic root dilatation in patients with Marfan’s
syndrome
M. Kohler, E. Blair, P. Risby, A. Nickol, P. Wordsworth, C. Forfar, J. Stradling (Oxford, United Kingdom)
P838 Daytime sleepiness and quality of life are not related to nocturnal Cheyne-Stokes respiration in heart failure
B. Midgren, L. Mared, K. Franklin, S. Berg, L. Erhardt, C. Cline (Lund, Umeå, Malmö, Sweden)
P839 Severity of nocturnal cardiac arrhythmias correlates with AHI in males with sleep apnoea
E. Szabóová, Z. Tomori, V. Donic, D. Holoubek (Ko˘
sice, Slovakia)
P840 Does sleepiness have an impact on echocardiographic parameters in obstructive sleep apnea (OSA) after 6M
CPAP therapy?
H. Vrints, C. Van De Heyning, M. Kerremans, W. De Backer, C. Vrints, B. Shivalkar, J. Verbraecken (Antwerp, Belgium)
P841 Antiarrhythmic effect of CPAP and uvulopalatopharyngoplasty (UPPP) in patients with severe OSAS
M. Marvisi, E. Bassi, G. Turrini, S. Aimi, G. Pedretti, G. Civardi (Fiorenzuola d’Arda, Fidenza, Italy)
P843 Proinflammatory cytokines in patients with congestive heart failure and sleep disordered breathing
T. Greulich, C. Schorr, B. Klenk, C. Vogelmeier, H. Becker (Hessen, Hamburg, Germany)
P844 Use of high frequency peak in spectral analysis of heart rate increment to improve screening of obstructive sleep
apnoea syndrome
L. Poupard, I. Court-Fortune, V. Pichot, J. C. Barthélémy, F. Roche (Rueil Malmaison, St-Etienne, France)
Hall 6.2-22
Session 100
12:50–14:40
Thematic Poster Session: Metabolic and sex-related aspects of obstructive sleep
apnoea
Chairs: A. Valipour (Vienna, Austria), B. Buyse (Leuven, Belgium)
P845 CPAP decreases elevated plasma levels of soluble tumor necrosis factor-
receptor 1 in OSAS patients
M. A. Arias, A. Alonso-Fernández, F. García-Río, M. De la Peña, J. Pierola, A. Barceló, L. Rodríguez-Padial,
A. Agustí García (Toledo, Palma de Mallorca, Madrid, Bunyola, Spain)
P846 A randomized, cross-over, placebo-controlled study of the effects of CPAP upon oxidative stress and nitrate
deficiency in patients with obstructive sleep apnea syndrome
A. Alonso-Fernández, F. García-Río, M. A. Arias, A. Hernanz, M. De la Peña, J. Pierola, A. Barceló, A. Agustí García
(Palma de Mallorca, Madrid, Toledo, Bunyola, Spain)
P847 Decrement in microalbuminuria after CPAP therapy
Z. Z. Ucar, Z. Asuk, C. Kirakli, P. Cimen, G. Tibet (Izmir, Turkey)
P848 Long term effect of APAP on C-reactive protein and IL-6 in obstructive sleep apnoea patients
s
es
M. Drummond, J. C. Winck, J. T. Guimaraes, A. C. Santos, J. Almeida, J. A. Marques (Porto, Portugal)
P849 Glucose metabolism markers in non-diabetic OSAS patients. Effect of compliance to CPAP treatment
P. Steiropoulos, N. Papanas, E. Nena, V. Tsara, G. Trakada, A. Tzouvelekis, C. Fytili, P. Christaki, D. Bouros
(Alexandroupolis, Thessaloniki, Greece)
P850 Amelioration of immune system activation in obstructive sleep apnea syndrome patients after continuous positive
airway pressure treatment
P. Steiropoulos, I. Kotsianidis, V. Tsara, E. Nena, O. Hatzizisi, G. Kyriazis, M. Froudarakis, P. Christaki, D. Bouros
(Alexandroupolis, Thessaloniki, Greece)
P851 Association of serum retinol-binding protein-4 (RBP4) levels and OSAS severity. Effect of long-term CPAP
treatment
P. Steiropoulos, A. Tzouvelekis, V. Tsara, E. Nena, V. Vasdekis, O. Hatzizisi, G. Kyriazis, G. Trakada, P. Christaki,
D. Bouros (Alexandroupolis, Thessaloniki, Athens, Greece)
P852 Severe sleep apnea, type 2 diabetes and beneficial effects of CPAP on nocturnal glucose control
M. Pallayova, V. Donic, Z. Tomori (Ko˘
sice, Slovakia)
ERS Berlin 2008 Annual Congr
P853 Blood rheological properties during six month CPAP treatment in patients with sleep apnea syndrome
182
M. Tazbirek, S. Skoczynski, L. Slowinska, M. Ograbek-Krol, W. Pierzchala (Katowice, Zabrze, Poland)
S U N D A Y O C T O B E R 5
P854 Does PAP treatment in obstructive sleep apnea (OSA) patients change functional MRI activation?
V. Castronovo, N. Canessa, D. Perani, M. Consonni, A. Bruschi, S. Cappa, A. Falini, A. Iadanza, A. Oldani, L. Ferini
Strambi (Milan, Italy)
P855 Microalbuminuria in patients with sleep apnea syndrome (SAS), before and after CPAP use
C. Liavvas, E. Daskalopoulou, E. Vlachogiannis, O. Nikitidou, E. Mastrogiannidou, N. Dombros (Thessaloniki, Greece)
P856 Incident diabetes mellitus is gender-dependent in a middle-aged sleep clinic cohort: a 16-year follow-up
Y. Peker, L. Grote, J. Hedner (Skövde, Gothenburg, Sweden)
P857 Impact of gender on the relationship between obstructive sleep apnoea and hypertension in an otherwise healthy
middle-aged sleep clinic cohort
E. Thunström, S. Thorvaldsson, J. Hedner, L. Grote, Y. Peker (Skövde, Gothenburg, Sweden)
P858 Comparison between subjective and objective measurements in the evaluation of erectile dysfunction in patients
with obstructive sleep apnea – hypopnea syndrome (OSAHS)
P. Vaios, F. Sofras, I. Bouloukaki, V. Moniaki, N. Siafakas, S. Schiza (Heraklion, Greece)
P859 Gender-related differences in compliance with continuous positive airway pressure for obstructive sleep apnea
M. Ruis, I. Mikulic, F. Tichelmann, O. C. Burghuber, A. Valipour (Vienna, Austria)
P860 Gender differences in Saudi patients with sleep apnea
H. Alotair, A. BaHammam (Riyadh, Saudi Arabia)
P861 Obstructive sleep apnoea/hypopnoea syndrome in the elderly: differences regarding the gender
D. Georgopoulos, K. Varela, E. Tsatsi, G. Androutsopoulos, C. Stavropoulou, I. Lichros (Patras, Greece)
P862 Gender differences in the sleep study in the patients with obstructive sleep apnea syndrome
K. J. Tang, Z. P. Li, H. Liao, Y. F. Luo, Y. Zhong, Y. B. Zhou, C. M. Xie (Guangzhou, China)
P863 Neck circumference – gender and comorbidity differences in OSA patients
S. Mihaicuta, S. Ursoniu, D. Muntean, D. Krohn, M. Marc, D. I. Marincu, D. Lighezan, V. Tudorache (Timisoara,
Romania)
P864 Impact of menopause and body mass index on prevalence and severity of obstructive sleep apnea syndrome
S. Cuozzo, A. Propati, G. Paone, F. Benassi (Rome, Italy)
Hall 6.2-23
Session 101
12:50–14:40
Thematic Poster Session: Socioepidemiological studies in obstructive sleep
apnoea
Chairs: Y. Peker (Skövde, Sweden), S. Ryan (Dublin, Ireland)
P865 Long term mortality in the overlap syndrome
J. M. Marin, R. DeAndres, J. Alonso, A. Sanchez, S. Carrizo (Zaragoza, Spain)
P866 Cheyne Stokes respiration predicts early but not late mortality in patients with severe heart failure
B. Midgren, L. Mared, K. Franklin, S. Berg, L. Erhardt, C. Cline (Lund, Umeå, Malmö, Sweden)
P867 The prevalence of sleep disordered breathing in subjects with moderate, optimally managed heart failure
A. Benjamin, K. Lewis (Wales, United Kingdom)
P868 Prevalence of sleep disordered breathing in stable chronic heart failure: preliminary data
A. Patrizi, M. Serpilli, I. Cammarella, M. Rulli, L. Viglietta, F. Fiorucci, E. Li Bianchi, G. Pulignano, S. Millarelli,
L. Di Michele (Rome, Italy)
P869 Snoring is associated with the development of increased systemic inflammation
D. Yoon, I. Baik, H. Kim, K. Jung, S. H. Lee, J. Kim, C. Shin (Ansan, Republic of Korea)
P870 The role of obstructive sleep apnea syndrome in the metabolic syndrome – a population-based study in women
J. Theorell-Haglöw, C. Berne, C. Janson, E. Lindberg (Uppsala, Sweden)
P871 Increased risk of stroke in patients with coronary artery disease and sleep apnea – a 10 year follow-up.
F. Valham, T. Mooe, T. Rabben, H. Stenlund, U. Viklund, K. Franklin (Umeå, Sweden)
s
P872 Prevalence of the metabolic syndrome (MS) in mediterranean patients with suspected OSAS
es
A. Zito, O. Marrone, E. Davi, A. Salvaggio, G. Insalaco, V. Bellia, M. Bonsignore (Palermo, Italy)
P873 Obstructive sleep apnea syndrome and road traffic accidents
J. Valenca, M. Aguiar, M. Garcia, F. Caeiro, F. Todo Bom, M. Felizardo, S. Moreira, R. Sotto-Mayor, A. Bugalho
de Almeida (Lisbon, Portugal)
P874 Prevalence and significance of snoring in primary care
B. Khassawneh, Y. Khader, M. Ghazzawi (Irbid, Jordan)
P875 Habitual snoring in primary school children: prevalence and associations with sleep related disorders and school
performance
U. Sahin, O. Ozturk, M. Ozturk, N. Songur, A. Akkaya (Isparta, Turkey)
P876 Prevalence of cough and nasal congestion in children presenting to the sleep disorders clinic
A. Riekstin, S. AlSaleh, S. Carpenter, I. Narang (Toronto, Canada)
P877 Prevalence and correlation of sleep apnea and degree of productivity among industrial workers in Tanta, Egypt
A. Farhat, W. El-Shimy, A. Abd Ella, G. El-Kholy, B. El-Shafey (Tanta, Egypt)
ERS Berlin 2008 Annual Congr
P878 Prevalence and clinical characteristics of obesity – hypoventilation syndrome in Greece
G. Trakada, P. Steiropoulos, A. Tzouvelekis, S. Bikou, D. Bouros (Alexandroupolis, Greece)
183
S U N D A Y O C T O B E R 5
P879 Symptoms of snoring and sleep apnea in women – a population-based study
E. Lindberg, M. Svensson, K. A. Franklin, J. Theorell-Haglöw, C. Janson (Uppsala, Umeå, Sweden)
P880 Comparing the sleep-work habits of international & US-born college students
A. Eliasson, A. Eliasson, C. Lettieri (Rockville, Bethesda, United States of America)
P881 Obstructive sleep apnoea doesn’t increase risk of cardiovascular morbidity and mortality in patients with arterial
hypertension
M. Bolotova, A. Litvin, P. Galitsin, I. Kolos, A. Aksyonova, I. Chazova (Moscow, Russian Federation)
P883 Is there an association between self-reported nasal congestion and symptoms of sleep disordered breathing in
hospital employees?
S. Hussain, M. Islam, Y. Cloonan, M. Rahbar (Kettering, United Kingdom; Karachi, Pakistan; East Lansing, United
States of America)
P884 Occupational accidents, work performance and obstructive sleep apnea syndrome (OSAS)
M. P. Accattoli, G. Muzi, O. Resta, D. Lacedonia, G. Abbritti (Perugia, Bari, Italy)
Hall 6.2-24
Session 102
12:50–14:40
Thematic Poster Session: Control of breathing and respiratory disorders during
sleep
Chairs: W. De Backer (Antwerp, Belgium), V. Donic (Ko˘
sice, Slovakia)
P885 Automatic CPAP performance in sleep apnea patients with associated COPD
A. Guerrero, C. Embid, R. Farre, F. Masa, F. Barbe, M. D. M. Centelles, J. M. Montserrat (Monterrey, Barcelona,
Caceres, Lerida, Spain)
P886 The condition of circadian rhythm of respiratory system in COPD patients depends on obstructive sleep apnoea-
hypopnea syndrome
K. Rajabov (Tashkent, Uzbekistan)
P887 Obstructive sleep apnea-hypopnea syndrome in patients with asthma
N. Akin, A. N. Annakkaya, O. Balbay, P. Arbak, U. Toru (Duzce, Turkey)
P888 Phrenic neuropathy: an unrecognized factor worsening obesity hypoventilation and obstructive sleep apnoea
syndrome
N. Coppens, G. Maury, L. Delaunois, E. Marchand (Yvoir, Belgium)
P889 Obstructive sleep apnea and nocturnal hypoventilation in adults and children with cystic fibrosis
L. Spicuzza, C. Sciuto, V. Tomarchio, M. La Rosa (Catania, Italy)
P890 Obesity hypoventilation syndrome: efficacy and predictive failure factors for CPAP treatment
N. Salord, R. Miralda, A. Farré, M. Carreras, M. Mayos (Barcelona, Spain)
P891 Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive
pulmonary disease) and obstructive sleep apnoea (OSA)
R. Plywaczewski, P. Bielen, A. Skoczylas, M. Czystowska, D. Gorecka, P. Sliwinski (Warsaw, Poland)
P892 Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
S. Osanai, S. Nakao, T. Ogasa, E. Toyoshima, Y. Ohsaki, N. Hasebe (Asahikawa, Japan)
P893 Salmeterol improves sleeping oxygen saturation in COPD
S. Ryan, L. Doherty, C. Rock, G. Nolan, W. McNicholas (Dublin, Ireland)
P894 Relationship between nocturnal gastrooesophageal reflux and bronchial obstruction
V. Gross, C. Reinke, K. Sabine, S. Kunsch, U. Koehler (Marburg, Germany)
P895 Clinical and polysomnographic findings in patients with connective tissue disease and pulmonary hypertension
M. Becker, N. Troester, G. Kovacs, M. Dominco, S. Scheidl, R. Wurm, G. Bachmaier, H. Olschewski (Graz, Austria)
P896 Respiratory drive in normal subjects
C. Rodrigues, J. Moita, J. Moutinho (Coimbra, Portugal)
s
es
P897 Hypoxia and cardiac arrhythmias during voluntary immersed breath-holds
J. Hansel, I. Solleder, W. Gfoerer, C. Muth, H. Heitkamp, P. Simon, K. Tetzlaff (Tuebingen, Ulm, Germany)
P898 Transient hypercortisolemia and hyperventilation following right cerebral ischemia-reperfusion injury
K. Ansarin, M. M. Shoja, R. S. Tubbs, M. Jamshidi, G. Shokouhi (Tabriz, Islamic Republic of Iran; Birmingham, United
States of America)
P899 Effects of anaesthesia on chest wall mechanics during spontaneous breathing and mechanical ventilation
A. Aliverti, P. Kostic, A. Lo Mauro, M. Quaranta, M. Andersson-Olerud, A. Pedotti, G. Hedenstierna, P. Frykholm (Milan,
Italy; Uppsala, Sweden)
P900 Modulation of cortical and respiratory activity by 5-HT2 receptor agonist in the rat
K. Budzinska, R. Ilasz (Warsaw, Poland)
P901 Distinct generators of aspiration and expiration reflexes: their localizations, mechanisms and effects
Z. Tomori, I. Poliacek, J. Konciková, J. Jaku˘
s, V. Donic (Ko˘
sice, Martin, Slovakia)
P902 Respiratory hypoxic response in animal model of Parkinson disease
R. Ilasz, K. Budzinska (Warsaw, Poland)
ERS Berlin 2008 Annual Congr
P903 Impaired ventilatory and breathing function in super-obese patients
184
A. Foresi, C. Rocco, A. Pelucchi, C. Leone, G. Moise, F. Luisi, P. Pozzi, G. Cremona (Sesto San Giovanni, Milan, Italy)
P904 Evaluation of interest of nocturnal transcutaneous PCO (PtcCO ) monitoring in chronic respiratory failure (CRF)
2
2
G. Bourdin, P. Nesme, A. Stagnara, N. Girerd, C. Depagne, J. C. Guérin (Lyon, France)
S U N D A Y O C T O B E R 5
Hall 6.2-25
Session 103
12:50–14:40
Thematic Poster Session: Respiratory muscles in disease
Chairs: M. Polkey (London, United Kingdom), E. Barreiro (Barcelona, Spain)
P905 Dichloroacetate reduces exercise-induced systemic oxidative stress in COPD
E. Mercken, L. Calvert, G. Hageman, A. Schols, M. Steiner (Maastricht, The Netherlands; Leicester, United Kingdom)
P906 Oxidative stress status in patients with chronic obstructive pulmonary disease and its relation to glucocorticoid
receptor levels
M. Zeng, L. Liu, C. Xie, Y. Yan, G. Lu, H. Wang, Y. He, X. Huang (Guangzhou, China)
P907 Submental electrical stimulation in post stroke oropharyngeal dysphagia rehabilitation
E. Verin, Y. Ouahchi, J. P. Marie (Rouen, France)
P908 Expression and modulation of PPARs during mitochondrial biogenesis in skeletal muscle
A. Remels, H. Gosker, R. Langen, P. Schrauwen, A. Schols (Maastricht, The Netherlands)
P909 Respiratory muscle mechanics during inspiratory resistive breathing (IRB) assessed by optoelectronic
plethysmography (OEP)
S. K. Illi, S. Hostettler, E. Mohler, C. M. Spengler (Zurich, Switzerland)
P910 Oscillatory bursts in eupnoeic and non-eupnoeic respiratory patterns during severe hypoxia and transitory brain
ischaemia
R. Benacka, E. Sedlakova, Z. Tomori (Ko˘
sice, Slovakia)
P911 The modification of configuration of men’s abdomen as manifestation of COPD systemic effect
T. Burhart, A. Kopakova, N. Gorbunov (Krasnoyarsk, Russian Federation)
P912 Expression and functional significance of nicotinamide N-methyltransferase (NNMT) in quadriceps and diaphragm
of patients with COPD
H. C. Kim, M. Mofarrahi, F. Maltais, T. Vassilakopoulos, G. Sigala, S. Hussain (Montreal, Quebec City, Canada; Athens,
Greece)
P913 Genioglossus and parasternal intercostal muscle activity during sniff
H. Imaizumi, M. Katagiri, M. Yokoba, Y. Nishii, T. Yanaihara, Y. Okada, N. Takada, N. Masuda, P. Easton, T. Abe
(Sagamihara, Izu, Japan; Calgary, Canada)
P914 Changes in respiratory muscle recruitment during normocapnic hyperpnoea assessed by optoelectronic
plethysmography (OEP)
S. Hostettler, S. K. Illi, E. Mohler, C. M. Spengler (Zurich, Switzerland)
P915 Hyperventilation, reduced muscle strength and pulmonary hypertension are the main determinants of chronic
dyspnea in chronic heart failure patients
R. Torchio, L. Biasco, C. Ciacco, M. Guglielmo, L. Montagna, P. Greco-Lucchina, C. Gulotta (Orbassano, Italy)
P916 Caveolin-1 in force regulation following airway smooth muscle inflammation
B. Yang, M. Thompson, Y. S. Prakash, C. Pabelick (Rochester, United States of America)
P917 Ultrasound estimation of functional activity of diaphragm in patients with COPD
E. Surkova, A. Alexandrov, E. Perley, A. Gichkin (St Petersburg, Russian Federation)
P918 Mitochondrial contribution to oxidative stress in the diaphragm of patients with severe COPD
J. Marin-Corral, J. Minguella, A. Ramirez-Sarmiento, S. Hussain, J. Gea, E. Barreiro (Barcelona, Spain; Montreal,
Canada)
P919 The effect of different respiratory muscle training modalities on respiratory muscle fatigue and performance
V. Samuel, A. S. Renggli, D. A. Notter, C. M. S. Spengler (Zurich, Switzerland)
P920 Characterization of COPD phenotype: comparison of the perceptual response to exercise in emphysema and
chronic bronchitis patients
R. Duranti, P. Laveneziana, G. Camiciottoli, G. Innocenti Bruni, D. Testaferrata, F. Bigazzi, G. Scano, M. Pistolesi
s
(Florence, Italy)
es
P921 The relationship of respiratory muscle function to survival in motor neurone disease
J. Chlumsky, P. Ridzon (Prague, Czech Republic)
P922 Respiratory muscle strength and perception of dyspnea during bronchodilator response test in patients with
stable COPD
V. Zugic, S. Stojilkovic, N. Mujovic, P. Rebic (Belgrade, Smederevska Palanka, Republic of Serbia)
P923 Serum leptin and tumor necrosis factor–
levels and maximal exercise performance in patients with chronic
obstructive pulmonary disease
A. Pataka, P. Argyropoulou, G. Kyriazis (Exohi, Thessaloniki, Greece)
P924 Evidence of systemic and pulmonary oxidative stress after local quadriceps endurance exercise in COPD
E. Mercken, H. Gosker, G. Hageman, A. Bast, E. Wouters, A. Schols (Maastricht, The Netherlands)
ERS Berlin 2008 Annual Congr
185
S U N D A Y O C T O B E R 5
Hall 6.2-26
Session 104
12:50–14:40
Thematic Poster Session: Lung function in respiratory disease
Chair: O. Pedersen (Aarhus, Denmark)
P925 Undiagnosed heart failure in elderly COPD patients does not affect the diffusion capacity
N. Stigter, F. Rutten, P. Zanen, J. W. Lammers (Utrecht, The Netherlands)
P926 Value of MEF50/MIF50 parameter in diagnosis of airflow disturbances in upper respiratory system tract
E. Kolarzyk, W. Szot (Krakow, Poland)
P927 Bronchodilator response assessed by computed tomography in chronic obstructive pulmonary disease
M. Hasegawa, Y. Nasuhara, H. Makita, N. Odajima, K. Nagai, Y. Ito, T. Betsuyaku, M. Nishimura (Sapporo, Japan)
P928 Determination of functional residual capacity and moment ratio from multiple breath inert gas wash-ins
N. Bell, A. Horsley, K. Macleod, S. Cunningham, A. Greening, A. Innes (Edinburgh, United Kingdom)
P929 Respiratory function in subjects living in mountain villages in Nepal exposed to indoor but not traffic or industrial
pollution
V. Fasano, L. Pomidori, S. Donghi, M. Amatya, A. Cogo (Milan, Ferrara, Italy; Kathmandu, Nepal)
P930 Features of the bronchodilatation response at overweighting asthma patients
T. O. Pertseva, S. S. Panina, N. P. Nudga, N. O. Gondulenko (Dniepropetrovsk, Ukraine)
P931 Indirect determination of viscous pressure losses (Pfr) and resistances (Rfr) upstream from the choke points in
humans breathing air and He/O2
O. Pedersen (Aarhus, Denmark)
P932 Methacholine-induced bronchoconstriction is associated with a decrease in NO airway wall diffusing capacity and
an increase in alveolar NO concentration
L. Barbinova, A. Preisser, X. Baur (Hamburg, Germany)
P933 Comparative study of pulmonary function tests before and after successful percutaneous ballon mitral valvotomy
in Shahid Rajaie hospital in 2004-2005
H. A. Sadeghi, N. Paziraee, M. M. Zahmatkesh (Tehran, Islamic Republic of Iran)
P934 Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) and smoking cessation in
exposed to low-dose radiation
K. Bazyka, V. Sushko, L. Shvajko (Kiev, Ukraine)
P935 The regional lung ventilation during pregnancy in patients with bronchial asthma with different autunomic activity
L. G. Nakhamchen, D. L. Nakhamchen (Blagoveschensk, Russian Federation)
P936 Impact of hemodialysis on dyspnoea and lung function in patients with chronic renal failure
A. Palamidas, J. Milic-Emili, F. Karakontaki, S. Gennimata, J. Papantoniou, A. Vourliotou, A. Koutsoukou, N. Koulouris
(Athens, Pireus, Greece; Montreal, Canada)
P937 Comparison of spirometry values between normal adults practising a novel breathing technique – SKY
(Sudarshan Kriya yoga) – and nonpractitioners
S. Bodi, D. Kumar, N. Reddy, S. V. Prasad, Vedamurtachar, S. S. RaviShankar (Hyderabad, Bangalore, India)
P938 Reference equations for lung function screening of healthy never smoking adults aged 18-80 years
S. P. Kuster, D. Kuster, C. Schindler, M. K. Rochat, J. Braun, L. Held, O. Brändli (Zurich, Basel, Switzerland)
P939 Airway responsiveness to methacholine and deep inhalations in obese subjects
R. Torchio, A. Gobbi, L. Maugeri, C. Gulotta, M. Tinivella, V. Brusasco, R. Pellegrino, R. Dellacà (Orbassano, Milan,
Genoa, Cuneo, Italy)
P940 Flow and volume responders: classification criteria
J. R. Gonçalves, M. C. Pereira, E. M. F. P. Cerqueira, J. F. Y. Costa, M. Povinelli, W. D. O. Villalba, D. O. Magro,
I. A. Paschoal (Campinas, Brazil)
P941 Lung function, insulin resistance and metabolic syndrome in Korean males: a population-based study
s
S. Y. Lim, K. C. Sung, S. Y. Lim (Seoul, Republic of Korea)
es
P942 Can per slip breathing cause dynamic hyperinflation?
A. Skoczylas, E. Wojda, E. Romanski, P. Sliwinski (Warsaw, Poland)
P943 Negative regional respiratory loops of healthy people
F. Tetenev, A. Levchenko, K. Tetenev, T. Ageeva, A. Kashuta, A. Yurchenko, S. Mishustin (Tomsk, Russian Federation)
P944 Small airways dysfunction in the general population
A. Kainu, A. Rouhos, A. Lindqvist, S. Sarna, A. Sovijarvi (Helsinki, Finland)
Hall 6.2-27
Session 105
12:50–14:40
Thematic Poster Session: Assessment of the respiratory system
Chairs: R. Dellaca (Milan, Italy), F. Petak (Szeged, Hungary)
P945 The effect of breathing frequency on forced oscillation mechanics in normal subjects: a pilot study
M. Brown, S. Morrison (Queensland, Australia)
ERS Berlin 2008 Annual Congr
P946 Functional pulmonary adaptation to hyperbarism in divers for a prolonged period of 14 days at a depth of 10 mt
A. Re, A. P. Santamaria, G. M. Corbo, C. Contu, D. Visca, S. Valente (Rome, Italy)
186
S U N D A Y O C T O B E R 5
P947 Small airways function in non-smoking elderly patients with short asthma period is similar to that in young adult
asthma using impulse oscillometry
H. Tanaka, J. Kitada, M. Fujii, Y. Tanaka, H. Takahashi (Sapporo, Japan)
P948 Resting cardiovascular function and ventilatory drive: correlation with exercise hyperventilation and sleep
disturbances in chronic heart failure patients
L. Biasco, R. Torchio, M. Guglielmo, D. Lodico, L. Montagna, P. Greco-Lucchina, C. Gulotta (Orbassano, Italy)
P949 Regional mechanical properties of the lungs of healthy people
F. Tetenev, A. Levchenko, K. Tetenev, T. Ageeva, A. Kashuta, A. Yurchenko, S. Mishustin (Tomsk, Russian Federation)
P950 Pulmonary function test and impulse oscillometry in severe COPD patients’ offspring
B. Amra, V. Beigi, M. Golshan (Isfahan, Islamic Republic of Iran)
P951 One lung ventilation: use of the impulse oscillation system to assess lung function in an animal model
M. E. Rodriguez, A. Olivant, T. Miller, T. Shaffer, M. Theroux (Wilmington, Philadelphia, United States of America)
P952 Distal airway function in haematopoietic stem cell transplantation recipients with normal spirometry; usefulness
of impulse oscillometry
J. Kitada, H. Tanaka, H. Takahashi, H. Yasui, T. Hayashi, T. Ishida, Y. Shinomura (Sapporo, Japan)
P953 Broadband forced oscillations in healthy and COPD subjects: the impact of velum position
G. Albu, C. Thamrin, P. Sly, Z. Hantos (Szeged, Hungary; Bern, Switzerland; Perth, Australia)
P954 Pilot study on the objective cough measurement
I. Damps-Konstanska, M. Krajnik, M. Grabowski, P. Pozanski, L. Gorska, B. Cynowska, E. Jassem (Gdansk, Bydgoszcz,
Gdynia, Poland)
P955 Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation
with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels
F. Gomez, P. Martinez-Camblor, M. Castresana, P. Rodriguez, G. Cueto, B. R. Celli (Manacor, Palma de Mallorca,
Bunyola, Spain; Boston, United States of America)
P956 Chaotic fractal characteristics of breathing rhythm oscillator
R. Zulkarneev, S. Zagidullin, G. Arslanova, L. Bakusov (Ufa, Russian Federation)
P957 Markers of fibrosis in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) in sarcoidosis
A. Rudnicka, E. Puscinska, J. Czerniawska, A. Rozy, J. Chorostowska-Wynimko, D. Górecka (Warsaw, Poland)
P958 Respiratory pattern analysis on the ventilatory response to incremental dead space loading
Y. Tasaku, H. Kurosawa, J. Ohishi, D. Kobayashi, K. Matsumoto, N. Mori, Y. Sano, R. Imanishi, W. Hida, M. Kohzuki
(Sendai, Japan)
P959 Response of the stomach to a solid-liquid meal in adult asthmatics
L. Amarasiri, J. De Silva, C. Ranasinha (Ragama, Sri Lanka)
P960 Effect of heliox breathing on tidal expiratory flow limitation and dynamic hyperinflation in chronic heart failure
patients
M. Pecchiari, C. Anagnostakos, S. Dimopoulos, A. Koutsoukou (Milan, Italy; Athens, Greece)
P961 Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups
of the exhaled breath
A. Kikowatz, G. Becher, S. Dietze, W. Steinhaeusser, E. Glaser (Berlin, Wuerzburg, Germany)
P962 Respiratory muscle function in type 2 diabetes mellitus
L. Fuso, A. Longobardi, D. Pitocco, A. P. Santamaria, C. Pozzuto, S. Basso, F. Varone, R. Antonelli Incalzi (Rome, Italy)
P963 Ampakine therapy to alleviate opioid and anesthetic induced respiratory depression
J. Greer, J. Ren, A. Lorier, F. Lenal, G. Funk (Edmonton, Canada)
Hall 6.2-28
Session 106
12:50–14:40
Thematic Poster Session: Respiratory structure and function
Chairs: W. Zin (Rio de Janeiro, Brazil), G. Miserocchi (Monza, Italy)
s
es
P964 Post stroke dysphagia rehabilitation by repetitive transcranial magnetic stimulation: a non controlled pilot study
E. Verin, Y. Ouahchi, J. P. Marie (Rouen, France)
P965 Probability of obstructive sleep apnea based on cephalometric analysis. A Bayesian analysis approach
P. Panagou, X. Mermingis, K. Tsintiris (Athens, Greece)
P966 Influences of central hypervolemia on respiratory function
N. Aleksandrova (St Petersburg, Russian Federation)
P967 The role of polymorphonuclear neutrophil leucocytes in the development of bronchial hyperreactivity in chronic
obstructive pulmonary disease
V. Cukic, V. Lovre, S. Genjac, A. Ustamujic, J. Mornjakovic, J. Maglajlic, M. Zecevic-Masic (Sarajevo, Bosnia and
Herzegovina)
P968 Phosphodiesterase 4 and 5 inhibitor and steroid actions on pulmonary injury induced by microcystin-LR
G. M. C. Carvalho, V. Oliveira, R. Cruz, S. Valenca, R. Soares, S. Azevedo, L. Lima, E. Barreiro, D. Faffe, W. Zin
(Rio de Janeiro, Brazil)
ERS Berlin 2008 Annual Congr
187
S U N D A Y O C T O B E R 5
P969 Community-acquired pneumonia acute period: neutrophil redox-potential and protein oxidative modification
process
T. Zhavoronok, E. Stepovaya, N. Ryazanceva, G. Petina, F. Tetenev, T. Ageeva, V. Ivanov, Y. Starikov, S. Mishustin
(Tomsk, Russian Federation)
P970 Size, number and surface influence the entering of particles into lung epithelial cells in vitro
C. Brandenberger, B. Rothen-Rutishauser, F. Blank, P. Gehr, C. Muehlfeld (Bern, Switzerland)
P971 Redox systems of neutrophils of patients with exacerbated COPD
P. Marharyta G., S. Galina N., S. Elena N., S. E. Savitskaya, S. N. Cherenkevitch (Minsk, Belarus)
P972 In vivo and in vitro regulation of angiopoietin expression by bacterial lipopolysaccharides (LPS)
M. Mofarrahi, T. Nouh, S. Qureshi, D. Mayaki, S. Hussain (Montreal, Canada)
P973 Role of the prefrontal cortex in respiratory control
V. Aleksandrov, T. Ivanova, N. Aleksandrova (St Petersburg, Russian Federation)
P974 Correlation of nasal nitric oxide, ciliary beat frequency, ciliary beat pattern and ultrastructural defects in patients
referred to a national diagnostic centre for primary ciliary dyskinesia
C. Jackson, P. Goggin, E. Adam, C. Barnes, E. Quinn, A. Page, T. Pond, P. Lackie, J. Lucas (Southampton, United
Kingdom)
P975 Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV ) in patients with severe chronic
1
obstructive pulmonary disease (COPD)
P. Pavlov, Y. Ivanov, P. Nikolova, T. Popova, E. Borisova, A. Velkova (Pleven, Bulgaria)
P976 Postural changes of lung volumes in b-thalassemia subjects affected by restrictive or obstructive impairment in
comparison to fibrotic and asthmatic patients
M. A. Romolotti, V. Fasano, C. Elena, V. Elisabetta, G. Piatti (Cremona, Milan, Italy)
P977 Factors affecting survival of bronchiectasis patients
F. Arslan Ciftci, E. Sen, B. Eris Gulbay, Z. P. Onen, O. Akkoca Yildiz, T. Acican, S. Bartu Saryal, G. Karabiyikoglu
(Ankara, Turkey)
P978 Repeated physical stress reduces the mucociliary clearance in guinea pigs with chronic allergic airway
inflammation
R. Almeida-Reis, F. da Silva, F. Reis, A. Choqueta-Toledo, R. Marques, E. Leick-Maldonado, C. Prado, M. Dolhnikoff,
M. Martins, I. Tibério (Sao Paulo, Brazil)
P979 Tracheal calcification: a change with age?
B. B. Yildirim, A. Karalezli, S. Kaya, H. C. Hasanoglu, A. N. Tokgonul, O. Tosun (Ankara, Turkey)
P980 Na+-glucose cotransporter is also expressed in mesothelium of species with thick visceral pleura
C. Sironi, F. Bodega, C. Porta, A. Monaco, L. Zocchi, E. Agostoni (Milan, Italy)
P981 Low pH alters the electrochemical function of human parietal pleura
V. Kouritas, C. Hatzoglou, C. Foroulis, A. Hevas, K. Gourgoulianis, P. A. Molyvdas (Larissa, Greece)
P982 Iron and the carotid body function
J. Antosiewicz, M. Walski, M. Pokorski (Warsaw, Poland)
Hall 6.2-29
Session 107
12:50–14:40
Thematic Poster Session: Pulmonary vascular biology
Chairs: R. Schermuly (Bad Nauheim, Germany), A. T. Dinh-Xuan (Paris, France)
P983 Role of nitric oxide pathway in pulmonary circulation of yaks and cows
A. Aldashev, M. Kochkorova, B. Kojonazarov, E. Usupova, M. Duishaliev, A. Sakai, T. Ishizaki (Bishkek, Kyrgyzstan;
Matsumoto, Fukui, Japan)
P984 The effect of acetazolamide on pulmonary hypertension induced by chronic hypoxia in rats
F. Favret, J. Brunet, M. Maignan, A. Pichon, J. P. Richalet (Bobigny, France)
s
P985 Endothelial function and vascular biomarkers in COPD
es
S. Pizarro, M. Diez, V. I. Peinado, E. Ferrer, Y. Torralba, M. Sitges, L. Molins, P. Macchiarini, I. Blanco, R. Rodríguez-
Roisin, J. Roca, J. A. Barberà (Barcelona, Spain)
P986 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive
pulmonary disease (COPD)
S. Duong-Quy, T. Hua-Huy, P. Dao, C. Perrotin, A. T. Dinh-Xuan (Paris, France)
P987 Counteracting the ET-1 induced pathological cell proliferation by bosentan – nuclear expression of cell cycle
inhibitors p21 (waf1) and p27 (kip1) induces G1-arrest in pulmonary artery smooth muscle cells
C. Lambers, P. Binder, M. Will, E. Hofbauer, M. Roth, V. Petkov, L. H. Block (Vienna, Austria; Sydney, Australia)
P988 Sildenafil inhibits human pulmonary artery smooth muscle cells proliferation by downregulation of capacitative
Ca2+ entry
C. Wang, J. Wang, Y. Wang, C. Wang (Beijing, China)
P989 Sildenafil and rolipram prevent pulmonary endothelial cells apoptosis and ANG-2 overexpression induced by
cigarette smoke
ERS Berlin 2008 Annual Congr
G. Juan, M. Ramon, J. Marin, M. Losada, J. Milara, J. L. Ortiz, E. Donet, J. Cortijo, E. Morcillo (Valencia, Madrid, Spain)
188
P990 Double-stranded RNA analog, poly I:C modulates histamine-triggered Ca2+ signaling in human pulmonary arterial
endothelial cells
Z. Bálint, W. F. Graier, K. T. Preissner, H. Olschewski, A. Olschewski (Graz, Austria; Giessen, Germany)
S U N D A Y O C T O B E R 5
P991 Inhaled sodium nitrite attenuates hypoxic pulmonary vasoconstriction
B. Egemnazarov, R. T. Schermuly, E. Dony, N. Weissmann, G. T. Elliott, N. C. Hoglen, M. W. Surber, F. Grimminger,
W. Seeger, H. A. Ghofrani (Giessen, Germany; San Diego, United States of America)
P992 Effect of apelin in pulmonary arteries
C. U. Andersen, B. E. Laursen, O. Hilberg, J. E. Nilsen-Kudsk, U. Simonsen (Aarhus, Denmark)
P993 Ca2+-activated K+ channel openers cause epithelium and endothelium-dependent relaxation in pulmonary tissue
C. Kroigaard, B. Elmedal Laursen, U. Simonsen (Aarhus C, Denmark)
P994 Impact of inhaled NO on development of neonatal rat lung
S. Duong-Quy, T. Hua-Huy, P. Olivier, O. Baud, J. C. Mercier, A. T. Dinh-Xuan (Paris, France)
P995 Estradiol exacerbates superoxide-induced nitrative lung injury and pulmonary hypertension
S. Tofovic, O. Rafikova (Pittsburgh, United States of America)
P996 2-Methoxyestrone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension
S. Tofovic, H. Zhu, E. Jackson, O. Rafikova (Pittsburgh, United States of America)
P997 Capillary coefficient filtration (Kfc) measurement on isolated lungs blocks treated with sildenafil
B. Carlos, A. Nadezhda, S. Patricio, J. Rogelio, S. Avelina (Mexico City, Mexico)
P998 Pulmonary artery endothelial cell secretion of factor VIII
C. Shovlin, G. Angus, R. Manning, M. Laffan, G. Birdsey, F. Mauri (London, United Kingdom)
P999 Endothelial and platelet dysfunction in pulmonary hypertension due to sarcoidosis
I. Popova, E. Popova, A. Ponomarev (Moscow, Russian Federation)
P1000 Mitogen activated protein kinase activated protein kinase 2 regulates actin stress fiber formation in ventilator
associated lung injury
M. Damarla, E. Hasan, A. Boueiz, A. Le, H. Pae, U. Kayyali, M. Gaestel, R. Damico, X. Peng, P. Hassoun (Baltimore,
Boston, United States of America; Hanover, Germany)
P1001 p38 MAP kinase mediates apoptosis related to ventilator associated lung injury
M. Damarla, R. Damico, E. Hasan, H. Pae, A. Boueiz, A. Le, X. Peng, P. Hassoun (Baltimore, United States of
America)
P1002 Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary
arterial hypertension (PAH)
R. T. Schermuly, X. Tian, M. Behrendts, S. S. Pullamsetti, N. Weissmann, W. Seeger, H. A. Ghofrani, F. Grimminger
(Giessen, Bad Nauheim, Germany)
Hall 6.2-30
Session 108
12:50–14:40
Thematic Poster Session: Pulmonary hypertension I
Chairs: H. A. Ghofrani (Giessen, Germany), O. Sitbon (Clamart, France)
P1003 Oral combination therapy bosentan/sildenafil delays time to clinical worsening in comparison to bosentan
monotherapy
W. Jacobs, A. Vonk Noordegraaf, A. Boonstra, P. E. Postmus (Amsterdam, The Netherlands)
P1004 A randomised-controlled trial of a physiotherapist-led rehabilitation programme in patients with pulmonary
hypertension
A. Wilkinson, C. A. Elliot, R. Condliffe, S. Mawson, I. J. Armstrong, C. Billings, D. G. Kiely (Sheffield, United Kingdom)
P1005 The value of transfer factor in interpreting walking distance in patients with SScl-PAH
C. Billings, L. Smith, C. Elliot, R. Condliffe, I. Armstrong, C. Billings, D. Kiely (Sheffield, United Kingdom)
P1006 Effects of training on endothelial function and circulating endothelial progenitor cells in COPD patients
P. A. Munoz, M. Diez, S. Pizarro, V. I. Peinado, D. Rodriguez, E. Gimeno, M. Sitges, E. Ferrer, Y. Torralba, J. Pètriz,
P. Marin, J. Roca, J. A. Barberà (Barcelona, Spain)
P1007 Pulmonary hypertension (PH) associated with haemolysis
s
K. L. Patrick, R. Condliffe, C. A. Elliot, I. J. Armstrong, J. Wright, D. G. Kiely (Sheffield, United Kingdom)
es
P1008 Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD)
I. Blanco, E. Gimeno, P. Munoz, F. P. Gomez, S. Pizarro, C. Gistau, R. Rodriguez-Roisin, J. Roca, J. A. Barbera
(Barcelona, Spain)
P1009 Ventricular mass index correlates with pulmonary haemodynamics in patients with systemic sclerosis and
suspected pulmonary arterial hypertension
D. Hagger, N. Woodhouse, C. A. Elliot, R. Condliffe, J. Wild, I. J. Armstrong, C. Hill, C. Davies, D. G. Kiely (Sheffield,
United Kingdom)
P1010 High prevalence of iron deficiency in idiopathic pulmonary arterial hypertension
E. Soon, M. Toshner, N. Morrell, J. Pepke-Zaba (Cambridge, United Kingdom)
P1011 Inhalation of endothelin receptor blockers in pulmonary hypertension
H. Leuchte, T. Meis, J. Michalek, J. Behr (Munich, Germany)
P1012 Prognostic value of end-tidal partial pressure of carbon dioxide during cardiopulmonary exercise test in
pulmonary hypertension
ERS Berlin 2008 Annual Congr
W. T. N. Lee, A. Brown, D. Raeside, A. Peacock, M. Johnson (Glasgow, United Kingdom)
P1013 Oxygen desaturation during six-minute walking test in pulmonary arterial hypertension associated with adult
cardiac congenital heart disease
189
A. Stanziola, M. D’Alto, G. Battiloro, S. Padula, P. Argiento, G. de Laurentiis, R. Calabro, M. Sofia (Naples, Italy)
S U N D A Y O C T O B E R 5
P1014 Air travel is safe and well tolerated in clinically stable PH patients
M. Thamm, R. Voswinckel, B. Karadas, H. Gall, F. Grimminger, H. A. Ghofrani (Giessen, Germany)
P1015 Cardiac output measurement by thermodilution using right heart catheter versus noninvasive rebreathing
technique in pulmonary hypertension
H. J. Baumann, J. K. Hennigs, S. Kluge, H. Klose (Hamburg, Germany)
P1016 Non-invasive measurement of stroke volume using an inert gas rebreathing device in patients with pulmonary
hypertension
L. E. R. McLure, W. N. Lee, A. C. Chuch, A. J. Peacock, M. K. Johnson (Glasgow, United Kingdom)
P1017 Iloprost treatment in portopulmonary hypertension
I. Blanco, M. T. Melgosa, G. Ricci, J. C. Garcia-Pagan, P. Escribano, F. Burgos, J. Roca, R. Rodriguez-Roisin, J. Bosch,
J. A. Barbera (Barcelona, Madrid, Spain; Rome, Italy)
P1018 Acute changes to sildenafil in pulmonary arterial hypertension assessed by magnetic resonance imaging
F. Reichenberger, O. Wuesten, C. Zeleny, K. Neu, M. Coch, R. Voswinckel, H. A. Ghofrani, W. Seeger (Giessen,
Germany)
P1019 Prevalence of anxiety and depression in patients freshly diagnosed with pulmonary hypertension
S. Ulrich, M. Fischler, L. C. Huber, M. Hersberger, R. Speich (Zurich, Switzerland)
P1020 TOPP: the first international registry in pediatric pulmonary hypertension
M. Beghetti, R. Berger, I. Schulze-Neick, R. Barst, T. Humpl, G. Raskob (Geneva, Switzerland; Groningen, The
Netherlands; London, United Kingdom; New York, Oklahoma, United States of America; Toronto, Canada)
P1021 Clinical feature of systemic sclerosis associated with pulmonary hypertension: results of one center study
A. Volkov, N. Eugeni (Moscow, Russian Federation)
P1022 Meaning of physiological dead space ventilation (VD/VT) increase in patients with precapillary pulmonary
hypertension (PH)
R. Pancani, C. Bauleo, G. Mirarchi, G. Catapano, B. Formichi, R. Prediletto, C. Marini (Pisa, Italy)
Hall 6.2-31
Session 109
12:50–14:40
Thematic Poster Session: Pulmonary hypertension II
Chair: L. Howard (London, United Kingdom)
P1023 The effects of multiple dosing of ketoconazole on the pharmacokinetics of a single dose ambrisentan
D. Richards, G. Walker, A. Mandagere, M. Magee, L. Henderson, S. Harris (Harlow, Essex, United Kingdom;
Westminster, Philadelphia, Miami, United States of America)
P1024 The role of nitric oxide in pathogenesis of high altitude pulmonary hypertension
B. Kojonazarov, A. Maripov, M. Kochkorova, T. Sooronbaev, M. Mirrakhimov, N. Morrell, M. Wilkins, A. Aldashev
(Bishkek, Kyrgyzstan; Cambridge, London, United Kingdom)
P1025 Evaluation of right ventricular function by tissue doppler imaging in highlanders
A. Maripov, B. Kojonazarov, A. Sarybaev, A. Aldashev (Bishkek, Kyrgyzstan)
P1026 Pulmonary veno-occlusive disease: clinical, functional, radiologic and hemodynamic characteristics and outcome
of 24 cases confirmed by histology
D. Montani, L. Achouh, P. Dorfmüller, A. Rabiller, R. Haque, O. Sitbon, X. Jaïs, P. Dartevelle, G. Simonneau,
M. Humbert (Clamart, Le Plessis-Robinson, France)
P1027 Hemodynamic response to supplemental oxygen in chronic pulmonary hypertension
H. Leuchte, C. Baezner, R. Baumgartner, P. Mernitz, C. Neurohr, J. Behr (Munich, Germany)
P1028 Nocturnal desaturations are common in portopulmonary hypertension
M. Halank, S. Langner, M. Kolditz, S. Miehlke, G. Hoeffken (Dresden, Germany)
P1029 Use of a telemedicine application for training and follow up of patients with pulmonary arterial hypertension
C. Nickerson, K. Nikander (Parsippany, United States of America)
s
P1030 Gas exchange abnormalities are linked to a decrease of capillary blood volume in cirrhotic patients
es
B. Degano, J. Rami, C. Bureau, B. Suc, L. Rostaing (Clamart, Toulouse, France)
P1031 Nitric oxide from alveolar origin in cirrhotic patients: relationship with pulmonary haemodynamics and potential
implications
B. Degano, J. Rami, B. Suc, C. Bureau, L. Rostaing (Clamart, Toulouse, France)
P1032 Baseline profile of patients initiating sitaxentan for pulmonary arterial hypertension (PAH): preliminary results
from thelin outcomes for patients surveillance (TOPS)
P. Blin, K. Bouillon, L. Abenhaim, N. Galie (Paris, France; Bologna, Italy)
P1033 Cystamine and sildenafil in treatment of right ventricular hypertrophy in rats with pulmonary hypertension
L. H. Markvardsen, J. D. Baandrup, M. Kruhoffer, U. Simonsen (Aarhus, Denmark)
P1034 Acute effect of sildenafil (PDE-5) on cardiopulmonary interactions in patients with pulmonary arterial
hypertension (PAH) secondary to pulmonary fibrosis
K. E. Lyskanowska, A. Pierini, L. Allegra, G. Milani, S. Aliberti, F. Blasi (Milan, Italy)
P1035 Cardiopulmonary assessment in morbid obese related to metabolic syndrome
ERS Berlin 2008 Annual Congr
T. E. Orizaga Franco, J. E. Morales Blanhir, E. Garcia Garcia, M. D. J. Rosas Romero (Mexico City, Mexico)
190
P1036 Pulmonary hypertension and obesity
O. Alexandrov, R. Alekhina, B. Kaganov, N. Ayrapetyan (Moscow, Russian Federation)
S U N D A Y O C T O B E R 5
P1037 Bedside prediction of pulmonary hypertension among cirrhotic patients with portal hypertension
W. Gadallah, S. Atta, L. Abdelbaki, M. Soliman (Assiut, Egypt)
P1038 Retrospective review of patient logging system data from an adaptive aerosol delivery system used for the
delivery of iloprost inhalation solution
K. Nikander, J. Denyer (Parsippany, United States of America; Chichester, United Kingdom)
P1039 Prevalence of pulmonary circulation abnormalities in liver transplantation candidates
M. Gazzana, A. John, S. Fagondes, S. Garcia, D. Spader, D. Rigotti, S. Menna Barreto (Porto Alegre, Brazil)
P1040 Dynamic hyperinflation during exercise in patients with pulmonary hypertension
F. Reichenberger, M. Richter, R. Voswinckel, H. Ghofrani, W. Seeger (Giessen, Germany)
P1041 Causes of death in patients with chronic obstructive pulmonary disease, analysis of autopsy material
B. Zvezdin, S. Milutinov, S. Hromis, M. Kojicic, S. Gavrilovic (Sremska Kamenica, Republic of Serbia)
P1042 Assessment of simvastatin treatment on pulmonary arterial hypertension
A. Mozafari (Qom City, Islamic Republic of Iran)
Hall 6.2-32
Session 110
12:50–14:40
Thematic Poster Session: Pulmonary venous thromboembolic disease
Chairs: C. Leroyer (Brest, France), A. Vonk Noordegraaf (Amsterdam, The Netherlands)
P1043 Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do
not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM)
F. Couturaud, C. Leroyer, J. Julian, S. Kahn, J. Ginsberg, P. Wells, J. Douketis, D. Mottier, C. Kearon (Brest, France;
Hamilton, Montreal, Ottawa, Canada)
P1044 Prothrombin 20210 G/A mutation and EPCR I/D polymorphisms were rare in patients with pulmonary
thromboembolism in Chinese Han population
Z. Zhai, Y. Yang, C. Wang (Beijing, China)
P1045 First international registry on chronic thromboembolic pulmonary hypertension (CTEPH)
G. Simonneau, M. Delcroix, E. Mayer, I. Lang, J. Pepke-Zaba (Paris, France; Leuven, Belgium; Mainz, Germany;
Vienna, Austria; Cambridge, United Kingdom)
P1046 Pulmonary embolism severity index is useful in predicting mortality in patients investigated for query pulmonary
embolism and negative CTPA
P. Rawat, K. Todd, M. Babores, S. Schembri (Macclesfield, United Kingdom)
P1047 Comparison of the clinical probability scores and diagnostic tests of deep venous thrombosis and pulmonary
embolism
I. Porfyridis, G. Stathopoulos, A. Tsimogianni, I. Nikoloutsou, K. Stavrakaki, C. Roussos, N. Rovina (Athens, Greece)
P1048 Comparison of three clinical probability methods among patients with suspected pulmonary thromboembolism
G. Atac, I. Ozmen, T. Sevim, E. Aksoy, L. Bostan, N. Aykac, K. Tahaoglu (Istanbul, Turkey)
P1049 C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism
M. Zivkovic, V. Atanaskovic, G. Koracevic, S. Salinger Martinovic, T. Kostic (Nis, Republic of Serbia)
P1050 Role of electrocardiography score in massive and non-massive pulmonary thromboembolism
L. Pur Ozyigit, G. Okumus, E. Kiyan, H. Issever, R. Engin Unver, T. Ozyigit, O. Arseven (Istanbul, Turkey)
P1051 Acute haemodynamics and gas exchange of CTEPH and pulmonary arterial hypertension
L. Luo, Y. Yang, Z. Zhai, W. Xie, C. Wang (Beijing, China)
P1052 Prevalence of chronic thromboembolic pulmonary hypertension 2 years after pulmonary embolism
D. Marti, D. Jimenez, C. Escobar, I. Rodriguez, M. Sarrion, D. Taboada, M. L. Giganto, G. Diaz, A. Sueiro, R. Yusen
(Madrid, Spain; St Louis, United States of America)
P1053 Homocysteine and serum-lipide levels in pulmonary thromboembolism
A. Karalezli, E. Parlak, A. Senturk, H. C. Hasanoglu (Ankara, Turkey)
s
P1054 Are clinical parameters and biomarkers predictive of severity of pulmonary emboli (PE) as seen on computed
es
tomography pulmonary angiogram (CTPA)?
V. Jeebun, S. Doe, L. Singh, S. Worthy, I. Forrest (Newcastle-upon-Tyne, United Kingdom)
P1055 Pulmonary embolism severity index is superior to the Geneva score at predicting which patients with suspected
pulmonary embolism are at increased risk of death
K. Todd, P. Rawat, M. Babores, S. Schembri (Macclesfield, United Kingdom)
P1056 Right heart dysfunction (RHD) in patients with acute pulmonary embolism (PE): correlation between distribution
of clots, troponin I and prognosis
L. Masotti, F. Antonelli, E. Venturini, G. Landini, P. Rottoli (Cecina, Siena, Italy)
P1057 The assessment of heart chambers volumes using modified transpulmonary thermodilution in patients with
chronic thromboembolic pulmonary hypertension (CTEPH)
N. Khorokhordin, P. Yablonsky, A. Boyarkin, O. Maltseva, E. Pavlushkov (St Petersburg, Russian Federation)
P1058 Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic
thromboembolic pulmonary hypertension
ERS Berlin 2008 Annual Congr
W. Xie, Y. Yang, Z. Zhai, L. Luo, Z. Ma, C. Wang (Beijing, China)
P1059 In-hospital mortality of acute pulmonary thromboembolism: comparison between patients with objective
diagnosis and non-confirmed suspicion
191
M. Gazzana, M. Knorst, S. Menna Barreto (Porto Alegre, Brazil)
S U N D A Y O C T O B E R 5
P1060 Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism
Y. Yang, C. Wang, Z. Zhai (Beijing, China)
P1061 Incidence of venous thromboembolism 8-weeks post discharge in hospitalised medical patients not receiving
thrombo-prophylaxis
J. Bujanova, S. Parakh, A. Guhan (Middlesbrough, United Kingdom)
Hall 6.2-33
Session 111
12:50–14:40
Thematic Poster Session: Pulmonary vascular disease and other pulmonary
conditions: miscellaneous
Chairs: O. Sanchez (Paris, France), E. Gruenig (Heidelberg, Germany)
P1062 The victim potential of sitaxentan: metabolism by human CYP450 enzymes
F. Stavros, W. Kramer, B. Ogilvie, A. Parkinson (Houston, North Potomac, Lenexa, United States of America)
P1063 The perpetrator potential of sitaxentan based on its ability to inhibit human cytochrome P450 (CYP) enzymes
F. Stavros, W. Kramer, B. Ogilvie, A. Parkinson (Houston, North Potomac, Lenexa, United States of America)
P1064 The perpetrator potential of sitaxentan: human CYP enzyme induction
F. Stavros, W. Kramer, B. Ogilvie, A. Parkinson (Houston, North Potomac, Lenexa, United States of America)
P1065 Improvement of exercise capacity due to beta blocker treatment in the model of MCT induced pulmonary
hypertension
S. Schroll, T. Lange, M. Arzt, D. Sebah, B. Stoelcker, M. Pfeifer (Regensburg, Donaustauf, Germany)
P1066 Systemic inflammation and pulmonary hypertension in patients with bronchial asthma
N. Karoli, A. Rebrov, A. Roshina (Saratov, Russian Federation)
P1067 New markers of endothelial dysfunction in patients with bronchial asthma with and without pulmonary
hypertension
N. Karoli, A. Roshina, A. Rebrov, T. Martinova, L. Novikova (Saratov, Russian Federation)
P1068 Pulmonary hypertension and endothelial dysfunction in patients with bronchial asthma
N. Karoli, A. Roshina, A. Rebrov, O. Karpova, L. Lukianova (Saratov, Russian Federation)
P1069 Day time pulmonary hypertension in patients with obstructive sleep apnea hypopnea syndrome
Z. He, X. Guo (Beijing, China)
P1070 Comparison between transthoracic doppler echocardiography and right heart catheterization for pulmonary
hypertension evaluation
M. Gazzana, A. John, S. Fagondes, M. Wainstein, D. Spader, D. Rigotti, S. Menna Barreto (Porto Alegre, Brazil)
P1071 An international investigation into the health status of COPD sufferers
A. Nadjar, F. Boucher, F. D. Uva, M. Garfield, T. Van der Molen (Lyon, France; Milford, United States of America;
Groningen, The Netherlands)
P1072 Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD)
Y. Y. Lin, S. Ma, J. He, J. O. Cantor, G. M. Turino (New York, United States of America)
P1073 Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with
chronic obstructive pulmonary disease
O. Korzh, S. Krasnokutskiy (Kharkov, Ukraine)
P1075 Clinical significance of P wave amplitude and axis in ECG of COPD patients during acute exacerbations
C. Ravindran, P. James, K. Moyinkutty, K. A. K. Abdul, C. C. Velayudhan (Calicut, Kerala, India)
P1076 Hypertonic saline cough provocation test with salbutamol pre-treatment: evidence for sensorineural dysfunction in
asthma
H. Koskela, M. Purokivi, K. Kontra, A. Taivainen, H. Tukiainen (Kuopio, Finland)
P1077 Efficiency of isolated hypertrophic rat papillary muscle is lower than control
Y. Y. Wong, L. Handoko, F. de Man, K. Mouchaers, A. Vonk-Noordegraaf, W. van der Laarse (Amsterdam,
s
es
The Netherlands)
P1078 Combination therapy with sildenafil and sitaxentan therapy for pulmonary arterial hypertension
R. Voswinckel, N. Gross, F. Reichenberger, M. Thamm, B. Karadas, H. Gall, H. Nef, F. Grimminger, W. Seeger,
H. A. Ghofrani (Giessen, Germany)
P1079 Maximal cardiopulmonary exercise testing in children with pulmonary hypertension
G. Smith, J. Russell, J. Reyes, T. Humpl (Toronto, Canada)
P1080 Pulmonary arterial hypertension induces ECG changes associated with arrhythmia propensity
K. T. B. Mouchaers, I. R. Henkens, A. Boonstra, M. J. Schalij, E. E. van der Wall, C. A. Swenne, H. W. Vliegen,
A. Vonk Noordegraaf (Amsterdam, Leiden, The Netherlands)
P1081 Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors
N. Marina, F. Uresandi, G. Iruin, V. Cabriada, B. Gomez, P. Sobradillo, S. Pedrero (Baracaldo, Spain)
Hall 6.2-34
Session 112
12:50–14:40
Thematic Poster Session: Cough and airway hyperresponsiveness
ERS Berlin 2008 Annual Congr
Chairs: A. Morice (Cottingham, United Kingdom), R. Polosa (San Gregorio, Italy)
192
P1082 Is there a relationship between cough reflex sensitivity and the subjective sensation of tussive challenge?
S. Barratt, M. Biggs, R. Tue, R. Stone (Taunton, United Kingdom)
S U N D A Y O C T O B E R 5
P1083 Reproducibility and sensitivity of Hull reflux cough questionnaire (HRCQ)
H. Fathi, H. Brook, R. Tompson, V. Hunter, A. H. Morice (Cottingham, United Kingdom)
P1084 Inhaled corticosteroids decrease cough reflex sensitivity to capsaicin in asthmatics but not in patients with COPD
K. Stravinskaite, B. Sitkauskiene, P. V. Dicpinigaitis, R. Sakalauskas (Kaunas, Lithuania; New York, United States of
America)
P1085 Cinnamaldehyde: a novel tussive agent in man
S. Faruqi, V. Mann, A. Morice (Cottingham, United Kingdom)
P1086 Women, iron deficiency, and chronic cough
B. Culla, L. Brussino, G. Guida, J. Badiu, G. Rolla, C. Bucca (Turin, Italy)
P1087 Cough response to brief mechanical stimulation depends on timing of the breathing cycle in anesthetized rabbits
F. Marchal, B. Demoulin, A. L. Leblanc, N. Bertin (Vandoeuvre, France)
P1088 Hypertonic histamine challenge induced cough in assessing the treatment response to inhaled corticosteroid in
asthma
M. Purokivi, H. Koskela, T. Koistinen, J. Magga, K. Kontra (Kuopio, Finland)
P1089 Predictors of efficacy of bronchodilator therapy for chronic non-productive cough: cough reflex sensitivity, exhaled
nitric oxide, bronchial responsiveness?
M. Fujimura, N. Ohkura, M. Abo, S. Furusho, Y. Waseda (Kanazawa, Japan)
P1090 The possible role of IL-5 and IFN- in the forming of cold airway hyperresponsiveness in patients with bronchial
asthma
M. J. Shcheglova, G. A. Makarova, V. P. Kolosov, J. M. Perelman (Blagoveschensk, Russian Federation)
P1091 The role of thyroidal insufficiency in the forming of cold airway hyperresponsiveness
A. B. Pirogov, V. P. Kolosov, J. M. Perelman, J. O. Krylova, I. N. Lukyanov (Blagoveschensk, Russian Federation)
P1092 Insulin therapy increases airway responsiveness in type 2 diabetes patients
C. Terzano, A. Petroianni, V. Conti, D. Ceccarelli, S. Morano, A. Gatti, E. Mandosi, M. Fallarino, A. Lenzi (Rome, Italy)
P1093 Association of bronchial responsiveness and allergic sensitization in the general population of Helsinki, Finland
M. Juusela, P. Pallasaho, E. Rönmark, S. Sarna, A. Sovijärvi, B. Lundbäck (Helsinki, Finland; Stockholm, Luleå,
Gothenburg, Sweden)
P1094 A comparison of inhaled mannitol, metacholine provocation and eucapnic voluntary hyperventilation as
diagnostic tests for exercised-induced bronchoconstriction in cross-country skiers
N. Stenfors, M. Sue-Chu (Ostersund, Sweden; Trondheim, Norway)
P1095 Airway responsiveness and inflammation in adolescent elite swimmers
L. Pedersen, T. Lund, P. Barnes, S. Kharitonov, V. Backer (Copenhagen, Denmark; London, United Kingdom)
P1096 EIA symptoms and night asthma – is it similar to AHR in larger groups of asthmatics?
V. Backer, L. M. Rasmussen (Copenhagen, Denmark)
P1097 Diagnostic value of exercise testing in young patients with atopic asthma
V. Tsybulkina, O. Skorohodkina, A. Luntsov, N. Tsybulkin, L. DuBuske (Kazan, Russian Federation; Gardner, United
States of America)
P1098 Exercise induced asthma: a new challenge in the pediatric population
M. Iscar, M. A. Montoliu, T. Ortega, M. J. Villanueva, B. Rodriguez (Oviedo, Spain)
P1100 Tracheal responsiveness to isoprenaline and b -adrenoreceptor blockade by propranolol in cigarette smoke
2
exposed and sensitized guinea pigs
M. H. Boskabady, S. Kiani, M. R. Aslani (Masshad, Islamic Republic of Iran)
P1101 Cigarette smoking modifies the association between IL-18 levels in induced sputum and airway
heperresponsiveness in asthmatics
N. Rovina, E. Dima, C. Gerassimou, C. Gratziou, C. Roussos (Athens, Greece)
Hall 6.2-35
Session 113
12:50–14:40
s
Thematic Poster Session: Inflammatory biomarkers
es
Chairs: A. Spanevello (Cassano Murge, Italy), S. Loukides (Athens, Greece)
P1102 Determinants of variability in exhaled breath condensate (EBC) in children
K. Bloemen, R. Van Den Heuvel, K. Desager, G. Schoeters (Mol, Antwerp, Belgium)
P1103 Eicosanoids in EBC of adults with asthma and their relation to clinical severity
K. Samitas, D. Chorianopoulos, S. Vittorakis, E. Zervas, E. Economidou, G. Papatheodorou, S. Loukides, M. Gaga
(Athens, Greece)
P1104 Zinc and magnesium in serum and exhaled breath condensate of patients with obstructive lung diseases and
healthy controls
K. Tanou, S. Zarogiannis, A. Papaioannou, A. Koutsokera, K. Georga, C. Tsolaki, K. Gourgoulianis, K. Kostikas
(Larissa, Greece)
P1105 Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients
L. Lasagna, S. Peveri, E. Pilotti, M. Corradi, G. Bertorelli (Parma, Italy)
ERS Berlin 2008 Annual Congr
P1106 Markers of airway remodeling in exhaled breath condensate in relation to clean-up work of the Prestige oil spill
and cigarette smoking
F. P. Gómez, G. G. Rodríguez-Trigo, J. P. Zock, Y. Torralba, A. Serrano, S. Kalko, C. Melero, H. Verea, C. Fuster, F. Pozo,
193
J. A. Barberà (Barcelona, Spain)
S U N D A Y O C T O B E R 5
P1107 Exhaled breath condensate pH and peak flow variability in asthma
P. Martins, I. Caires, J. Rosado Pinto, S. Torres, N. Neuparth (Lisbon, Viseu, Portugal)
P1108 Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma
E. Tseliou, V. Bessa, G. Papadaki, V. Delikoura, G. Hillas, C. Roussos, S. Papiris, P. Bakakos, S. Loukides (Athens,
Greece)
P1109 Alkaline mineral water inhalation causes permanent alkalization of exhaled breath condensate
B. Szili, A. Bikov, B. Antus, A. Zsembery, M. Kollai, I. Horváth (Budapest, Hungary)
P1110 Cytokines in exhaled breath condensate of patients with asthma
I. Dugarova, E. Anaev, T. Ospelnikova, T. Anokhina, A. Chuchalin (Moscow, Russian Federation)
P1111 Ability of an individual device for measurement of the temperature of exhaled breath to detect changes in
patients recovering from mild exacerbations of asthma
T. Kralimarkova, C. Lazarova, V. Dimitrov, T. Popov (Sofia, Bulgaria)
P1112 Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and
non treated asthmatics
F. L. Dente, L. Melosini, L. Malagrinò, A. Di Franco, F. Costa, F. Novelli, M. Latorre, P. Paggiaro (Pisa, Italy)
P1113 A retrospective analysis of induced sputum from patients referred to a district general hospital with chronic cough
S. Barratt, S. Holwill, R. Tue, M. Biggs, R. Stone (Taunton, United Kingdom)
P1114 Increased serum levels of interleukin 6 are associated with ventilator-associated pneumonia in extremely
premature infants
D. Dmytriiev, K. Dmytriieva, K. Bercun (Vinnitsa, Ukraine)
P1115 Alcohol metabolites are detectable in exhaled breath of healthy, unaffected by a breath holding maneuver and
may serve as novel pro-inflammatory biomarkers in asthma and COPD
K. Paschalaki, R. Brauer, S. Papiris, P. Barnes, S. Kharitonov (London, United Kingdom; Athens, Greece)
P1116 Increase of exhaled carbon monoxide in subjects with non-controlled asthma
G. Garcia, M. Bergna, E. Giugno, D. Colodenco (La Plata, Vicente Lòpez, Buenos Aires, Argentina)
P1117 Exhaled breath molecular profiling in measuring inflammatory status in COPD
N. Fens, M. P. C. van der Schee, S. B. de Nijs, E. Dijkers, E. H. Bel, P. J. Sterk (Amsterdam, The Netherlands)
Hall 6.2-36
Session 114
12:50–14:40
Thematic Poster Session: Clinical utility of exhaled nitric oxide measurement
Chairs: S. Kharitonov (London, United Kingdom), B. Antus (Budapest, Hungary)
P1118 Exhaled nitric oxide as a marker of hypertension in young individuals with type 1 diabetes
E. Paraskakis, E. Galanakis, D. Mamoulakis, H. Panierakis, M. Bitsori, M. Kalmanti (Heraklion, Greece)
P1119 Correction equation to compare exhaled nitric oxide measured by a portable analyzer to that obtained by the
gold-standard device
S. Pizzimenti, E. Heffler, M. Bugiani, P. Piccioni, G. Guida, I. Badiu, S. Sciascia, G. Rolla (Turin, Italy)
P1120 Stability of exhaled nitric oxide (F NO) in patients with severe, steroid-dependent asthma
E
S. Hashimoto, A. Ten Brinke, A. C. Roldaan, H. P. Van Veen, G. M. Moller, J. K. Sont, E. J. Weersink, J. S. Van der Zee,
P. J. Sterk, E. H. Bel (Amsterdam, Leeuwarden, Den Haag, Enschede, Leiden, The Netherlands)
P1121 Alveolar nitric oxide (C
) measurement. Reference values in healthy people
alvNO
A. M. Fortuna, N. Calaf, P. Casan (Barcelona, Spain)
P1122 Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic
disease
G. H. Wan, C. S. Tang, D. C. Yan, H. S. Lin (Tao-Yuan, Taipei, Taiwan, Republic of China)
P1123 Comparison of exhaled nitric oxide measurements between NIOX MINO electrochemical analyzer and ecomedics
chemoluminescence analyzer
s
J. D. Boot, L. de Ridder, M. de Kam, A. F. Cohen, Z. Diamant (Leiden, The Netherlands)
es
P1124 Exhaled nitric oxide measured by a new hand-held device in clinical practice
S. Pizzimenti, E. Heffler, M. Bugiani, P. Piccioni, A. Carosso, I. Badiu, G. Guida, G. Rolla (Turin, Italy)
P1125 Exhaled NO in asthma and rhinitis patients from a random adult population sample
C. Porsbjerg, V. Backer, H. Harving (Copenhagen, Aalborg, Denmark)
P1126 Exhaled nitric oxide and bronchial hyperresponsiveness in patients with cough variant asthma or new-onset
classic mild asthma
N. Voznessensky, R. Akhmetov, T. Pashkova (Moscow, Russian Federation)
P1127 How do exhaled nitric oxide (eNO) and a bronchial provocation test (BPT) compare in the diagnostic work up of
asthmatic symptoms?
E. Van Neck, C. Sohy, O. Vandenplas, E. Marchand (Yvoir, Belgium)
P1128 FeNO in relation to asthma control in steroid treated asthmatics
S. Vermeire, Y. Dewandeleer, L. Dupont (Leuven, Belgium)
P1129 Increased inflammation in peripheral airways of patients with systemic sclerosis, measured by fractional nitric
ERS Berlin 2008 Annual Congr
oxide
194
D. Wuttge, D. Aronsson, R. Hesselstrand, A. Scheja, L. Bjermer, E. Tufvesson (Lund, Sweden)
S U N D A Y O C T O B E R 5
P1130 Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects
P. Paredi, P. J. Barnes (London, United Kingdom)
P1131 Normal NO exhaled related to chronic cough in asthma – another possible hypothesis of inflammation
V. Tudorache, C. Bunu, E. Galca, S. Mihaicuta, R. Potre (Timisoara, Romania)
P1132 Seasonal pattern of exhaled nitric oxide
M. Andersson, K. Wass, J. Nilsson, B. Forsberg, A. C. Olin (Gothenburg, Umeå, Sweden)
P1133 Does exhaled nitric oxide and blood eosinophil count correlate in phenotypes of severe and brittle asthma?
J. Sullivan, L. Midgley, S. Manney, A. Mansur (Birmingham, United Kingdom)
P1134 Nitric oxide in exhaled breath is poorly correlated to eosinophilic bronchitis in prednisone-dependent asthma
P. Nair, M. Kjarsgaard, S. Armstrong, M. Inman, M. Pizzichini, A. Efthimiadis, E. Pizzichini, P. O’Byrne, F. Hargreave
(Hamilton, Canada)
Hall 6.2-37
Session 115
12:50–14:40
Thematic Poster Session: Asthma: growing understanding of influential factors
Chairs: E. Bel (Amsterdam, The Netherlands), G. Losonczy (Budapest, Hungary)
P1135 Vibration response imaging (VRI) in asthma; evaluation pre and post bronchodilation
A. Florou, S. Vakali, D. Michailidis, C. Roussos, C. Gratziou (Athens, Greece)
P1136 Efficacy of Flutter and forced expiration technique (FET) in induced sputum assessment in asthmatic and COPD
patients
A. L. Morsch, M. M. Amorim, A. Barbieri, A. L. Fernandes (Erechim, Sao Paulo, Brazil)
P1137 Perception of dyspnea: a comparison between asthma and upper airway dysfunction
J. L. van Gaalen, S. L. J. Vrenken, P. J. Sterk, C. M. Salome, H. K. Reddel (Camperdown, Australia; Leiden, Amsterdam,
The Netherlands)
P1138 Paradoxical conducting airway response and heterogeneous regional ventilation after histamine inhalation in
healthy rabbit studied by synchrotron radiation CT
S. Bayat, L. Porra, H. Suhonen, P. Suortti, A. R. A. Sovijärvi (Amiens, Grenoble, France; Helsinki, Finland)
P1139 The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma
S. Arantes, A. Lopes, G. Reis, D. Xisto, P. Silva, E. Parra, W. Teodoro, V. Capelozzi, F. Tatiana, P. Silva, M. Martins,
P. Rocco (Rio de Janeiro, Sao Paulo, Brazil)
P1140 The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and
quality of life in patients with asthma
P. Giouleka, P. Liberopoulos, G. Papatheodorou, A. Karakatsani, C. Roussos, S. Papiris, S. Loukides (Athens, Greece)
P1141 A prospective randomised control trial of medical weight loss in obese asthmatics
S. Scott, P. Albert, J. Currie, P. Parry, P. Calverley, J. Wilding (Liverpool, United Kingdom)
P1142 Effect of weight loss in severely obese asthmatic females
M. Maniscalco, A. Zedda, S. Faraone, G. de Laurentiis, M. Sofia (Casoria, Naples, Italy)
P1143 Is beta-agonist alone prescribed in case of uncontrolled asthma?
J. Elers, L. M. Rasmussen, V. Backer (Copenhagen, Denmark)
P1144 Acute effect of smoking in normal and asthmatic smokers
A. Papaioannou, A. Koutsokera, K. Tanou, T. Kiropoulos, I. Tsilioni, S. Oikonomidi, K. Liadaki, K. Gourgoulianis,
K. Kostikas (Larissa, Greece)
P1145 Evaluation of high sensitivity C reactive protein in patients of bronchial asthma and its correlation with
exacerbation rate and pulmonary function
B. Menon, C. Kaur, R. Kaushik, S. Pandita (New Delhi, India)
P1146 Safety of research bronchoscopy in mild, moderate and severe asthma
E. Economidou, P. Lambrou, K. Samitas, E. Zervas, P. Karydi, A. Liapikou, S. Vittorakis, M. Gaga (Athens, Greece)
s
P1147 Gender effect on airway and lung parenchyma remodelling in an experimental model of chronic allergic asthma
es
M. Antunes, S. Abreu, P. Silva, J. Assy, E. Parra, W. Teodoro, V. Capelozzi, M. Martins, P. Silva, P. Rocco (Rio de Janeiro,
Sao Paulo, Brazil)
P1148 Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis
T. Bilitchenko, M. Baldueva, N. Vosnesensky, Y. Lebedin (Moscow, Russian Federation)
P1149 Use of metacholine test to improve maintenance and reliever therapy in mild-moderate asthma
G. Sera (Turin, Italy)
P1150 Markers of inflammation and airway responses to allergen in asthmatic patients
Z. Goseva, A. Gjorcev, D. Dimitrievska, D. Dokic, Z. Arsovski (Skopje, FYROM)
P1151 Asthma control test (ACT) versus spirometry for monitoring patients’ treatment – 1 year experience as an ERS
Fellow
I. G. Stoica (Bucharest, Romania)
P1152 The course of aspirin-induced asthma may be helpful in predicting the type of response to aspirin
M. Swierczynska, E. Nizankowska-Mogilnicka, P. Strek, A. Gielicz, M. Grzywacz, A. Szczeklik (Krakow, Poland)
ERS Berlin 2008 Annual Congr
P1153 Assessment of a 20% fall in FEF25-75% in patients with negative methacholine provocation test
H. R. Kang, S. H. Jang, K. M. Sohn, Y. I. Hwang, D. G. Kim, K. S. Jung (Anyang-si, Chuncheon, Republic of Korea)
195
S U N D A Y O C T O B E R 5
Hall 6.2-38
Session 116
12:50–14:40
Thematic Poster Session: COPD – clinical and epidemiological aspects
Chairs: G. Viegi (Pisa, Italy), M. Kogevinas (Barcelona, Spain)
P1154 Validation of the Yale physical activity survey in COPD patients
D. Donaire-Gonzalez, I. Serra, J. M. Antó, J. Roca, E. Balcells, E. Rodriguez, E. Farrero, J. Garcia-Aymerich (Barcelona,
Spain)
P1155 An increase of 1%-predicted in FEV considerably saves costs for COPD
1
S. A. Jansson, J. Rocklöv, A. Lindberg, B. Forsberg, J. Björkman, E. Rönmark, B. Lundbäck (Stockholm, Umeå, Luleå,
Gothenburg, Sweden)
P1156 The impact of body composition on walking distance in the six-minute walk test in COPD patients
M. Waatevik, P. Bakke, J. Hardie, T. M. Eagan (Bergen, Norway)
P1157 COPD medications and risk of pneumonia in the UK
D. Miller, H. Muellerova, T. Sampson, R. Baxter, K. Davis (Research Triangle Park, United States of America;
Greenford, United Kingdom)
P1158 Increase in plasma -linolenic acid is positively associated with lung function. The emphysema and cancer action
program (EMCAP) study
S. Mesia-Vela, J. H. M. Austin, H. Campos, D. Yankelevitz, F. Ahmed, R. G. Barr (New York, Boston, Ithaca, United
States of America)
P1159 Chronic obstructive pulmonary disease in waterpipe smokers; a population-based controlled study
M. Bahtouee, F. Azizi, N. Motamed, F. Nekouee (Bushehr Port, Islamic Republic of Iran)
P1160 Risk of bias in COPD trials
B. Bausch, A. Spaar, J. Kleijnen, M. Puhan (Zurich, Switzerland; York, United Kingdom)
P1161 Gender impact on associations between socioeconomic status and lung function decline in a general population
A. Johannessen, T. Eagan, E. Omenaas, A. Gulsvik (Bergen, Norway)
P1162 Genetic influence on chronic mucus hypersecretion – a twin study
T. Ingebrigtsen, S. F. Thomsen, K. O. Kyvik, E. K. Silverman, J. Vestbo, V. Backer (Copenhagen, Odense, Denmark;
Boston, United States of America)
P1163 Preselection of patients at high risk for COPD by simple screening questions
H. Koegler, N. Metzdorf, T. Welte, T. Glaab (Ingelheim, Hanover, Germany)
P1164 COPD treatment in primary care in “living with COPD” study
P. De Lucas, J. M. Rodriguez Gonzalez-Moro, J. L. Izquierdo, E. Anton, A. Martin (Madrid, Guadalajara, Alcobendas,
Spain)
P1165 FEV /Height2 could be a better alternative than FEV in predicting all cause mortality in patients with COPD
1
1
S. Schembri, S. Morant, T. MacDonald, J. Winter, J. Winter (Dundee, United Kingdom)
P1166 Use of the multidimensional index BOD to characterise the natural history of COPD
N. Keaney, A. Kay, K. Ansari, M. Shamssain, T. Hildreth, I. Taylor (Sunderland, United Kingdom)
P1167 High prevalence of vertebral deformities in COPD patients is not related only to systemic steroid use
A. Kjensli, M. S. Ryg, J. A. Falch, I. Ellingsen (Hakadal, Oslo, Norway)
P1168 Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study)
I. Tillie Leblond, F. Masure, G. Birraux, I. Boucot, F. Deschamps, A. Myftiu, J. Ostinelli, C. Pribil, C. Philippe (Lille,
Reims, Paris, Marly Le Roi, Rueil Malmaison, France)
P1169 Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO
study – interim analysis)
I. Tillie Leblond, F. Masure, G. Birraux, I. Boucot, F. Deschamps, A. Myftiu, J. Ostinelli, C. Pribil, C. Philippe (Lille,
Reims, Paris, Marly Le Roi, Rueil Malmaison, France)
s
P1170 The OLIN-studies COPD-cohort, 3-year mortality
es
A. Lindberg, L. G. Larsson, A. C. Jonsson, S. Sundberg, E. Rönmark, B. Lundbäck (Luleå, Umeå, Gothenburg,
Sweden)
P1171 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease
B. D. Kent, E. Eltayeb, A. G. Stack (Letterkenny, Ireland)
P1172 Predictors of mortality in COPD
M. Puhan, P. Dietrich, G. Ter Riet (Zurich, Switzerland)
P1173 A prospective study on vascular reactivity of the brachial artery in patients with stable COPD
L. Cekici, A. Valipour, P. Eickhoff, K. Geyer, O. C. Burghuber (Vienna, Austria)
Hall 6.2-39
Session 117
12:50–14:40
Thematic Poster Session: Epidemiology of asthma and allergy
Chairs: C. Svanes (Bergen, Norway), F. Pistelli (Pisa, Italy)
ERS Berlin 2008 Annual Congr
P1174 Health-related quality of life (HRQL) and asthma control in the EGEA2 study
V. Siroux, A. Boudier, L. Vignoud, J. Bousquet, F. Gormand, J. Just, N. Le Moual, C. Pison, P. Scheinmann, D. Vervloet,
196
F. Kauffmann, I. Pin (Grenoble, Montpellier, Lyon, Paris, Villejuif, Marseille, France)
S U N D A Y O C T O B E R 5
P1175 Asthma incidence is associated to indoor chlorinated pool attendance
M. Ferrari, W. Mantovani, C. Papadopoulou, L. Tonellotto, C. Posenato, K. Schenk, S. Tardivo, C. Coppo, L. Tomaello,
F. Bonella, P. Ferrari, A. Poli (Verona, Italy)
P1176 Asthma and job selection: an international population-based analysis
M. Olivieri, M. Mirabelli, E. Plana, J. M. Antò, P. Bakke, A. D’Errico, D. Jarvis, P. Henneberger, D. Norback, K. Radon,
K. Torén, M. Van Sprundel, S. Villani, J. P. Zock, M. Kogevinas (Verona, Turin, Pavia, Italy; Barcelona, Spain; Bergen,
Norway; London, United Kingdom; Uppsala, Gothenburg, Sweden; Munich, Germany; Antwerp, Belgium)
P1177 Antioxidant vitamins and the risk of asthma: systematic review and meta-analysis
S. Allen, J. Britton, J. Leonardi-Bee (Nottingham, United Kingdom)
P1178 Fruit and fish may keep asthma away
M. Uddenfeldt, M. Leander, C. Janson, D. Norback, L. Larsson, A. Rask-Andersen (Uppsala, Sandviken, Ostersund,
Sweden)
P1179 Dietary patterns and asthma: results from three countries in the European community respiratory health survey
(ECRHS)
R. Hooper, J. Heinrich, E. Omenaas, S. Sausenthaler, V. Garcia-Larsen, P. Burney (London, United Kingdom;
Neuherberg, Germany; Bergen, Norway)
P1180 Agreement between teenager and parent reports of rhinitis, eczema and environmental risk factors
L. Hedman, A. Bjerg, S. Sundberg, E. Rönmark (Luleå, Umeå, Sweden)
P1181 Premenstrual asthma: frequency changes according to definition applied
J. M. Bravo Nieto, A. Pereira Vega, J. L. Sanchez Ramos, J. A. Maldonado Perez, I. Sanchez Rodriguez, F. Alvarez
Gutierrez, R. Vazquez Oliva, J. M. Ignacio Garcia, P. Romero Palacios (Huelva, Seville, Malaga, Granada, Spain)
P1182 Respiratory symptoms and asthma among swimming pool workers – results from a questionnaire study
G. Nordberg, B. Forsberg, J. Nilsson, N. G. Lundstrom, A. Blomberg, A. Hagenbjork-Gustafsson, M. Svensson,
K. Eriksson (Umea, Sweden)
P1183 Gender differences in asthma: prevalence, diagnosis, and incidence of atopic and non atopic asthma
B. Leynaert, J. Sunyer, R. Garcia-Esteban, C. Svanes, D. Jarvis, P. Burney, J. M. Anto, F. Neukirch (Paris, France;
Barcelona, Spain; Bergen, Norway; London, United Kingdom)
P1184 Sex-specific trends in wheeze could be explained by trends in exposures. Prevalence and risk factors 1996-2006
in Northern Sweden
A. Bjerg, B. Lundbäck, E. Rönmark (Luleå, Gothenburg, Sweden)
P1185 Differences between intermediate phenotypes underlying asthma and rhinitis
J. Werner Hansen, S. Francis Thomsen, V. Backer (Copenhagen, Denmark)
P1186 Quantitative genetic analysis of intermediate asthma phenotypes
S. Francis Thomsen, M. Ferreira, K. Ohm Kyvik, M. Fenger, V. Backer (Copenhagen, Odense, Denmark; Boston, United
States of America)
P1187 Characterization of uncontrolled asthma (UA) in Asia
C. Lai, A. Bhome, T. de Guia, G. Wong, Z. Zainudin, A. Mukhopadhyay, The Asthma Insights and Reality in Asia Pacific
2 Steering Committee (Hong Kong)
P1188 Population based relationship between three prominent morbidities: asthma, mental health and obesity
W. David, A. Sarah, R. Richard, H. Graeme, A. Robert (Adelaide, Australia)
P1189 The “iceberg” of adult asthma in the Italian general population
S. Accordini, V. Cappa, M. Braggion, M. Bugiani, P. Pirina, S. Villani, G. Verlato, R. de Marco (Verona, Turin, Sassari,
Pavia, Italy)
P1190 The relation between paracetamol use and asthma: a European case-control study
J. Potts, S. Shaheen, P. Burney (London, United Kingdom)
P1191 Exposure to environmental tobacco smoke in childhood and GSTM1 polymorphism are associated to lung
function in adults
s
O. Omland, T. H. Malling, C. B. Andersen, I. Brandslund, D. Sherson, L. Skadhauge, T. Sigsgaard (Aalborg, Odense,
es
Vejle, Haderslev, Aarhus, Denmark)
P1192 The risk of cardiovascular disease associated with asthma may be mediated by short-acting b -agonists
2
R. Adams, S. Appleton, D. Wilson, R. Ruffin (Woodville, Australia)
P1193 The association of wheeze and FEV with free androgen index
1
D. Jarvis, M. Kaakinen, A. Ruokonen, A. Hartikainen, J. Pekkanen, D. Canoy, S. Franks, A. Pouta, H. Martikainen,
M. R. Jarvelin (London, Manchester, United Kingdom; Oulu, Kuopio, Finland)
Hall 6.2-40
Session 118
12:50–14:40
Thematic Poster Session: The air we breathe indoors and outdoors
Chairs: D. Norback (Uppsala, Sweden), D. Heederik (Utrecht, The Netherlands)
P1194 Are there house-dust mites on moldy wall surfaces?
D. Charpin, P. Parola, A. Palot, C. Charpin-Kadouch, I. Arezki, H. Dumon (Marseille, Paris, France)
ERS Berlin 2008 Annual Congr
P1195 New methods to monitor indoor allergens and fungal contamination – airborne allergens and fungal DNA in
allergen avoidance and conventional Swedish day care centers
G. Cai, K. Broms, M. Bjorn, K. Anders, Z. Zhao, J. L. Kim, K. Svardsudd, D. Norback (Uppsala, Sweden)
197
S U N D A Y O C T O B E R 5
P1196 Respiratory symptoms and physiological signs in Swedish elementary school pupils in relation to type of
ventilation system at school – an experimental study
D. Norback, G. Wieslander, Z. Zhao (Uppsala, Sweden)
P1197 Characterizing the role of the occupant as a source of house dust bacteria
M. Täubel, H. Rintala, M. Pitkäranta, A. Hyvärinen, L. Paulin, J. Pekkanen, A. Nevalainen (Kuopio, Helsinki, Finland)
P1198 Modulating effect of maternal fish consumption on the occurrence of respiratory symptoms in early infancy
attributed to prenatal exposure to fine particles
W. Jedrychowski (Krakow, Poland)
P1199 Workers compensation for lung cancer due to ETS exposure in hospitality workers: retrospective exposure
assessment
U. Brueckner, S. Kolb, D. Nowak, K. Radon (Munich, Germany)
P1200 Effectiveness of Microstop and Greenfirst treated home furnishings on mite allergen exposure: a 12 months study
M. Ott, N. Glasser, F. Schwartz, A. Verot, A. Dazy, F. de Blay (Strasbourg, Illkirch Graffenstaden, France)
P1201 Long-term study of chronic obstructive pulmonary disease in clean-up workers of the Chernobyl catastrophe, who
were undergone to radionuclides inhalation
V. Sushko (Kyiv, Ukraine)
P1202 Exposure to nanoparticles in residential environment
X. Ji, C. Mandin, O. Ramalho, O. Le Bihan, L. Martinon, D. Bard, J. C. Pairon (Verneuil en Halatte, Creteil, Champs sur
Marne, Paris, Rennes, France)
P1203 Oxidative stress index in the women exposed to pollutants from biomass combustion, in a rural area of Turkey
E. Kose, P. Pazarli, H. Celik (Sanliurfa, Sakarya, Turkey)
P1204 Ear-nose-throat and broncho-pulmonary occupational pathology in bar workers exposed to second-hand smoke
M. Margineanu, I. Margineanu, A. Vicovan (Iasi, Romania)
P1205 Healthy sustainable houses in Stockholm, the 3H field study
G. Emenius, M. Hult, C. Ostman, M. Svartengren, R. Corner, K. Engvall (Stockholm, Sweden)
P1206 Lung cancer in non-smokers: retrospective study of 67 cases
C. Clement-Duchene, C. Paris, A. Stoufflet, Y. Martinet (Vandoeuvre-Lès-Nancy, Nancy, France)
P1207 Respiratory health in children exposed to volcanic air pollution
I. Bakolis, R. Hooper, P. Cullinan, A. Hansell, P. Baxter, D. Jarvis (London, Cambridge, United Kingdom)
P1208 Snoring and obstructive sleep apnea among former World Trade Center (WTC) rescue workers
R. de la Hoz, R. N. Aurora, L. Paul, B. Hatfield, L. Bienenfeld, A. Afilaka, H. Robin (New York, United States of
America)
P1209 MCS (multiple chemical sensitivity) patients’ stress during clinical examinations
M. Oldenburg, C. Sevenich, X. Baur (Hamburg, Germany)
P1211 Inhalation accidents in leather industry: a propos of two cases
I. Türkçüer, M. Serinkent, F. Evyapan, B. Polat, H. Sungurtekin (Denizli, Turkey)
P1212 Characterization of phosphatidylcholine in exhaled particles collected with a novel non-invasive technique
A. Bredberg, P. Larsson, E. Mirgorodskaya, A. C. Almstrand, E. Ljungstrom, R. Karlsson, A. C. Olin (Gothenburg,
Sweden)
P1213 Decrease of serum Clara cell protein-16 and increase of exhaled NO induced by short-term exposure to traffic
pollution in healthy subjects
G. Gabriella, L. Veronica, F. Silvia, A. Bordin, V. Roberta, Z. Martina, M. Piero (Padua, Italy)
Hall 6.2-41
Session 119
12:50–14:40
Thematic Poster Session: The biology of smoking and COPD
Chairs: S. Nardini (Vittorio Veneto, Italy), I. Annesi-Maesano (Paris, France)
s
P1214 Perception of the role of smoking in patients with COPD
es
V. Osman-Hicks, P. Albert, P. Calverley (Liverpool, Merseyside, United Kingdom)
P1215 Candidate gene associations in chronic obstructive pulmonary disease (COPD)
A. Friedlander, Y. Tesfaigzi, L. Silveira, R. Bowler (Denver, Albuquerque, United States of America)
P1216 Influence of polymorphic variants of DRD2 and SLC6A3 genes and their combinations on smoking habit in Polish
population
A. Sieminska, K. Buczkowski, E. Jassem, M. Niedoszytko, E. Tkacz (Gdansk, Bydgoszcz, Poland)
P1217 Sputum secretory leukocyte inhibitor and Clara cell protein 16 levels are not altered after 6 month and 1 year
smoking cessation
I. Bouloukaki, M. Tsounakidou, I. Mitrouska, N. Siafakas, N. Tzanakis (Heraklion, Greece)
P1218 Six month cigarette smoke effect on the selected BAL inflammatory parameters and lung tissue in experiment
M. Hurbankova, M. Beno, S. Cerna, E. Tatrai (Bratislava, Slovakia; Budapest, Hungary)
P1219 Alveolar changes in a chronic tobacco smoke inhalation COPD mouse model
N. Parajuli, M. Seimetz, M. Roth, B. Fuchs, R. T. Schermuly, H. A. Ghofrani, C. Schudt, C. Hesslinger, W. Seeger,
ERS Berlin 2008 Annual Congr
F. Grimminger, N. Weissmann (Giessen, Konstanz, Germany)
198
P1220 Local and systemic inflammation in healthy smokers
J. M. Diez, S. Mayoralas, D. Alvaro, A. Florez, P. Rodriguez, R. Perez, T. Bilbao, L. Comeche (Mostoles, Madrid, Spain)
S U N D A Y O C T O B E R 5
P1221 Effects of smoking on lymphocyte subsets of peripheral blood in patients with chronic renal failure
S. Akcay, S. Sarinc Ulasli, I. Dogrul, G. Ulubay, S. Sezer (Ankara, Turkey)
P1222 Plasma homocysteine, folic acid levels and 5,10 methylenetetrahydrofolate reductaseC677T polymorphism in
male patients with chronic obstructive pulmonary disease
B. Isik, M. Batur, R. Isik, M. Yurt, M. Dasdag (Diyarbakir, Turkey)
P1223 Smoking changes serum immunoglobulin level and peripheral blood phagocytes oxidative burst in asthmatic
school children
A. Kamenov, D. Stojkovic, L. Brankovic, B. Kamenov, S. Cekic (Nis, Republic of Serbia)
P1224 Follow-up survey of COPD in primary care physicians
M. Sawada, T. Kawayama, T. Iwanaga, H. Aizawa (Kurume, Japan)
P1225 Scrining spirometric and inquiry assessment among residents of an ecological clear high mountain region and of
an industrial town in Bulgaria
F. Shterev, R. Ivancheva, Z. Iankova, N. Mateva (Plovdiv, Bulgaria)
P1226 Fighting public ignorance on COPD in Athens Greece
E. Kosmas, K. Kouyianos, S. Dumitru, P. Rozana, M. Georgiou, M. Tsaggouli, A. Tsarouha, K. Dimakou,
N. Anagnostopoulou, T. Gregoratou, M. Toumbis, G. Birba, N. Tzanakis, N. Siafakas (Athens, Greece)
P1227 Allergic airway inflammation can be a matter of fetal programming/the impact of pre and postnatal smoking
exposure on future asthma
T. Zaharov, C. Vrang, V. Brændholt, B. Kamenov (Naestved, Denmark; Nis, Republic of Serbia)
P1228 Cigarette smoking pattern in patients with COPD
R. Zulkarneev, N. Zagidullin, S. Zagidullin, R. Ahmetdinov, G. Araslanova (Ufa, Russian Federation)
P1229 Early detection of COPD among smokers including young age group
W. Tarsin, N. Eshtewi, M. Soussi, I. Elshamli (Tripoli, Libyan Arab Jamahiriya)
P1230 Smoking habits and long term oxygen therapy
F. Martins, M. Raposo, J. M. Correia, F. Nogueira (Lisbon, Portugal)
P1231 Smoke and chronic obstructive peripheric arterial disease (COPAD) of lower limbs
N. D. Tesloianu, A. Tesloianu, C. Morosanu, L. Sorodoc (Iasi, Romania)
P1232 Influence of overweight on indices of external respiration function (ERF) and parameters of quality of life (QL) in
people of young age
N. Slepchenko, Y. Mostovoy, A. Sidorov, N. Tsymbalyuk, H. Tomashkevych (Vinnitsa, Ukraine)
P1233 Comparison of exhaled carbon monoxide between patients with high dose and lowdose exposure to mustard gas
M. Mozaffarian, M. Shahsavan (Tehran, Islamic Republic of Iran)
Hall 6.2-42
Session 120
12:50–14:40
Thematic Poster Session: Cystic fibrosis: factors affecting lung health
Chairs: A. Horsley (Edinburgh, United Kingdom), P. Drevinek (Prague, Czech Republic)
P1234 Clinical course of cystic fibrosis lung disease and tumour necrosis factor-b gene polymorphism
G. Shmarina, A. Pukhalsky, D. Pukhalskaya, L. Perederko, E. Zakharova (Moscow, Russian Federation)
P1235 Preventing cross-contamination in cystic fibrosis – is outpatient segregation effective?
S. Poole, B. Enderby, S. Panagea, C. Will, L. Warren (Stoke-on-Trent, United Kingdom)
P1236 Neutrophil functional activity of patients with cystic fibrosis
T. Bulgakova, E. Surkova, T. Guembitskaia, L. Jelenina, E. Boitsova (St Petersburg, Russian Federation)
P1237 Computed tomography scoring in adults with cystic fibrosis (CF): correlation with clinical and functional
measurements
E. Amelina, Y. Marchenkov, A. Cherniak, S. Krasovsky (Moscow, Russian Federation)
P1238 Cystic fibrosis related diabetes (CFRD) and diabetic control as a determinant of pulmonary function: fact or
s
fiction?
es
L. Akijian, W. N. Wan Montil, U. Damachi, S. H. Chotirmall, P. Branagan, D. Smith, C. Gunaratnam, N. G. McElvaney
(Dublin, Ireland)
P1239 Measurement of airways obstruction among preschoolers with cystic fibrosis
E. Hatziagorou, F. Kirvassilis, J. Tsanakas (Thessaloniki, Greece)
P1240 Long-term treatment with corticosteroids and bone mineral density in patients with cystic fibrosis
T. Kapustina, V. Fedorova, A. Voronkova, N. Kapranov (Moscow, Russian Federation)
P1241 Clinical status and activity of lysosomal carboxypeptidase A and cathepsin D in mixed saliva of cystic fibrosis
patients
L. Minarowski, A. Minarowska, D. Sands, A. Karwowska (Bialystok, Warsaw, Poland)
P1242 Female gender & body mass index (BMI) as a determinant of lung function in cystic fibrosis
U. Damachi, W. N. Wan Montil, L. Akijian, S. H. Chotirmall, R. O’Reilly, P. Branagan, C. Gunaratnam, N. G. McElvaney
(Dublin, Ireland)
P1243 Does vitamin D deficiency & bone fragility affect pulmonary function in cystic fibrosis?
ERS Berlin 2008 Annual Congr
W. N. Wan Montil, U. Damachi, L. Akijian, W. See, S. H. Chotirmall, R. O’Reilly, P. Branagan, C. Gunaratnam,
N. G. McElvaney (Dublin, Ireland)
199
S U N D A Y O C T O B E R 5
P1244 Massive hemoptysis in cystic fibrosis adult patients
J. Mazza-Stalder, D. Sistek, J. P. Revelly, S. D. Qanadli, A. Sauty (Lausanne, Switzerland)
P1245 Prevalence of massive haemoptysis in cystic fibrosis: a six year review
H. K. Ramadan (Southampton, United Kingdom)
Hall 6.2-43
Session 121
12:50–14:40
Thematic Poster Session: Cystic fibrosis: a disease with many aspects
Chairs: A. Lindblad (Gothenburg, Sweden), B. Assael (Verona, Italy)
P1246 Anatomopathological bronchopulmonary peculiarities in children with cystic fibrosis
O. Turcu, S. Sciuca, V. Petrovici, E. Chioroglo (Chisinau, Republic of Moldova)
P1247 Children with cystic fibrosis are MBL deficient or not?
I. Ciuca, I. Popa, Z. Popa, L. Pop, A. Rosca, S. Turcu (Timisoara, Romania)
P1248 Neutrophil elastase in children with chronic lung diseases
Y. Gorinova, O. Simonova, E. Vasilieva (Moscow, Russian Federation)
P1249 Correlation between inflammatory and oxidation markers in adults with cystic fibrosis
E. Acosta, F. Espíldora, G. Olveira, C. Olveira, A. Dorado, E. Casado, V. Alonso, J. L. De la Cruz (Málaga, Spain)
P1250 Whether low frequency of hepatobiliary abnormalities in cystic fibrosis patients is associated with anti-
inflammatory treatment?
A. Pukhalsky, G. Shmarina, D. Pukhalskaya, L. Perederko (Moscow, Russian Federation)
P1251 Exercise tolerance in adults with cystic fibrosis
I. Peres Claro, E. Fragoso, C. Lopes, M. Felizardo, P. Azevedo, J. Valenca, R. Sotto-Mayor, A. Bugalho de Almeida
(Lisbon, Portugal)
P1252 Hypomagnesaemia in patients with cystic fibrosis (CF) in R. Macedonia
T. Jakovska, S. Fustik, L. Spirevska (Skopje, FYROM)
P1253 Physical aerobic training program in children with cystic fibrosis
A. C. Oliveira, R. Mesquita, J. Oliveira, N. Damasceno, L. Sampaio (Sao Paulo, Brazil)
P1254 Efficiency of west airway clearance system in combination with autogenic drainage physiotherapy technique in
adult CF patients during lung exacerbation
A. Scherbakova (Moscow, Russian Federation)
P1255 Retrograde scientometric analysis of the scientific impact of cystic fibrosis
S. Falahkohan, D. Groneberg, C. Scutaru, A. Fischer, D. Quarcoo, B. Kloft (Berlin, Germany)
P1256 Multiple breath washout (MBW) using an ultrasonic flow sensor (USFS) – hygienic aspects
S. Fuchs, M. Waltner-Romen, M. Gappa, H. Ellemunter (Hanover, Germany; Innsbruck, Austria)
P1257 Totally implantable venous access devices in patients with cystic fibrosis
G. Thalhammer, E. Eber, B. Oberwaldner, D. Dacar, M. Zach (Graz, Austria)
P1258 A 5-year retrospective study of totally implatable ports in CF patients
E. De Wachter, I. De Schutter, T. De Backer, A. Malfroot (Brussels, Belgium)
P1259 A three-year follow-up of nasal polyposis in children and adolescents with cystic fibrosis
S. Weber, G. Ferrari (Botucatu, Brazil)
Hall 6.2-44
Session 122
12:50–14:40
Thematic Poster Session: The use of fibreoptic bronchoscopy in children with
diffuse or localised lung disease
Chairs: K. Priftis (Kifisia, Greece), G. Rossi (Genoa, Italy)
P1260 Twins with the same and/or different diseases
s
E. Eber, W. Gruber, M. Zach (Graz, Austria)
es
P1261 Tracheobronchial foreign body aspiration in childhood: an analysis of 119 cases
E. Provoost, K. M. de Winter – de Groot, H. G. M. Arets, C. K. van der Ent (Utrecht, The Netherlands)
P1262 Microbiological investigation of bronchoalveolar lavage fluid and gastric aspirate in pediatric pulmonary
tuberculosis
G. Vilotijevic Dautovic, S. Petrovic, B. Bjelica Rodic, R. Ljustina, S. Cegar (Novi Sad, Republic of Serbia)
P1263 Lipoid pneumonia in children: clinical and radiological features
S. Sias, P. Daltro, E. Marchiori, R. Caetano, T. Quirico-Santos, J. Dutra (Niterói, Rio de Janeiro, Brazil)
P1264 Primary ciliary dyskinesia: the experience of a pediatric tertiary care bronchopneumology unit
T. Salerno, F. Petreschi, G. Ciofetta, R. Boldrini, A. Di Marco, A. Turchetta, R. Cutrera (Rome, Italy)
P1266 Primary endobronchial leiomyoma in children
S. Pekcan, M. Kose, N. Cobanoglu, U. Ozcelik, Z. Akcaoren, S. Gucer, B. Talim, E. Kotiloglu, M. Caglar, M. E. Senocak,
E. Yalcin, D. Dogru, N. Kiper (Ankara, Turkey)
P1267 Bronchoalveolar lavage in children with diffuse lung disease
ERS Berlin 2008 Annual Congr
N. F. Pires, A. Morais, I. Azevedo, C. Palmares, L. Delgado, A. Magalhães, V. Hespanhol (Porto, Portugal)
200
P1268 Bronchological findings in children with persistent stridor
S. Galbova, B. Dimceva, K. Obocki, V. Stevic, K. Boskova (Skopje, FYROM)
P1269 Plastic bronchitis. A case report
S. S. Flores-Hernandez, M. D. L. Gonzalez-Flores (Mexico City, Mexico)
S U N D A Y O C T O B E R 5
P1270 Plastic bronchitis in childhood – case report (2)
Y. H. Kim, S. M. Choi, M. C. Hyun (Daegu, Gyeongju, Republic of Korea)
P1271 Primay anaplasic large cell tumour of the lung in children
A. Conejo, P. Caro, E. Perez-Ruiz, J. L. De la Cruz, J. Perez-Frias (Malaga, Spain)
P1272 A study on interleukin-8 and monokine induced by interferon in serum and bronchoalveolar lavage of critically
ill children with interstitial lung disease
S. El-Sahrigy, N. Saad (Cairo, Egypt)
P1273 Bronchiectasis in children (five years material)
K. Boskovska, M. Maneva, L. Petrusevska, A. Dodevski (Skopje, FYROM)
P1274 How do patients with vascular rings/slings die?
K. O. Dubowy, D. Kececioglu, U. Blanz, S. Sarikouch (Bad Oeynhausen, Germany)
Room 1.2a
Session 123
13:00–14:00
Clinical trial – Understanding the potential long-term impacts on function with
Tiotropium: the UPLIFT trial
Aims: The aims of this session are:
- to discuss issues related to the design of the UPLIFT trial;
- to update the audience with the results of the UPLIFT trial;
- to discuss the results and their implications for the treatment of COPD.
An abstract on this clinical trial is included in the Abstract Book (PDF version only, available during and after the ERS 2008
Congress).
Target audience: Pulmonologists, general practitioners and nurses with interest in COPD.
Chairs: P. M. A. Calverley (Liverpool, United Kingdom), E. F. M. Wouters (Maastricht, The Netherlands)
13:00 Introduction
P. M. A. Calverley (Liverpool, United Kingdom)
1275
13:20 Understanding the potential long-term impacts on function with Tiotropium: the UPLIFT trial – Design and
efficacy data
M. Decramer (Leuven, Belgium)
1276
13:40 Understanding the potential long-term impacts on function with Tiotropium: the UPLIFT trial – Safety data
D. Tashkin (Los Angeles, United States of America)
1277
Room 2.2a
Session 124
13:00–14:30
Paediatric respiratory research award
Aims: To honour a distinguished person who has a lifetime of service to the ERS; and to acknowledge the research of two outstanding
young investigators.
Target audience: Paediatricians, adult physicians and allied health professionals with an interest in paediatric research.
Chairs: A. Bush (London, United Kingdom), E. Baraldi (Padova, Italy)
13:00 Lifetime achiever award: On the shoulders of giants
M. Silverman (Leicester, United Kingdom)
1278
13:30 1st prize: Airway remodelling in cystic fibrosis
N. Regamey (Bern, Switzerland)
1279
14:00 2nd prize: Bridging the gap between respiratory physiology and epidemiology
P. Latzin (Bern, Switzerland)
1280
Room Helsinki
Session 125
13:00–14:30
ERS fellows’ lunch
s
Chairs: S-E. Dahlén (Stockholm, Sweden), B. Nemery (Leuven, Belgium)
es
13:00 Overview of fellowship programme
S-E. Dahlén (Stockholm, Sweden), B. Nemery (Leuven, Belgium)
1281
13:10 Presentation by fellows of their experience and achievements
1282
14:15 Refreshments and group photo
1283
Room 1.2b
Session 126
13:00–14:00
Meet the Professor: MP1
1284 Physiotherapy in the critical care areas
R. Gosselink (Leuven, Belgium)
ERS Berlin 2008 Annual Congr
Room 1.2g
Session 127
13:00–14:00
Meet the Professor: MP2
1285 Rehabilitation and exercise in patients other than COPD
201
E. Clini (Modena, Italy)
S U N D A Y O C T O B E R 5
Room 1.2d
Session 128
13:00–14:00
Meet the Professor: MP3
1286 Oxidative stress in lung diseases
A. Bast (Maastricht, The Netherlands)
Room 1.2e
Session 129
13:00–14:00
Meet the Professor: MP4
1287 The right decision, in an interactive session: making your next career move
O. Eickelberg (Giessen, Germany)
Room 1.2f
Session 130
13:00–14:00
Meet the Professor: MP5
1288 Sensory nerves and airway irritability
C. Page (London, United Kingdom)
Room 1.2c
Session 131
13:00–14:00
Meet the Professor: MP6
1289 Role of allied respiratory professionals in clinical research
S. Walker (Warwick, United Kingdom)
1290 Models of translating clinical research into practice
G. L. Narsavage (Morgantown, United States of America)
ERS Members’ Meetings
Open to ERS Members and interested participants
Sessions 132–137
Scientific Group Members’ Meetings
13:45–14:30
1.4 Interventional Pulmonology
Room New York 1
1.6 General Practice and Primary Care
Room Paris 2
3.2 Airway Cell Biology and Immunopathology
Room Europa 2
5.3 Allergy and Immunology
Room 5.2c
6.3 Tobacco, Smoking Control and Health Education
Room Dublin
9.2 Physiotherapists
Room Berlin
Room 1.2a
Session 138
14:15–14:50
Sadoul Lecture
Chairs: L. M. Fabbri, ERS President (Modena, Italy), I. Annesi-Maesano (Paris, France)
14:15 Introduction
I. Annesi-Maesano (Paris, France)
1296
14:20 Just correlations? Unravelling the origins of the asthma epidemic
P. Burney (London, United Kingdom)
1297
s
es
Room 1.2a
14:50–15:10
ELF Award
Chairs: K-H. Carlsen, ELF Chair (Oslo, Norway), L. M. Fabbri, ERS President (Modena, Italy)
14:50 Fighting the global tobacco epidemic – a presentation by the 2008 ELF Awardee
Michael Bloomberg, Mayor of New York City
Room 1.2a
Session 139
15:10–16:35
Hot Topic: Should we change our attention to respiratory diseases because of
climate change?
Aims: It is now widely accepted that climate change is occurring as a result of the accumulation of greenhouse gases in the
atmosphere arising from the combustion of fossil fuels. Climate change may affect health through a range of pathways (increased
frequency and intensity of heat waves, heat- and cold-related deaths, changes in the distribution of vector-borne diseases etc.). The
ERS Berlin 2008 Annual Congr
aim of the symposium is to advance scientific understanding of and encourage an international scientific debate on the long-term
implications of climate change in respiratory health and the relevance of adaptation strategy; and to encourage research on these
202
issues.
Target audience: Respiratory medicine specialists, public health specialists, paediatricians, toxicologists, basic scientists.
S U N D A Y O C T O B E R 5
Chairs: I. Annesi-Maesano (Paris, France), F. Forastiere (Rome, Italy)
15:10 Climate changes and adaptation strategies for respiratory health
B. Menne (Rome, Italy)
1291
15:30 Climate changes and energy
P. Wilkinson (London, United Kingdom)
1292
15:50 Climate changes, morbidity and mortality
B. Ostro (Oakland, United States of America)
1293
16:10 Winter mortality modifies the temperature effect in summer
B. Forsberg (Umea, Sweden)
1294
16:30 Recommendations
J. Ayres (Aberdeen, United Kingdom)
1295
Room 2.2a
Session 140
14:45–16:45
Symposium: Non-CPAP therapies in sleep apnoea: crossing the borders?
Aims: This symposium aims to:
- improve the knowledge on alternatives to continuous positive airway pressure (CPAP) therapy in sleep-disordered breathing;
- review evidence of efficient treatment options besides CPAP;
- identify patients to whom alternative methods can be recommended;
- demonstrate that critical selection of patients can improve outcome;
- evaluate the impact of the severity of the disease on the efficacy of these therapies.
Target audience: Pneumologists, ear-nose-throat (ENT) specialists, general practitioners, sleep laboratory technicians.
Chairs: W. Randerath (Solingen, Germany), J. Verbraecken (Antwerp, Belgium)
14:45 Body fat, weight change and sleep apnoea
S. Caples (Rochester, United States of America)
1298
15:15 Pharmacological treatment of obstructive sleep apnoea (OSA) consequences
L. Grote (Gothenburg, Sweden)
1299
15:45 ENT and surgical procedures in snoring and sleep apnoea
A. Boudewyns (Edegem, Belgium)
1300
16:15 Mandibular advancement devices
M. Marklund (Umea, Sweden)
1301
Room Dublin
Session 141
14:45–16:45
Symposium: Lung imaging in critically ill patients
Aims: At the end of the symposium, participants will have better knowledge of the diagnostic and therapeutic use of different imaging
techniques in critically ill patients.
Target audience: Pneumologists, intensivists, emergency medicine doctors, nurses, respiratory therapists.
Chairs: P. Pelosi (Milan, Italy), B. Schoenhofer (Hanover, Germany)
14:45 Chest radiograph
M. Pistolesi (Florence, Italy)
1302
15:15 Computed tomography (CT) scan
P. Pelosi (Milan, Italy)
1303
15:45 Echography
J. Rouby (Paris, France)
1304
16:15 Electric impedance tomography
C. Putensen (Bonn, Germany)
1305
s
Room 5.2b
Session 142
14:45–16:45
es
Symposium: The use of inhaled mannitol for assessing airway disease
Aims: The aims of this symposium will be:
- to discuss the effect of various bronchial provocation tests on people with asthma;
- to identify the advantages and limitations of inhaled mannitol in children and adults;
- to discuss implications for everyday practice.
Target audience: Respiratory technologists/scientists, pulmonologists, paediatricians, primary care physicians, epidemiologists.
Chairs: G. Joos (Ghent, Belgium), I. Steenbruggen (Zwolle, The Netherlands)
14:45 Direct versus indirect airway challenges
G. Joos (Ghent, Belgium)
1306
15:15 Using a dry powder of mannitol versus methacholine as challenge for routine practice
H. Kerstjens (Groningen, The Netherlands)
1307
15:45 Inhaled mannitol as treatment for children with cystic fibrosis
ERS Berlin 2008 Annual Congr
A. Bush (London, United Kingdom)
1308
16:15 Implications for everyday practice
R. Rodríguez-Roisin (Barcelona, Spain)
1309
203
S U N D A Y O C T O B E R 5
Room Helsinki
Session 143
14:45–16:45
Symposium: Is microbiological diagnosis of community-acquired pneumonia
possible and useful?
Aims: The symposium will update the audience on the cost-benefit value of new microbiological and non-microbiological techniques
for the diagnosis of bacterial infection in pneumonia.
Target audience: Researchers, clinical scientists and clinicians with an interest in infection, inflammation and pathogenesis of
community-acquired pneumonia.
Chairs: W. Lim (Nottingham, United Kingdom), G. Dimopoulos (Athens, Greece)
14:45 Rapid diagnostic methods: from urinary antigens to multiplex PCR
M. Ieven (Antwerp, Belgium)
1310
15:15 Biomarkers of bacterial infection
M. Tamm (Basel, Switzerland)
1311
15:45 Invasive approaches to the aetiologic diagnosis: when and why?
A. Torres (Barcelona, Spain)
1312
16:15 Microbiological diagnosis and clinical outcome: where are we?
S. Ewig (Bochum, Germany)
1313
Room Budapest
Session 144
14:45–16:45
Symposium: Guideline development workshop summary: ATS/ERS integrating and
coordinating efforts in COPD
Aims: This symposium will describe the results of an ATS/ERS conference which aimed to produce a template for international
guideline development for COPD.
Target audience: Clinicians who both manage patients with COPD and have to follow guidelines. Anyone with an interest in guideline
development.
Chairs: M. Woodhead (Manchester, United Kingdom), A. Anzueto (San Antonio, United States of America)
14:45 Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a
case in point
H. Schunemann (Rome, Italy)
1314
15:15 Practical guideline development
A. Qaseem (Philadelphia, United States of America)
1315
15:45 Describing what evidence and outcomes to use in guidelines
G. Viegi (Pisa, Italy)
1316
16:15 Disseminating and implementing guidelines
S. Buist (Portland, United States of America)
1317
Room Berlin
Session 145
14:45–16:45
Oral Presentation: Vascular and interstitial remodelling in chronic lung disease:
therapeutic interventions on the horizon
Chairs: C. Kaehler (Innsbruck, Austria), O. Eickelberg (Giessen, Germany)
14:45 Introduction – Vascular remodelling: from basics to clinical application
T. Schermuly (Bad Nauheim, Germany)
1318
15:00 Protease-activated receptor-2 (PAR-2) overexpression induces pulmonary hypertension and vascular
structural changes in mice chronically exposed to cigarette smoke
s
M. Lucattelli, G. De Cunto, S. Cardini, G. Lungarella (Siena, Italy)
1319
es
15:15 Gene transfer of the BMP-antagonist gremlin induces fibroblastic foci and pulmonary fibrosis in rats
L. Farkas, K. Ask, D. Farkas, J. Gauldie, M. Inman, W. Shi, M. Kolb (Hamilton, Canada; Regensburg, Germany;
Los Angeles, United States of America)
1320
15:30 The lung epithelium is a prominent source of Wnt ligands and inhibitors in idiopathic pulmonary fibrosis
M. Königshoff, E. M. Pfaff, N. Balsara, I. Chrobak, O. Eickelberg (Giessen, Germany)
1321
15:45 The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation
L. Borthwick*, S. Parker, K. Brougham, G. Johnson, M. Gorowiec, C. Ward, J. Lordan, J. Kirby, P. Corris, A. Fisher
(Newcastle-upon-Tyne, United Kingdom)
1322
16:00 Stimulation of pulmonary smooth muscle cell proliferation by endothelial progenitor cells
I. M. Heidegger, T. Resch, S. Desole, H. Vogelsinger, C. M. Kaehler (Innsbruck, Austria)
1323
16:15 A role for PAR1 in lipopolysaccharide induced acute lung injury
P. Mercer*, C. Scotton, J. Moffatt, C. Derian, R. Chambers (London, United Kingdom; Spring House,
United States of America)
1324
ERS Berlin 2008 Annual Congr
16:30 Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition
of partial EMT
204
A. Gazdhar, A. Temuri, R. Friis, R. Schmid, M. Gugger, T. Geiser (Bern, Switzerland)
1325
*: winners of Best Oral Presentation Awards, as selected at the ERS 2008 Lung Science Conference (Estoril).
S U N D A Y O C T O B E R 5
Room 5.2c
Session 146
14:45–16:45
Oral Presentation: Assessing profiles of rehabilitation candidates
Chairs: N. Ambrosino (Pisa, Italy), A. Schols (Maastricht, The Netherlands)
14:45 Metabolic syndrome (MS) in COPD patients entering pulmonary rehabilitation (PR)
M. K. Breyer, M. Spruit, E. Rutten, A. Celis, L. Fransen, E. Wouters (Horn, Maastricht, The Netherlands; Vienna,
Austria)
1326
15:00 The relation in body composition and exercise capacity assessed with incremental shuttle walking test in
stable COPD
P. Ergun, D. Kaymaz, U. Turay, F. Sengul, T. Sert, A. Caglar (Ankara, Mugla, Turkey)
1327
15:15 Expanding the use of the MRC dyspnoea scale
R. A. Evans, R. Collier, S. J. Singh, M. D. L. Morgan (Leicester, United Kingdom)
1328
15:30 Degree of agreement between two modified BODE indexes. Are they useful?
E. Marquez-Martin, J. L. Lopez-Campos, P. Cejudo, F. Ortega, C. Carmona, M. Echevarria, E. Barrot (Seville,
Spain)
1329
15:45 Distribution of leg muscle weakness in chronic obstructive pulmonary disease (COPD)
J. Seymour, K. Ward, J. Steier, C. Jolley, C. Reilly, M. Polkey, J. Moxham, G. Rafferty (London, United Kingdom)
1330
16:00 Relationship between peripheral muscle force and systemic and localized muscle mass in healthy subjects,
smokers and COPD patients
F. Figueirôa Sanchez, S. Tanni, M. Maria Faganello, P. Adolfo Lucheta, N. Gelamo Pelegrino, I. Godoy
(Araçatuba, Botucatu, Lins, Brazil)
1331
16:15 Cut-off point of anthropometric mid-arm muscle area to identify systemic fat-free mass depletion in COPD
patients
F. Figueirôa Sanchez, S. Tanni, M. Maria Faganello, S. Reiko Hasegwa, N. Gelamo Pelegrino, I. Godoy
(Araçatuba, Botucatu, Lins, Brazil)
1332
16:30 Peak cough expiratory flow: a useful tool to guide diet prescription in dysphagic patients?
L. Bianchi, T. Meschini, M. Vitacca (Lumezzane, Italy)
1333
Room Europa 2
Session 147
14:45–16:45
Oral Presentation: Biology in thoracic tumours
Chairs: E. Brambilla (Grenoble, France), R. M. Huber (Munich, Germany)
14:45 Tissue inhibitors of metalloproteinase-2 C-303T and G-418C genetic polymorphisms are associated with an
increased risk of non-small cell lung cancer in Taiwan
S. C. Chen, Y. L. Lee, W. Chen, W. E. Cheng, C. M. Shih (Taichung, Taiwan, Republic of China)
1334
15:00 The association of MMP-7 and MMP-13 genetic polymorphisms with susceptibility to non-small cell lung
cancer in Taiwan
Y. L. Lee, S. C. Chen, W. Chen, W. E. Cheng, C. M. Shih (Taichung, Taiwan, Republic of China)
1335
15:15 Lung cancer in the younger patient with COPD: a more susceptible host?
A. Patel, C. Cote, R. Peniston, L. Dordelly (Bay Pines, United States of America)
1336
15:30 Vascular endothelial growth factor (VEGF) in serum and exhaled breath condensate (EBC) as a potential
biomarker for early detection of non-small cell lung cancer (NSCLC)
C. Montero-Martínez, L. Núñez-Naveira, L. A. Mariñas-Pardo, R. Fraga-Iriso, A. Souto-Alonso,
N. S. Brienza, H. Verea, D. Ramos-Barbón (A Coruña, Spain)
1337
15:45 Espression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1-Flt1, VEGF-R2-Flk1) in
non small cell (NSCLC) and small cell lung carcinomas (SCLC). Correlation with clinical outcome
s
G. Hardavella, E. Arkoumani, Y. Dalavanga, P. Galanis, D. Stefanou, S. Constantopoulos (Ioannina, Athens,
es
Greece)
1338
16:00 SiRNA mediated growth factor receptors inhibition in A549 cell model of lung cancer gene therapy:
insulin-like growth factor-I receptor (IGF-R1) blockade produces changes that potentially induce
anti-tumor immunity
P. Kopinski, M. Dancewicz, E. Polgesek, M. Jankowski, A. Jaworska, J. Kowalewski (Bydgoszcz, Poland)
1339
16:15 Exhaled microsatellite analysis of 3p predicts poor survival in non small cell lung cancer
G. E. Carpagnano, A. Spanevello, F. Carpagnano, G. P. Palladino, M. G. Cagnazzo, M. P. Foschino Barbaro
(Foggia, Bari, Italy)
1340
16:30 The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in
patients with malignant mesothelioma
A. M. Carletti, S. Roncella, L. Pratticò, M. Sivori, B. Bacigalupo, P. Ferro, F. Fedeli, P. A. Canessa
(Sarzana, La Spezia, Italy)
1341
ERS Berlin 2008 Annual Congr
205
S U N D A Y O C T O B E R 5
Room Paris 1
Session 148
14:45–16:45
Oral Presentation: Nursing interventions in the management of COPD and
dyspnoea
Chairs: G. South (Chesterfield, United Kingdom), E. Austegard (Oslo, Norway)
14:45 Testing a measurement model of dyspnoea in adults hospitalized for heart failure
M. Parshall, R. Taylor, J. Powers, U. Ice, A. Carle (Albuquerque, Jacksonville, United States of America)
1342
15:00 The experience of families in which the wife has severe breathing difficulties: a dialogue to facilitate health
H. Jonsdottir (Reykjavik, Iceland)
1343
15:15 Support intervention in a nurse clinic for people with COPD and their families: enhancing quality of life
T. S. Ingadottir, H. Jonsdottir (Fossvogur, Reykjavík, Iceland)
1344
15:30 Home healthcare and outcomes in discharged patients with COPD and/or lung cancer
G. Narsavage, Y. J. Chen (Morgantown, United States of America)
1345
15:45 Enhanced care services to reduce unplanned admissions in high risk COPD patients are ready for extensive
deployment
C. Hernandez, L. LLop, A. Alonso, J. Gracia-Aymerich, I. Serra, W. Lalinde, R. Rodriguez-Roisin, F. Pozo,
J. Roca (Barcelona, Madrid, Spain)
1346
16:00 Preliminary evaluation of a nurse-led oxygen prescription review service
F. Bates, T. Stallard, K. Stevens, S. Murphy, G. Antunes (Middlesbrough, United Kingdom)
1348
16:15 The differences between nurse care in patients with invasive ventilation (IV) and noninvasive ventilation (NIV)
S. Stefankovicova, Y. Stankova, L. Rausova (Brno, Czech Republic)
1349
Room Paris 2
Session 149
14:45–16:45
Oral Presentation: Multidrug-resistant and the emerging threat of extensively
drug-resistant tuberculosis
Chairs: G. B. Migliori (Tradate, Italy), R. Loddenkemper (Berlin, Germany)
14:45 Second-line injectables: are they essential to treat MDR/XDR-TB cases?
G. B. Migliori, R. Muetterlein, G. Sotgiu, G. De Iaco, K. Kliiman, O. Toungoussova, J. Ortmann, H. Hoffmann,
E. Girardi, F. Lauria, C. Lange, TBNET Study Group (Tradate, Sassari, Sondalo, Cassano delle Murge, Rome,
Italy; Parsberg, Bad Lippspringe, Gauting, Borstel, Germany; Tartu, Estonia)
1350
15:00 Treatment outcomes of the use of moxifloxacin in management of patients with XDR-TB in Tomsk Oblast
of the Russian Federation
T. Tonkel, S. Mishustin, A. Strelis, G. Yanova, N. Chukova, A. Yedilbayev (Tomsk, Russian Federation; Boston,
United States of America)
1351
15:15 Increasing anti-tuberculosis drug resistance in the UK
J. Watson, M. Kruijshaar, F. Drobniewski, J. Magee, G. Smith, I. Abubakar (London, Newcastle-upon-Tyne,
Birmingham, United Kingdom)
1352
15:30 Evaluation of the efficacy and safety of moxifloxacin in the treatment of drug-resistant pulmonary
tuberculosis; a clinical trial
A. Abu-Hussein, A. H. Mahmoud, S. Al-Ashmawy, M. Wafae, S. Abdalla (Tanta, Cairo, Egypt)
1353
15:45 Extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB): a
retrospective comparative study
A. Vilarica, C. Gomes, J. Pina (Lisbon, Portugal)
1354
16:00 MDR- and XDR-TB in Germany
B. Eker, J. Ortmann, G. B. Migliori, R. Muetterlein, R. Centis, A. Esselmann, B. Kretz, T. Schaberg, C. Schaudt,
s
H. Hang, S. Ott, D. Kirsten, P. Hammel, R. Eberhardt, M. Pletz, H. Flick, S. Ruesch-Gerdes, P. Hannemann,
es
S. Stenger, A. Paulick, K. D. Schneider, T. Wolf, D. Wagner, A. de Roux, G. Liebetrau, M. Rau, C. Laumann,
C. Lange (Borstel, Bad Lippspringe, Pasberg, Hemer, Gauting, Rotenburg, St.Blasien, Schillerhoehe, Berlin,
Gr. Hansdorf, Immenhausen, Heidelberg, Hanover, Neustadt, Ulm, Coswig, Frankfurt, Freiburg, Lostau,
Wangen, Solingen, Germany; Tradate, Italy)
1355
16:15 Efficacy and tolerability of linezolid in the treatment of MDR-TB cases: a TBNET study in Germany and Italy
G. B. Migliori, B. Eker, A. Esselmann, R. Centis, B. Kretz, J. Ortmann, G. De Iaco, C. Schaudt, A. Paulick, G. Enrico,
N. Bevilacqua, H. Hang, C. Laumanns, D. Kirsten, T. Schaberg, C. Lange, TBNET Study Group (Tradate, Sondalo,
Rome, Italy; Borstel, Hemer, Gauting, Bad Lippspringe, St.Blasien, Coswig, Gerlingen, Solingen, Rotenburg,
Grosshansdorf, Germany)
1356
16:30 Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis
H. S. Nam, W. J. Koh, S. H. Park, S. H. Kim, C. R. Ham, S. W. Um, G. Y. Suh, M. P. Chung, H. Kim, O. J. Kwon
(Seoul, Republic of Korea)
1357
ERS Berlin 2008 Annual Congr
206
S U N D A Y O C T O B E R 5
Room 5.2a
Session 150
14:45–16:45
Oral Presentation: Strategies of patient management in different settings
Chairs: O. C. Burghuber (Vienna, Austria), C. Criee (Goettingen-Bovenden, Germany)
14:45 The web-based cough clinic
H. Fathi, P. Dettmar, V. Strugala, H. Dettmar, C. Wright, A. Morice (Cottingham, Hull, United Kingdom)
1358
15:00 Socio-economic consequences of asthma – an epidemiological study based on weekly individualized data
C. Hansen, D. Sherson, J. Baelum, G. Thomsen, O. Omland, L. Skadhauge, RAV Group (Vejle, Odense, Esbjerg,
Aalborg, Haderslev, Denmark)
1359
15:15 Cost-effectiveness of an INTERdisciplinary COMmunity-based COPD lifestyle program (INTERCOM) in
patients with moderate COPD
M. Hoogendoorn, C. van Wetering, A. Schols, M. Rutten-van Mölken (Rotterdam, Veldhoven, Maastricht, The
Netherlands)
1360
15:30 Asthma school program in children
Z. Zivkovic, S. Radic, S. Smiljanic, M. Micic-Stanojevic, S. Cerovic, J. Jocic-Stojanovic (Belgrade, Republic
of Serbia)
1361
15:45 Implementing an educational smoking cessation curriculum for medical students – a randomized, controlled
trial
D. Stolz, W. Langewitz, A. Meyer, K. Pierer, P. Tschudi, W. Strobel, A. Perruchoud, K. Fagerstroem, M. Tamm
(Basel, Switzerland; Helsingborg, Sweden)
1362
16:00 A retrospective study of home oxygen prescribing costs in the UK
H. Ward, L. Dowson (Wolverhampton, United Kingdom)
1363
16:15 End of life choices in chronic respiratory failure, an experience with a questionnaire in 100 patients in oxygen
therapy
D. Rinnenburger, D. Bigioni, G. Brunetti, C. Liberati, V. Magliacani, P. Marazzi, M. Pasquarelli, L. Reggiani,
A. Sebastiani, G. Taronna, C. Luca (Rome, Italy)
1364
16:30 A study to investigate whether the views of next of kin reflect those of patients admitted to hospital with
COPD
S. D. W. Miller, C. Armstrong, M. W. Elliott (Leeds, United Kingdom)
1365
Room New York 1
Session 151
14:45–16:45
Oral Presentation: Severe asthma: a heterogeneous clinical entity
Chairs: E. Bel (Amsterdam, The Netherlands), M. Gaga (Athens, Greece)
14:45 What defines abnormal lung function in asthma? Results from European community respiratory health survey
(ECRHS)
I. Cerveri, A. Corsico, S. Accordini, R. Niniano, E. Ansaldo, G. Cervio, C. Janson, N. Künzli, D. Jarvis, R. de Marco
(Pavia, Verona, Italy; Uppsala, Sweden; Barcelona, Spain; London, United Kingdom)
1366
15:00 A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in
refractory severe asthmatics
D. Pinot, A. Nieves, A. M. Lorec, K. Botturi, A. Cavailles, D. Breen, D. Vervloet, A. Magnan (Marseille, France)
1367
15:15 Smoking asthmatics – does smoking make them differ in disease manifestations?
L. Rasmussen, V. Backer (Copenhagen, Denmark)
1368
15:30 Increased serum IL-17 is an independent risk factor for severe asthma
I. Agache, L. Duca, M. Anghel (Brasov, Romania)
1369
15:45 Control of severe asthma and its relationship with satisfaction with treatment and with general health status
s
J. L. Rodriguez Hermosa, C. Barcina, M. Calle, M. Munoz, M. Leal, M. J. Gomez, J. L. Alvarez-Sala (Madrid,
es
Spain)
1370
16:00 Are we routinely using severity assessment in hospital admissions with acute severe asthma?
W. Ahmed, S. Saha, C. J. Brook, T. Fernandez, S. Fong, R. Ali, A. Choudhury (London, Romford, United Kingdom) 1371
16:15 Improved quality of life by internet-based self-management versus usual care in asthma: a randomized
controlled trial
V. van der Meer, M. J. Bakker, K. F. Rabe, P. J. Sterk, J. Kievit, W. J. J. Assendelft, J. K. Sont (Leiden, Amsterdam,
The Netherlands)
1372
Room New York 2
Session 152
14:45–16:45
E-Communication Session: Air pollution effects on lung and heart
Chairs: M. Raulf Heimsoth (Bochum, Germany), R. Zlotkowska (Sosnowiec, Poland)
E1373 The RUPIOH study: EBC total NOx in relation to ambient air pollution in chronic lung disease, a city by city
analysis
ERS Berlin 2008 Annual Congr
S. Manney, A. Mansur, J. Ayres (Birmingham, Aberdeen, United Kingdom)
207
S U N D A Y O C T O B E R 5
E1374 Outdoor air pollution is associated with disease severity in alpha-1-antitrypsin deficiency (AATD)
A. Wood, R. Harrison, S. Semple, J. Ayres, R. Stockley (Birmingham, Aberdeen, United Kingdom)
E1376 Comparative study of airway inflammatory response after exposure in metro underground respectively car tunnel
A. Klepczynska Nystrom, B. M. Larsson, A. Eklund, J. Grunewald, I. Rodin, A. Lundin, T. Sandstorm, A. Blomberg,
C. Muller Suur, M. Svartengren (Stockholm, Umea, Sweden)
E1377 Time-series analysis of respiratory and cardiovascular morbidity in Nicosia, Cyprus, 1995-2004: the effect of air
pollution and dust storms
N. Middleton, P. Yiallouros, S. Kleanthous, O. Kolokotroni, J. Schwartz, D. Dockery, P. Demokritou, P. Koutrakis
(Nicosia, Cyprus; Boston, United States of America)
E1378 Environmental air pollutants and arrhythmia emergency room visits
G. Braga, A. Braga, L. Martins, L. Pereira, D. Zanetta, U. Santos (Sao Paulo, Brazil)
E1379 Personal exposure to traffic related air pollutants in Umeå, Sweden, 2001 and 2007
A. Hagenbjork-Gustafsson, L. Modig, B. Forsberg (Umea, Sweden)
E1380 Long-term exposure to particulate matter (PM) and lung function. The MESA lung study
R. G. Barr, A. V. Diez Roux, M. Shen, P. L. Enright, E. A. Hoffman, J. Kaufman, T. Ragunathan (New York, Ann Arbor,
Tucson, Iowa City, Seattle, United States of America)
E1381 Complex estimation of effect metals in particulate pollutants on pathogenesis of chronic lung diseases
K. Alla, M. Nikolay, K. Fedor (Krasnoyarsk, Novosibirsk, Russian Federation)
E1382 Ageing augmented endothelial dysfunction due to diesel exhaust particles
N. Bai, S. van Eeden (Vancouver, Canada)
E1383 Relationship between respiratory symptoms and lung function in rural and urban Nepalese adults
J. Ayres, O. P. Kurmi, S. Semple, M. Steiner, P. Simkhada, C. Smith (Aberdeen, United Kingdom)
E1384 PM10 from road dust and FeNO in adults with asthma in Umeå, Sweden
H. Bertilsson, D. Olsson, L. Modig, B. Forsberg (Umea, Sweden)
E1385 Effect of prenatal and postnatal exposure to urban air pollution on the myocardial lipid peroxidation levels of
adult mice
N. R. Damaceno-Rodrigues, M. M. Veras, E. M. Negri, A. C. T. Zanchi, C. Rodhen, P. H. N. Saldiva, M. Dolhnikoff,
E. G. Caldini (Sao Paulo, Porto Alegre, Brazil)
E1386 The evaluation of obstruction risk among people living in the vicinity of busy roads and in the rural areas
A. Badyda, W. Lubinski (Warsaw, Poland)
E1387 Air pollution significantly influences mutagenesis in the oral mucosa: a study in street workers in Sao Paulo,
Brazil
A. Negri, M. A. Ferreira, E. G. Caldini, P. H. N. Saldiva (Sao Paulo, Brazil)
E1388 Effects of air pollution and smoking in oxygen saturation and heart rate in normal individuals
L. Belinaso, N. Martins, L. Morinaga, M. Bussacos, U. Santos (Sao Paulo, Brazil)
E1389 Assessment of low dose effects of acute sulfur dioxide exposure on the airways using non-invasive methods
M. Raulf-Heimsoth, C. van Thriel, F. Hoffmeyer, J. Buenger, H. Berresheim, T. Bruening (Bochum, Dortmund, Germany)
E1390 The annual decline in FEV is steeper if it is estimated from baseline data using cross-sectional analysis than
1
obtained by longitudinal analysis
V. Søyseth, H. L. Johnsen, J. Kongerud (Lørenskog, Oslo, Norway)
E1391 Diesel exhaust-induced impairment of vasomotor function is inhibited by a particle trap
M. Lundbäck, S. Barath, N. Mills, A. Lucking, T. Sandström, D. Newby, A. Blomberg (Umeå, Sweden; Edinburgh,
United Kingdom)
E1392 Daily air pollution levels in Gothenburg, Sweden, and FENO in healthy adults
J. Nilsson, A. C. Olin, L. Modig, M. Andersson, B. Forsberg (Umeå, Gothenburg, Sweden)
Room New York 3
Session 153
14:45–16:45
s
es
E-Communication Session: Management, quality aspects and prognosis in
thoracic oncology
Chairs: M. Muers (Leeds, United Kingdom), N. Schoenfeld (Berlin, Germany)
E1393 The National (UK) Lung Cancer Audit: data from 2006
M. Peake, P. Beckett, N. Chanarin, S. Roz (London, Leeds, United Kingdom)
E1394 Quality management system for lung cancer – an open source approach for a lasting improvement of quality care
by the Tumour Centre Berlin, Germany
T. Blum, N. Schoenfeld, A. Jagota, The Task Force Lung Cancer of the Tumor Zentrum Berlin e.V. (Berlin, Germany)
E1395 The role of a trained respiratory physician in lung cancer management
P. Gupta, M. Bhattacharya, R. Mukherjee (Milton Keynes, United Kingdom)
E1396 Patients referred to a lung cancer clinic – does a clinical assessment at the outset have an impact on the
investigations requested?
B. Barker, H. Moudgil, K. Srinivasan (Telford, United Kingdom)
ERS Berlin 2008 Annual Congr
E1397 Oncological pulmonary cases with emergency room admission
208
D. Tatar, C. Anar, Y. Yildirim, A. K. Cirak, H. Halilcolar (Izmir, Turkey)
E1398 A retrospective study of the cause and impact of delayed diagnosis of lung cancer (LC)
A. A. Lwin, B. Khan, E. Sawicka (Farnborough Common, Orpington, United Kingdom)
S U N D A Y O C T O B E R 5
E1399 Outcomes from a monographic clinic for rapid diagnosis of lung cancer
D. Sanchez, F. Andreo, E. Valverde, J. Sanz, E. Monsó, J. Roca, J. Morera (Badalona, Barcelona, Spain)
E1400 Are patients with malignant pleural effusions being referred appropriately for surgical intervention?
N. Acharya, M. Hewson (Carlisle, United Kingdom)
E1401 Rapid access lung cancer clinics: do you have one?
S. Chandramouli, K. Saraswathi, M. Winson (Crewe, United Kingdom)
E1402 Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London
teaching hospital
Y. E. Ong, S. Goddard, A. Draper (Tooting, London, United Kingdom)
E1403 Histological pattern, gender and smoking status in lung cancer in the last decade
P. Grigore, E. Crisan, R. Ulmeanu, M. Alexe, P. Galbenu, D. Leonte, A. Serbescu, L. Cervis, R. Nemes (Bucharest,
Romania)
E1404 Comparing the prognostic impacts of angiogenesis, lymphangiogenesis and lymphatic invasion (LI) in small cell
lung carcinomas (SCLC)
G. Hardavella, E. Arkoumani, Y. Dalavanga, P. Galanis, D. Stefanou, S. Constantopoulos (Ioannina, Athens, Greece)
E1405 Pre-operative levels of serum vascular endothelial growth factor A (VEGF-A), C (VEGF-C) and D (VEGF-D) in
non-small cell lung cancer (NSCLC). Preliminary report
M. Kozlowski, O. Kowalczuk, G. Lapuc, A. Sulewska, W. Laudanski, M. Garbowicz, W. Niklinska, P. Dziegielewski,
L. Chyczewski, J. Niklinski, J. Laudanski (Bialystok, Poland)
E1406 Serum angiopoietins as a clinical marker for resected early lung cancer
S. S. Sheen, K. J. Park, J. H. Park, W. Y. Chung, K. S. Lee, Y. J. Oh, Y. S. Kim, S. C. Hwang (Suwon, Republic of Korea)
E1407 Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a
prognostic factor of survival in patients with lung adenocarcinoma
E. Boutsikou, K. Zarogoulidis, V. Tzarou, E. Eleftheriadou, T. Galaktidou, V. Zarogoulidou, H. Lithoxopoulou,
G. Balassoulis, T. Kontakiotis (Exochi, Thessaloniki, Thessaloniki, Greece)
E1408 Comparative evaluation of survival time between women and men with advanced lung cancer
E. Mylonaki, V. Voutsas, S. Matzourani, M. Antoniadou, A. Kapetangeorgis, F. Iordanidis, T. Kontakiotis, P. Christaki
(Thessaloniki, Greece)
E1409 Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker
of small cell lung cancer?
W. Naumnik, E. Chyczewska, M. Ossolinska (Bialystok, Poland)
E1410 Use of FDG-PET in the investigative pathway for lung cancer – real world experience in Southern England
M. Schuhmann, H. Rupani, K. Adenji, K. McKinlay, M. Roland (Portsmouth, Basingstoke, Southampton, United
Kingdom)
E1411 Radio-clinical and prognosis profiles of lung cancer in Casablanca
M. H. Afif, M. Nassaf, H. Sellal, A. Riah, A. Aichane, Z. Bouayad (Casablanca, Morocco)
E1412 Resectable proportion of lung cancers in an unselected population
V. Søyseth, F. Frøiland, A. D. Høiseth, J. Wesche, K. Stavem (Lørenskog, Norway)
Room London 1
Session 154
14:45–16:45
E-Communication Session: Pulmonary arterial hypertension and other pulmonary
vascular diseases
Chairs: M. Delcroix (Leuven, Belgium), H. Olschewski (Graz, Austria)
E1413 Results of a 12-week outpatient cardiovascular rehabilitation in patients with idiopathic pulmonary arterial
hypertension (iPAH)
K. Boutet, G. Garcia, B. Degano, M. Gonzalves-Tavares, C. Tcherakian, X. Jaïs, M. Humbert, P. Escourrou,
s
G. Simonneau, O. Sitbon (Clamart, France)
es
E1414 Non-invasive hemodynamic assessment in patients with pulmonary hypertension
S. Desole, C. Seemann, P. Heininger, R. Hiemetzberger, S. Mueller, C. M. Kaehler (Innsbruck, Austria)
E1415 The REVEAL registry: a tool for the evaluation of PAH disease management
R. Barst, M. McGoon, R. Benza, D. Badesch, S. Giles, K. Feldkircher, D. Miller (New York, Rochester, Birmingham,
Denver, South San Francisco, San Francisco, United States of America)
E1416 Clinical characteristics of pulmonary arterial hypertension in Ireland: results of a national register
D. O’Callaghan, S. Doherty, S. Gaine (Dublin, Ireland)
E1417 Incidence of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study
M. Humbert, P. de Groote, V. Gressin, J. Sibilia, E. Diot, P. Carpentier, L. Mouthon, P. Y. Hatron, P. Jego, Y. Allanore,
K. P. Tiev, C. Agard, A. Cosnes, D. Cirstea, J. Constans, D. Farge, J. F. Viallard, J. R. Harle, P. Clerson, E. Hachulla
(Clamart, Paris, France)
E1418 Ambrisentan therapy for patients with PAH associated with connective tissue disease (PAH-CTD): one year
follow-up
ERS Berlin 2008 Annual Congr
N. Galie, D. Richards, T. Hutchinson, C. Dufton, On Behalf of the ARIES Study Group (Bologna, Italy; Harlow, United
Kingdom; Westminster, United States of America)
209
S U N D A Y O C T O B E R 5
E1419 Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for
pulmonary arterial hypertension
G. Kovacs, R. Maier, S. Scheidl, C. Hesse, E. Aberer, M. Brodmann, W. Salmhofer, W. Graninger, E. Gruenig,
H. Olschewski (Graz, Austria; Heidelberg, Germany)
E1420 NT-proBNP correlation with disease severity in PAH-SSc versus IPAH
S. Mathai, H. Champion, A. Zaiman, R. Girgis, P. Hassoun (Baltimore, United States of America)
E1421 Cardiopulmonary exercise testing, six minute walk and hemodynamics in patients with chronic thromboembolic
pulmonary hypertension (CTEPH)
J. Klemm, H. Wilkens, C. Frantz, T. Kramm, G. W. Sybrecht (Homburg, Merzig, Germany)
E1422 Pulmonary artery distensibility correlates with functional response to sildenafil in distal chronic thrombo-embolic
pulmonary hypertension
M. Toshner, J. Suntharalingam, E. Soon, N. Screaton, D. Gopalan, J. Pepke-Zaba (Cambridgeshire, Bath,
United Kingdom)
E1423 Prognostic factors in non-surgical chronic thromboembolic pulmonary hypertension
R. Condliffe, D. G. Kiely, J. S. R. Gibbs, P. A. Corris, A. J. Peacock, D. P. Jenkins, K. Goldsmith, J. G. Coghlan,
J. Pepke-Zaba (Cambridge, Sheffield, London, Newcastle-upon-Tyne, Glasgow, United Kingdom)
E1424 Haemodynamic correlation and prognostic value of ventricular mass index (VMI) in non-surgically treated chronic
thromboembolic pulmonary hypertension (CTEPH)
R. Condliffe, N. Woodhouse, C. A. Elliot, J. Wild, D. Hagger, I. J. Armstrong, C. Davies, C. Hill, D. G. Kiely (Sheffield,
United Kingdom)
E1425 C-reactive protein and platelet-activating factor-acetylhydrolase activity: new predictors of outcome in pulmonary
hypertension
R. Quarck, T. Nawrot, E. Ninio, B. Meyns, D. Van Raemdonck, E. Verbeken, M. Delcroix (Leuven, Belgium; Paris,
France)
E1426 Pleural effusions induced by right heart failure in patients with idiopathic and familial pulmonary arterial
hypertension
K. J. Tang, I. M. Robbins, R. W. Light, C. M. Xie (Guangzhou, China; Nashville, United States of America)
E1427 Assessment of satisfaction in patients with pulmonary hypertension treated with epoprostenol
E. Vandevelde, V. Vanloo, E. Smeyers, V. De Broyer, C. Vanaken, M. Delcroix (Leuven, Belgium)
E1428 Endothelin and high altitude pulmonary hypertension
B. Kojonazarov, J. Isakova, M. Kochkorova, A. Maripov, T. Sooronbaev, M. Mirrakhimov, N. Morrell, M. Wilkins,
A. Aldashev (Bishkek, Kyrgyzstan; Cambridge, London, United Kingdom)
E1429 Pulmonary distension restrains pulmonary blood flow during exercise in COPD patients
L. Bertoletti, J. M. Vergnon, F. Costes (St-Etienne, France)
E1430 Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial
hypertension
S. van Eijl, G. P. Diller, D. O. Okonko, L. S. Howard, O. Ali, T. Thum, S. J. Wort, E. Bédard, J. S. R. Gibbs, J. Bauersachs,
A. J. Hobbs, M. R. Wilkins, M. A. Gatzoulis, J. Wharton (London, United Kingdom; Würzburg, Germany)
E1431 Pregnancy and pulmonary arteriovenous malformations
C. Shovlin, C. Mordin, J. Jackson, J. M. B. Hughes, M. Sheppard (London, United Kingdom)
E1432 Transcatheter embolization of pulmonary arterio-venous malformations (PAVMs) – does a successful occlusion
last for ever?
O. Almås, A. Naalsund, P. Giæver, G. Hafsahl, R. Andersen, E. Dorenberg (Oslo, Norway)
Room London 2
Session 155
14:45–16:45
E-Communication Session: Paediatric airway diseases – pathophysiology and
s
monitoring
es
Chairs: E. Piippo-Savolainen (Lapinlahti, Finland), R. Iles (Cambridge, United Kingdom)
E1433 Predictive factors for wheeze in children less than 2 years following lower respiratory infection
M. Han, J. Kim (Seoul, Republic of Korea)
E1434 Secretors immune globulin A in exhaled breath condensate and serum of young patients with bronchiectases
A. Baigenjin, N. Rutenko, S. Baydurin, S. Tuganbekova, Erlan, N. Popova (Astana, Kazakhstan)
E1435 Incidence, genetic variability and clinical characteristics of nosocomial infection by respiratory virus in children
S. E. Vieira, A. E. Gilio, D. B. Leal, E. L. Durigon (Sao Paulo, Brazil)
E1436 Are there risk factors that may influence use of antibiotics in viral lower respiratory tract infections in children?
L. L. Dracea, F. Olar (Brasov, Romania)
E1437 Air pollution during pregnancy and cord blood cytokine secretion
B. Schaub, U. Frey, M. Röösli, P. Latzin (Munich, Germany; Bern, Switzerland)
E1438 Are there predictive factors for bronchiectasis in children with recurrent lower respiratory tract infections?
H. Abid, I. Bachouch, J. Ammar, M. Hsairi, S. Sanai, F. Marouen, A. Hamzaoui (Ariana, Tunis, Tunisia)
ERS Berlin 2008 Annual Congr
E1439 Pulmonary lymphoid hyperplasia (PLH) / lymphoid interstitial pneumonitis (LIP) complex in HIV-1 infected
210
Brazilian children: associations and prognosis
A. A. D. C. Toro, A. M. A. Altemani, M. T. N. Da Silva, J. D. Ribeiro, M. A. G. O. Ribeiro, A. M. Morcillo, M. M. D. S. Vilela
(Campinas, Brazil)
S U N D A Y O C T O B E R 5
E1440 Clinical and epidemiological study of mycoplasma pneumoniae and adenoviral pneumonia in a Barcelona general
hospital
M. Alvaro, S. Ortigosa, A. Martinez-Roig, L. Ymbert, J. Lozano, R. M. Busquets (Barcelona, Spain)
E1441 Correlation between O air concentration and H O value in asthmatic children
3
2
2
F. Saretta, M. Mauro, M. Guerra, A. Caglieri, M. Canciani (Udine, Parma, Italy)
E1442 The consequences of different definitions in the prediction of asthma in children
K. van Wonderen, L. van der Mark, P. Bindels, W. van Aalderen, G. Ter Riet (Amsterdam, The Netherlands; Zurich,
Switzerland)
E1443 Is there any role of Helicobacter pylori in the pathogenesis of bronchiectasis?
T. Aydin Teke, Y. Akyon Yilmaz, E. Yalcin, H. Ozen, N. Cobanoglu, S. Pekcan, M. Kose, D. Dogru Ersoz, N. Kiper,
U. Ozcelik (Ankara, Turkey)
E1444 Palivizumab prophylaxis, subsequent recurrent wheezing and atopy
E. A. F. Simoes, X. Carbonell-Estrany, J. L. L. Kimpen, C. H. L. Rieger, I. Mitchell, L. M. Fredrick, A. Campbell,
J. R. Groothuis (Denver, Abbott Park, Gaithersburg, United States of America; Barcelona, Spain; Utrecht,
The Netherlands; Bochum, Germany; Calgary, Canada)
E1445 Superiority of hydrogen peroxide to exhaled nitric oxide as a marker of bronchial inflammation in asthmatic
children
F. Saretta, M. Mauro, I. Benfatto, A. Orioles, A. Caglieri, M. Canciani (Udine, Parma, Italy)
E1446 Comparison between hydrogen peroxide and spirometry in airways inflammation of asthmatic children
F. Saretta, M. Mauro, A. Gimmillaro, M. Corradi, M. Canciani (Udine, Parma, Italy)
E1447 Leukotriene E4 and influenza infection in children with wheezing-associated respiratory illness (WARI)
J. Deerojanawong, K. Pongsanon, N. Prapphal, S. Sritippayawan, R. Samransamruajkit (Bangkok, Thailand)
E1448 Importance of indoor air pollution in a paediatric population
E. Salvagni, F. Moimas, A. Marchiol, E. Baiutti, A. Marotta, M. Canciani (Udine, Italy)
E1449 Respiratory symptoms in children exposed to indoor and outdoor air pollution
M. Guerra, I. Toller, F. Saretta, I. Rosso, L. Calligaris, M. Canciani (Udine, Italy)
E1450 Post-infectious and chemical obliterative bronchiolitis (PicOB). A Portuguese experience
T. Bandeira, L. Lobo, A. M. Silva, J. C. Trindade (Lisbon, Portugal)
Room London 3
Session 156
14:45–16:45
E-Communication Session: Trends in interventional pulmonology
Chairs: R. Yung (Baltimore, United States of America), K. Roth (Alesund, Norway)
E1451 Ultrathin-bronchoscopy-guided deployment of self-expanding metallic stents without fluoroscopy in the
management of critical airway narrowing in critically ill patients
R. Yung, J. Brandes, M. Pipeling (Baltimore, United States of America)
E1452 Bronchoscopy-guided topical hemostatic tamponade therapy as the initial management for hemoptysis: a pilot
study (Philippines)
R. Capatoy, Z. Sara, J. L. Danguilan, J. Mendoza (Quezon City Metro Manila, Zamboanga del Sur, Philippines)
E1453 Airway catheterization in the assessment of tracheal stenosis during interventional bronchoscopy
H. Nishine, T. Hiramoto, H. Kida, F. Ishikawa, M. Nakamura, J. Saji, M. Oshige, A. Ishida, S. Nobuyama, M. Hoshino,
T. Shirakawa, M. Mineshita, T. Inoue, T. Miyazawa (Kawasaki, Japan)
E1454 “Unusual” endobronchial foreign bodies
M. Alexe, I. Ion, R. Ulmeanu, E. Crisan, P. Grigore (Bucharest, Romania)
E1455 Is endobronchial management of tracheal stenosis a viable alternative to tracheal surgery for selected patients?
M. Wilde, S. Abijat, M. Brendan (London, United Kingdom)
E1456 Bronchoscopic argon plasma coagulation versus cryotherapy in management of endobronchial tumors
s
Y. Mohamed, M. Metwally, M. El Khooly, T. Mahfouz (Assuit, Egypt)
es
E1457 Extrinsic compression of the airways: what to do and when to do
S. Feijó, M. Aguiar, M. M. Marques, J. R. Gonçalves, A. Bugalho Almeida (Lisbon, Portugal)
E1458 Retrospective analysis of a fully covered self-expanding hybrid stent
W. Krimsky, S. Sarkar (Baltimore, United States of America)
E1459 The interventional bronchoscopy procedures with patients with postintubation tracheal stenoses
V. Karlicic, S. Banjari (Belgrade, Republic of Serbia)
E1460 Tracheobronchial injuries. Conservative treatment
S. Feijo, M. M. Marques, P. Monteiro, J. R. Gonçalves, A. Bugalho Almeida (Lisbon, Portugal)
E1461 Endobronchial sclerotherapy for management of hemoptysis
N. N. Shah, R. Bhargava, Z. Ahmad, Q. Syed, K. Dar, M. Shameem, M. M. Mirza (Srinagar, Aligarh, India)
E1462 Bronchoscopic approach in tracheobronchial foreign body cases
S. Cikrikcioglu, H. Ozyurt, S. Altin, F. Kosar, M. Kiyik, Y. S. Intepe (Istanbul, Turkey)
E1463 Usefulness of domiciliary flexible bronchoscopy
ERS Berlin 2008 Annual Congr
D. Samolski, R. Dure (Buenos Aires, Argentina)
E1464 Therapeutic whole-lung lavage in alveolar proteinosis
Y. Martins, R. Pato (Coimbra, Portugal)
211
S U N D A Y O C T O B E R 5
E1465 Characteristics of an ideal sealant to reduce pneumothorax following lung biopsy: evaluation of a newly
developed material
S. Kee, E. Lee, C. Loh, G. Gong, M. Cham, D. Yankelevitz (Los Angeles, New York, Mountain View, United States of
America)
E1466 Pleuro-pulmonary needle biopsy in differential diagnosis of pulmonary contusion
V. Voiculescu, R. Glaja, O. Burlacu, E. Memu, G. Nicodin, A. Nicodin (Timisoara, Romania)
E1467 Ultrasound guided pigtail catheter drainage of different pleural effusions
M. Gomaa, S. Abdel Ghaffar (Cairo, Egypt)
E1468 Emergency bronchoscopies in a university hospital – 4 years experience
F. Salajka, V. Koblizek, V. Sedlak, V. Bartos, J. Ruta, J. Polak, K. Vonkova, R. Dvorakova, P. Barton (Hradec Kralove,
Czech Republic)
E1469 CT and bronchoscopic findings in patients having haemoptysis with normal chest X-Rays
S. Boga, B. Ocakli, H. Turker, O. Ocakli, O. Devran, B. Uskul (Istanbul, Turkey)
ERS Members’ Meetings
Open to ERS Members and interested participants
Sessions 157–165
Scientific Group Members’ Meetings
17:00–18:00
1.2 Rehabilitation and Chronic Care
Room 2.2a
1.3 Imaging
Room London 1
3.3 Mechanisms of Lung Injury and Repair
Room 5.2b
5.2 Airway Regulation, Provocation and Monitoring
Room 5.2a
6.2 Occupational and Environmental Health
Room New York 1
7.1 Paediatric Respiratory Physiology
Room New York 2
7.2 Paediatric Asthma and Allergy
Room New York 2
7.3 Cystic Fibrosis
Room New York 3
7.4 Paediatric Respiratory Infection and Immunology
Room London 3
7.5 Neonatology and Paediatric Intensive Care
Room London 3
7.6 Paediatric Respiratory Epidemiology
Room London 3
7.7 Paediatric Bronchology
Room New York 3
9.3 Nurses
Room London 2
Room 1.2a
Session 166
17:15–19:15
Evening Symposium: COPD: Current views on the clinical course of COPD
Organised jointly by Boehringer Ingelheim GmbH and Pfizer Inc.
Chairs: C. Vogelmeier (Marburg, Germany), M. Decramer (Leuven, Belgium)
17:15 Introduction and the burden of COPD
C. Vogelmeier (Marburg, Germany)
1470
17:25 The relevance of lung function decline
s
D. Tashkin (Los Angeles, United States of America)
1471
es
17:45 The clinical course of COPD
B. R. Celli (Boston, United States of America)
1472
18:05 Therapeutic advances that impact the clinical course of COPD
P. J. Barnes (London, United Kingdom)
1473
18:25 Insights from tiotropium clinical trials
M. Decramer (Leuven, Belgium)
1474
18:55 Panel discussion
M. Decramer (Leuven, Belgium), C. Vogelmeier (Marburg, Germany), B. R. Celli (Boston, United States
of America), D. Tashkin (Los Angeles, United States of America), P. J. Barnes (London, United Kingdom)
1475
19:10 Closing remarks
M. Decramer (Leuven, Belgium)
1476
ERS Berlin 2008 Annual Congr
212
S U N D A Y O C T O B E R 5
Room Dublin
Session 167
17:15–19:15
Evening Symposium: Maintaining asthma control: the main challenge for both
patients and physicians?
Organised by GlaxoSmithKline
Chair: N. Barnes (London, United Kingdom)
17:15 Welcome and Introduction
N. Barnes (London, United Kingdom)
1477
17:25 Asthma: should we treat to target as in other chronic disease?
I. Pavord (Leicester, United Kingdom)
1478
17:45 Is normal life a reasonable goal for asthma patients?
A. Greening (Edinburgh, United Kingdom)
1479
18:10 Strategies for maintaining asthma control
N. Barnes (London, United Kingdom)
1480
18:35 Guidelines: time for implementation?
P. Paggiaro (Pisa, Italy)
1481
19:00 General discussion and conclusion
N. Barnes (London, United Kingdom)
1482
Room Helsinki
Session 168
17:15–19:15
Evening Symposium: Taking a multi-faceted view on COPD
Organised by AstraZeneca
Chairs: M. Partridge (London, United Kingdom), D. M. G. Halpin (Exeter, United Kingdom)
17:15 Welcome and Introduction
M. Partridge (London, United Kingdom)
1483
17:20 COPD – disease or syndrome?
S. Rennard (Omaha, United States of America)
1484
17:40 Exacerbations versus daily symptoms in COPD
M. Partridge (London, United Kingdom)
1485
18:05 Budesonide and formoterol: why do they work so well?
G. Anderson (Melbourne, Australia)
1486
18:30 Budesonide/formoterol in COPD: What do patients gain?
D. M. G. Halpin (Exeter, United Kingdom)
1487
18:55 Panel discussion
D. M. G. Halpin (Exeter, United Kingdom), M. Partridge (London, United Kingdom)
1488
19:10 Conclusions
D. M. G. Halpin (Exeter, United Kingdom)
1489
Room Budapest
Session 169
17:15–19:15
Evening Symposium: Phenotypes: the forefront of asthma diagnosis and
treatment
Organised by Merck Sharp & Dohme
Chair: J. C. Virchow (Rostock, Germany)
17:15 Welcome and opening remarks
s
J. C. Virchow (Rostock, Germany)
1490
es
17:20 Characterizing asthma phenotypes – why does it matter?
R. Polosa (San Gregorio, Italy)
1491
17:50 What tools do we have to predict therapeutic response?
J. C. Virchow (Rostock, Germany)
1492
18:20 Putting it all together: what we know about using phenotypes, genotypes, and biomarkers to improve
patient care
L. Bjermer (Lund, Sweden)
1493
18:50 Panel discussion; questions and answers
Closing remarks
J. C. Virchow (Rostock, Germany)
1494
ERS Berlin 2008 Annual Congr
213
S U N D A Y O C T O B E R 5
Room Berlin
Session 170
17:15–19:15
Evening Symposium: EXACTLE: EXAcerbations and CT scans as Lung Endpoints in
Alpha-1-Antitrypsin Deficiency
Organised by Talecris Biotherapeutics GmbH
Chairs: N. G. McElvaney (Dublin, Ireland), B. Stoel (Leiden, The Netherlands)
17:15 Welcome and Introduction
N. G. McElvaney (Dublin, Ireland), B. Stoel (Leiden, The Netherlands)
1495
17:20 EXACTLE-Trial: Study protocol and CT techniques
D. Parr (Birmingham, United Kingdom)
1496
17:40 EXACTLE-Trial: Main results. How can EXACTLE help in AATD patients’ treatment?
A. Dirksen (Hellerup, Denmark)
1497
18:10 Integrated analysis: Main results
R. A. Stockley (Birmingham, United Kingdom)
1498
18:40 Summary
B. Stoel (Leiden, The Netherlands), N. G. McElvaney (Dublin, Ireland)
eALTA Award 2007
1499
18:45 Immune cell function in Alpha-1-Antitrypsin Deficiency
T. P. Carroll (Dublin, Ireland)
1500
18:55 Heterozygosity for Alpha-1-Antitrypsin Deficiency: underestimated in chronic liver disease?
K. F. Kok (Nijmegen, The Netherlands)
1501
19:05 eALTA Awards 2008 – Laudation
M. Wencker (Frankfurt, Germany)
1502
Room 5.2c
Session 171
17:15–19:15
Evening Symposium: Mastering pulmonary arterial hypertension: defined by
evidence – enhanced by experience
Organised by Actelion Pharmaceuticals Ltd
Chairs: G. Simonneau (Clamart, France), W. Seeger (Giessen, Germany)
17:15 Introduction
W. Seeger (Giessen, Germany)
1503
17:25 EARLY: Clear cut evidence in WHO functional class II
M. Humbert (Clamart, France)
1504
17:45 Pulmonary arterial hypertension associated with connective tissue disease: an integrated approach
G. Coghlan (London, United Kingdom)
1505
18:05 Joining forces: when to escalate therapy
N. Galie (Bologna, Italy)
1506
18:25 Dual endothelin receptor blockade: advances in pulmonary disease
G. Raghu (Seattle, United States of America)
1507
18:45 Questions and answers
G. Simonneau (Clamart, France), W. Seeger (Giessen, Germany)
1508
19:05 Conclusions
G. Simonneau (Clamart, France)
1509
Room Europa 2
Session 172
17:15–19:15
s
Evening Symposium: From revolution to evolution in anti-IgE therapy
es
Organised by Novartis Pharma AG
Chair: S. Holgate (Southampton, United Kingdom)
17:15 Welcome
S. Holgate (Southampton, United Kingdom)
1510
17:20 Omalizumab in practice: demonstrating real-life effectiveness
R. Buhl (Mainz, Germany)
1511
17:35 New insights into the effects of anti-IgE on markers of inflammation in the inflammatory cascade
J. Bousquet (Montpellier, France)
1512
17:55 New directions in anti-IgE research: exploring the potential for disease modification
U. Wahn (Berlin, Germany)
1513
18:15 Exploring new patient populations: paediatric asthma
B. Lanier (Fort Worth, United States of America)
1514
ERS Berlin 2008 Annual Congr
18:45 Summary
214
S. Holgate (Southampton, United Kingdom)
1515
19:00 Questions, answers and close
S. Holgate (Southampton, United Kingdom)
1516
S U N D A Y O C T O B E R 5
Room Paris 1
Session 173
17:15–19:15
Evening Symposium: Inspiring approaches to clinical challenges in pulmonary
hypertension
Organised by Bayer Schering Pharma AG
Chair: V. McLaughlin (Ann Arbor, United States of America)
17:15 Welcome and Introduction
V. McLaughlin (Ann Arbor, United States of America)
1517
17:30 Pulmonary hypertension in children: measuring treatment success and identifying unmet needs
M. Beghetti (Geneva, Switzerland)
1518
17:50 Management of the patient with CTEPH: evolving pharmacological treatment options
I. Lang (Vienna, Austria)
1519
18:10 Review of clinical data: long-term treatment with inhaled iloprost in pulmonary hypertension
H. Olschewski (Graz, Austria)
1520
18:30 Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy
H. A. Ghofrani (Giessen, Germany)
1521
18:50 Questions and closing comments
V. McLaughlin (Ann Arbor, United States of America)
1522
s
es
ERS Berlin 2008 Annual Congr
215
M O N D A Y O C T O B E R 6
Room 1.2a
Session 181
08:30–10:30
Paediatric year in review
Aims: To give an update on the important literature published in the field of paediatric respiratory medicine since the last Annual
Congress.
Target audience: Paediatricians, respiratory nurses and allied health professionals, adult physicians with an interest in sleep,
interstitial lung disease, asthma and cystic fibrosis.
Chairs: E. Dagli (Istanbul, Turkey), M. Zach (Graz, Austria)
08:30 Asthma
N. Kulkarni (Leicester, United Kingdom)
1523
09:00 Orphan lung diseases
A. Clément (Paris, France)
1524
09:30 Sleep and non-invasive ventilation
I. Narang (Toronto, Canada)
1525
10:00 Cystic fibrosis and other chronic pulmonary suppurative diseases
B. Assael (Verona, Italy)
1526
Room 2.2a
Session 182
08:30–10:30
Symposium: Multigenic expression analyses: a guide for diagnosis and therapy
Aims: This symposium will give an overview of the possibilities and limitations of microarrays for the identification of therapeutic
targets.
Target audience: Clinicians and basic scientists.
Chairs: R. Bals (Marburg, Germany), R. Lucas (Augusta, United States of America)
08:30 Host–pathogen interactions at the epithelial surface
P. Hiemstra (Leiden, The Netherlands)
1527
09:00 Investigation of the status of cystic fibrosis airway epithelial cells
C. Verhaeghe (San Francisco, United States of America)
1528
09:30 Microarray-based analysis of ventilator-induced lung injury
M. Wurfel (Washington, United States of America)
1529
10:00 Host gene expression profiling in pathogen-host interactions
T. Chakraborty (Giessen, Germany)
1530
Room Dublin
Session 183
08:30–10:30
Symposium: Defining COPD using the “fixed ratio” (FEV1/FVC <0.70) – pro and con
Aims: The audience will have a better understanding of the physiological criteria of COPD.
Target audience: Clinicians, general practitioners, nurses, respiratory technicians, health educators.
Chairs: J. Vestbo (Hvidovre, Denmark), P. Bakke (Bergen, Norway)
08:30 Implications of using the fixed ratio in diagnosing COPD in the elderly
J. Hardie (Paradis, Norway)
1531
09:00 Distribution of respiratory symptoms by age in subjects fulfilling criteria of COPD defined by the fixed ratio
P. Burney (London, United Kingdom)
1532
09:30 The fixed ratio is RELEVANT for identifying COPD
K. F. Rabe (Leiden, The Netherlands)
1533
10:00 The fixed ratio is NOT RELEVANT for identifying COPD
A. Gulsvik (Bergen, Norway)
1534
s
es
Room 5.2b
Session 184
08:30–10:30
Symposium: Multidisciplinary approach in interstitial lung disease
Aims: To update on advances in pathology and imaging and also on more or less invasive techniques in the diagnosis of interstitial
lung disease.
Target audience: Pulmonary physicians, pathologists, radiologists, thoracic surgeons.
Chairs: C. Robalo Cordeiro (Coimbra, Portugal), M. Noppen (Brussels, Belgium)
08:30 Pathology: what do we actually want to know?
V. Poletti (Forli, Italy)
1535
09:00 Imaging: can you see it?
G. Ferretti (Grenoble, France)
1536
09:30 Bronchoscopy and medical thoracoscopy: can the pneumologist get it?
P. Astoul (Marseille, France)
1537
10:00 Do we give steroids to everybody anyhow?
ERS Berlin 2008 Annual Congr
A. Wells (London, United Kingdom)
1538
216
M O N D A Y O C T O B E R 6
Room Helsinki
Session 185
08:30–10:30
Symposium: Chest physiotherapy in the intensive care unit
Aims: The aims of this symposium will be to assess the real benefits of chest physiotherapy in the acute and the perioperative setting.
Target audience: Chest physicians, physiotherapists, nurses, intensivists, anaesthesiologists.
Chairs: J-F. Muir (Rouen, France), F. de Jongh (Enschede, The Netherlands)
08:30 The role of chest physiotherapy in the intensive care unit setting
R. Gosselink (Leuven, Belgium)
1539
09:00 Post-operative chest physiotherapy is not useful to prevent post-operative pulmonary complications
J-F. Muir (Rouen, France)
1540
09:30 Pre-operative chest physiotherapy is useful to prevent post-operative pulmonary complications
E. Hulzebos (Utrecht, The Netherlands)
1541
10:00 Non-invasive ventilation (NIV) or chest physiotherapy in the perioperative setting?
P. Navalesi (Novara, Italy)
1542
Room Budapest
Session 186
08:30–10:30
Symposium: Treating cough
Aims: The audience will learn the scientific rationale for new treatments of chronic cough. They will also receive practical advice on
management strategies for patients with intractable cough which will incorporate recent developments in the pharmacological and
non-pharmacological management. Clinicians will be provided with new strategies for care pathways and those involved in drug
development will hear of recently discovered targets for antitussives.
Target audience: Clinicians and scientists.
Chairs: A. Morice (Cottingham, United Kingdom), M. Belvisi (London, United Kingdom)
08:30 New developments in the neuro-pharmacology of the cough reflex
B. Canning (Baltimore, United States of America)
1543
09:00 Sensory receptors as targets for antitussives
P. Geppetti (Florence, Italy)
1544
09:30 Non-pharmacological treatments for cough
A. Morice (Cottingham, United Kingdom)
1545
10:00 The clinical pharmacology of cough in man
T. Kiljander (Pikkio, Finland)
1546
Room Berlin
Session 187
08:30–10:30
Oral Presentation: Therapy in thoracic oncology
Chairs: J-P. Sculier (Brussels, Belgium), E. Quoix (Strasbourg, France)
08:30 Aerosoltherapy in lung cancer
L. Guilleminault, A. Maillet, S. Pesnel, G. Paintaud, N. Congy-Jolivet, G. Thibault, H. Watier, S. Lerondel,
L. Etienne, N. Heuze-Vourch (Tours, Orleans, France)
1547
08:45 Bevacizumab as first line treatment for advanced non-small cell lung cancer (NSCLC): a meta-analysis of
randomised placebo-controlled trials (RCTs)
M. Borges, J. Costa, S. Paulo, L. Pinheiro, A. Vaz-Carneiro (Lisbon, Portugal)
1548
09:00 Safety analysis of anti-VEGF therapy bevacizumab (Bv) in patients (pts) with untreated advanced
non-small cell lung cancer (NSCLC) in MO19390 (SAiL) trial
D. Stroyakovskiy, C. Zhou, Z. Guan, W. Spengler, M. Wang, Y. D. Ko, C. K. Cheng, J. Mezger, A. Bearz, N. Pavlakis
(Moscow, Russian Federation; Shanghai, Guangzhou, Beijing, China; Gerlingen, Bonn, Karlsruhe, Germany;
s
Kowloon, Hong Kong; Aviano, Italy; Sydney, Australia)
1549
es
09:15 A blood-based test for epidermal growth factor receptor mutations in patients with non-small cell lung
cancer
M. Liu, C. He, J. Xu (Guangzhou, China)
1550
09:30 Detection of epidermal growth factor receptor mutation in plasma as predictor of gefitinib response in non
small cell lung cancer
C. He, M. Liu, J. Xu (Guangzhou, China)
1551
09:45 Multicenter phase II trial of carboplatin (Cb) and gemcitabine (G) followed by concurrent chemoradiation
(CRT) in patients with unresectable stage III non-small-cell-lung cancer (NSCLC): Cher@Nos trial
P. Germonpré, A. Janssens, L. Van Moorter, D. Verresen, D. Galdermans, R. Devogelaere, H. Ottevaere,
Y. Menstens, C. De Pooter, C. Goor (Antwerp, Aalst, Wilrijk, Oostende, Oudenaarde, Herentals, Belgium)
1552
10:00 Radiotherapy planning based on positron emission tomography with fluordeoxyglucose in non small cell lung
cancer – a pilot study
A. Gröschel, U. Nestle, J. Fleckenstein, Y. Ploner, A. Schaefer-Schuler, S. Kremp, D. Hellwig, C. Rübe,
ERS Berlin 2008 Annual Congr
C. M. Kirsch, G. W. Sybrecht (Homburg, Germany)
1553
10:15 Radiofrequency ablation of primary lung tumours (4 years experience in the university hospital of Coimbra,
Portugal)
217
A. Szantho, A. Pego, G. Teixeira, F. Alves, A. Marques, M. Loureiro, M. F. Baganha (Coimbra, Portugal)
1554
M O N D A Y O C T O B E R 6
Room 5.2c
Session 188
08:30–10:30
Oral Presentation: Factors related to outcome of community-acquired pneumonia
Chairs: W. Boersma (Alkmaar, The Netherlands), S. Ewig (Bochum, Germany)
08:30 Exposure to gases and fumes increase the mortality from pneumonia
I. Qvarfordt, K. Torén, I. Bergdahl, B. Järvholm (Gothenburg, Umeå, Sweden)
1555
08:45 Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired
pneumonia
S. Krueger, T. Wibmer, T. Merk, C. Schumann, V. Hombach, R. Marre (Aachen, Ulm, Germany)
1556
09:00 Excess age dependent short- and long-term mortality in patients with community acquired pneumonia
S. Krueger, C. Schumann, R. Marre, N. Suttorp, T. Welte (Aachen, Berlin, Ulm, Hanover, Germany)
1557
09:15 Influence of antibiotic pre-treatment on inflammatory markers in community-acquired pneumonia
S. Krueger, J. Kunde, A. Hanschmann, R. Marre, N. Suttorp, T. Welte (Aachen, Hennigsdorf, Ulm, Berlin, Hanover,
Germany)
1558
09:30 Community-aquired pneumonia: systemic and local inflammatory response in treatment failure
M. J. Lorenzo, I. Moret, E. Cases, B. Sarria, R. Martinez, S. Reyes, R. Menendez (Valencia, Spain)
1559
09:45 Usefulness of C-reactive protein and procalcitonin in predicting mortality in community-acquired pneumonia
R. Menéndez, R. Martínez, S. Reyes, C. Esquinas, A. Martínez, J. Mensa, X. Filella, A. Torres (Valencia, Barcelona,
Spain)
1560
10:00 Systolic blood pressure is superior to other haemodynamic predictors of severity in community acquired
pneumonia
J. D. Chalmers, A. Singanayagam, A. T. Hill (Edinburgh, United Kingdom)
1561
10:15 The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia
(CAP) in young patients: results from the CAPO international study
V. Betti, S. Aliberti, P. Peyrani, P. Tarsia, F. Blasi, J. Ramirez (Milan, Italy; Louisville, United States of America)
1562
Room Europa 2
Session 189
08:30–10:30
Oral Presentation: New frontiers in noninvasive assessment of the lungs
Chairs: I. Horvath (Budapest, Hungary), P. J. Sterk (Amsterdam, The Netherlands)
08:30 Metabonomic analysis of EBC in adults by nuclear magnetic resonance spectroscopy
G. de Laurentiis, D. Paris, D. Melck, M. Maniscalco, S. Marsico, G. Corso, A. Motta, M. Sofia (Naples, Pozzuoli,
Foggia, Italy)
1563
08:45 Breath analysis in renal failure: effect of hemodialysis
E. Heffler, N. Ferrero, L. Bommarito, M. Bugiani, R. Bergia, G. Guida, S. Pizzimenti, M. Bruno, M. Petrarulo,
G. Rolla (Turin, Italy)
1564
09:00 Effect of exercise on exhaled breath condensate pH in young healthy subjects
A. Bikov, B. Szili, B. Antus, M. Kollai, I. Horvath (Budapest, Hungary)
1565
09:15 Alpha-1-antitrypsin is detectable and can be quantified in exhaled breath condensate
S. Noeske, R. Bals, C. Herr, C. Vogelmeier, A. R. Koczulla (Marburg, Germany)
1566
09:30 An electronic nose distinguishes the exhaled breath condensates of AATD patients and healthy controls
R. Koczulla, A. Hattesohl, S. Noeske, C. Vogelmeier, R. Bals (Marburg, Germany)
1567
09:45 Repeated eNose assessment in the monitoring of O -induced changes in exhaled breath metabolites in
2
COPD
M. de Vries, J. van der Maten, P. J. Sterk, A. Ten Brinke (Leeuwarden, Amsterdam, The Netherlands)
1568
10:00 Breath analysis by ion mobility spectrometry in sarcoidosis – results of a feasibility study
s
M. Westhoff, P. Litterst, B. Obertrifter, A. Bunkowski, J. I. Baumbach (Hemer, Dortmund, Germany)
1569
es
10:15 Is vibration response imaging (VRI) valuable in early detection of airways obstruction in smokers?
A. Florou, S. Vakali, D. Michailidis, C. Roussos, C. Gratziou (Athens, Greece)
1570
Room Paris 1
Session 190
08:30–10:30
Oral Presentation: Environmental tobacco smoke and smoking ban
Chairs: A. Trofor (Iasi, Romania), C. Gratziou (Athens, Greece)
08:30 Environmental tobacco smoke in the Netherlands. First estimates of exposure
B. van Gelder, A. Blokstra, T. Feenstra (Bilthoven, The Netherlands)
1571
08:45 Passive smoking and risk of fatal and non-fatal myocardial infarction in a cohort of Danish workers
N. S. Godtfredsen, E. Prescott, M. Osler, C. Pisinger, H. O. Hein (Copenhagen, Denmark)
1572
09:00 Influence of passive smoking in childhood on asthma development – ECAP study (preliminary results)
K. Specjalski, M. Chelminska, I. Damps-Konstanska, E. Wasilewska, K. Kuziemski, L. Gorska, B. Wajda, A.
ERS Berlin 2008 Annual Congr
Drozdowska, K. Kempinski, A. Gorska, J. Lata, A. Szymanowska, A. Tomaszewska, E. Jassem, B. Samolinski
(Gdansk, Warsaw, Poland)
1573
218
09:15 Association between second hand smoke exposure and COPD, quality of life, and health care use in
smokers and ex-smokers
M. Gerbase, P. O. Bridevaux, C. Schindler, N. Probst-Hensch, J. Schwartz, N. Kunzli, J. M. Gaspoz, T. Rochat
(Geneva, Basel, Zurich, Switzerland; Boston, United States of America; Barcelona, Spain)
1574
M O N D A Y O C T O B E R 6
09:30 Outdoor environmental tobacco smoke: a relevant contribution to outdoor pollution in selected city areas.
The case of Brera historical neighborhood in Milan, Italy
G. Invernizzi, R. Ario, R. Mazza, C. De Marco, R. Boffi (Milan, Italy)
1575
09:45 Impact of tobacco control policies on exhaled carbon monoxide in non-smokers: lesson from the European
campaign help
S. Tual, J. P. Piau, I. Annesi-Maesano, B. Dautzenberg (Paris, France)
1576
10:00 Respiratory health improvement continues 3 years after workplace smoking ban in Ireland
M. Agnew, P. Goodman, L. Clancy (Dublin, Ireland)
1577
10:15 Effects of the smoking ban on health care professionals in a district general hospital
G. Tack, L. Watkins, A. Collins, M. Babores (Cheshire, United Kingdom)
1578
Room Paris 2
Session 191
08:30–10:30
Oral Presentation: Pulmonary vascular medicine
Chairs: S. Gaine (Dublin, Ireland), P. Hassoun (Baltimore, United States of America)
08:30 Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension
versus idiopathic pulmonary arterial hypertension
M. Overbeek, T. J. Gan, N. Westerhof, J. Marcus, A. Boonstra, A. Voskuyl, J. Bronzwaer, E. Smit, B. Dijkmans,
A. Vonk-Noordegraaf (Amsterdam, The Netherlands)
1579
08:45 Survival of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal
study
M. Humbert, P. de Groote, V. Gressin, J. Sibilia, E. Diot, P. Carpentier, L. Mouthon, P. Y. Hatron, P. Jego, Y. Allanore,
K. P. Tiev, C. Agard, A. Cosnes, D. Cirstea, J. Constans, D. Farge, J. F. Viallard, J. R. Harle, P. Clerson, E. Hachulla
(Clamart, Paris, France)
1580
09:00 Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and
emphysema and associated pulmonary hypertension
V. Cottin, J. Le Pavec, H. Mal, G. Prévot, A. Bérézné, D. Coetmeur, I. Danner-Boucher, M. Funke, D. Israel-Biet,
M. Humbert, G. Simonneau, J. F. Cordier (Lyon, Clamart, Paris, Toulouse, Saint-Brieuc, Nantes, France; Bern,
Switzerland)
1581
09:15 Cardiovascular complications and norfenfluramine exposure with benfluorex use
K. Boutet, I. Frachon, Y. Jobic, C. Gut-Gobert, O. Sitbon, C. Leroyer, P. Le Mevel, G. Le Garff, D. Carlhant, G.
Simonneau, M. Humbert (Clamart, Brest, France)
1582
09:30 Long-term effects of bosentan in patients with human immunodeficiency virus-associated pulmonary arterial
hypertension
B. Degano, J. Le Pavec, L. Savale, X. Jais, C. Tcherakian, G. Simonneau, M. Humbert, O. Sitbon (Clamart,
France)
1583
09:45 Polymorphism of the serotonin transporter and 2a receptor gene in COPD with and without pulmonary
hypertension
S. Ulrich, M. Fischler, M. Hersberger, U. Treder, E. W. Russi, R. Speich (Zurich, Switzerland)
1584
10:00 Pulmonary arterial pressure at rest and during exercise in normal controls
G. Kovacs, S. Scheidl, H. Olschewski (Graz, Austria)
1585
10:15 Pulmonary arterial pressure and embolization of pulmonary arteriovenous malformations
C. Shovlin, H. Tighe, R. Davies, S. Gibbs, J. Jackson (London, United Kingdom)
1586
Room 5.2a
Session 192
08:30–10:30
Oral Presentation: New trends in interventional pulmonology
Chairs: A. Ernst (Brookline, United States of America), C. Marquette (Nice, France)
s
es
08:30 Update on the European multicenter, blinded and randomized study of bronchoscopic placement of valves
for the treatment of severe emphysema
V. Ninane, C. Geltner, J. Gottlieb, T. Welte, A. Rosell, L. Seijo, J. Zulueta, X. Gonzalez (Brussels, Belgium;
Innsbruck, Austria; Hanover, Germany; Barcelona, Pamplona, Spain; Redmond, United States of America)
1587
08:45 Evaluation of a bronchoscopically delivered non-valve implant that mechanically compresses diseased lung
for the treatment of emphysema
D. Ost, A. Ernst, R. Maxfield, F. Herth, M. Ginsberg, M. DeCamp, R. Yung, P. Wu, R. McKenna (New York, Boston,
Baltimore, Mountain View, Los Angeles, United States of America; Heidelberg, Germany)
1588
09:00 Non-valve minimally invasive implantable device for the treatment of late stage homogeneous and
heterogeneous emphysema – results of a feasibility trial
F. J. F. Herth, R. Eberhardt, A. Ernst (Heidelberg, Germany; Boston, United States of America)
1589
09:15 Multicentre experience with bronchial valve treatment of life-threatening prolonged air leaks
D. Sterman, C. Gillespie, R. Cerfolio, R. Mularski, X. Gonzalez, S. Springmeyer (Philadelphia, Birmingham,
ERS Berlin 2008 Annual Congr
Portland, Redmond, United States of America)
1590
219
M O N D A Y O C T O B E R 6
09:30 Endo-cytoscopy system is a novel endoscopic technology to visualize microscopic imaging of the
tracheobronchial tree
K. Shibuya, K. Yasufuku, M. Chiyo, T. Nakajima, T. Fujiwara, K. Nagato, H. Suzuki, A. Iyoda, S. Yoshida, M. Suzuki,
Y. Sekine, K. Hiroshima, Y. Nakatani, I. Yoshino (Chiba, Japan)
1591
09:45 Relapsing polychondritis and airway involvement
S. Rafeq, D. Trentham, P. Boiselle, C. Reddy, G. Michaud, A. Majid, F. Herth, A. Ernst (Boston, United States of
America; Heidelberg, Germany)
1592
10:00 Close surveillance strategy for early lung cancer: results of 15 years of observation
E. Reinen, P. Lee, D. A. M. Heideman, A. Vonk-Noordegraaf, C. Kooi, P. J. F. Snijders, P. E. Postmus, T. G. Sutedja
(Amsterdam, The Netherlands)
1593
10:15 In-vivo confocal endomicroscopy of peripheral lung nodules using 488nm / 660 nm induced fluorescence
and topical methylene blue
L. Thiberville, M. Salaun, S. Lachkar, S. Moreno-Swirc, G. Bourg-Heckly (Rouen, Paris, France)
1594
Room New York 1
Session 193
08:30–10:30
Oral Presentation: Clinical epidemiology of tuberculosis
Chairs: G. Bothamley (London, United Kingdom), E. Girardi (Rome, Italy)
08:30 Is there enough evidence to support recommendations on tuberculosis control?
G. Gualano, R. Mancini, M. Sane Schepisi, T. Jefferson, F. N. Lauria, E. Girardi (Rome, Anguillara Sabazia, Italy) 1595
08:45 Effect of time since seroconversion to HIV: rates and risks of recurrent tuberculosis
J. Murray, P. Sonnenberg, A. Bester, G. Nelson, S. Shearer, J. R. Glynn (Johannesburg, South Africa; London,
United Kingdom)
1596
09:00 Variations in the definition of a positive tuberculin skin test across Europe
G. Bothamley, L. Ditiu, G. Migliori, C. Lange (London, United Kingdom; Copenhagen, Denmark; Tradate, Italy;
Borstel, Germany)
1597
09:15 A small audio device may be alternative to hypertonic saline inhalation for sputum induction in patients
with pulmonary tuberculosis
A. Fujita, K. Murata, M. Takamori, A. Wada (Tokyo, Japan)
1598
09:30 Quality assessment of tuberculosis guidelines
G. Gualano, M. Sane Schepisi, R. Mancini, F. N. Lauria, T. Jefferson, E. Girardi (Rome, Italy)
1599
09:45 Performance outcomes of a standardized LAM antigen-detected test in TB suspects recruited in Cape Town,
South Africa
K. Dheda, R. van Zyl-Smit, R. Meldau, A. Whitelaw, D. Singanga, H. Chordnum, M. Isaacs, S. Isaacs, R. Dawson,
E. Bateman, A. Zumla (Cape Town, South Africa; London, United Kingdom)
1600
10:00 Incidence of tuberculosis in The Netherlands in 2030
F. van Leth, N. Kalisvaart, C. Erkens, M. Borgdorff (The Hague, Amsterdam, The Netherlands)
1601
10:15 Flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis
from successfully treated disease
U. Sester, U. Mack, M. Fousse, G. W. Sybrecht, A. Lalvani, M. Sester (Homburg, Germany; London, United
Kingdom)
1602
Room New York 2
Session 194
08:30–10:30
E-Communication Session: Diagnostic aspects of sleep apnoea
Chairs: W. Randerath (Solingen, Germany), J-L. Pepin (Grenoble, France)
E1603 Breathing flow pattern characteristics as a marker to detect wakefulness during night studies in patients with
s
sleep apnea
es
A. Guerrero, C. Embid, R. Farre, F. Masa, J. Duran, J. M. Montserrat (Monterrey, Mexico; Barcelona, Caceres, Vitoria,
Spain)
E1604 Comparison of visual and automatic methods for scoring leg movements in polygraphic sleep recordings. Validity
of a modified automatic method
P. Deblois, N. Zrek, H. Khemliche, F. Bour, F. Cheliout-Heraut (Gonesse, Garches, France)
E1605 PURE RED – PUlse wave REcognition for REspiratory Disorders
D. Sommermeyer, L. Grote, M. Schwaibold, B. Schoeller, J. Hedner (Karlsruhe, Germany; Gothenburg, Sweden)
E1606 Distinguishing obstructive from central sleep apnea events with diaphragm EMG
Z. H. Qiu, J. Tang, C. Jolley, J. Steier, J. Moxham, M. Polkey, Y. M Luo (Guangzhou, China; London, United Kingdom)
E1607 Predictive models for the apnea hypopnea index (AHI)
M. Andreani, G. Rizzotto, L. Berardini, G. Mennuni, R. Pistelli (Rome, Italy)
E1608 Respiratory polygraphy for diagnosis and evolution of sleep apnea/hypopnea syndrome in children
M. L. Alonso-Alvarez, J. Tera-Santos, J. A. Cordero-Guevara, A. I. Navazo-Egüia, E. Ordax-Carbajo (Burgos, Spain)
ERS Berlin 2008 Annual Congr
E1609 Validation of a novel surface electrode array to measure genioglossus fatiguability
D. McSharry, M. Lowery, M. O’Sullivan, C. O’Connor, S. Langran, W. McNicholas (Dublin, Ireland)
220
E1610 The concordance of manual (visual) scoring and automatic analysis in sleep staging
O. Ozturk, L. Mutlu, G. Sagcan, Y. Deniz, C. Cuhadaroglu (Isparta, Tekirdag, Istanbul, Turkey)
M O N D A Y O C T O B E R 6
E1611 Comparison of a non-contact sensor with polysomnography in the assessment of obstructive sleep apnoea
C. O’Connell, B. Patricia, P. De Chazal, J. Garvey, C. Heneghan, W. McNicholas (Dublin, Ireland)
E1612 Technical and digital polysomnography specifications for the new AASM sleep scoring rules
T. Penzel, I. Fietze (Berlin, Germany)
E1613 Two different hypopnea definition: influence to diagnosis
L. Pur, F. Comce, A. Pihtili, T. Yildiz, C. Cuhadaroglu (Istanbul, Diyarbakir, Turkey)
E1614 A scoring for respiratory events: apneic and non-apneic sleep respiratory events
E. Garcia, J. F. Masa, J. Corral, J. Teran, M. J. Martin, C. Disdier, M. Rubio, M. Mota, J. M. Montserrat (Caceres, Burgos,
Badajoz, Barcelona, Spain)
E1615 Pre-test stratification for likelihood of obstructive sleep apnoea
E. Livingston, S. Hadeed, D. MacFarlane, S. Banham (Glasgow, United Kingdom)
E1616 Clinical utility of ApneaLink for the diagnosis of sleep apnea in the home setting
G. Weinreich, R. Ragette, Y. Wang, Y. M. Wang, H. Teschler (Essen, Germany)
E1617 Usefulness of cardiac interval increment or of pulse transit time for obstructive sleep apnea hypopnea syndrome
screening. The SYNAPSE study
F. Chouchou, V. Pichot, S. Celle, J. C. Barthelemy, F. Roche (Lyon, St-Etienne, France)
E1618 A noninvasive device to measure endothelial dysfunction and its response to CPAP treatment in obstructive sleep
apnoea patients
M. Uzbeck, A. Liew, I. Saleem, K. Khan, R. Baggott, J. J. Gilmartin (Galway, Ireland)
E1619 Use of pulse transit time on all night polysomnography
S. Ekici, T. Demir (Istanbul, Turkey)
E1620 Evaluation of a simplified sleep recording and analyzing device at the bedside
P. Moirot, N. Amiot, C. Hemet, F. Portier, C. Molano (Rouen, France)
E1621 Sleep study with monochannel device: new diagnostic tool for family physician in collaboration with a
pulmonologist
K. Granatin, J. Romero, D. Torrado, U. Brito (Faro, Portugal)
E1622 A portable accelerometer-based device for apnea diagnosis
D. Sanchez, J. L. Rojas, W. Stork, A. Leon, L. F. Crespo, N. Gross, A. Arnedillo, C. Garcia (Cadiz, Spain; Karlsruhe,
Germany)
Room New York 3
Session 195
08:30–10:30
E-Communication Session: Lung and bone marrow transplantation:
miscellaneous
Chairs: M. Iversen (Copenhagen, Denmark), F. Meloni (Pavia, Italy)
E1623 Does the BODE index predict survival in patients suitable for lung transplantation?
A. McDiarmid, A. De Soyza, G. Parry, J. Lordan, A. Fisher, P. A. Corris (Newcastle-upon-Tyne, United Kingdom)
E1624 Interferon- release assays (IGRA) for detecting latent tuberculosis (LTBI) after lung transplantation (LTX)
E. Perrin, P. Roux-Lombard, J. P. Janssens, L. Kern, M. Metzger, T. Rochat, P. Soccal-Gasche (Geneva, Switzerland)
E1625 Diffusing capacity for nitric oxide and carbon monoxide in lung transplant recipients
A. Winkler, H. Dressel, P. Huppmann, C. Neurohr, D. de la Motte, D. Nowak, R. Jörres, J. Behr (Munich, Germany)
E1626 Effects of inpatient rehabilitation on quality of life and exercise capacity in long-term lung transplant survivors
F. Ihle, C. Neurohr, P. Huppmann, R. Baumgartner, G. Zimmermann, H. Leuchte, K. Kenn, B. Sczepanski, J. Behr
(Munich, Schoenau, Germany)
E1627 Patient reported quality of life in advanced cystic fibrosis (CF) lung disease assessed for lung transplantation
S. Doe, A. De Soyza, J. Lordan, A. Fisher, P. Corris (Newcastle-upon-Tyne, United Kingdom)
E1628 Azithromycin in bronchiolitis obliterans (BO) and BO organizing pneumonia complicating bone marrow
s
transplantation
es
F. S. Oymak, N. Tutar, L. G. Kaynar, H. Buyukoglan, M. Gulec, O. Kontas, R. Demir, I. Gulmez (Kayseri, Turkey)
E1629 Trachea replacement with 8 mm ringed goretex prosthesis in the rabit
J. A. Santibanez, J. R. Olmos, R. Jasso, J. Villalba, A. Rey, D. Perez, A. Sotres, M. Gaxiola, M. Baltazares, S. Flores
(Mexico City, Mexico)
E1630 Treating post transplantation airway stenoses with a fully covered metallic stent
B. Schmidt, H. Lehmkuhl, L. Hanitsch, C. Knosalla, D. Kemper, R. Hetzer, C. Witt (Berlin, Germany)
E1631 Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant
recipients
F. Lemonnier, E. Catherinot, H. Neveu, L. J. Couderc, E. Rivaud (Suresnes, France)
E1632 Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients
P. Morales, M. Santos, A. Gil, A. Navarro, M. Gobernado (Valencia, Spain)
E1633 Long time decline of lung function in patients with chronic myeloid leukemia after allogeneic stem cell
transplantation
ERS Berlin 2008 Annual Congr
C. Lambers, B. Marzluf, C. Hussein, S. Woehrer, A. Boehm, P. Kahls, W. Rabitsch (Vienna, Austria; Zurich, Switzerland)
E1634 Quality of life in lung transplantation candidates and its relationship with psychosocial disorders
A. Fardmousavi, K. Najafizadeh, M. Marashian, A. Rostami, N. Yamani (Tehran, Isfahan, Islamic Republic of Iran)
221
M O N D A Y O C T O B E R 6
E1635 Pulmonary aspergillosis in solid organ transplant patients: a report from Iran
M. Marjani, P. Tabarsi, K. Najafizadeh, M. R. Masjedi, D. Mansouri (Tehran, Islamic Republic of Iran)
E1636 Canine trachea replacement with knitted dacron and woven collagen prosthesis reinforced with surgical wire and
silicon
J. A. Santibanez, J. R. Olmos, R. Jasso, J. Villalba, A. Rey, D. Perez, M. Gaxiola, A. Sotres, M. Baltazares, I. A. Gonzalez
(Mexico City, Mexico)
E1637 Exercise capacity following lung transplantation in cystic fibrosis patients
N. Germain-Lacroix, C. Poirier, A. Yannopoulos, C. Poirier (Montreal, Canada)
Room London 1
Session 196
08:30–10:30
E-Communication Session: Risk factors for allergic asthma and allergic rhinitis
Chair: M. Kabesch (Munich, Germany)
E1638 Clinical significance of asthma related SNP (single nucleotide polymorphism) in well defined asthma patients
M. Haida, K. Koyanagi, A. Hashiguchi (Tokyo, Saitama, Japan)
E1639 TLR4 pathway analysis in the development of total IgE – the Allergenic study
N. E. Reijmerink, R. W. B. Bottema, M. Kerkhof, J. Gerritsen, F. F. Stelma, C. Thijs, C. P. van Schayck, H. A. Smit,
B. Brunekreef, G. H. Koppelman, D. S. Postma (Groningen, Maastricht, Bilthoven, Utrecht, The Netherlands)
E1640 Common IRF1 promoter polymorphisms induce changes in transcription factor binding subsequently affecting
IRF1 gene expression
M. Schedel, L. A. Pinto, B. Schaub, P. Rosenstiel, D. Cherkasov, L. Cameron, N. Klopp, T. Illig, C. Vogelberg,
S. K. Weiland, E. von Mutius, M. Lohoff, M. Kabesch (Munich, Campus Kiel, Marburg, Neuherberg, Dresden, Ulm,
Germany; Edmonton, Canada)
E1641 Alpha-tryptase haplotype: association with asthma and allergy susceptibility
A. Abdelmotelb, M. Rose-Zerilli, A. F. Walls, J. W. Holloway (Southampton, United Kingdom)
E1642 Pathway analysis of co-stimulatory genes and serum IgE levels in childhood – the allergenic study
R. W. B. Bottema, D. S. Postma, N. E. Reijmerink, C. Thijs, F. F. Stelma, H. A. Smit, C. P. van Schayck, B. Brunekreef,
G. H. Koppelman, M. Kerkhof (Groningen, Maastricht, Bilthoven, Utrecht, The Netherlands)
E1643 Neonatal fecal microflora in a clinical birth cohort study on the development of persistent wheeze and eczema in
early life
N. Li, H. Bisgaard, B. Smith, L. Nørgaard, K. Smith (Beijing, China; Gentofte, Copenhagen, Copenhagen, Denmark)
E1644 Opisthorchis felineus helminth infection is associated with decreased level of IL-4 in atopic asthma patients
E. E. Kremer, O. S. Fedorova, N. A. Cherevko, M. V. Vasilyeva, M. B. Freidin, L. M. Ogorodova (Tomsk, Russian
Federation)
E1645 Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk
M. S. D. Kormann, R. Ferstl, M. Depner, N. Klopp, T. Illig, C. Vogelberg, E. von Mutius, C. Kirschning, M. Kabesch
(Munich, Neuherberg, Dresden, Germany)
E1646 The association between metabolic syndrome, obesity and asthma
Y. Varol, A. Demir, U. Varol, B. Zeynep, S. Olcay, R. Ozacar (Izmir, Turkey)
E1647 CD95 expression, annexin-V binding of phosphatidylserine and caspase-3 activity in lymphocytes in bronchial
asthma
V. Mineev, I. Nesterovich, V. Trofimov, V. Emanuel, A. Lugovaya (St Petersburg, Russian Federation)
E1648 Airway hyperresponsiveness, but not exhaled nitric oxide, as a risk factor for decline in post-bronchodilator FEV1
in patients with stable asthma
N. Ohkura, M. Fujimura, A. Tokuda, N. Katayama, M. Abo, S. Nakao (Kanazawa, Japan)
E1649 Influence of genetic component on susceptibility to atopic bronchial asthma and tuberculosis in Tomsk
population: xenobiotic-metabolising enzymes
s
E. Bragina, M. Freidin, A. Rudko, O. Kolokolova, V. Pusyrev, L. Ogorodova (Tomsk, Russian Federation)
es
E1650 Correlation between immunological and allergic profile of kids born to mothers with asthma
E. E. Lokshina, O. V. Zaitseva (Moscow, Russian Federation)
E1651 Dust samples from different animal stables do not differ in their potency of allergy prevention
S. Hagner, R. Teich, P. Pfefferle, H. Renz, G. Holger (Marburg, Germany)
E1652 Airways inflammation is related to bronchial responsiveness only in atopic subjects with rhinitis and/or asthma
A. Malinovschi, C. Janson, M. Högman, G. Rolla, K. Torén, D. Norbäck, A. C. Olin (Uppsala, Gävle, Gothenburg,
Sweden; Turin, Italy)
E1653 Predisposing factors to asthma in adults living in the rural community of south western Nigeria
O. Ige, G. Falade, O. Arinola (Ibadan, Nigeria)
E1654 Churg Strauss syndrome after polypectomy in asthmatic and allergic patients
B. Mokri, S. Fallah Tafti, N. Mansoori (Tehran, Islamic Republic of Iran)
E1655 Specific serum IgE is associated with seasonal symptom load in children with allergic rhinitis
C. Rolinck-Werninghaus, T. Keil, U. Wahn, E. Hamelmann (Berlin, Germany)
ERS Berlin 2008 Annual Congr
E1656 Lipoxin and eotaxin as markers of severity in patients with bronchial asthma
222
M. Mahmoud, A. Rabie, P. Moez, N. AbdElWahab, M. Omar (Alexandria, Egypt)
M O N D A Y O C T O B E R 6
Room London 2
Session 197
08:30–10:30
E-Communication Session: Pleural diseases and interventions
Chairs: A. Valipour (Vienna, Austria), C. Bolliger (Cape Town, South Africa)
E1657 Influence of intravenous bevacizumab in cytokines expression on experimental pleurodesis induced by talc
S. Ribeiro, F. Vargas, M. Acencio, L. Antonangelo, G. Carnevale, R. Wu, E. Marchi, L. Teixeira (Sao Paulo, Brazil)
E1658 The diagnostic yield of pleural cytology, needle biopsy, and video assisted thoracoscopic surgery: a survey
M. Malekmohammad, A. Fakharian, P. Faraji, P. Zarrinnegar, H. Emami (Tehran, Islamic Republic of Iran)
E1659 Intrapleural injection of talc and silver nitrate produce excellent pleurodesis in mice
H. Liao, M. Na, R. Light (Guangzhou, China; Nashville, United States of America)
E1660 IL-8, VEGF and TGFb levels in serum (S) and bronchoalveolar lavage (BAL) of rabbits submitted to intrapleural
injection of two different types of talc
L. Antonangelo, V. Figueiredo, E. Marchi, M. Acencio, L. Teixeira, C. Silva, F. Vargas (Sao Paulo, Brazil)
E1661 Experimental pleurodesis using iodopovidone
L. Teixeira, F. Vargas, M. Acencio, F. Pitta, N. Novaes, V. Ribeiro, F. Zelada, L. Antonangelo, E. Marchi (Sao Paulo,
Brazil)
E1662 Is tube thoracostomy by the non consultant hospital doctors (NCHD) a safe procedure?
A. Aziz, L. Kelly, M. Saba, J. McKenna (Sligo, Ireland)
E1663 Is blind closed pleural biopsy using Abraham’s needle a viable procedure?
A. Dushianthan, S. Packham, C. Grange (Swansea, United Kingdom)
E1664 A case of etanercept-induced alternating pleural effusions
I. Porfyridis, I. Kalomenidis, I. Psallidas, G. Stratakos, T. Vassilakopoulos, C. Roussos, G. T. Stathopoulos (Athens,
Greece)
E1665 Audit of success rate and complications of talc slurry pleurodesis for malignant pleural effusions
M. Lavender, D. Laws, T. Desai, C. Baker (Southampton, Bournemouth, United Kingdom)
E1666 Unilateral massive transudative pleural effusion
I. Ozmen, E. Aksoy, N. Aykac, T. Sevim, G. Atac, K. Terzioglu, H. Arpag, K. Tahaoglu (Istanbul, Turkey)
E1667 The role of vascular endothelial growth factor in tuberculous and parapneumonic pleural effusions
D. Tas, O. Okutan, O. M. Ipcioglu, F. Ciftci, Z. Kartaloglu (Istanbul, Turkey)
E1668 Compliance to the British Thoracic Society (BTS) guidelines of the investigation and management of pleural
effusion in adults: an audit of practice from a general hospital in Ireland
A. AZIZ, J. O’ Halloran, M. Saba, J. McKenna (Sligo, Ireland)
E1669 Chest drainage as a curative and palliative method
J. Plutinsky, H. Pechacova, S. Petricek, D. Magula, K. Bitter, M. Michalickova, B. Matula (Nitra, Slovakia)
E1670 Specialist clinic for exudative pleural effusions (EPE) improves outcome
A. Nataraja, C. Winterbottom, S. Menzies, A. Datta, J. Ojoo (Northampton, Oxford, York, United Kingdom)
E1671 The diagnostic value of low pleural fluid pH
J. Madi, K. Mousbah, H. Sudani (Tripoli, Libyan Arab Jamahiriya)
E1672 Variation of the atmospheric pressure and primary spontaneous pneumothorax – new data in pathophysiology
G. Silva, A. Szantho, C. Alcobia, M. Loureiro, M. Baganha (Coimbra, Portugal)
Room London 3
Session 198
08:30–10:30
E-Communication Session: Border patrol: the alveolar barrier in lung injury
Chairs: R. Morty (Giessen, Germany), H. Fehrenbach (Borstel, Germany)
E1673 Differential roles of tumour necrosis factor receptors in a murine model of acid induced lung injury
s
B. Patel, M. Wilson, M. Takata (London, United Kingdom)
es
E1674 Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in
mice
J. Xu, J. Qu, L. Cao, Y. Sai, C. Chen, L. He, L. Yu (Shanghai, China)
E1675 Effects of static stretch on secretory function and morphology in alveolar epithelial type II cells
Y. H. Ren, Q. Y. Zhan, C. Yang, C. Wang (Beijing, China)
E1676 Alveolar recruited macrophages contribute to lung epithelial apoptosis and barrier dysfunction by expression of
TNF-related apoptosis-inducing ligand during influenza virus pneumonia
S. Herold*, M. Steinmueller, W. von Wulffen, L. Cakarova, S. Pleschka, W. Seeger, J. Lohmeyer (Giessen, Germany)
E1677 Moxifloxacine increases the tolerance of alveolar type II cells to mechanical stretch
S. Hammerschmidt, H. Kuhn, R. Berlinghoff, H. Wirtz (Leipzig, Berlin, Germany)
E1678 Nitric oxide inhibits sodium absorption across cultured human airway (H441) epithelial cells
A. Pichl, M. Althaus, M. Fronius, W. Clauss, R. Morty (Giessen, Germany)
E1679 Oxidized phospholipids exhibit protective effects against ventilator-induced vascular leak and inflammation
ERS Berlin 2008 Annual Congr
A. Birukova, J. Xing, P. Fu, K. Birukov (Chicago, United States of America)
E1680 Adhesion molecules and extracellular matrix proteins in co-cultures of airway epithelial cells and fibroblasts
C. Folli, D. Descalzi, A. M. Riccio, C. Gamalero, G. W. Canonica (Genoa, Italy)
223
M O N D A Y O C T O B E R 6
E1681 The lectin-like domain of TNF-
improves alveolar fluid balance in endo/exotoxin-induced lung injury
I. Vadasz, R. Schermuly, A. Ghofrani, S. Rummel, S. Wehner, I. Muehldorfer, S. Klaus, W. Seeger, R. Morty, F.
Grimminger, N. Weissmann (Giessen, Konstanz, Germany)
E1682 ATF3 is activated in ventilator induced lung injury (VILI)
A. Akram, J. Haitsma, C. Dos Santos (Toronto, Canada)
E1683 Differential role of NO synthases in ischemia/reperfusion-induced lung injury
A. Sydykov, B. Egemnazarov, R. T. Schermuly, N. Weissmann, W. Seeger, F. Grimminger, H. A. Ghofrani (Giessen,
Germany)
E1684 Time-dependency of cell death induced by biaxial cyclic stretching in human pneumocyte-like cells
S. J. Schließmann, K. Höhne, S. Schumann, K. Gamerdinger, G. Zissel, J. Guttmann (Freiburg, Germany)
E1685 Autocrine secretion of bradykinin prevents alveolar type II cells from mechanical stretch-induced apoptosis by
activation – role of PI3K and Akt
S. Hammerschmidt, H. Kuhn, H. J. Seyfarth, C. Gessner, S. Heyder, H. Wirtz (Leipzig, Germany)
E1686 Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration
inhibitory factor-induced epithelial repair
L. Marsh, L. Cakarova, G. Kwapiszewska, W. Seeger, J. Lohmeyer (Giessen, Germany)
E1687 Carbon monoxide modulates the activity of lung amiloride-sensitive epithelial sodium channels
M. Althaus, M. Fronius, I. Vadasz, Y. Buchaeckert, W. Clauss, R. Motterlini, W. Seeger, O. Eickelberg, R. Morty
(Giessen, Germany; Harrow, United Kingdom)
E1688 Effects of hypoxia on VEGF and VEGF-R expression by human alveolar epithelial (ATII) and human pulmonary
microvascular endothelial (HMVEC-l) cells
L. Gilmartin, S. Harper, D. Bates, A. Millar (Bristol, United Kingdom)
E1689 TGF-b modulates Na+,K+-ATPase expression and activity in the lung epithelium
V. Arnoldt, I. Vadasz, W. Seeger, O. Eickelberg, R. Morty (Giessen, Germany)
E1690 The harmful effects of nitrogen mustard on lung and the contribution of proanthocyanidin to decrease this effect
O. Yucel, O. Genc, O. Onguru, A. Aydin, H. Yaren, M. A. Sahin, A. Guler, T. Karayilanoglu, A. Sayal, M. Dakak, S. Gurkok
(Ankara, Turkey)
*: winner of the Best Poster Presentation Award, as selected at the ERS 2008 Lung Science Conference (Estoril).
Room 1.2a
Session 199
10:45–12:45
Thoracic Oncology Grand Round – an interactive session
Aims: The aim of this session is to improve knowledge in the diagnostic and therapeutic management of thoracic malignancies.
Target audience: Chest physicians, thoracic surgeons, radiologists, etc. involved in the management of thoracic malignancies.
Chairs: A-P. Meert (Brussels, Belgium), M. Muers (Leeds, United Kingdom)
10:45 A 64-year-old lady with back ache
N. Schoenfeld (Berlin, Germany)
1691
11:15 A 27-year-old man with progressive dyspnoea
D. Jovanovic (Belgrade, Republic of Serbia)
1692
11:45 A previously healthy man with cough and dyspnoea
G. Hillerdal (Stockholm, Sweden)
1693
12:15 A 59-year-old patient with a solitary pulmonary nodule after pneumonectomy
P. Van Schil (Edegem, Belgium)
1694
Room 2.2a
Session 200
10:45–12:45
Symposium: Update on lung transplantation 2008
s
Aims: The symposium will update the audience on the latest developments in the field of lung transplantation.
es
Target audience: Pulmonologists, paediatric pulmonologists, fellows and researchers interested in lung transplantation and airway
diseases.
Chairs: G. Verleden (Leuven, Belgium), A. Boehler (Zurich, Switzerland)
10:45 New referral and transplant criteria
J. J. G. Egan (Dublin, Ireland)
1695
11:15 What can be expected from a transplant today: results from 2008
A. Fisher (Newcastle-upon-Tyne, United Kingdom)
1696
11:45 Expanding the donor pools: options and results
W. Klepetko (Wien, Austria)
1697
12:15 Issues in paediatric lung transplantation: results and specific considerations
C. Benden (Zurich, Switzerland)
1698
ERS Berlin 2008 Annual Congr
224
M O N D A Y O C T O B E R 6
Room Dublin
Session 201
10:45–12:45
Symposium: Impact of nursing interventions on the quality of care for COPD
patients
Aims: This symposium will give an update on:
- the impact of the clinical pathway on the quality of care for COPD patients;
- the risk of malnutrition in COPD patients: method of screening;
- the impact of education in oxygen therapy.
Target audience: Nurses, physicians, pharmacists, occupational therapists, physiotherapists.
Chairs: C. Lodewijckx (Leuven, Belgium), G. South (Chesterfield, United Kingdom)
10:45 Clinical pathway for acute COPD exacerbations reduces hospital stay and readmission rate
G. Celis (Leuven, Belgium)
1699
11:15 Smoking cessation in respiratory patients: special needs and difficulties
P. Tonnesen (Gentofte, Denmark)
1700
11:45 Screening for the risk of malnutrition in COPD patients
K. Boeykens (Sint-Niklaas, Belgium)
1701
12:15 Promoting excellence in COPD care – through a community team approach
N. O’Kelly (Spilsby, United Kingdom)
1702
Room 5.2b
Session 202
10:45–12:45
Symposium: “Omics” and systems biology: the promise of future disease
understanding
Aims: The aims of this symposium are to:
- improve understanding of what researchers mean by the term “systems biology”;
- give an appreciation of the possibilities of this approach in understanding complex diseases.
Target audience: Researchers, clinical scientists and clinicians with an interest in understanding the strengths of the new systems
biology approach to complex diseases such as asthma and COPD.
Chairs: G. Anderson (Melbourne, Australia), I. M. Adcock (London, United Kingdom)
10:45 An introduction to systems biology
G. Anderson (Melbourne, Australia)
1703
11:15 A genomic approach to understanding epithelial cell function in COPD
R. Djukanovic (Southampton, United Kingdom)
1704
11:45 Systems biology, animal models and drug discovery
P.W. Finn (La Jolla, United States of America)
1705
12:15 Genetics, genomics and a systems approach to asthma
W. Cookson (London, United Kingdom)
1706
Room Helsinki
Session 203
10:45–12:45
Symposium: Priorities for tuberculosis research in Europe: discussing the results
of the Tuberculosis Network European Trials Group (TBNET)
Aims: The aim of this symposium is to inform participants about the latest research proceedings of collaborative clinically orientated
research on tuberculosis in Europe. At the end of the symposium the audience should be familiar with the latest results of ongoing
and recently finished trials within the TBNET.
Target audience: Clinicians, immunologists, microbiologists, specialist nurses and public health specialists involved in the research,
care, surveillance and control of tuberculosis.
Chairs: F. Blasi (Milan, Italy), C. Lange (Borstel, Germany)
s
es
10:45 How do guidelines for contact tracing compare in European countries?
G. Bothamley (London, United Kingdom)
1707
11:15 Clinical outcomes of patients with drug-resistant and extensively drug-resistant tuberculosis in Europe
G. B. Migliori (Tradate, Italy)
1708
11:45 Identification of Mycobacterium tuberculosis (MTB)-infection in immunocompromised hosts
M. Sester (Homburg, Germany)
1709
12:15 Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific
immunoresponses
D. Goletti (Rome, Italy)
1710
Room Budapest
Session 204
10:45–12:45
Hot Topic: Noninvasive positive pressure in heart failure – where are we now with
two large multicentre studies showing no apparent benefit?
ERS Berlin 2008 Annual Congr
Aims: To present up-to-date information on the pros and cons of using noninvasive ventilation in acute and chronic heart failure.
Target audience: Pulmonologists, intensivists, cardiologists, respiratory therapists, nurses.
225
M O N D A Y O C T O B E R 6
Chairs: M. W. Elliott (Leeds, United Kingdom), M. D’Ortho (Creteil, France)
10:45 Why positive pressure ventilation in chronic heart failure?
P. Levy (Grenoble, France)
1711
11:15 Positive pressure in chronic heart failure – any role? The evidence from clinical trials
W. McNicholas (Dublin, Ireland)
1712
11:45 Why positive pressure ventilation in acute heart failure?
T. Welte (Hanover, Germany)
1713
12:15 Acute cardiogenic pulmonary oedema – meta analyses versus single large trial – which to believe?
M. W. Elliott (Leeds, United Kingdom)
1714
Room Berlin
Session 205
10:45–12:45
Oral Presentation: Preschool wheezing: advances in diagnosis, phenotyping and
therapy
Chairs: J-C. Dubus (Marseille, France), P. L. P. Brand (Zwolle, The Netherlands)
10:45 Introduction – Diagnosis and management of preschool wheeze: highlights from the ERS Task Force report
P. L. P. Brand (Zwolle, The Netherlands)
1715
11:00 Reliability of clinical classifications of wheezing in preschool children
A. Schultz, S. Devadason, S. Olga, P. Sly, P. Le Souëf, P. Brand (Perth, Australia; Zwolle, The Netherlands)
1716
11:15 Feasibility of non-invasive methods for an early asthma diagnosis in preschool children
K. D. G. van de Kant, Q. Jobsis, J. C. de Jongste, C. P. van Schayck, J. W. Muris, E. Dompeling
(Maastricht, Rotterdam, The Netherlands)
1717
11:30 The importance of spirometry in detection of airway obstruction in preschool children
A. Vracaric, P. Minic (Uzice, Belgrade, Republic of Serbia)
1718
11:45 Exhaled nitric oxide is elevated in young preschool children with persistent asthma at school age
A. Moeller, I. Luchsinger, N. Knauer, D. Inci, J. Wildhaber (Zurich, Fribourg, Switzerland)
1719
12:00 Improving the diagnosis of preschool-asthma by the use of forced oscillation technique and AMP-challenge
test
F. Horak, K. Deforth, T. Frischer, Z. Szepfalusi (Vienna, Austria)
1720
12:15 Developing a caregiver quality of life score for wheezy preschool children
P. Seddon, C. Olden, E. Juniper (Brighton, United Kingdom; Hamilton, Canada)
1721
12:30 Is low dose inhaled fluticasone propionate safe in young children with asthma?
T. Narciso, A. Abdullah, N. Freezer (Melbourne, Australia)
1722
Room 5.2c
Session 206
10:45–12:45
Oral Presentation: Lung, traffic and volcanoes
Chairs: B. Forsberg (Umea, Sweden), I. Annesi-Maesano (Paris, France)
10:45 Long term exposure to particulate matter (PM) and cardiopulmonary output in the multi-ethnic study of
atherosclerosis (MESA)
Y. Chervona, A. Diez Roux, D. Bluemke, M. Shen, J. Kaufman, S. Kawut, V. Van Hee, R. G. Barr (New York,
Ann Arbor, Baltimore, Seattle, United States of America)
1723
11:00 Exhaled nitric oxide in children and air pollution in urban school environment
M. Flamant-Hulin, D. Caillaud, I. Annesi-Maesano (Paris, Clermont-Ferrand, France)
1724
11:15 Air pollutants and emergency department visits for respiratory disease in three Swedish cities
K. Meister, B. Segerstedt, B. Forsberg (Umeå, Sweden)
1725
s
11:30 Outdoor biomass burning air pollution and pneumonia hospital admissions
es
M. A. Arbex, S. P. Cendon, A. C. Lopes, F. F. Arbex, E. P. Moysés, S. L. Santiago, P. H. N. Saldiva, L. A. A. Pereira,
A. L. F. Braga (Sao Paulo, Santos, Brazil)
1726
11:45 Objective assessments of indoor air pollutants at home related to asthma in children
M. Flamant-Hulin, D. Caillaud, I. Annesi-Maesano (Paris, Clermont-Ferrand, France)
1727
12:00 The effect of a volcano eruption on asthma symptoms and treatments
K. Dobashi, Y. Shimizu, T. Hisada, A. Ono, M. Todokoro, H. Iijima, M. Utsugi, K. Iizuka, A. Morikawa, M. Mori
(Maebashi, Tomioka, Japan)
1728
12:15 Low doses of PM2.5 induces inflammation and oxidative stress with lung functional changes in mice
W. Zin, D. Riva, C. Magalhães, P. Selmi, D. Laks, T. Lanças, T. Mauad, O. Malm, P. Saldiva, D. Faffe
(Rio de Janeiro, Sao Paulo, Brazil)
1729
12:30 Fine indoor particulate matter effects on COPD symptoms and inflammation
M. McCormack, N. Hansel, E. Tonorezos, S. Karam, A. Bilderback, P. Breysse, G. Diette (Baltimore, New York,
Bronx, United States of America)
1730
ERS Berlin 2008 Annual Congr
226
M O N D A Y O C T O B E R 6
Room Europa 2
Session 207
10:45–12:45
Oral Presentation: Novel mechanisms in the pathogenesis of pulmonary
inflammation
Chairs: M. Idzko (Freiburg, Germany), S. L. Johnston (London, United Kingdom)
10:45 Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in
acute and chronic asthma models
F. Quesada Calvo, C. Crahay, R. Maree, D. de Seny, G. Paulissen, M. Gueders, L. Wehenkel, R. Louis,
J. M. Foidart, A. Noel, M. Fillet, D. Cataldo (Liege, Belgium)
1731
11:00 Mast cell activation induces dendritic cell migration following allergen challenge
S. Reuter, N. Dehzad, A. Heinz, M. Sieren, R. Wiewrodt, M. Stassen, R. Buhl, C. Taube (Mainz, Germany)
1732
11:15 Reduced numbers of bronchial mature dendritic cells in COPD
M. Tsoumakidou, Y. Qiu, J. Zhu, M. Johnson, N. Barnes, P. K. Jeffery (London, United Kingdom)
1733
11:30 Different kinetics of blood plasmatocytoid (pDCs) and myeloid dendritic cells (mDCs) upon allergen
challenge in the skin of atopic patients
S. Vittorakis, K. Samitas, M. Agelakopoulou, M. Semitekolou, V. Panoutsakopoulou, G. Xanthou, M. Gaga
(Athens, Greece)
1734
11:45 Subcutaneous immunotherapy recruits plasmacytoid dendritic cell from blood
S. Hansen, R. Dahl, H. J. Hoffmann (Aarhus, Denmark)
1735
12:00 Effects of IL-4R
blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu,
a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice
D. Swart, P. Anders, J. Tocker (Seattle, United States of America)
1736
12:15 Upregulation of airway smooth muscle (ASM) cell apoptosis may limit ASM growth during airway
remodeling in experimental asthma
R. Fraga-Iriso, L. Núñez-Naveira, L. A. Mariñas-Pardo, N. S. Brienza, H. Verea, J. G. Martin,
D. Ramos-Barbón (A Coruña, Spain; Montreal, Canada)
1737
12:30 Close spatial relationship between CD3+ and -actin ( -SMA)+ cells suggests T cell-myocyte/myofibroblast
contact as a mechanism of airway smooth muscle (ASM) growth in asthma
D. Ramos-Barbón, R. Fraga-Iriso, N. S. Brienza, C. Montero-Martínez, H. Verea, R. Olivenstein, C. L. Lemiere,
P. E. Ernst, Q. A. Hamid, J. G. Martin (A Coruña, Spain; Montreal, Canada)
1738
Room Paris 1
Session 208
10:45–12:45
Oral Presentation: Alternatives for continuous positive airway pressure therapy in
obstructive sleep apnoea
Chairs: M. Marklund (Umea, Sweden), A. Boudewyns (Edegem, Belgium)
10:45 The effect of 12-month growth hormone treatment on obstructive sleep apnoea in abdominally obese men
M. Karimi, Y. Peker, D. Eder, C. Franco, J. Hedner (Gothenburg, Skövde, Sweden)
1739
11:00 Nasal surgery versus sham nasal surgery for obstructive sleep apnoea
I. Koutsourelakis, E. Perraki, E. Vagiakis, P. Dimitrokalli, S. Zakynthinos, C. Roussos (Athens, Greece)
1740
11:15 A randomized crossover trial of nasal CPAP and a mandibular advancement splint in mild OSA
L. G. Olson, A. Ambrogetti, Z. Trevillian (Newcastle, Warners Bay, Australia)
1741
11:30 Assessment of mandibular advancement device (MAD) efficiency through functional imaging using computer
methods
J. De Backer, W. Vos, A. Devolder, J. Verbraecken, M. Braem, P. Van de Heyning, W. De Backer (Antwerp,
Belgium)
1742
s
11:45 The effect of adenotonsillectomy on frequent positional change during sleep in pediatric obstructive sleep
es
apnea syndrome
J. H. Choi, S. H. Lee, S. H. Lee, H. M. Lee, T. H. Kim, C. Shin (Seoul, Republic of Korea)
1743
12:00 Polysomnographic results before and after adenotonsillectomy in children with OSA
S. Weber, V. Moraes, H. Protetti, J. V. Tagliarini (Botucatu, Brazil)
1744
12:15 Rapid maxillary expander in the treatment of obstructive sleep apnea syndrome in children
M. P. Villa, A. Rizzoli, A. C. Massolo, M. C. Paolino, M. Cecili, F. Ianniello, C. Alceo (Rome, Italy)
1745
12:30 Profile soft tissue changes after maxillo-mandibular advancement surgery in the treatment of sleep
obstructive apnoea syndrome: predictors of aesthetic outcome
J. Cohen-Levy, B. Petelle, R. Garcia, B. Meyer, B. Fleury (Paris, France)
1746
Room Paris 2
Session 209
10:45–12:45
Oral Presentation: Effects of rehabilitation in very disabled COPD patients
Chairs: F. De Blasio (Naples, Italy), C. Préfaut (Montpellier, France)
ERS Berlin 2008 Annual Congr
10:45 The effect of nutritional status on the outcome of outpatient pulmonary rehabilitation in COPD
N. Greening, S. Singh, J. Williams, M. Morgan, M. Steiner (Leicester, United Kingdom)
1747
227
M O N D A Y O C T O B E R 6
11:00 Effect of pulmonary rehabilitation on peripheral muscle wasting, functional capacity and quality of life in
cachectic patients with COPD
I. Vogiatzis, D. Simoes, G. Stratakos, G. Terzis, E. Kourepini, D. Athanasopoulos, A. Daskalakis, S. Spetsioti,
I. Tsiokou, S. Zakynthinos, C. Roussos (Athens, Greece)
1748
11:15 Randomised controlled trial of electrical stimulation of the quadriceps in patients with very severe COPD
hospitalized for an acute exacerbation
A. Couillard, M. Hayot, P. Massanet, M. Desplan, F. Gouzi, O. Jonquet, C. Prefaut (Lodeve, Montpellier, France)
1749
11:30 Effectiveness of a short intensive pulmonary rehabilitation programme in post-acute COPD patients
G. Vagheggini, S. Meini, J. Bandini, A. Tafi, G. Palmiero, D. Michela, B. Paola, D. Berrighi, A. Di Paco,
N. Ambrosino (Volterra, Pisa, Italy)
1750
11:45 Significant improvement in arterial stiffness after endurance training in COPD patients
I. Vivodtzev, C. Minet, B. Wuyam, J. C. Borel, G. Votterro, D. Monneret, J. P. Baguet, P. Lévy, J. L. Pépin (Grenoble,
Nyons, France)
1751
12:00 Powerful effects of multidisciplinary pulmonary rehabilitation on fatigue in COPD patients
J. B. Peters, L. H. Ven, Y. F. Heijdra, J. Molema, P. N. R. Dekhuijzen, J. H. Vercoulen (Nijmegen, Groesbeek, The
Netherlands)
1752
12:15 Effectiveness of upper limb training on daily activities of COPD patients
K. Corsini, E. Crisafulli, C. Beneventi, F. Degli Antoni, O. Coletti, G. Cirelli, C. Cilione, B. Beghè, S. Costi,
L. M. Fabbri, E. M. Clini (Pavullo, Modena, Italy)
1753
12:30 The effects of Nordic walking on exercise capacity and physical activity in daily life (AoDL) in COPD
M. K. Breyer, R. Kohansal, O. C. Burghuber, S. Hartl (Vienna, Austria)
1754
Room 5.2a
Session 210
10:45–12:45
Oral Presentation: Best of lung epithelial cells 2008
Chairs: R. Bals (Marburg, Germany), M. Spiteri (Stoke-on-Trent, United Kingdom)
10:45 Cathelicidin modulates the epithelial innate immune response to endotoxin
J. Sierigk, R. Shaykhiev, C. Vogelmeier, R. Bals (Marburg, Germany)
1755
11:00 NKG2D triggers MHC I unrestricted effector function of alloreactive CD8+ T cells
B. Stoelcker, K. Krätzel, B. Ruhland, M. Pfeifer, C. Schulz (Regensburg, Donaustauf, Germany)
1756
11:15 Characterization of the bacterial community within the respiratory tract of healthy mice; a molecular
approach
J. Mac Sharry, P. Scanlan, J. Marchesi, J. G. Martin (Cork, Ireland; Montreal, Canada)
1757
11:30 Rhinovirus uses EGFR signaling to coordinate IL-8 and ICAM-1 expression in bronchial epithelial cells
K. Liu, R. Gualano, M. Hibbs, G. Anderson, S. Bozinovski (Victoria, Australia)
1758
11:45 Cigarette smoke-induced emphysema occurs in the absence of TLR4-signalling in a murine model of COPD
T. Maes, K. Bracke, G. Joos, G. Brusselle (Ghent, Belgium)
1759
12:00 The role of Interleukin-6 in pulmonary and systemic effects in a murine model of COPD
N. S. Pauwels, K. R. Bracke, T. Maes, G. F. Joos, G. G. Brusselle (Ghent, Belgium)
1760
12:15 Analysis of the tight and adherens junction protein expression in macrophages and dendritic cells and its
functional aspects drawn from an airway model
A. D. Lehmann, F. Blank, B. Oliver, M. Wehrli, P. Gehr, B. Rothen-Rutishauser (Bern, Switzerland)
1761
12:30 Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of
bactericidal activity
S. Halldórsson, T. Gudjónsson, M. Gottfredsson, G. H. Gudmundsson, O. Baldursson (Reykjavík, Iceland)
1762
Room New York 1
Session 211
10:45–12:45
s
Oral Presentation: Management of COPD
es
Chairs: V. Cottin (Lyon, France), K. F. Rabe (Leiden, The Netherlands)
10:45 Prescription of inhaled corticosteroids for COPD in general practice in Denmark – changes after participating
in an educational programme
C. S. Ulrik, K. Roslind, M. K. Jakobsen, G. Hansen, J. Dollerup, M. S. Jensen, E. F. Hansen, K. K. Andersen
(Hvidovre, Aarup, Aarhus, Ballerup, Skive, Lyngby, Denmark)
1763
11:00 Hospital at home for exacerbations of COPD – are doctors and x-rays required?
S. Grundy, S. Mason, M. Evison, S. Murray, D. Weir (Manchester, United Kingdom)
1764
11:15 Effects of a written action plan on COPD exacerbation recovery
E. Bischoff, D. Hamd, A. Benedetti, M. Sedeno, S. Bernard, F. Maltais, J. Bourbeau (Nijmegen, The Netherlands;
Montreal, Sainte-Foy, Canada)
1765
11:30 Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian
multicentre observational study (the COXER study)
ERS Berlin 2008 Annual Congr
I. Cerveri, P. Bortolotti, F. Buonocore, M. Cavazza, M. Frascisco, E. Gatto, S. Grifoni, F. Perlasca, M. Zammataro,
R. Tosatto, L. M. Fabbri (Pavia, Pordenone, Verona, Orbassano, Florence, Varese, Catania, Modena,
228
Bologna, Italy)
1766
M O N D A Y O C T O B E R 6
11:45 COPD exacerbation: resolution of symptoms after starting antibiotic treatment was unaltered by the timing
of therapy but was dependent on baseline gas transfer
K. Vijayasaratha, R. Stockley (Birmingham, United Kingdom)
1767
12:00 Acute exacerbations of COPD: are at-risk patients identified early and managed appropriately?
S. Fong, W. Ahmed, S. Saha, C. Brook, T. Fernandez, P. Raines, A. Choudhury (London, Romford, United
Kingdom)
1768
12:15 A comparison of the management of COPD exacerbations in six European hospitals: demographics and
baseline data
K. Armitage, M. Woodhead, M. Pappalettera, L. Sieske, S. Vila, F. Blasi, S. Ewig, G. Huchon, T. Schaberg, A. Torres,
The European COPD Exacerbation Study Group (Manchester, United Kingdom; Rotenburg, Herne, Bochum,
Germany; Milan, Italy; Barcelona, Spain; Paris, France)
1769
12:30 Long-term treatment with clarithromycin of stage II COPD patients with frequent exacerbations
K. Zykov, A. Rvatcheva, A. Pustovalov, A. Averyanov (Moscow, Russian Federation)
1770
Room New York 2
Session 212
10:45–12:45
E-Communication Session: Mucociliary clearance, novel techniques and
assessments, in adult, paediatric and mechanically ventilated patients
Chairs: E. Main (London, United Kingdom), R. Gosselink (Leuven, Belgium)
E1771 Prone or supine: which is the most beneficial position for thoracoabdominal motion of preterm newborn
recovering from RDS?
T. Oliveira, R. Britto, D. Franca, N. Pereira, L. Vaz, V. Parreira (Belo Horizonte, Brazil)
E1772 Effects of a new chest physiotherapy protocol in infant RSV bronchiolitis. A RCT
G. Postiaux, J. Louis, J. Gerroldt, A. C. Kotik, A. Lemuhot, C. Patte (Charleroi, Belgium)
E1773 Glossopharyngeal breathing in children with spinal muscular atrophy type II
A. Markstrom, M. Nygren-Bonnier, P. Lindholm, E. Mattson, B. Klefbeck (Stockholm, Sweden)
E1774 Evaluation of peripheral muscle strength and resistance in asthmatic female children
F. V. A. Barros, C. M. Jacob, J. Maria Santarem Sobrinho, A. C. Melo, M. Arruda Martins, R. Paula Vieira, C. Ricardo
Fernandes de Carvalho (Sao Paulo, Brazil)
E1775 Demonstrate effects of RP on respiratory function using advanced functional imaging
W. Vos, K. Ides, J. De Backer, E. Boelen, D. Vissers, S. Truijen, W. De Backer (Antwerp, Belgium)
E1776 Computer aided lung sound analysis before and after physiotherapy for mucociliary clearance
A. Marques, A. Bruton, A. Barney, P. White (Southampton, United Kingdom)
E1777 Reliability of computer aided lung sound analysis detecting crackles in bronchiectasis patients – a potential
outcome measure for respiratory physiotherapy
A. Marques, A. Bruton, A. Barney, P. White (Southampton, United Kingdom)
E1778 The impact of physiotherapy interventions on gastroesophageal function in bronchiectasis and COPD
A. Lee, L. Denehy, S. Roberts, R. Stirling, J. Wilson, B. Button (Melbourne, Australia)
E1779 Positive expiratory pressure and lung function in cystic fibrosis patients
V. Parreira, S. Pires, N. Sulmonett, P. Camargos, J. Haddad, R. Britto (Belo Horizonte, Brazil)
E1780 Bone mineral density, body composition, peripheral muscle endurance, and quality of life in cystic fibrosis
M. Bosnak-Guclu, S. Savci, D. Inal-Ince, H. Arikan, M. Saglam, Z. Ozaydin, D. Dogru (Ankara, Turkey)
E1781 Are chest wall vibrations in ventilated patients more effective with ventilator or manual hyperinflation?
R. Stiger, H. Shannon, E. Main (London, Staffordshire, United Kingdom)
E1782 Impact of mechanical ventilation (MV) on the mucociliary system in rabbits
V. Piccin, C. Calciolari, K. Yoshizake, S. Gomes, C. Albertini-Yagi, M. Dolhnikoff, M. Macchione, E. G. Caldini,
E. M. Negri (Sao Paulo, Brazil)
s
E1783 Determination of the best threshold to initiate inspiratory muscle training in mechanically ventilated patients
es
F. Guimaraes, S. Constantino, A. C. Pezzino, M. Coelho, R. Silva, S. Menezes, C. Dias (Rio de Janeiro, Brazil)
E1784 Respiratory effects of three different physiotherapeutic techniques after cardiac surgery
C. Dias, R. Vieira, C. Peixoto, P. Backer, S. Menezes, F. Guimarães (Rio de Janeiro, Brazil)
E1785 Assesment of activity of daily living, quality of life and alexitymia in patient with preoperative coronary artery graft
bypass surgery
Z. Gultekin, N. Duruturk, P. Taskin, E. Gurer, B. Oksar, A. Akgun, S. Ozcobanoglu (Ankara, Turkey)
E1786 The role of physiotherapist in the multidisciplinary team in emergency situation in the Clinical Hospital – Faculty
of Medicine, University of Sao Paulo
C. Stipanich, L. Cunha, S. Aguera, A. Rodrigues, C. Tanaka, J. Torquato, J. Lucato (Sao Paulo, Brazil)
E1787 Effects of sodium chloride high concentrated solution inhalations in patients with chronic non-allergic obstructive
bronchopulmonary diseases
V. Kobylyansky, E. Gamal, T. Petrova, I. Litvinenko, G. Babadzhanova, M. Burmistrova (Moscow, St Petersburg, Russian
Federation)
ERS Berlin 2008 Annual Congr
229
M O N D A Y O C T O B E R 6
Room New York 3
Session 213
10:45–12:45
E-Communication Session: Diagnostic paediatric lung function: technical and
clinical aspects
Chair: E. Lombardi (Florence, Italy)
E1788 Severity of acute RSV bronchiolitis in infants and parental lung function
C. Calogero, M. M. H. Kusel, P. D. Sly (Perth, Australia; Florence, Italy)
E1789 Baseline lung function and bronchodilator response in young children with different wheezing phenotypes
E. Oostveen, S. Dom, K. Desager, W. De Backer, J. Weyler (Antwerp, Belgium)
E1790 Multiple breath washout (MBW): within-test repeatability and short-term reproducibility of FRC and lung
clearance index (LCI) in healthy children and adolescents
S. Fuchs, M. Gappa (Hanover, Germany)
E1791 Evaluation of sleep quality in primary ciliary dyskinesia patients
S. Oktem, A. Caglar, R. Ersu, Z. S. Uyan, F. Karakoc, B. Karadag, I. Akpinar, S. Sirvanci, E. Dagli (Istanbul, Turkey)
E1792 Patterns of early expiration in spirometric testing in preschool children
G. Mesiano, J. Frei, M. Davis, D. Sinks (Montreal, Canada)
E1793 Six-minute walk distance in healthy North African children cannot be predicted using previous reference
equations
H. Ben Saad, C. Prefaut, R. Missaoui, I. Hadj Mohamed, A. Zbidi, Z. Tabka, M. Hayot (Sousse, Tunisia; Montpellier,
France)
E1794 Physiological benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases
B. Fauroux, G. Aubertin, E. Cohen, A. Clement, F. Lofaso (Paris, Garches, France)
E1795 No clinical benefit for the use of respiratory system admittance to measure lung function in young children
S. Straszek, S. Stick, P. Sly, G. Hall (Perth, Australia; Aarhus, Denmark)
E1796 Lung function in bronchopulmonary dysplasia: relationship with age and nutrition status
A. Meneguzzi, M. Sanchez-Solis, M. D. Pastor-Vivero, P. Mondejar-Lopez, J. Valverde-Molina, L. Garcia-Marcos
(Murcia, Santiago de la Ribera, Spain)
E1797 The safety, efficacy and utility of cold air challenge in UK schoolchildren
W. Carroll, C. Ian, B. Phillipa, C. Sadie, L. Warren (Derbyshire, Stoke-on-Trent, United Kingdom)
E1798 Respiratory efficiency in children with differences in oral/nasal respiration and presence of malocclusions
J. Lyszczarz, J. Kalukin, W. Szot (Krakow, Poland)
E1799 Effects of spinal-thoracic deformities on respiratory function in patients with severe cerebral palsy
N. Mori, H. Kurosawa, M. Yosida, A. Hiramoto, N. Chiba, S. Nisiyama, Y. Tasaku, T. Satou, H. Fujii, E. Fukuda
(Yamagata, Sendai, Asahikawa, Japan)
E1800 Respiratory resistance measured by the interrupter technique: feasibility versus spirometry in 7 to 8 years
children
S. Man, S. Tatar, M. Nanulescu (Cluj Napoca, Romania)
E1801 A cardiopulmonary study on thalassemic children: relation to oxidant-antioxidant balance and iron overload
G. Agmy, A. Mohamed, M. Ghanem, H. Makhlouf, N. Abdel-Hafez, T. El-Metwally (Assiut, Egypt)
E1802 Comparison of lung function tests in preschoolers with cystic fibrosis and healthy subjects
E. Hatziagorou, F. Kirvassilis, J. Tsanakas (Thessaloniki, Greece)
Room London 1
Session 214
10:45–12:45
E-Communication Session: Inflammatory trigger mechanisms in asthma and
COPD
s
Chairs: P. Hiemstra (Leiden, The Netherlands), M. Konigshoff (Giessen, Germany)
es
E1803 Glutathione peroxidase-1 differentially controls susceptibility to LPS and cigarette smoke-induced lung
inflammation
R. Vlahos, S. Bozinovski, P. Crack, G. Anderson (Parkville, Australia)
E1804 Special features of cellular contents of induced sputum of patients with bronchial asthma associated with
psycho-emotional stresses
E. Nemerov, V. Bojarko (Tomsk, Russian Federation)
E1805 Acute cigarette smoke induced airway neutrophilia in a mouse model is ROS dependent
D. Rezayat, M. van der Toorn, R. Gras, H. G. de Bruin, A. J. M. van Oosterhout, D. J. Slebos (Groningen, The
Netherlands)
E1806 Inferon efficacy in the treatment of chronic obstructive pulmonary disease
S. Farkhutdinov, U. Farkhutdinov (Ufa, Russian Federation)
E1807 Stability of reference genes in five C57/Bl6 models of lung inflammation
J. H. J. Vernooy, N. E. A. Drummen, A. Haegens, A. Shukla, K. R. Bracke, T. Maes, J. de Wilde, V. Limapassos,
ERS Berlin 2008 Annual Congr
G. F. Joos, G. G. Brusselle, B. T. Mossman, E. F. M. Wouters (Maastricht, The Netherlands; Burlington,
230
United States of America; Ghent, Belgium)
E1808 Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation
E. Pace, M. Ferraro, A. Giarratano, S. Mangione, M. Gjomarkaj (Palermo, Italy)
M O N D A Y O C T O B E R 6
E1809 Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of
metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs
J. Prakash Muyal, A. Plagens, C. Wild, C. Vogelmeier, H. Fehrenbach, C. Seifart (Marburg, Germany)
E1810 Pulmonary mechanics in a mouse model of emphysema: in vivo and in vitro evaluation
T. S. Pinto, H. T. Moriya, P. JC Biselli, A. M. Anciaes, M. Dolhnikoff, F. D. T. Q. S. Lopes, M. A. Martins (Sao Paulo, Brazil)
E1811 iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation
C. Starling, C. Prado, T. Lanças, E. Leick-Maldonado, F. dos Reis, L. Aristóteles, M. Dolhnikoff, M. Martins, I. Tibério
(Sao Paulo, Brazil)
E1812 Chronic L-NAME treatment effects on 8-iso-PGF2
expression in distal lung parenchyma in guinea pigs with
chronic allergic inflammation
P. Angeli, C. Prado, P. Silva, C. Pássaro, H. Nakazato, E. Leick-Maldonado, D. Xisto, M. Martins, P. Rocco, I. Tibério
(Sao Paulo, Rio de Janeiro, Brazil)
E1813 Early administrations of dexamethasone, n-acetylcysteine and aprotinin have beneficial effects on inflammatory
and oxidant-antioxidant status after lung contusion in rats
H. Turut, H. Ciralik, M. Kilinc, D. Ozbag, S. Imrek (Kahramanmaras, Turkey)
E1814 Th2 immune response and respiratory bronchiolitis-associated interstitial lung disease in p66Shc KO smoking
mice
M. Lucattelli, G. De Cunto, B. Lunghi, G. Lungarella (Siena, Italy)
E1815 Systemic inflammation and endothelial dysfunction in patient with bronchial asthma
N. Karoli, A. Rebrov, A. Roshina (Saratov, Russian Federation)
E1816 Influence of active smoking on systemic TNF-
concentration in COPD patients
S. Tanni, A. Angeleli, N. Pelegrino, C. Correa-Camacho, C. Correa, L. Inoue, I. Godoy (Botucatu, Brazil; Seattle,
United States of America)
E1817 Elevation of neutrophil collagenase (MMP-8) and elastase during COPD exacerbation
H. Ilumets, P. Rytilä, A. Sovijärvi, T. Tervahartiala, T. Sorsa, V. Kinnula (Helsinki, Finland)
E1818 Role of low-grade inflammation markers and soluble cell adhesion molecules in patients with chronic obstructive
pulmonary disease
O. Korzh, O. Pavlova (Kharkov, Ukraine)
E1819 Peroxisome proliferator-activated receptor inhibits acrolein-induced airway mucus hypersecretion in rats
X. Wang, W. J. Liu, F. Q. Wen, Y. L. Feng, D. S. Liu (Chengdu, China)
E1820 Pro-inflammatory stimuli affect the production of cytokines and growth factors by human bone marrow-derived
mesenchymal stem cells
S. Zuyderduyn, Y. de Visser, M. van Sterkenburg, H. Roelofs, F. Walther, J. Stolk, P. Hiemstra, G. Wagenaar,
J. Oostendorp (Leiden, The Netherlands)
E1821 Neutrophil number, cytokine and elastase postoperative increase as probable pneumonia predictor
A. Trepakov, L. Romanova, V. Iliyn, L. Makarova, R. Bugrilova (Moscow, Russian Federation)
Room London 2
Session 215
10:45–12:45
E-Communication Session: COPD epidemiology
Chairs: E. Omenaas (Bergen, Norway), L. Carrozzi (Pisa, Italy)
E1822 Gender and its relation to asthma phenotype and comorbidities in difficult-to-control asthma patients from Czech
National Severe Asthma Registry
V. Sedlak, Z. Parakova, B. Kral, V. Koblizek, F. Salajka (Hradec Kralove, Czech Republic)
E1823 Development and pilot testing of a new 7-item cough severity patient reported outcome measure
M. Vernon, N. Leidy, A. Nacson, L. Nelsen (Bethesda, North Wales, United States of America)
E1824 Patients’ knowledge and perception of therapy, and declared behaviours toward inhaled corticosteroids –
s
preliminary results from a community pharmacists study
es
L. Laforest, E. Van Ganse, C. Ritleng, G. Desamericq, L. M. Osman, N. Hoang Thy, G. Chamba, French Council of
Pharmacists (Lyon, Paris, France; Oxford, United Kingdom)
E1825 Repeatability of health economic data in COPD
R. Nielsen, A. Johannessen, H. M. Schnelle, P. S. Bakke, E. R. Omenaas, J. E. Askildsen, A. Gulsvik (Bergen, Norway)
E1826 Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey
L. Laforest, F. Denis, E. Van Ganse, C. Ritleng, C. Saussier, N. Passante, G. Devouassoux, G. Chatté, Y. Pacheco
(Lyon, Reims, Caluire, France)
E1827 Correlates of quality of life in COPD outpatients. Preliminary results from the PRE-SPIRO survey
L. Laforest, F. Denis, E. Van Ganse, C. Ritleng, C. Saussier, N. Passante, G. Devouassoux, G. Chatté, Y. Pacheco
(Lyon, Reims, Caluire, France)
E1828 Mortality figures for chronic obstructive pulmonary disease obtained from death certificates underestimate the
true burden of disease; a five year retrospective analysis
S. Schembri, S. Morant, J. Winter, J. Winter, T. MacDonald (Dundee, United Kingdom)
ERS Berlin 2008 Annual Congr
E1829 Spirometric values in a random population sample and their relation to ERS reference values and COPD criteria
S. Karrasch, J. Behr, K. Ernst, J. Heinrich, R. A. Jörres, D. Nowak, R. M. Huber, H. E. Wichmann, H. Schulz (Munich,
Germany)
231
M O N D A Y O C T O B E R 6
E1830 Prevalence of COPD associate to the PM10 air pollution in the city of Medellin, Colombia
C. Orduz, M. V. Toro, J. C. Gomez (Medellin, Colombia)
E1831 Survey of COPD management among the primary care physicians in Korea – study for the development and
dissemination of the COPD guidelines – clinical research center for chronic obstructive airway disease
M. J. Park, C. W. Choi, S. J. Kim, Y. K. Kim, S. Y. Lee, K. H. Kang, K. C. Shin, K. H. Lee, J. H. Lee, Y. I. Kim, S. C. Lim,
Y. B. Park, K. S. Jung, T. H. Kim, D. H. Shin, J. H. Yoo, H. M. Kang, H. S. Choi, Y. H. Kim (Seoul, Daegu, Kwangju,
Republic of Korea)
E1832 COPD prevalence in Spain in 2007 (EPI-SCAN study results)
M. Miravitlles, J. B. Soriano, L. Munoz, F. Garcia Rio, G. Sanchez, M. Sarmiento, V. Sobradillo, E. Duran-Tauleria,
J. Ancochea (Barcelona, Palma de Mallorca, Cordoba, Madrid, Barakaldo, Spain)
E1833 Gender differences in expression of COPD: a study from western Rajasthan
N. Jain, M. Thakkar, P. Gupta, K. K. Sharma, S. P. Agnihotri (Jaipur, India)
E1834 Prevalence of psychiatric disorders in seriously-ill COPD patients
C. Kuhn, K. Kühl, W. Rief, K. Kenn (Marburg, Schoenau am Koenigssee, Germany)
E1835 COPD management in general practice – the Swiss COPD cohort study
J. D. Leuppi, F. Neubauer, S. Schafroth Török, D. Miedinger, M. Tamm (Basel, Switzerland)
E1836 Detection of COPD in the setting of occupational medicine
G. Prevot, M. Niezborala, L. Tetu, H. Millet, A. Didier (Toulouse, France)
E1837 Risk factors related to chronic respiratory diseases at primary healthcare in Cape Verde
P. Martins, J. Rosado Pinto, N. Neuparth, O. Silva, I. Annesi-Maesano, N. Khaltaev (Lisbon, Portugal; Sao Vicente,
Cape Verde; Paris, France; Geneva, Switzerland)
E1838 Impaired swallowing and cough reflex predispose to chronic obstructive pulmonary disease exacerbations
K. Terada, S. Muro, T. Ohara, A. Haruna, S. Marumo, D. Kinose, M. Kudo, E. Ogawa, Y. Hoshino, A. Niimi, M. Mishima
(Kyoto, Japan)
E1839 Early report on the influence of BMI on lung volume and efficiency of respiratory muscle
F. Ando, F. Arcangeli, M. Santoro, F. Polverino, C. Musolino, G. Navarra, A. Proietto, S. Picciolo, P. Ruggeri, R. Cantile,
G. Girbino (Messina, Cava de Tirreni, Italy)
E1840 Pulmonary embolism in young people: risk factors and clinical presentation
O. V. Fesenko, A. V. Glechikov (Moscow, Russian Federation)
Room London 3
Session 216
10:45–12:45
E-Communication Session: Treatment and outcome in hospitalised patients with
community-acquired pneumonia
Chairs: D. Stolz (Basel, Switzerland), G. Rohde (Bochum, Germany)
E1842 Management and outcomes of lower respiratory tract infection in UK primary care
C. Winchester, T. Macfarlane, M. Thomas, D. Price (Aberdeen, United Kingdom)
E1843 Patients’ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with
community-acquired pneumonia (CAP): results from the CAPO international study
S. Aliberti, P. Peyrani, F. Blasi, P. Tarsia, L. Allegra, J. Ramirez (Milan, Italy; Louisville, United States of America)
E1844 Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-
acquired pneumonia outcomes
V. Dudzevicius, N. Ghazal, R. Ineson, S. Muzaffar, G. Antunes, N. Krishnaraj, S. Murphy (Middlesbrough, United
Kingdom)
E1845 Community-acquired pneumonia in alcohol abuse patients
A. Cervera, E. Fernández-Fabrellas, J. Blanquer, M. L. Briones, F. Sanz, C. Senent, E. Chiner, M. C. Aguar (Valencia,
Spain)
s
es
E1846 Site of care for community-acquired pneumonia (CAP) patients with CRB-65 score of 0-1 and pneumonia severity
index (PSI) risk class (RC) of IV-V: what to do when this discrepancy occurs. Results from the CAPO international
study
P. F. Castellotti, V. Rossetti, S. Aliberti, P. Tarsia, P. Peyrani, F. Blasi, J. Ramirez (Milan, Italy; Louisville, United States of
America)
E1847 Can improved outcomes be achieved when patients with community acquired pneumonia are managed in
accordance with the national guidelines?
R. Parthasarathy, C. Cannon, V. Williams (Grimsby, Swindon, United Kingdom)
E1848 Clinical characteristics and symptoms in older and younger patients with community acquired pneumonia
S. Krueger, C. Schumann, R. Marre, N. Suttorp, T. Welte (Aachen, Ulm, Berlin, Hanover, Germany)
E1849 Pro-atrial natriuretic peptide to predict short-term and long-term mortality in community-acquired pneumonia
S. Krueger, J. Kunde, A. Hanschmann, R. Marre, N. Suttorp, T. Welte (Aachen, Hennigsdorf, Ulm, Berlin, Hanover,
Germany)
E1850 Plasma fibrinogen concentration is an independent marker of severity in patients with community acquired
ERS Berlin 2008 Annual Congr
pneumonia
232
J. Chalmers, A. Singanayagam, M. Murray, A. Hill (Edinburgh, United Kingdom)
M O N D A Y O C T O B E R 6
E1851 Severity of illness score in patients with bacteremic pneumococcal pneumonia: implications for ICU care
C. Feldman, S. Alanee, V. Yu, G. Richards, A. Ortqvist, J. Rello, C. Chiou, M. Wagener, K. Klugman (Pittsburgh, United
States of America; Johannesburg, South Africa; Stockholm, Sweden; Tarragona, Spain)
E1852 CURB-65 score is related to length of stay in community-acquired pneumonia
D. Snijders, C. de Graaff, W. Boersma (Alkmaar, The Netherlands)
E1853 Risk factors of treatment failure of community acquired pneumonia in patients with COPD
U. Sohta, M. Kato, C. Yonemoto, Y. Koshimo, N. Tanabe, K. Miura, S. Goto, M. Kawashima (Kishiwada, Japan)
E1854 Acute myocardial infarction in hospitalized patients with community-acquired pneumonia: results from the CAPO
international cohort study
J. Ramirez, S. Aliberti, M. Mirsaeidi, P. Peyrani, G. Filardo, G. Levy, P. Fernandez, D. Legnani, M. Mateo, M. Bodi,
J. Martinez, F. Blasi, The CAPO Investigators (Louisville, Dallas, United States of America; Milan, Italy; Caracas,
Venezuela; Santiago, Chile; Manila, Philippines; Tarragona, Spain; La Plata, Buenos Aires, Argentina)
E1855 Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired
pneumonia: results from the CAPO international cohort study
M. Mirsaeidi, P. Peyrani, J. Portillo, M. Allen, F. Arteta, J. Porras, J. Roig, E. Rodriguez, M. Rodriguez, J. Ramirez,
The CAPO Investigators (Louisville, United States of America; Barquisimeto, Venezuela; Tarragona, Spain; Escaldes,
Andorra; La Plata, Buenos Aires, Argentina)
E1856 Tigecycline vs levofloxacin for the treatment of community-acquired pneumonia (CAP): EU experience
N. Dartois, N. Castaing, H. Gandjini, G. Dukart, A. Cooper (Paris, France; Collegeville, United States of America)
E1857 A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-
acquired pneumonia: results from the CAPO cohort international study
P. Peyrani, J. Rello, R. Menendez, P. Rossi, A. Torres, F. Blasi, R. Cosentini, C. Luna, C. Feldman, J. Ramirez, The CAPO
Investigators (Louisville, United States of America; Tarragona, Valencia, Barcelona, Spain; Udine, Milan, Italy;
Buenos Aires, Argentina; Johannesburg, South Africa)
E1858 Impact of host status, bacteria and antibiotic therapy on systemic inflammatory response syndrome (SIRS)
development in community-acquired pneumonia (CAP)
F. Sanz, J. Blanquer, E. Fernández, A. Cervera, C. Aguar, E. Chiner, R. Blanquer (Valencia, Spain)
E1859 Fluoroquinolone versus b-lactam plus macrolide in patients hospitalized with community-acquired pneumonia
(CAP)
M. Volpi, S. Aliberti, A. M. Brambilla, R. Cosentini, A. Torri, F. Blasi (Milan, Italy)
E1860 The effect of educational interventions of administering the first dose of antibiotics within 4 hours on community
acquired pneumonia management
J. H. Chung, C. J. Kim, S. M. Lee, C. H. Han (Koyang, Republic of Korea)
E1861 Reasons that justify hospitalization for community-acquired pneumonia (CAP) patients with CURB-65 score 0-1
S. Aliberti, P. F. Castellotti, A. M. Brambilla, R. Cosentini, V. Rossetti, F. Tantardini, P. Tarsia, P. Peyrani, J. Ramirez,
F. Blasi (Milan, Italy; Louisville, United States of America)
ERS Members’ Meetings
Open to ERS Members and interested participants
Session 217
Scientific Assembly and Group Members’ Meetings
12:50–14:40
4 Clinical Physiology and Integrative Biology
Room Paris 1
Hall 6.2-1
Session 218
12:50–14:40
s
Thematic Poster Session: Role of bronchoalveolar lavage in studying the
es
pathophysiology of interstitial lung disease
Chair: V. Poletti (Forli, Italy)
P1862 The impact of age on broncholaveolar lavage (BAL) cytoimmunological results in nonsmoking patients with
interstitial lung diseases (ILD) and in healthy volunteers
P. Kopinski, J. Szczeklik, B. Balicka-Slusarczyk, A. Dyczek, G. Przybylski, A. Rozy, J. Golinska, J. Chorostowska-Wynimko
(Bydgoszcz, Krakow, Warsaw, Poland)
P1863 Effect of cigarette smoking on alveolar macrophages (AM) and lymphocytes (AL) apoptosis in selected interstitial
lung diseases (ILD)
P. Kopinski, B. Balicka-Slusarczyk, G. Przybylski, A. Jarzemska, G. Pinis, J. Garlicki, M. Krawczyk, J. Szczeklik
(Bydgoszcz, Krakow, Poland)
P1864 Clinical implications of CCR5 expression and IL-2 secretion in bronchoalveolar lavage in hypersensitivity
pneumonitis
J. Cemlyn-Jones, S. Freitas, T. M. Alfaro, A. Henriques, I. Silva, A. Paiva, L. Pais, C. Robalo Cordeiro (Coimbra,
ERS Berlin 2008 Annual Congr
Portugal)
233
M O N D A Y O C T O B E R 6
P1865 Induced sputum in interstitial lung diseases; comparison with bronchial wash and BAL
B. Sahin, N. Aksel, A. Mertoglu, A. Ozsoz, N. Yucel (Izmir, Turkey)
P1866 Induced sputum in nonsarcoid interstitial lung diseases; comparison with bronchial wash and BAL
B. Sahin, N. Aksel, A. Mertoglu, A. Ozsoz, N. Yucel (Izmir, Turkey)
P1867 Induced sputum in patients with sarcoidosis; comparison with bronchial wash and bronchoalveolar lavage
B. Sahin, N. Aksel, A. Ozsoz, A. Mertoglu, N. Yucel (Izmir, Turkey)
P1868 Alveolar epithelium in sarcoidosis (S) and hypersensitivity pneumonitis (HP)
Z. Kosjerina, V. Kosjerina Ostric (Sremska Kamenica, Republic of Serbia)
P1869 The diagnostic value of the examination of the tumor markers CYFRA 21-1, NSE, TPA and CEA from the
bronchoalveolar lavage fluid in diffuse pulmonary disorders
V. Lostakova, V. Kolek, M. Kapustova (Olomouc, Czech Republic)
P1870 HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts
M. Faehling, D. Anders, M. Hetzel, V. Hombach, M. Bachem (Esslingen, Stuttgart, Ulm, Germany)
P1871 Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis
factor-
(TNF ) levels as a possible consequence of common TNF receptor type 2 expression
B. Balicka-Slusarczyk, P. Kopinski, J. Chorostowska-Wynimko, K. Sladek, G. Pinis, J. Soja, J. Garlicki, K. Szablowska,
A. Szpechcinski, J. Szczeklik (Krakow, Bydgoszcz, Warsaw, Poland)
P1872 The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients
E. Bargagli, A. Mazzi, F. Mezzasalma, A. Perrone, P. Rottoli (Siena, Italy)
P1873 Increased myeloid dendritic cells in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
M. Tsoumakidou, K. P. Karagiannis, N. Tzanakis, N. Siafakas (Heraklion, Greece)
P1874 Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis is not
associated with difference in expression of fas or fas ligand
F. Drakopanagiotakis, E. Tsiambas, V. Polychronopoulos, A. Karameris, D. Bouros (Athens, Alexandroupolis, Greece)
P1875 Elevated percentage of hemosiderin-laden macrophages in the BAL fluid of patients with diffuse alveolar damage
F. Maldonado, J. Parambil, E. Yi, J. Ryu (Rochester, Cleveland, United States of America)
P1876 Increased Clara cell protein 16 levels in the bronchoalveolar lavage fluid of idiopathic pulmonary fibrosis patients
M. Tsoumakidou, I. Bouloukaki, K. Thimaki, N. Tzanakis, N. Siafakas (Heraklion, Greece)
P1877 Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA
but not in IPF
A. Cui, O. Anhenn, D. Theegarten, S. Ohshimo, F. Bonella, S. U. Sixt, J. Peters, J. Guzman, U. Costabel (Essen,
Bochum, Germany)
P1878 CXCR3 and CCR4 T cells in the follow-up of idiopathic pulmonary fibrosis patients
P. Pignatti, G. Moscato, M. Pisati, M. Vicari, A. Alessandrini, E. Rottoli, S. Nava, G. Brunetti (Pavia, Legnano, Italy)
P1879 Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with
interstitial lung diseases
F. Economidou, K. Antoniou, K. Samara, G. Soufla, C. Choulaki, A. Proklou, I. Politis, D. Moraitaki, N. Tzanakis,
N. Siafakas (Heraklion, Greece)
P1880 Correlation of cytokine gene polymorphisms and BALF cytokine levels in ILD
M. Vasakova, M. Sterclova, L. Kolesar, A. Slavcev, I. Striz, P. Pohunek, J. Sulc (Prague, Czech Republic)
P1881 HRCT-score and markers of fibrosis in BAL in DPLD patients
A. Szlubowski, J. Soja, P. Grzanka, R. Tomaszewska, P. Kopinski, J. Kuzdzal, A. Cmiel, K. Sladek (Zakopane, Krakow,
Bydgoszcz, Poland)
Hall 6.2-2
Session 219
12:50–14:40
Thematic Poster Session: Interstitial lung disease in systemic and vascular
s
disorders
es
Chairs: A. Wells (London, United Kingdom), J. Grutters (Nieuwegein, The Netherlands)
P1882 Pulmonary function testing parameters and exercise capacity in subjects with scleroderma
A. Boutou, P. Siakka, T. Sfetsios, G. Pitsiou, I. Trigonis, E. Serasli, N. Chavouzis, P. Boura, P. Argyropoulou, I.
Stanopoulos (Thessaloniki, Greece)
P1883 Intravenous cyclophosphamide therapy for patients with interstitial pulmonary disease associated with collagen
vascular disorders. A single-center experience
M. Elshazly, A. Shahin, S. Alwakil (Cairo, Egypt)
P1884 Cytomegalovirus antigenemina in idiopathic interstitial pneumonias and collagen vascular disease-related lung
diseases treated with immunosuppressive drugs
T. Arai, Y. Inoue, K. Tachibana, J. Otsuka, K. Tsuyuguchi, S. Minamoto, M. Kitaichi, K. Suzuki, S. Hayashi, M. Oakada,
M. Sakatani (Sakai City, Osaka, Japan)
P1885 Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening
interstitial lung disease associated with systemic sclerosis: a retrospective multicentered open-label study
ERS Berlin 2008 Annual Congr
A. Berezne, B. Ranque, D. Valeyre, M. Brauner, Y. Allanore, D. Launay, J. E. Kahn, L. J. Couderc, C. Joel, E. Hachulla,
234
A. Kahan, J. Cabane, L. Guillevin, L. Mouthon (Paris, Bobigny, Lille, Suresnes, Bordeaux, France)
M O N D A Y O C T O B E R 6
P1886 Interstitial lung disease (ILD) associated with anti-PM/Scl and anti-aminoacyl-tRNA synthetase (ARS)
autoantibodies: a similar condition?
J. C. Lega, V. Cottin, N. Fabien, J. F. Cordier (Lyon, France)
P1887 The prognostic factors of cases with pulmonary involvement of rheumatoid arthritis at first discharge
K. Hashimoto, Y. Hasegawa, A. Yamasaki, N. Burioka, Y. Ueda, H. Nakazaki, T. Igishi, M. Watanabe, E. Shimizu (Tottori,
Japan)
P1888 Rheumatoid arthritis-related lung disease
Y. Tsuchiya, N. Takayanagi, Y. Miyahara, D. Tokunaga, Y. Sugita, H. Sugiura, Y. Kawabata (Saitama, Japan)
P1889 Novel markers of connective tissue disease in patients with idiopathic interstitial pneumonia
H. Gunawardena, Z. Betteridge, P. Owen, N. McHugh, N. Foley (Bath, United Kingdom)
P1890 Study on collagen synthesis related factors in patients with idiopathic interstitial pneumonia
Z. Shu, W. Chen, D. Huaping, P. Baosen, M. Li (Beijing, China)
P1891 Autoantibodies to the surfactant protein D in patients with interstitial lung diseases associated with amyopathic
dermatomyositis and systemic sclerosis
H. Chiba, M. Otsuka, N. Hayashi, K. Kudo, S. Murakami, M. Shiratori, H. Takahashi (Sapporo, Japan)
P1892 Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental
systemic sclerosis
W. R. Teodoro, A. P. Velasa, D. dos Anjos, R. Konno, C. C. de Oliveira, M. L. Katayama, E. R. Parra, N. Yoshinari,
V. L. Capelozzi (Sao Paulo, Brazil)
P1893 Interaction between vascular collagen V and endothelial apoptosis reinforce the vascular pathway in SSC
pathogenesis
E. R. Parra, A. C. Aguiar, Jr., R. Gonçalves, W. R. Teodoro, W. T. de Souza, N. H. Yoshinari, V. L. Capelozzi (Sao Paulo,
Brazil)
P1894 Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and
idiopathic pulmonary fibrosis
A. C. Aguiar, Jr., E. R. Parra, S. D. M. Fernezliam, W. T. de Souza, D. P. Cuentas, V. L. Capelozzi (Sao Paulo, Brazil)
P1895 Anti-a-enolase antibodies in systemic sclerosis identify a subset of patients with diffuse cutaneous sclerosis and
interstitial lung disease
B. Terrier, M. Tamby, L. Camoin, A. Berezne, P. Guilpain, N. Tamas, M. Humbert, G. Simonneau, C. Broussard,
L. Guillevin, L. Mouthon (Paris, Clamart, France)
P1896 Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4)
biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen
vascular disease: a bronchoalveolar lavage fluid study
G. Margaritopoulos, K. Antoniou, G. Soufla, F. Economidou, C. Choulaki, A. Proklou, R. Lymbouridou, I. Lambiri,
N. Tzanakis, N. Siafakas (Heraklion, Greece)
P1897 The prevalence and subtypes of interstitial lung disease in polymyositis and dermatomyositis patients
R. Jenkins, H. Gunawardena, G. Robinson, N. McHugh, N. Foley (Bath, United Kingdom)
P1898 Molecular diagnosis of the inherited disorders of surfactant homeostasis
R. Epaud, R. Aboutaam, L. Jaunard, M. Bahuau, M. Tredano, R. Couderc, J. De Blic, A. Clement, D. Feldmann
(Paris, France)
P1899 Yellow nail syndrome: analysis of 41 consecutive patients
F. Maldonado, H. Tazelaar, W. Chih-Wei, J. H. Ryu (Rochester, Scottsdale, United States of America; Taoyuan, Taiwan,
Republic of China)
P1900 Lenalidomid induced interstitial pneumonitis
S. Györik, J. Feichenfeldt, F. Quadri, E. Lerch (Bellinzona, Switzerland)
P1901 Immunophenotypic profiles of lung carcinomas associated with idiopathic pulmonary fibrosis
M. Chilosi, S. Tomassetti, A. Dubini, A. Cavazza, G. Rossi, M. Kambouchner, A. Cancellieri, M. Barbareschi,
s
S. Damiani, R. Carella, G. Pelosi, B. Murer, V. Poletti (Verona, Forlì, Reggio-Emilia, Modena, Bologna, Trento,
es
Bolzano, Milan, Mestre, Italy; Paris, France)
Hall 6.2-3
Session 220
12:50–14:40
Thematic Poster Session: Acute lung injury and weaning
Chairs: W. Zin (Rio de Janeiro, Brazil), A. Aliverti (Milan, Italy)
P1902 A comparative validation of early predictive indices of hospitalisation in acute severe asthma
A. K. Singh, S. N. Gaur, R. Kumar (New Delhi, India)
P1903 Role of serum procalcitonin in evaluation of sepsis severity among patients in south India
S. Bodi, A. Ahmed, Haseena, Jayasree, Ashok, Bharati, B. Ramulu (Hyderabad/Andhra Pradesh, India)
P1904 The sedation scale for practical use in an intensive care unit
G. Gungor, Z. Karakurt, T. Yarkin, N. Adiguzel, O. Yazicioglu Mocin, D. Ozgul, R. Baran (Istanbul, Turkey)
P1905 Non invasive pressure support ventilation versus proportional assist ventilation in management of acute
ERS Berlin 2008 Annual Congr
hypercapnic respiratory failure
G. Agmy, K. Hussein (Assiut, Egypt)
235
M O N D A Y O C T O B E R 6
P1907 Mortality and epidemiological features of early and late tracheotomy in ICU patients
I. Maia, L. Oliveira, M. Pincelli, A. C. Grumann, C. Jorge (Florianópolis, Brazil)
P1908 New device for continuous and contact-free monitoring of heart and respiratory rates in hospitalized patients
P. Sorkine, N. Adi, R. Cenz, T. Sharon, S. Levkovitch, R. Karasik, A. Averbouch, N. Vulfin, D. Argaman, L. Ardon, G.
Meger, J. Ben-Ari (Tel Aviv, Ramat Gan, Israel)
P1909 Ultrasound-guided pigtail drainage of pleural effusions in critically ill patients
W. Chen, S. J. Liang, W. H. Hsu, C. M. Shih (Taichung, Taiwan, Republic of China)
P1911 Clinical characteristics and outcomes of patients with obstructive sleep apnea requiring intensive care
W. Chen, S. J. Liang, K. L. Chiu, W. H. Hsu, C. M. Shih (Taichung, Taiwan, Republic of China)
P1912 Regional filling capacity in a smoke inhalation lung injury
C. Grant, T. Pham, A. Schibler (South Brisbane, Australia)
P1913 Invasive ventilation in patients with acute respiratory disease: clinial course and in hospital mortality. Data from
the ALKK (Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte) BEAT registry
J. Friedrich, S. Schneider, M. Weber, U. Tebbe, U. Zeymer, R. Zahn, J. Senges, U. Sechtem (Ludwigshafen, Dachau,
Detmold, Stuttgart, Germany)
P1914 Risk factors for ICU acquired pneumonia
K. Verhamme, A. Willemse, I. Demeyer, P. Jordens (Aalst, Belgium)
P1915 Role of continuous tracheal gas insufflation (c-TGI) with protective lung ventilation in respiratory acidosis
T. Rawat, Y. Javeri, R. Mani, S. Bal, R. Uttam, A. K. Mandal, H. Tewari, R. Kumar, N. Singh, D. Nama, P. Pandey, P. Arora
(New Delhi, India)
P1916 Predictors of successful weaning in patients undergoing prolonged mechanical ventilation
S. J. Liang, W. Chen, C. M. Shih, C. Y. Tu, H. J. Chen (Taichung, Taiwan, Republic of China)
P1917 Audit of initial oxygen therapy in COPD patients admitted with exacerbations
S. Tariq, I. Mohammed, A. Noorani (King’s Lynn, United Kingdom)
P1918 Is early detection of acute mountain sickness possible with bioelectric impedance analysis?
C. Eismann, P. Saile, W. Schuette, D. Vinnikov, N. Brimkulov (Halle, Wittenberg, Germany; Bishkek, Kyrgyzstan)
P1919 Is the lung biopsy an useful diagnostic test in pulmonary disease?
Y. Aguilera, J. Fonseca, E. Rivero, G. Dominguez (Mexico City, Mexico)
Hall 6.2-4
Session 221
12:50–14:40
Thematic Poster Session: Mechanical ventilation and airway management
Chairs: C. Gregoretti (Turin, Italy), F. Fanfulla (Pavia, Italy)
P1920 A new early predictive index for hospitalisation in acute exacerbations of asthma
A. K. Singh, S. N. Gaur, R. Kumar (New Delhi, India)
P1921 A one-day prevalence with 28-day follow-up survey of prolonged mechanical ventilation
J. Li, Q. Zhan, C. Wang, Chinese Prolonged Mechanical Ventilation Study Group (Beijing, China)
P1922 A retrospective study comparing early to delayed tracheostomy in acute brain-injured patients
B. Pinheiro, R. Tostes, C. Brum, E. Carvalho, S. P. Pinto, J. Oliveira (Juiz de Fora, Brazil)
P1923 The study of the role of procalcitonin (PCT) in early detection of nosocomial infections in chest patients
E. Ibrahim, A. Al-Gnady, A. Gad, M. Alsawi (Alexandria, Egypt)
P1924 Importance of low-invasive monitoring for prevention of ARDS in patients with severe inhalation injury
M. Tarasenko, S. Petrachkov, A. Samarev (St Petersburg, Russian Federation)
P1925 Frequency of anxiety-depression among chronic obstructive pulmonary disease (COPD) patients with frequent
emergency room admission and home oxygen therapy
D. Tatar, E. Gediktas, S. Ustunsoy, Y. Yildirim, E. Tellioglu, A. K. Cirak, G. Tibet (Izmir, Turkey)
P1926 Percutaneous dilatational tracheostomy in patients undergoing prolonged mechanical ventilation: retrospective
s
analysis of 66 cases
es
C. Kirakli, Z. Asuk, P. Cimen, Z. Ucar, S. Bilaceroglu, C. Emel (Izmir, Turkey)
P1927 Simple, difficult, prolonged weaning: risk factors
Z. Karakurt, T. Yarkin, G. Gungor, O. Yazicioglu Mocin, N. Adiguzel, M. Yalcinsoy, E. Acarturk, R. Baran (Istanbul, Turkey)
P1928 Testing of expired air condensates for prognosis of respiratory complication in surgical patients
T. A. Shumatova, V. B. Shumatov, N. G. Prikhodchenko (Vladivostok, Russian Federation)
P1929 Ventilator associated pneumonia, relationship between risk factors, microbiology and resistance pattern in a
tertiary respiratory center, a retrospective study
M. Malekmohammad, S. M. Hashemian, M. Nayebi, N. Basharzad, H. Emami, H. Jamaati (Tehran, Islamic Republic of
Iran)
P1930 A study of gastro-oesophageal reflux in mechanically ventilated children and its relation to ventilation associated
pneumonia in pediatric intensive care unit
T. Abdel Gawad, M. Hodhod, H. Ibrahim (Cairo, Egypt)
P1931 Importance of neutrophil elastase in pathogenesis of ALI/ARDS: assessment by bronchoscopic microsampling
ERS Berlin 2008 Annual Congr
A. Ishizaka (Tokyo, Japan)
236
P1932 Effects of lateral position and independent lung ventilation on unilateral lung injury in dogs
X. Bu, C. Wang, Z. Cao, B. Pang, S. Wang (Beijing, China)
M O N D A Y O C T O B E R 6
P1933 A cross-sectional study on the volume of air required to inflate endotracheal and tracheal tubes to achieve
minimum adequate cuff pressure
M. Tan, S. Abesamis, C. Macatuno, P. G. Ong, C. M. Campomanes (Metro Manila, Philippines)
P1934 Two-year survival of cases with severe COPD requiring invasive mechanical ventilation and factors affecting
survival
B. Ozbay, S. Asker, S. Ekin, B. Sertogullarindan, H. Yildiz (Van, Turkey)
P1935 Cause and management of massive hemoptysis: five years study from national research institute of lung and
tuberculosis (NRITLD)
P. Adimi Naghan, M. Miri, S. Pejhan, H. Jabari, M. R. Masjedi, R. Eberhart (Tehran, Islamic Republic of Iran;
Heidelberg, Germany)
P1936 Fiberoptic bronchoscopy in diagnosis of tracheobronchial fungal infections: 13 case series with fungal infection in
intensive care unit
Z. Karakurt, F. Aksoy, G. Gungor, O. Yazicioglu Mocin, M. Partal, R. Baran (Istanbul, Turkey)
P1937 CPAP versus BiPAP in acute cardiogenic pulmonary edema: experience with 129 patients
G. Agmy, H. Makhlouf, A. Mohamed, M. Ghanem, H. Mohamed (Assiut, Egypt)
P1938 Diagnosis and severity as predictors of prolonged mechanical ventilation
V. S. Martins, C. Martins, C. Lopes, P. Azevedo, J. Monteiro, F. Monteiro, G. Brum, R. Sotto-Mayor, A. Bugalho de
Almeida (Lisbon, Portugal)
P1939 Inspiratory resistive work as an indicator of progressive lung oedema in a porcine model of acute lung injury
Y. B. Cikirikcioglu, D. Morel (Lausanne, Geneva, Switzerland)
Hall 6.2-5
Session 222
12:50–14:40
Thematic Poster Session: Noninvasive mechanical ventilation in the acute setting
Chairs: B. Schoenhofer (Hanover, Germany), M. W. Elliott (Leeds, United Kingdom)
P1940 Home mechanical ventilation in the post weaning period: long-term results in difficult-to-wean-patients with
COPD
F. Heinemann, F. Roesch, S. Budweiser, M. Pfeifer (Donaustauf, Regensburg, Germany)
P1941 Effect of non-invasive ventilation during exercise on exercise performance in acutely unwell patients with
hypercapnia
C. Menadue, E. Ellis, A. Piper, D. Flunt, J. Alison (Camperdown, Lidcombe, Australia)
P1942 Humidification during non invasive ventilation with helmet
D. Chiumello, V. Berto, M. Botticelli, C. Mietto (Milan, Italy)
P1943 The second national survey of Italian respiratory high dependency units: changes from 1996 to 2006
R. Scala, A. Corrado, M. Confalonieri, N. Ambrosino, M. Gorini, S. Marchese, C. De Michelis, Respiratory Intensive
Care Study Group AIPO (Arezzo, Florence, Trieste, Pisa, Palermo, Imperia, Italy)
P1944 The impact of cardiac morbidity on 30 day survival following COPD exacerbations requiring non-invasive
ventilation (NIV)
V. Osman-Hicks, B. Chakrabarti, S. Agarwal, R. Angus, P. Calverley (Liverpool, Merseyside, United Kingdom)
P1945 Intubation rate in acute cardiogenic pulmonary oedema (ACPE) using prehospital CPAP
A. Jerrentrup, S. Canisius, T. Ploch, W. Cassel, C. Kill, C. Vogelmeier (Marburg, Germany)
P1946 Are outcomes similar for patients with MND starting assisted ventilation as unplanned intubation and elective
NIV?
I. Smith, R. Chadwick, V. Nadig, T. Quinnell, J. Shneerson (Cambridge, United Kingdom)
P1947 Non-invasive ventilation (NIV) in hospital-acquired pneumonia (HAP) of non-ICU COPD patients
S. Avdeev, G. Baimakanova, X. Popova, A. Chuchalin (Moscow, Russian Federation)
P1948 Predicting mortality in acute exacerbation of chronic obstructive pulmonary disease (AECB) treated with non
s
invasive ventilation (NIV) in an emergency department (ED)
es
T. Maraffi, F. Tardini, F. Piffer, A. M. Brambilla, R. Cosentini, S. Aliberti (Milan, Italy)
P1949 Home-NIV in patients with COPD after acute respiratory failure
K. Schild, P. Mindermann, W. Körber, C. P. Crièe (Göttingen, Germany)
P1950 Ward-based non-invasive ventilation can be used to successfully treat severely acidotic patients with an
exacerbation of chronic obstructive pulmonary disease
J. P. Lomas, P. Cadden, T. Duncan (Manchester, United Kingdom)
P1951 Noninvasive mechanical ventilation in patients with end-stage lung
S. Baglioni, E. Scoscia, A. Eslami, C. Iacoacci, O. Penza, M. Dottorini (Perugia, Italy)
P1952 Noninvasive ventilation in routine respiratory care of critical patients at a large university-affiliated hospital: a
prospective cohort study
L. Yamauchi, T. Travaglia, M. Figueiroa, S. Bernardes, C. Fu (Sao Paulo, Sao Caetano do Sul, Brazil)
ERS Berlin 2008 Annual Congr
237
M O N D A Y O C T O B E R 6
Hall 6.2-6
Session 223
12:50–14:40
Thematic Poster Session: Noninvasive ventilation in the chronic setting
Chairs: W. Windisch (Freiburg, Germany), P. Navalesi (Novara, Italy)
P1953 Effect of high and low level pressure support during walking in patients with severe kyphoscoliosis
C. Menadue, J. Alison, A. Piper, C. Hollier, D. Flunt, E. Ellis (Camperdown, Lidcombe, Australia)
P1954 Nutritional intake during NIV therapy
V. Osman-Hicks, A. Hicks, R. Angus, T. Bongers (Liverpool, Merseyside, United Kingdom)
P1955 A novel simple internet-based system for real time monitoring and optimizing home mechanical ventilation
R. Dellaca, L. Govoni, D. Navajas, A. Pedotti, R. Farre (Milan, Italy; Barcelona, Spain)
P1956 Noninvasive positive pressure ventilation (NPPV) as a tool to help tracheal decanulation in children
G. Aubertin, N. Leboulanger, E. N. Garabedian, A. Clement, B. Fauroux (Paris, France)
P1957 The role of nocturnal non-invasive ventilation in pulmonary rehabilitation of COPD patients
T. Köhnlein, U. Schönheit-Kenn, T. Welte, K. Kenn (Hanover, Berchtesgaden, Germany)
P1958 Non invasive domicilary ventilation (NIV) in elderly patients
R. Alonso Moralejo, J. M. Echave-Sustaeta, P. Benavides Mañas, R. Garcia Luján, V. Pérez González, A. López
Encuentra (Madrid, Spain)
P1959 Preventative NIV in spinal muscular atrophy (SMA) type I and II
M. Chatwin, A. Bush, A. Simonds (London, United Kingdom)
P1960 Long-term survival in Charcot Marie tooth disease (CMTD) with non-invasive ventilation (NIV) and continuous
positive airway pressure (CPAP)
P. Molanguri, M. Ali, I. Smith, J. Shneerson (Cambridge, United Kingdom)
P1961 Does the BODE index predict the success of NIPPV in critically ill COPD patients?
M. Michalickova, L. Bajcar, J. Plutinsky, S. Petricek, D. Magula (Nitra, Slovakia)
P1962 Relationship between apnoea and patient triggered breathing in sleep apnoea patients on nocturnal pressure
support
E. M. Williams, A. Cai, A. Kainth, C. Wells, B. V. Prathibha (Ashford, United Kingdom)
P1963 Knowledge of staff managing patients with COPD requiring non-invasive ventilation (NIV)
E. Ballard, L. Mcdonnell, S. Keilty, C. Davidson, N. Hart (London, United Kingdom)
P1964 Noninvasive ventilation (NIV) in the management of chronic heart failure (CHF)
P. Carratu, C. Grigoratos, A. Palumbo, L. Loponte, S. Dragonieri, A. Mallardi, O. Resta (Bari, Italy)
P1965 Bi-level positive airways pressure ventilation (BIPAP) versus continuous positive airway pressure (CPAP) for
treatment of sleep disordered breathing (SDB) in patients with Prader – Willi syndrome (PWS)
A. Petrone, M. Pavone, E. Verrillo, M. G. Paglietti, A. Schiavino, C. Pedace, R. Cutrera (Rome, Italy)
P1966 The situation in Serbia with NIV and why ERS training is important
M. Vukcevic (Belgrade, Republic of Serbia)
P1967 The critical cancer patient: impact of non-invasive mechanical ventilation in palliative care and pulmonary
defense mechanisms
G. Marcon Manfrim, F. C. Almeida Leite Figueiredo, C. S. Albertini Yagi, E. M. Negri (Sao Paulo, Brazil)
P1968 Physiological differences in patients with kyphoscoliosis, post tuberculosis sequelae and obesity hypoventilation
syndrome when starting long-term noninvasive positive pressure ventilation (NPPV)
J. H. Storre, B. Schulte, M. Dreher, W. Windisch (Freiburg, Germany)
P1969 Intentional and unintentional leaks modelization during noninvasive ventilation: a bench test study
L. Achour, V. Leroux, J. F. Muir, A. Cuvelier (Rouen, France)
P1970 Non-invasive ventilation (NIV) practices: a European web-survey
C. Crimi, A. Noto, A. Esquinas, S. Nava (Pavia, Messina, Italy; Murcia, Spain)
s
es
Hall 6.2-7
Session 224
12:50–14:40
Thematic Poster Session: Basic science in asthma and COPD II
Chairs: P. Hiemstra (Leiden, The Netherlands), H. Fehrenbach (Borstel, Germany)
P1971 Expression of muscarinic M5 receptors on tissue lymphocytes and alveolar macrophages in mild and severe
COPD
M. Mori, C. Andersson, L. Bjermer, C. G. Löfdahl, J. Erjefält (Lund, Sweden)
P1972 Structural alterations in childhood asthma are not dependent on eosinophilic inflammation
S. Baraldo, G. Turato, E. Bazzan, S. Agostini, F. Polverino, K. Lokar-Oliani, B. Nordio, A. Ballarin, F. Calabrese,
C. Panizzolo, A. Barbato, R. Zuin, M. Saetta (Padova, Cava de Tirreni, Italy)
P1973 Cigarette smoke significantly reduces proliferation and modulates the expression levels of CEBP
and CEBPb in
cultured human lung fibroblasts
N. Miglino, M. Roth, M. Tamm, P. Borger (Basel, Switzerland; Sydney, Australia)
ERS Berlin 2008 Annual Congr
P1974 Endogenous indoleamine 2,3-dioxygenase activity reduces local inflammatory cell numbers
K. van der Sluijs, K. van Gisbergen, R. Lutter (Amsterdam, The Netherlands)
238
M O N D A Y O C T O B E R 6
P1975 Ultrastructure analysis of airway smooth muscle cells in fatal asthma
B. Araújo, E. Caldini, L. F. Silva, C. Seow, V. Peinado, M. Dolhnikoff, T. Mauad (Sao Paulo, Brazil; Vancouver, Canada;
Barcelona, Spain)
P1976 Increased proportion of Fas positive T-cells in never smoking patients with COPD
J. Domagala-Kulawik, M. Dabrowska, G. Hoser, R. Rubinsztain, A. Doboszynska, R
